附录2 2021年PCT国际专利申请统计分析报告

附录2.7 各技术领域的PCT专利申请状况

附录2.7.5 药物和家庭日用化学品领域的PCT专利申请状况

第5个技术领域是药物和家庭日用化学品，主要包括医用配置品和药物制剂，以及盥洗、梳妆和化妆等家庭日用化学品。2021年，该领域的PCT专利申请总计12906项（增长率为6.1%），占总申请量的4.9%，是申请量第1多的领域。

2021年，中国局在药物和家庭日用化学品领域上申请PCT专利1236项，占该领域申请量的9.6%。美国局在该领域上申请专利5256项，份额为40.7%。日本局申请专利1180项，份额为9.1%。欧洲局申请专利2195项，份额为17%。

附表2.7.5-1 2021年药物和家庭日用化学品领域各专利局的PCT专利申请数量

	专利局	申请数量	占本局比例	占领域比例
1	中国	1236	1.8%	9.6%
2	美国	5256	9.4%	40.7%
3	日本	1180	2.5%	9.1%
4	欧洲	2195	5.9%	17.0%
5	韩国	742	4.0%	5.7%
6	国际	862	6.9%	6.7%
7	英国	271	7.9%	2.1%
8	法国	85	3.4%	0.7%
9	加拿大	113	6.1%	0.9%
10	澳大利亚	126	8.2%	1.0%
11	土耳其	152	10.6%	1.2%
12	德国	10	0.7%	0.1%
13	以色列	152	10.9%	1.2%
14	瑞典	24	1.9%	0.2%
15	其他	502	--	3.9%
	小计	12906	--	100%

注：本表按照提交PCT国际专利申请的专利局进行统计。

附图2.7.5-1 2021年药物和家庭日用化学品领域各专利局的PCT专利申请数量对比

2021年，在药物和家庭日用化学品领域上PCT专利申请最多的机构是欧莱雅、加州大学、株式会社资生堂。

附表2.7.5-2 2021年药物和家庭日用化学品领域的PCT国际专利申请前10机构

	机构名称	国家	机构英文名称	2021
1	欧莱雅	法国	L'OREAL	187
2	加州大学	美国	THE REGENTS OF THE UNIVERSITY OF CALIFORNIA	142
3	株式会社资生堂	日本	SHISEIDO COMPANY, LTD.	91
4	联合利华知识产权控股私人有限公司	荷兰	UNILEVER IP HOLDINGS B.V.	88
5	汉高股份有限及两合公司	德国	HENKEL AG & CO., KGAA	85
6	宝洁公司	美国	THE PROCTER & GAMBLE COMPANY	72
7	法国国家健康与医学研究院	法国	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)	67
8	花王株式会社	日本	KAO CORPORATION	65
9	拜尔斯道夫公司	德国	BEIERSDORF AG	64
10	诺华公司	瑞士	NOVARTIS AG	58

注：本表数据按照第一申请人进行统计。

附图2.7.5-2 2021年药物和家庭日用化学品领域的PCT国际专利申请前10机构

致谢

感谢大连理工大学刘则渊教授、河南师范大学梁立明教授、科技部中国科学技术发展战略研究院武夷山研究员、大连理工大学丁堃教授、大连理工大学杨中楷教授对本报告的大力支持与帮助。同时，向以不同形式对本报告提出意见和建议的专家学者们表示诚挚的感谢。

如需要中美欧日韩五局及PCT专利数据、专利报告，以及咨询相关专利问题请添加微信号。

微信号：chenlixinip5

附表 2021年该领域PCT国际专利申请

ID	Title	Applicant
WO/2021/087536	DENTAL FLOSS	LENZING PLASTICS GMBH & CO KG
WO/2021/159155	COMPOSITION	BENTSEN, Paal
WO/2021/222964	IMMUNOGENIC COMPLEXES AND METHODS OF PRODUCING AND USING THE SAME	ESS HOLDING GMBH
WO/2021/222965	MANNOSE-BINDING LECTIN FOR TREATMENT OR PROPHYLAXIS OF INFECTIOUS DISEASES	ESS HOLDING GMBH
WO/2021/000004	METHODS OF TREATING MYOCARDITIS AND/OR CARDIOMYOPATHY AND REAGENTS THEREFOR	CELLMID LIMITED
WO/2021/051149	BIODEGRADABLE DRUG-POLYMER CONJUGATE	POLYACTIVA PTY LTD
WO/2021/051151	ORAL HEALTH IMPROVING PRODUCTS	YNDK PTY. LTD.
WO/2021/051153	PROTEIN PARTICLES COMPRISING A DIPHTHERIA TOXIN CROSS REACTING MATERIAL (CRM) AMINO ACID SEQUENCE AND USES THEREOF	GRIFFITH UNIVERSITY
WO/2021/056048	THERAPEUTIC FORMULATIONS AND USES THEREOF	BIONOMICS LIMITED
WO/2021/016652	METHODS AND COMPOSITIONS FOR MONITORING, TREATING AND PREVENTING CMV INFECTION OR GRAFT REJECTION USING γδ T-CELLS	THE UNIVERSITY OF MELBOURNE
WO/2021/127722	PHARMACEUTICAL COMPOSITIONS	PROTA THERAPEUTICS PTY LTD
WO/2021/174284	COMBINATION TREATMENT FOR MICROORGANISMS	THE UNIVERSITY OF ADELAIDE
WO/2021/000013	COMPOSITIONS AND METHODS OF USE	THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH
WO/2021/000024	METHODS AND AAV VECTORS FOR <i>IN VIVO</i> TRANSDUCTION	CHILDREN'S MEDICAL RESEARCH INSTITUTE
WO/2021/007610	INJECTABLE NUTRITIONAL SUPPLEMENT	CHEMVET AUSTRALIA PTY LTD
WO/2021/003531	PEPTIDES AND USES THEREOF	LATERAL IP PTY LTD
WO/2021/003535	METHOD FOR GUT MUCOSA PREPARATION TO ENHANCE MICROBIAL ENGRAFTMENT	MILIS, Antony
WO/2021/007618	IMMUNO-ONCOLOGY THERAPY USING ISOFLAVONE COMPOUNDS	NOXOPHARM LIMITED
WO/2021/007623	COMPOSITIONS FOR MAINTAINING OR MODULATING MIXTURES OF ETHER LIPID MOLECULES IN A TISSUE OF A HUMAN SUBJECT	BAKER HEART AND DIABETES INSTITUTE
WO/2021/016663	KLF INDUCED CARDIOMYOGENESIS	VICTOR CHANG CARDIAC RESEARCH INSTITUTE
WO/2021/016668	IMMUNOCONJUGATE	DENDROCYTE BIOTECH PTY LTD
WO/2021/022336	COMPOSITIONS OF PROBIOTICS AND BIOMASS AND METHODS FOR PROMOTING HEALTH IN A SUBJECT	COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
WO/2021/022340	USES OF LONG-CHAIN POLYUNSATURATED FATTY ACIDS	SWINBURNE UNIVERSITY OF TECHNOLOGY
WO/2021/030867	METHOD OF MODULATING ADIPOSITY	BAKER HEART AND DIABETES INSTITUTE
WO/2021/035289	THERAPEUTIC METHODS AND USES THEREOF	EUSTRALIS PHARMACEUTICALS LIMITED (TRADING AS PRESSURA NEURO)
WO/2021/035310	TARGETED DENDRIMER CONJUGATES	STARPHARMA PTY LTD
WO/2021/042171	CANCER IMMUNOTHERAPY	ENA THERAPEUTICS PTY LTD
WO/2021/042174	CANCER TREATMENT	ENA THERAPEUTICS PTY LTD
WO/2021/042178	TREATMENT OF OPIOID WITHDRAWAL	KINOXIS THERAPEUTICS PTY LTD
WO/2021/056051	METHOD AND COMPOSITION FOR THE TREATMENT OF DISEASE	DIMERIX BIOSCIENCE PTY LTD
WO/2021/051172	LIPID PRODRUGS OF CELECOXIB AND USES THEREOF	MONASH UNIVERSITY
WO/2021/056053	SILICONE DROPLETS	FORMULAE 8 PTY LTD
WO/2021/056056	PHARMACEUTICAL COMPOUNDS AND METHODS OF USE	DERMCARE-VET PTY LTD
WO/2021/056064	TREATMENT OF TAUOPATHIES	MACQUARIE UNIVERSITY
WO/2021/056071	TREATMENT OF DEMENTIA	MACQUARIE UNIVERSITY
WO/2021/056072	TREATMENT OF EXCITOTOXICITY-RELATED CONDITIONS	MACQUARIE UNIVERSITY
WO/2021/056077	THERAPEUTIC DENDRIMER	STARPHARMA PTY LTD
WO/2021/062472	MEDICINAL COGNITIVE TREATMENTS	ACTINOGEN MEDICAL LIMITED
WO/2021/062481	COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF TRAUMATIC BRAIN INJURY	INCANNEX HEALTHCARE LIMITED
WO/2021/077162	MODULATION OF CELLULAR VIABILITY	MACQUARIE UNIVERSITY
WO/2021/077166	CONTRAST AGENTS	MONASH UNIVERSITY
WO/2021/077174	METHODS OF TREATING CANCER USING ANDROGEN RECEPTOR ANTAGONISTS	GARVAN INSTITUTE OF MEDICAL RESEARCH
WO/2021/081580	TREATMENT OF RENAL CYSTIC DISEASE	MONASH UNIVERSITY
WO/2021/081581	ANTIBODIES FOR BINDING PLASMINOGEN	MONASH UNIVERSITY
WO/2021/097537	MAGNETIC TRACER COMPOSITIONS	FERRONOVA PTY LTD
WO/2021/097538	BONE FORMATION	THE UNIVERSITY OF SYDNEY
WO/2021/097540	IMMUNOSTIMULATORY COMPOSITIONS COMPRISING SOLUBLE PARASITE EXTRACTS AND USES THEREOF	GRIFFITH UNIVERSITY
WO/2021/102508	METHODS OF TREATING HIV-1 INFECTION	BIOTRON LIMITED
WO/2021/102510	METHODS AND PRODUCTS FOR REDUCING SIDE EFFECTS ASSOCIATED WITH USE OF IMMUNE AGONIST ANTIBODIES	SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE LIMITED
WO/2021/102513	LEGIONELLA TREATMENT USING CANNABINOIDS	BOTANIX PHARMACEUTICALS LIMITED
WO/2021/102514	MORAXELLA TREATMENT USING CANNABINOIDS	BOTANIX PHARMACEUTICALS LIMITED
WO/2021/102515	ANTIBACTERIAL TREATMENT USING A CANNABINOID AND AN ACTIVE AGENT	BOTANIX PHARMACEUTICALS LIMITED
WO/2021/102516	NEISSERIA TREATMENT USING CANNABINOIDS	BOTANIX PHARMACEUTICALS LIMITED
WO/2021/108853	POLYMER NANOPARTICLES	THE UNIVERSITY OF QUEENSLAND
WO/2021/108855	NEUROLOGICALLY ACTIVE FLAVONOID COMPOSITIONS AND METHODS OF USE THEREOF	GRETALS AUSTRALIA PTY LTD
WO/2021/108861	TREATMENT OF NEURODEGENERATIVE DISEASES USING ULTRASOUND AND AMYLOID-BETA ANTIBODIES	THE UNIVERSITY OF QUEENSLAND
WO/2021/108867	METHODS OF ACTIVATING CYTOTOXIC LEUKOCYTES USING PTP1B AND PTPN2 INHIBITORS	MONASH UNIVERSITY
WO/2021/108868	ANTIGEN LOADING	DENDROCYTE BIOTECH PTY LTD
WO/2021/113912	THERAPEUTIC COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF DIASTOLIC DYSFUNCTION	AMBETEX PTY LTD
WO/2021/113914	THERAPEUTIC COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF DIASTOLIC DYSFUNCTION	AMBETEX PTY LTD
WO/2021/113917	THERAPEUTIC COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF DIASTOLIC DYSFUNCTION	AMBETEX PTY LTD
WO/2021/113926	BOTULINUM TOXIN FORMULATIONS AND METHODS FOR INTRANASAL DELIVERY THEREOF FOR THE TREATMENT OF ALLERGIC RHINITIS	BARBAGALLO, Francesco
WO/2021/119749	TREATMENT OF GASTROINTESTINAL DISEASE	THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/127736	ALLERGY TREATMENT	PROTA THERAPEUTICS PTY LTD
WO/2021/127749	COMPOSITIONS COMPRISING TERPENES AND THEIR USE IN THE TREATMENT OR ALLEVIATION OF PAIN OR ANXIETY	CANNADOL PHARMACEUTICALS LTD
WO/2021/127752	CYCLIC PEPTIDE RECEPTOR LANTHIONINE SYNTHETASE C-LIKE PROTEIN (LANCL) AND USES THEREOF	LATERAL IP PTY LTD
WO/2021/222967	TREATMENT OF PROLIFERATIVE DISEASES OF THE CNS	AUCENTRA THERAPEUTICS PTY LTD
WO/2021/237270	METHOD OF TREATING LEUKAEMIA	ST VINCENT'S HOSPITAL SYDNEY LIMITED
WO/2021/138721	SELF-ASSEMBLING, SELF-ADJUVANTING SYSTEM FOR DELIVERY OF VACCINES	THE UNIVERSITY OF QUEENSLAND
WO/2021/142513	COMPOSITIONS AND METHOD	MONASH UNIVERSITY
WO/2021/142514	COMPOSITIONS AND METHODS	MONASH UNIVERSITY
WO/2021/142516	ORAL PEPTIDE ADMINISTRATION	THE UNIVERSITY OF SYDNEY
WO/2021/151156	DRUG DELIVERY DEVICE	SIDERIS, Anders William James
WO/2021/151168	METHOD OF CANNABINOID THERAPY	AUSCANN GROUP HOLDINGS LTD
WO/2021/151169	CANNABINOID COMPOSITION AND MANUFACTURING METHOD	AUSCANN GROUP HOLDINGS LTD
WO/2021/155427	COMPOSITION AND METHOD	SNORETOX PTY LTD
WO/2021/155443	PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING OR PREVENTING CORONAVIRUS INFECTION	CENTRE FOR DIGESTIVE DISEASES PTY LIMITED
WO/2021/159187	METHOD OF TREATMENT USING META-ARSENITE	KOMIPHARM INTERNATIONAL AUSTRALIA PTY LTD
WO/2021/168516	METHODS OF TREATMENT AND RELATED COMPOSITIONS	ASCEND BIOPHARMACEUTICALS LTD
WO/2021/168518	S1P RECEPTOR MODULATORS	AKAAL PHARMA PTY LTD
WO/2021/179047	TREATMENT FOR CORONAVIRUS INFECTION AND ASSOCIATED CYTOKINE TOXICITY	CULLIS-HILL, Sydney David
WO/2021/179050	VIRAL INHIBITION	MONASH UNIVERSITY
WO/2021/184059	TREATMENT METHODS	NEWSOUTH INNOVATIONS PTY LIMITED
WO/2021/195691	METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING AN INFLAMMATORY CONDITION	INCANNEX HEALTHCARE LIMITED
WO/2021/184062	COMPOSITIONS FOR TREATING RESPIRATORY TRACT INFECTION AND USES THEREOF	LATERAL IP PTY LTD
WO/2021/184070	ANTIVIRAL COMPOSITION FOR ORAL CARE	ADVANCE NANOTEK LTD.
WO/2021/189109	QUERCETIN ENHANCEMENT FORMULATION	SMARTDNA PTY LTD
WO/2021/195694	ATTENUATED POXVIRUS VECTOR BASED VACCINE FOR PROTECTION AGAINST COVID-19	SEMENTIS LIMITED
WO/2021/195698	METHODS FOR THE TREATMENT OF INFLAMMATION ASSOCIATED WITH INFECTION	NOXOPHARM LIMITED
WO/2021/195703	COMBINATION THERAPY FOR INFLAMMATORY BOWEL DISEASE	SERVATUS LTD
WO/2021/195706	NEW DYNAMIN INHIBITORS AND USES	CHILDREN'S MEDICAL RESEARCH INSTITUTE
WO/2021/243396	THERAPEUTIC METHODS OF USING CD 14 ANTAGONISTIC ANTIBODIES IN TREATING CONDITIONS ASSOCIATED WITH A CORONAVIRUS INFECTION INCLUDING SARS-COV-2 (COVID-19)	IMPLICIT BIOSCIENCE LIMITED
WO/2021/195723	METHODS FOR TREATMENT OF CORONAVIRUS INFECTIONS	THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/203168	TREATMENT FOR SEPSIS-INDUCED ORGAN DYSFUNCTION	THE FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH
WO/2021/203174	TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) WITH POLYSULFATED POLYSACCHARIDES	PARADIGM BIOPHARMACEUTICALS LTD
WO/2021/207790	METHOD OF PROPHYLAXIS OF CORONAVIRUS AND/OR RESPIRATORY SYNCYTIAL VIRUS INFECTION	STARPHARMA PTY LTD
WO/2021/207801	IMMUNE CELLS WITH ENHANCED FUNCTION	THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCH
WO/2021/212168	METHODS AND COMPOSITIONS	MONASH UNIVERSITY
WO/2021/212181	METHODS AND COMPOSITIONS FOR TREATING FUNGAL INFECTIONS	NEOCULI PTY LTD
WO/2021/212183	PRODUCTS OF MANUFACTURE AND METHODS FOR TREATING, AMELIORATING OR PREVENTING MICROBIAL INFECTIONS	CENTRE FOR DIGESTIVE DISEASES PTY LIMITED
WO/2021/217221	PREVENTING AND TREATING VIRAL INFECTIONS	MUCPHARM PTY LTD
WO/2021/222971	TREATMENT FOR VIRUS INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME	DIMERIX BIOSCIENCE LTD
WO/2021/222972	TREATMENT FOR ACUTE RESPIRATORY DISTRESS SYNDROME	DIMERIX BIOSCIENCE LTD
WO/2021/222987	COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND TREATMENT OF FIBROTIC AND INFLAMMATORY CONDITIONS	GRETALS AUSTRALIA PTY LTD
WO/2021/222988	CELL ENTRY-MODULATING AGENTS AND USES THEREFOR	GRIFFITH UNIVERSITY
WO/2021/226662	USE OF AMINOACETONITRILE COMPOUNDS FOR THE TREATMENT OF INFECTION AND DISEASE	PITNEY PHARMACEUTICALS PTY LIMITED
WO/2021/226664	A HEPATITIS C NUCLEIC ACID VACCINE COMPRISING A VARIABLE DOMAIN DELETED E2 POLYPEPTIDE	MACFARLANE BURNET INSTITUTE FOR MEDICAL RESEARCH AND PUBLIC HEALTH LIMITED
WO/2021/226672	METHODS AND COMPOSITIONS FOR ATI DIGESTION	GLUTAGEN PTY LTD
WO/2021/226677	TREATMENT OF THROMBOSIS AND ASSOCIATED DISORDERS WITH AN ANTI-PLATELET AGENT.	THE HEART RESEARCH INSTITUTE LTD
WO/2021/237273	METHODS OF TREATING PULMONARY FIBROSIS	AMPLIA THERAPEUTICS PTY LTD
WO/2021/232094	HEDGEHOG SIGNALING -DEPENDENT CANCER TREATMENT	HUDSON INSTITUTE OF MEDICAL RESEARCH
WO/2021/237291	TREATMENT OF CORONAVIRUS	AXELIA ONCOLOGY PTY LTD
WO/2021/237295	CELL HARVEST METHOD	THE UNIVERSITY OF MELBOURNE
WO/2021/237297	ANTI-VIRAL EXTRACELLULAR VESICLES, THEIR METHODS OF PREPARATION AND USES	EXOPHARM LIMITED
WO/2021/237299	METHODS OF ANTIPATHOGENIC TREATMENT	CROFT INFRASTRUCTURE DESIGNS PTY LTD
WO/2021/243399	METHODS FOR TREATING MAJOR DEPRESSIVE DISORDER AND TREATMENT-RESISTANT DEPRESSION	IX BIOPHARMA LIMITED
WO/2021/243410	ANTI-MICROBIAL AND ANTI-INFLAMMATORY COMPOSITION COMPRISING ARTHROSPIRA EXTRACTS AND AN ORGANIC ACID	BIOVITE AUSTRALIA PTY LTD
WO/2021/243415	THERAPEUTIC CONJUGATES	STARPHARMA PTY LTD
WO/2021/243417	IMMUNOGENIC FORMULATIONS	CENTENARY INSTITUTE OF CANCER MEDICINE AND CELL BIOLOGY
WO/2021/243424	METHOD OF TREATING OR PREVENTING ACUTE RESPIRATORY DISTRESS SYNDROME	CSL INNOVATION PTY LTD
WO/2021/248189	COMPOUND FOR PREVENTION OR TREATMENT OF A SKIN CANCER OR SKIN PRECANCER	UNIQUEST PTY LTD
WO/2021/248196	IMPROVED VIRUCIDAL FORMULATIONS	FIREBRICK PHARMA LIMITED
WO/2021/248207	COMPOSITION AND METHOD FOR TREATING CHRONIC PAIN	ZELIRA THERAPEUTICS OPERATIONS PTY LTD
WO/2021/248210	TREATMENT METHODS AND FORMULATIONS	CURTIN UNIVERSITY
WO/2021/253087	NOVEL ANTIBACTERIAL HYDROGELS	NEWSOUTH INNOVATIONS PTY LIMITED
WO/2021/253098	AMIDO COMPOUNDS	ANAXIS PHARMA PTY LTD
WO/2021/258140	CD83 BINDING PROTEIN CONJUGATES FOR TREATING LYMPHOMA	KIRA BIOTECH PTY LIMITED
WO/2021/258150	METHODS OF TREATING OR PREVENTING ORGANOPHOSPHORUS POISONING	LACHESIS BIOSCIENCES LIMITED
WO/2021/258159	HALOALLYLAMINE DUAL AMINE OXIDASE INHIBITORS	PHARMAXIS LTD.
WO/2021/258163	LIQUID DISPERSIBLE CURCUMINOID COMPOSITIONS AND METHODS OF IMPROVING COGNITIVE FUNCTION	PHARMAKO BIOTECHNOLOGIES PTY LTD
WO/2021/168522	METHOD FOR OBTAINING OF AN ANTITUMOR COMPOSITION, AN ANTITUMOR COMPOSITION AND ITS USE	HADJIEVA, Nasya Spartakova
WO/2021/007626	ORAL MEDICATION FOR TREATING LIPOEDEMA	BENITTI, Daniel Augusto
WO/2021/016679	ANHYDROUS SUNSCREEN COMPOSITION COMPRISING SILICA AEROGEL	L'OREAL
WO/2021/016680	ANHYDROUS SUNSCREEN COMPOSITION COMPRISING SILICA AEROGEL	L'OREAL
WO/2021/016682	ANHYDROUS COSMETIC COMPOSITION WITH HIGH CONCENTRATION OF HYDROPHOBIC FILLERS AND USE THEREOF FOR REDUCING SKIN LESIONS AND OILINESS	L'OREAL
WO/2021/016683	ANHYDROUS ANTIPERSPIRANT AND DEODORANT COMPOSITION, PROCESS FOR ITS PRODUCTION AND USE THEREOF	L'OREAL
WO/2021/016684	COSMETIC COMPOSITION, PROCESS FOR MANUFACTURING THE COSMETIC COMPOSITION AND ITS USE	L'OREAL
WO/2021/022344	COSMETIC COMPLEX FOR MOISTURIZING SKIN, USE OF THE COSMETIC COMPLEX, COSMETIC COMPOSITION AND SKIN MOISTURIZING METHOD	NATURA COSMéTICOS S.A.
WO/2021/022345	TOPICAL COSMETIC COMPOSITION, USE OF THE COMPOSITION AND TONIC FOR FACIAL APPLICATION	NATURA COSMéTICOS S.A.
WO/2021/022346	TOPICAL COSMETIC COMPOSITION, USE OF THE COMPOSITION AND SERUM FOR FACIAL APPLICATION	NATURA COSMéTICOS S.A.
WO/2021/022347	TOPICAL COSMETIC COMPOSITION, USE OF THE COSMETIC COMPOSITION AND MASK FOR FACIAL APPLICATION	NATURA COSMéTICOS S.A.
WO/2021/046622	NATURAL SILICONE REPLACEMENT COMPOSITION, PRODUCTION METHOD AND USE THEREOF	MAIAN INDUSTRIA DE PRODUTOS QUIMICOS LTDA
WO/2021/056086	ORAL-HEALTH COMPOSITION AND PREPARATION METHOD FOR ORAL-HEALTH COMPOSITION	MMF&T DESENVOLVIMENTO TECNOLóGICO E INOVAÇÃO LTDA.
WO/2021/119770	COSMETIC COMPOSITION FOR A KERATIN SUBSTANCE, PROCESS FOR MANUFACTURING A COSMETIC COMPOSITION AND USE OF THE COSMETIC COMPOSITION	L'OREAL
WO/2021/119771	COSMETIC COMPOSITION, PROCESS OF MANUFACTURING THE COSMETIC COMPOSITION AND USE OF THE COSMETIC COMPOSITION	L'OREAL
WO/2021/134118	COSMETIC COMPOSITION COMPRISING A FATTY AMINE, A FATTY ALCOHOL, A VEGETABLE FAT, A CATIONIC SURFACTANT AND A SILICONE CROSS-POLYMER FOR USE IN HAIR CARE	L'OREAL
WO/2021/151174	ORAL COMPOSITION WITH SYNERGISTIC ASSOCIATION OF ORGANIC AND INORGANIC COMPONENTS FOR COMPLETE MAINTENANCE OF ORAL HEALTH, METHOD FOR OBTAINING SAME AND USES	VILHENA, Fabiano Vieira
WO/2021/151177	COSMETIC COMPOSITION, USE OF A COSMETIC COMPOSITION, PROCESS FOR THE PREPARATION OF A COSMETIC COMPOSITION AND METHOD FOR STYLING THE HAIR	L'OREAL
WO/2021/203180	HAIR COSMETIC COMPOSITION AND PROCESS FOR SHAPING OR ALTERING THE SHAPE OF THE HAIR	L'OREAL
WO/2021/217225	HAIR CARE COSMETIC COMPOSITION, METHOD FOR TREATING AND/OR SHAPING HAIR, AND PROCESS FOR MANUFACTURING A HAIR CARE COSMETIC COMPOSITION	L'OREAL
WO/2021/072514	COMPOSITION, USE OF A COMBINATION OF SILVER NANOPARTICLES AND OF A NITRIC OXIDE DONOR, PHARMACEUTICAL KIT FOR TREATING CANCER, AND METHOD FOR TREATING CANCER	FUNDAÇÃO UNIVERSIDADE FEDERAL DO ABC -UFABC
WO/2021/237317	ANTIPERSPIRANT COMPOSITION, PROCESS FOR ITS PRODUCTION AND USE THEREOF	L'OREAL
WO/2021/237318	COSMETIC COMPOSITION COMPRISING UNSATURATED DIOIC ACID AND USES THEREOF	L'OREAL
WO/2021/000037	METHOD FOR OBTAINING BIOACTIVE INGREDIENTS, USE OF SUBCRITICAL-WATER EXTRACTION PROCESS, BIOACTIVE INGREDIENT, USE OF BIOACTIVE INGREDIENT AND COSMETIC COMPOSITION	NATURA COSMéTICOS S.A.
WO/2021/003543	IMMUNOMODULATORY COMPOUNDS AND/OR THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PHARMACEUTICAL COMPOSITION INCLUDING IMMUNOMODULATORY COMPOUNDS AND USE OF IMMUNOMODULATORY COMPOUNDS IN THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRAL DISEASES	UNIVERSIDADE ESTADUAL DE CAMPINAS
WO/2021/007635	PROCESS FOR OBTAINING A FREEZE-DRIED COMPOSITION OF CHITOSAN-BASED NANOPARTICLES CONTAINING BROMELAIN, FREEZE-DRIED COMPOSITION OF CHITOSAN-BASED NANOPARTICLES CONTAINING BROMELAIN AND USE IN THE TREATMENT OF WOUNDS	UNIVERSIDADE ESTADUAL DE CAMPINAS
WO/2021/012028	HAIR TREATMENT COMPOSITION, METHOD FOR OBTAINING SAME, USE OF THE COMPOSITION AND HAIR TREATMENT METHOD	CHEMYUNION LTDA
WO/2021/207806	LONG-LASTING REABSORBABLE SUBCUTANEOUS IMPLANT WITH CONTROLLED RELEASE OF PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE SUBSTANCE IN POLYMER FOR THE TREATMENT OF ENDOMETRIOSIS	LUIZ PERACCHI, Edson
WO/2021/237321	LONG-LASTING REABSORBABLE SUBCUTANEOUS IMPLANT WITH SUSTAINED RELEASE OF PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE SUBSTANCE IN POLYMER FOR THE TREATMENT OF CHRONIC ADRENAL INSUFFICIENCY OR HYPOCORTISOLISM	LUIZ PERACCHI, Edson
WO/2021/237322	LONG-LASTING REABSORBABLE SUBCUTANEOUS IMPLANT WITH SUSTAINED RELEASE OF PRE-CONCENTRATED PHARMACOLOGICALLY ACTIVE SUBSTANCE IN POLYMER FOR THE TREATMENT OF ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIA	LUIZ PERACCHI, Edson
WO/2021/042193	METHOD AND USE OF PNPP-19 FOR PREVENTING AND TREATING EYE DISEASES	BIOZEUS DESENVOLVIMENTO DE PRODUTOS BIOFARMACêUTICOS
WO/2021/042194	COMPOUND DERIVED FROM QUINOLINE, USE OF A COMPOUND, COMPOSITION AND METHOD FOR THE TREATMENT OR PROPHYLAXIS OF A CONDITION CAUSED BY A BLOOD PARASITE	FUNDAÇÃO OSWALDO CRUZ
WO/2021/092667	PHOTOPROTECTIVE COMPOSITIONS, PHOTOPROTECTIVE FORMULATIONS INCLUDING PHOTOPROTECTIVE COMPOSITIONS, PREPARATION METHODS AND USES THEREOF	BIOART BIOCOSMéTICOS LTDA - ME
WO/2021/151178	WATER-BASED PROPYLENE GLYCOL-FREE MICROEMULSION FOR DELIVERY OF MINOXIDIL IN THE TREATMENT OF HAIR LOSS AND METHOD FOR OBTAINING SAME	GERALDI, Katia Solange Cardoso Rodrigues Dos Santos
WO/2021/077191	METHOD FOR OBTAINING CB-AG-NMS AND CB-AG-<sb> </sb><sb> </sb><sb><i>P</i></sb><sb> </sb><sb> </sb>ABA DEVICES, CB-AG-NMS AND CB-AG-<sb> </sb><sb> </sb><sb><i>P</i></sb><sb> </sb><sb> </sb>ABA DEVICES, AND USE OF CB-AG-NMS AND CB-AG-<sb> </sb><sb> </sb><sb><i>P</i></sb><sb> </sb><sb> </sb>ABA DEVICES	UNIVERSIDADE ESTADUAL DE CAMPINAS
WO/2021/108884	PROCESS FOR PRODUCING A PROPHYLACTIC AND THERAPEUTIC DNA IMMUNOLOGICAL COMPOSITION FOR HPV AND CANCERS ASSOCIATED WITH THE VIRUS, HYBRID PROTEIN, EXPRESSION VECTOR, IMMUNOLOGICAL COMPOSITION AND USES THEREOF	INSTITUTO BUTANTAN
WO/2021/113938	VITAMIN AND MINERAL FOOD SUPPLEMENT	CELLAVIT REPRESENTAÇÃO DE PRODUTOS NATURAIS LTDA
WO/2021/163776	SUBCUTANEOUS IMPLANTS FOR SLOW CONTROLLED RELEASE OF ACTIVE AGENTS	BITTENCOURT, Marco Antonio
WO/2021/119791	OLEAGINOUS COMPLEX OBTAINED FROM ACHIOTE SEEDS AND RELATED USES	UNIVERSIDADE ESTADUAL DE CAMPINAS
WO/2021/127768	ANTI-PERSPIRANT COMPOSITION, COSMETIC USE AND METHOD FOR APPLYING SAME	HART'S ALIMENTOS NATURAIS LTDA
WO/2021/127769	COMPOSITION FOR TREATING CONJUNCTIVITIS	NARDINI, Antonio Roberto
WO/2021/151185	HERBAL MEDICINE, HERBAL MEDICINAL PRODUCT AND USE THEREOF	EVOLUÇÕES CIENTíFICAS E TECNOLóGICAS LTDA
WO/2021/184094	ADDITIVE FOR DETOXIFICATION	SILVA, Wellington Nascimbeni
WO/2021/184095	BIOACTIVE SUPPLEMENT	SILVA, Wellington
WO/2021/163777	COSMETIC COMPOSITION FOR KERATIN FIBERS AND APPLICATION METHODS FOR SAID COMPOSITION	GLOSS EXPRESS DO BRASIL COMERCIO DE PRODUTOS DE BELEZA LTDA - EPP
WO/2021/159198	METHOD FOR PRODUCING DECELLULARIZED BIOMATERIAL, DECELLULARIZED BIOMATERIAL AND USE THEREOF	KHEIROS PATER INOVAÇÃO S.A
WO/2021/189121	PARAMAGNETIC NANOPARTICLES, MANUFACTURING METHOD AND USE THEREOF WITH MAGNETIC RESONANCE IMAGING CONTRAST	UNIVERSIDADE DE SÃO PAULO - USP
WO/2021/195730	ANTIBACTERIAL COMBINATION COMPOSITION FOR REDUCING THE RESISTANCE OF BACTERIA TO THE MEDICINAL DRUGS IN USE AND METHOD FOR OBTAINING SAME	WEGHER, Ermete Antonio
WO/2021/207813	TERPENE-CONTAINING COMPOSITION AND ITS COSMETIC USE	BERACA INGREDIENTES NATURAIS S.A.
WO/2021/232123	TASTE-MASKING SYSTEM	OUROFINO SAUDE ANIMAL LTDA
WO/2021/222997	COMPOSITION FOR REGULATING THE NEURO-IMMUNE-ENDOCRINE SYSTEM	ABOU NEHMI FILHO, Victor
WO/2021/223001	NIGHT-TIME ORAL GEL COMPOSITION	OLIVEIRA, Eder Gonzaga De
WO/2021/258180	PROCESS FOR OBTAINING ANTIGEN-PRESENTING VESICLES (APV) THAT ENABLES THE COUPLING OF ONE OR MORE ANTIGENS	INSTITUTO BUTANTAN
WO/2021/046628	STABLE MEDICINAL CANNABIDIOL COMPOSITIONS	CARDIOL THERAPEUTICS INC.
WO/2021/081619	HEMP PEPTIDE COMPOSITIONS FOR NUTRACEUTICAL AND PERSONAL CARE PRODUCTS	EC LABS INC.
WO/2021/243432	PHARMACEUTICAL COMPOSITIONS FOR STAINING MEMBRANES AND OTHER BIOLOGICAL STRUCTURES	TANG, Connie
WO/2021/003553	COMPOUNDS FOR TREATMENT OF DIARRHEA, INFLAMMATORY BOWEL DISEASE AND METHODS THEREOF	ALGERNON PHARMACEUTICALS INC.
WO/2021/081624	USE OF GLUTAMATE 2B RECEPTOR ANTAGONISTS AND SIGMA RECEPTOR AGONSISTS AS ANTITUSSIVES	ALGERNON PHARMACEUTICALS INC.
WO/2021/000046	QUORUM-SENSING INHIBITORS AND/OR POSTBIOTIC METABOLITES AND RELATED METHODS	MICROSINTESIS INC.
WO/2021/012046	CANNABINOIDS COMPOSITIONS WITH POLYUNSATURATED FATTY ACID MONOGLYCERIDES, METHODS AND USES THEREOF	SCF PHARMA INC.
WO/2021/016710	CONTROLLED RELEASE FORMULATIONS OF MULTIPLE ACTIVE PHARMACEUTICAL AGENTS, AND PSILOCYBE-DERIVED AGENTS IN COMBINATION WITH CANNABIS-DERIVED AGENTS AND METHODS FOR THEIR USE	TASSILI LIFE SCIENCES, CORP.
WO/2021/022377	PERIVASCULAR LYSATES AND USES THEREOF	TISSUE REGENERATION THERAPEUTICS INC.
WO/2021/022378	ORAL FORMULATIONS OF CANNABIS EXTRACTS AND METHODS OF MAKING SAME	NEPTUNE WELLNESS SOLUTIONS INC.
WO/2021/026653	CHOLINERGIC POTENTIATION OF BINOCULAR VISION	THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING / MCGILL UNIVERSITY
WO/2021/035335	COMPOSITION AND METHOD FOR FORMING A COMPOSITION FOR INCREASING DERMAL NITRIC OXIDE	SPINAL RELIEF CENTRES OF CANADA INC.
WO/2021/030913	CANNABINOID COMPOSITIONS, METHODS OF MAKING SAME AND USES THEREOF	HEXO OPERATIONS INC.
WO/2021/035344	METHODS FOR REDUCING THC CONTENT IN COMPLEX CANNABINOID MIXTURES IN WHICH THC IS A MINOR COMPONENT	CANOPY GROWTH CORPORATION
WO/2021/046634	METHODS OF TREATING CANCER BY THE USE OF PD-1 AXIS INHIBITORS AND ANTI-PERIOSTIN ANTIBODIES	BOEHRINGER INGELHEIM IO CANADA, INC.
WO/2021/046646	AVOCATIN B FOR THE TREATMENT OF DISEASES AND CONDITIONS	SP NUTRACEUTICALS INC.
WO/2021/046652	INHIBITING ZD17-JNK INTERACTION AS A THERAPY FOR ACUTE MYOCARDIAL INFARCTION	THE UNIVERSITY OF BRITISH COLUMBIA
WO/2021/051192	COMPOSITION OF RADIOACTIVE AND NON-RADIOACTIVE MICROPARTICLES	ABK BIOMEDICAL INCORPORATED
WO/2021/056098	NEOGLYCOCONJUGATES AS VACCINES AND THERAPEUTIC TOOLS	KORANEX CAPITAL
WO/2021/056105	COMPOSITIONS AND METHODS BASED ON HIV GP120 MUTANTS	CENTRE HOSPITALIER DE L'UNIVERSITé DE MONTRéAL
WO/2021/056106	LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS	DDS RESEARCH INC.
WO/2021/056109	GEL BASE COMPOSITION FOR COMPOUNDING INTO A MUCOADHESIVE DELIVERY SYSTEM	MEDISCA PHARMACEUTIQUE INC.
WO/2021/062546	USE OF IBALIZUMAB FOR THE TREATMENT OF HIV-2 INFECTION	TAIMED BIOLOGICS INC.
WO/2021/062554	ORAL CARE COMPOSITION COMPRISING CUTTLEFISH BONE POWDER	VISIONATUROLAB INC.
WO/2021/062555	TOPICAL FORMULATIONS AND INSTILLATES, KITS, AND METHODS FOR TREATING INTEGUMENTARY WOUNDS, AND USES THEREOF	VINSAN THERAPEUTICS INC.
WO/2021/072530	CONTROLLED RELEASE FORMULATIONS OF PSILOCYBE-DERIVED AGENTS AND METHOD FOR THEIR USE, AND METHODS AND COMPOSITIONS FOR THREATING MILD TRAUMATIC BRAIN INJURY WITH POST TRAUMATIC STRESS DISORDER.	TASSILI LIFE SCIENCES, CORP.
WO/2021/072535	OIL-IN-WATER EMULSION FORMULATIONS FOR DELIVERY OF ACTIVE OR THERAPEUTIC AGENTS	IMMUNOVACCINE TECHNOLOGIES INC.
WO/2021/072538	SKIN CARE FORMULATION WITH LIPOPHILIC PEPTIDES	DECIEM BEAUTY GROUP INC.
WO/2021/072555	COMPOSITIONS AND METHODS FOR THE TREATMENT AND/OR PROPHYLAXIS OF DIABETES AND OTHER CONDITIONS	LIFELOCK SOLUTIONS INC.
WO/2021/077211	CANNABIDIOL COMPOSITIONS FOR USE IN TREATING HEART CONDITIONS	CARDIOL THERAPEUTICS INC.
WO/2021/081634	FORMULATION TO REDUCE OR PREVENT OXIDATIVE STRESS DAMAGE	MURPHY, Kieran
WO/2021/081640	FLOWABLE CANNABINOID COMPOSITIONS HAVING HIGH EFFECTIVE CONCENTRATIONS	CANOPY GROWTH CORPORATION
WO/2021/081642	BIOPHOTONIC COMPOSITIONS, USES AND METHODS FOR MODULATING MITOCHONDRIAL DYNAMICS AND FUNCTIONALITY IN SKIN AND SOFT TISSUE CONDITIONS	ZAGO, Michela
WO/2021/081652	METHODS AND RELATED SYSTEMS FOR MAKING A RECONSTITUTED CANNABIS MATERIAL	1769474 ALBERTA LTD.
WO/2021/081654	SELF-EMULSIFYING DRUG DELIVERY SYSTEM AND USES THEREOF	SP NUTRACEUTICALS INC.
WO/2021/092684	CHEWING GUM CONTAINING SYNERGISTIC MEDICINAL COMPOUNDS	LONDON PHARMACEUTICALS AND RESEARCH CORPORATION
WO/2021/097562	TOP LIQUID FILL METHOD AND APPARATUS FOR HARD CAPSULES	CAO, Karl Wei
WO/2021/108911	USE OF PSILOCIN, PSILOCYBIN OR ANALOGS THEREOF IN WEIGHT LOSS, TREATMENT OF OBESITY AND COMPULSIVE EATING DISORDER	NEONMIND BIOSCIENCES INC.
WO/2021/108918	TREATMENT FOR ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROME	UNIVERSITY HEALTH NETWORK
WO/2021/108923	COMBINED USE OF SODIUM TRANS-[TETRACHLORIDOBIS(1H-INDAZOLE)RUTHENATE(III)] AND ETOMOXIR FOR TREATING CANCERS	BOLD THERAPEUTICS INC.
WO/2021/108929	SORTILIN BINDING CONJUGATE COMPOUNDS, COMPOSITIONS AND USES THEREOF FOR TREATING CANCER	THERATECHNOLOGIES INC.
WO/2021/113982	MINERAL SUPPLEMENTS FOR RUMINANT NUTRITION	ALBERTA VETERINARY LABORATORIES LTD.
WO/2021/113983	CHOLINE BOLUS COMPOSITIONS FOR RUMINANTS	ALBERTA VETERINARY LABORATORIES LTD.
WO/2021/113986	COMPLEXES COMPRISING A CARBOHYDRATE POLYMER AND AN ACTIVE INGREDIENT AND PROCESSES FOR THEIR PREPARATION	FOLIUM LABS INC.
WO/2021/119810	ORAL DELIVERY SYSTEMS BASED ON IN SITU FORMING PROTEIN/POLYSACCHARIDE COACERVATES	9286-3620 QUéBEC INC.
WO/2021/119817	HASHISH PRODUCT HAVING ENHANCED USER EXPERIENCE AND MANUFACTURING PROCEDURE FOR OBTAINING SAME	HEXO OPERATIONS INC.
WO/2021/119822	EMULSIONS OF BIOACTIVE LIPOPHILIC COMPOUNDS INCLUDING OILS	NATIONAL RESEARCH COUNCIL OF CANADA
WO/2021/119826	EXTRACTS ENRICHED WITH POLYPHENOLIC COMPOUNDS AND RELATED METHODS	ROTHSTEIN, Steven
WO/2021/119827	USE OF GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR (GDNF) FOR THE TREATMENT OF ENTERIC NEUROPATHIES	TRANSFERT PLUS, SOCIéTé EN COMMANDITE
WO/2021/119834	MODULATORS OF CULLIN 3 ADAPTOR KBTBD4 AS ANTI-CANCER COMPOUNDS	UNIVERSITE DE MONTREAL
WO/2021/119844	EMULSIFYING FORMULATIONS OF CANNABINOIDS AND/OR CANNABINOID EXTRACTS	ORGANIGRAM INC.
WO/2021/127786	CANNABICHROMENE COMPOSITIONS AND METHODS OF SYNTHESIZING CANNABICHROMENE	CANOPY GROWTH CORPORATION
WO/2021/127787	CANNABICITRAN COMPOSITIONS AND METHODS OF SYNTHESIZING CANNABICITRAN	CANOPY GROWTH CORPORATION
WO/2021/127788	METHODS OF SYNTHESIZING HIGH-PURITY CANNABICYCLOL AND ARTIFICIAL RESINS COMPRISING CANNABICYCLOL	CANOPY GROWTH CORPORATION
WO/2021/138742	COMPOSITION THAT PROMOTE PRO-RESOLVING MEDIATORS	ACASTI PHARMA INC.
WO/2021/146812	USE OF ANTI-AGING GLYCOPEPTIDES FOR INHIBITION OF IMMUNE REJECTION OF A GRAFT	PROTOKINETIX INC.
WO/2021/151212	SYSTEM AND METHOD FOR QUANTIFYING, FORMULATING AND ENHANCING USER EXPERIENCE PROFILE OF CANNABIS	HEXO OPERATIONS INC.
WO/2021/159213	METHOD FOR PRODUCING AN EXTRACT OF MUSHROOM AND MUSHROOM EXTRACT MADE THEREFROM	NEONMIND BIOSCIENCES INC.
WO/2021/163796	METHODS AND COMPOSITIONS FOR THE INHIBITION OF HEPATITIS B AND HEPATITIS D VIRUS INFECTIONS	REPLICOR INC.
WO/2021/163802	USE OF CASTALAGIN OR ANALOGS THEREOF FOR ANTI-CANCER EFFICACY AND TO INCREASE THE RESPONSE TO IMMUNE CHECKPOINT INHIBITORS	THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY
WO/2021/163811	POLYMERIC BINDER AND HIGH MOLECULAR WEIGHT POLYMER ANTIFOULING COMPOSITIONS	THE UNIVERSITY OF BRITISH COLUMBIA
WO/2021/207822	DETECTION, TREATMENT, AND MONITORING OF MICROBIOME-DEPENDANT PROTEIN FERMENTATION METABOLITES	MCPHARMA BIOTECH INC.
WO/2021/168561	PROCESSES FOR THE PREPARATION OF MULTICOMPONENT CRYSTALLINE FORMS OF ACTIVE PHARMACEUTICAL INGREDIENTS USING SOLVENT VAPOUR	APOTEX INC
WO/2021/168572	STABLE LIQUID DISPERSINB COMPOSITIONS	KANE BIOTECH INC.
WO/2021/168573	NANOSTRUCTURE LIPID CARRIER DELIVERY SYSTEM, COMPOSITION, AND METHODS	CAPCIUM INC.
WO/2021/168577	GENE DELIVERY SYSTEM	SYMVIVO CORPORATION
WO/2021/174351	COACTIVE COMBINATIONS OF ANTIMICROBIALS WITH DISPERSINB	KANE BIOTECH INC.
WO/2021/179072	METHODS AND APPARATUSES TO REDUCE SETTLING RATE OF A MICRO-PARTICLE SUSPENSION	SKINLIFE TECHNOLOGIES INC.
WO/2021/179081	USE OF ANTI-AGING GLYCOPEPTIDES FOR TREATMENT OF DRY EYE DISEASE, RETINAL DEGENERATIVE DISEASES, OR OCCULAR INFLAMMATION	PROTOKINETIX INC.
WO/2021/179087	TERPENE-ENHANCED COMPOSITIONS AND USES THEREOF	HEXO OPERATIONS INC.
WO/2021/179088	TERPENE-ENHANCED COMPOSITIONS AND USES THEREOF	HEXO OPERATIONS INC.
WO/2021/179094	COMPOSITION AND USE OF A CAFFEIC ACID PHENETHYL ESTER (CAPE) COMPOUND TO TREAT CANCER	UNIVERSITY OF NEW BRUNSWICK
WO/2021/184115	USE OF BUCILLAMINE IN THE TREATMENT OF INFECTIOUS DISEASES	REVIVE THERAPEUTICS LTD.
WO/2021/184116	METHOD FOR PRODUCING ENHANCED ANTI-INFLAMMATORY/ ANTI-CATABOLIC AGENTS FROM AUTOLOGOUS PHYSIOLOGICAL FLUID	ANTNOR LIMITED
WO/2021/207824	USE OF PSILOCYBIN IN THE TREATMENT OF NEUROLOGICAL BRAIN INJURY AND MIGRAINES	REVIVE THERAPEUTICS LTD.
WO/2021/184123	COMPOSITIONS AND METHODS FOR THE TREATMENT OF CORONAVIRUS INFECTION AND RESPIRATORY COMPROMISE	SZEWCZUK, Myron R.
WO/2021/184125	DISCOVERY OF FIFTEEN NEW ANTI-AGING PLANT EXTRACTS AND IDENTIFICATION OF CELLULAR PROCESSES THEY AFFECT AS NEW CALORIC RESTRICTION MIMETICS	IDUNN TECHNOLOGIES
WO/2021/184128	METHODS OF TREATING A CORONAVIRUS INFECTION USING COLCHICINE	INSTITUT DE CARDIOLOGIE DE MONTREAL
WO/2021/189151	ANTIMICROBIAL COMPOSITION	COVALON TECHNOLOGIES INC.
WO/2021/189153	USE OF FENRETINIDE FOR THE TREATMENT OF SARS-CORONA VIRUS INFECTION	LAURENT PHARMACEUTICALS INC.
WO/2021/195750	METHODS FOR TREATING ALZHEIMER'S DISEASE	JEFFERIES, Wilfred
WO/2021/195763	ANTIVIRAL RUTHENATE(III) THERAPEUTICS	BOLD THERAPEUTICS INC.
WO/2021/195765	DAPSONE FORMULATIONS AND METHODS OF USING SAME	PULMONEM INC.
WO/2021/212209	CANNABICHROMENE FORMULATION FOR PAIN MANAGEMENT	ZYUS LIFE SCIENCES INC.
WO/2021/195777	FUROSEMIDE COMPOSITIONS AND USES THEREOF FOR SUPPORTIVE THERAPY IN CORONAVIRUS INFECTION	UNIVERSITY HEALTH NETWORK
WO/2021/195782	METHODS OF USING MYT1 INHIBITORS	REPARE THERAPEUTICS INC.
WO/2021/195785	FERRITIN FOR CELLULAR TRACKING UTILIZING T1-WEIGHTED MRI	THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
WO/2021/203190	COMBINATION THERAPIES FOR INHIBITION OF POLO-LIKE KINASE 4	UNIVERSITY HEALTH NETWORK
WO/2021/203198	COMPOSITIONS AND METHODS FOR TREATMENT OF CORONAVIRIDAE INFECTIONS	PICCHIO INTERNATIONAL INC.
WO/2021/203205	PROBIOTIC COMPOSITIONS AND METHODS OF USE	CHANDLER BIOPHARMACEUTICAL CORPORATION
WO/2021/203206	COMBINATION OF CANNABIDIOL AND A PPAR AGONIST	LAVIOLETTE, Steven Robert
WO/2021/207828	METHODS FOR TREATING CYTOKINE RELEASE SYNDROME	UNIVERSITY HEALTH NETWORK
WO/2021/207833	METHOD OF LONG-TERM PRESERVATION OF CHEMICAL AND BIOLOGICAL SPECIES USING SUGAR GLASSES	MCMASTER UNIVERSITY
WO/2021/207850	WATER SOLUBLE FORMULATIONS CONTAINING CANNABINOIDS	NATIONAL RESEARCH COUNCIL OF CANADA
WO/2021/212215	COMPOSITIONS AND METHODS FOR PREVENTING, CONTROLLING AND DIAGNOSING MYCOBACTERIAL INFECTIONS	UNIVERSITY OF SASKATCHEWAN
WO/2021/212222	COMPOSITIONS AND METHODS FOR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME	EDESA BIOTECH RESEARCH INC.
WO/2021/212239	USES OF SUPER-OXYGENATED WATER AND GEL	GIS GAS INFUSION SYSTEMS INC.
WO/2021/217259	BIOMEDICAL IMAGING OF BACTERIA AND BACTERIOPHAGE	MULTI-MAGNETICS INCORPORATED
WO/2021/217275	IMMUNOMODULATORY AND ANTIVIRAL ACTION OF BOSWELLIA GUM RESIN EXTRACTS, DERIVED FORMULATIONS, AND BOSWELLIC ACIDS AGAINST RESPIRATORY VIRUSES AND USES THEREOF	KONDOR PHARMA INC.
WO/2021/226725	HASHISH HAVING SUBSTANTIALLY UNIFORM CHARACTERISTICS AND METHOD FOR PRODUCING SAME AT AN INDUSTRIAL SCALE	HEXO OPERATIONS INC.
WO/2021/232156	CANNABINOID PHARMACEUTICAL COMPOSITION	AMACATHERA INC.
WO/2021/232169	SYNERGISTIC ANTI-VIRAL PHARMACEUTICAL COMPOSITION CONTAINING TARGETING NANOPARTICLES	NUECOLOGY BIOMEDICAL INC.
WO/2021/237366	TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE	PEMI31 THERAPEUTICS INC.
WO/2021/243460	METHOD FOR WEIGHT LOSS WITH THERAPY	NEONMIND BIOSCIENCES INC.
WO/2021/243461	USE OF LSD, ESA, OR DMT FOR WEIGHT LOSS.	NEONMIND BIOSCIENCES INC.
WO/2021/243467	CANNABINOID-HYALURONIC ACID BIOCONJUGATES	LONDON PHARMACEUTICALS AND RESEARCH CORPORATION
WO/2021/248251	USE OF PHYTOCANNABINOIDS FOR TREATING MULTIPLE MYELOMA	ENTOURAGE BIOSCIENCES INC.
WO/2021/253116	COMPOSITIONS COMPRISING PSYCHOACTIVE COMPOUNDS FROM PSYCHOACTIVE ORGANISMS	PSILO SCIENTIFIC LTD
WO/2021/253123	EXTRACTION OF PSYCHOACTIVE COMPOUNDS FROM PSYCHEDELIC FUNGUS	PSILO SCIENTIFIC LTD
WO/2021/253124	METHANOL-BASED EXTRACTION OF PSYCHOACTIVE COMPOUNDS FROM FUNGUS	PSILO SCIENTIFIC LTD
WO/2021/258206	WATER-SOLUBLE ARTESUNATE-BASED THERAPY FOR CORONAVIRUS INFECTION	SOLSTAR PHARMA
WO/2021/258209	COMPOSITE COATING FOR AN ACTIVE AGENT	13400719 CANADA INC.
WO/2021/258218	USE OF SOLUBLE NRP1 POLYPEPTIDES FOR THE TREATMENT OF CORONAVIRUS INFECTIONS	SEMATHERA INC.
WO/2021/207860	COMPOSITION OF HERBS AND SPICES FOR USE IN MEDICINE	MUESSLI, Daniel
WO/2021/000057	FORMULATION THAT ALLOWS THE PROTECTION OF POLYPHENOLS, PARTICULARLY THOSE OBTAINED FROM BEE POLLEN EXTRACT	PONTIFICIA UNIVERSIDAD CATóLICA DE CHILE
WO/2021/022386	WATER-SOLUBLE FILM WITH BIOACTIVE AGENTS OR NATURAL EXTRACTS FOR COSMETIC USE	UNIVERSIDAD DE CHILE
WO/2021/077236	ONION SKIN EXTRACT WITH PROPERTIES THAT PROTECT THE GASTROINTESTINAL MUCOSA AGAINST DAMAGE INDUCED BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS OR BY ALCHOL, PHARMACEUTICAL COMPOSITION OR FOOD COMPRISING IT, METHOD OF OBTAINMENT, AND USE TO PREVENT, TREAT AND/OR MITIGATE THE ADVERSE EFFECTS OF NSAIDS OR ALCOHOL	UNIVERSIDAD DE CHILE
WO/2021/097584	AGAROPHYTON CHILENSIS EXTRACT, RICH IN FREE FATTY ACIDS, AS A NUTRACEUTICAL OR NUTRITIONAL SUPPLEMENT, SUITABLE FOR MODULATING PPARϒ ACTIVITY	UNIVERSIDAD ANDRES BELLO
WO/2021/119858	METHOD FOR GENERATING ALLERGEN-SPECIFIC TOLEROGENIC CELLS, TOLEROGENIC CELLS OBTAINED, AND METHODS FOR INDUCING ALLERGEN TOLERANCE BY MEANS OF AUTOLOGOUS IMMUNOTHERAPY	PONTIFICIA UNIVERSIDAD CATóLICA DE CHILE
WO/2021/127793	ANTIVIRAL COMPOSITION BASED ON EXTRACTS OF <i>DURVILLAEA ANTARCTICA</i>, USEFUL FOR TREATING LESIONS CAUSED BY ALPHAHERPESVIRINAE VIRUSES	PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
WO/2021/127794	ANTIVIRAL COMPOSITION BASED ON EXTRACTS OF <i>MACROCYSTIS PYRIFERA</i>, USEFUL FOR TREATING LESIONS CAUSED BY ALPHAHERPESVIRINAE VIRUSES	PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
WO/2021/119864	MULTI-POLYMER HYDROGEL AS A DEVICE FOR ADMINISTERING PHARMACEUTICAL AND CELLULAR THERAPEUTIC COMPONENTS	UNIVERSIDAD DE CONCEPCIóN
WO/2021/119866	USE OF STRAINS OF <i>LACTOBACILLUS KUNKEEI</i> AND <i>BIFIDOBACTERIUM ASTEROIDES</i> AS A PROBIOTIC BIOSTIMULANT FOR BEES	UNIVERSIDAD DE CONCEPCIóN
WO/2021/119868	PROBIOTIC STRAINS OF <i>LACTOBACILLUS SP.</i> AND OF <i>PEDIOCOCCUS SP</i>. AND USE THEREOF IN THE PREPARATION OF A PROBIOTIC FORMULATION FOR THE PREVENTION OF DIARRHEA CAUSED BY BACTERIAL PATHOGENS THAT AFFECT DOGS AND CATS	UNIVERSIDAD DE CONCEPCIóN
WO/2021/127797	NEW USE OF BCG IMMUNOGENIC FORMULATION EXPRESSING A RESPIRATORY SYNCITIAL VIRUS PROTEIN AGAINST HMPV	PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
WO/2021/195797	NOVEL USE OF BCG IMMUNOGENIC FORMULATION EXPRESSING A HUMAN RESPIRATORY SYNCYTIAL VIRUS PROTEIN AGAINST HMPV IN CATTLE	PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE
WO/2021/000062	USE OF COMBINATION OF COMPOUND OF SCLEROTIORIN AND RIFAMPICIN IN PREPARATION OF ANTI-TUBERCULOSIS DRUG	SUN YAT-SEN UNIVERSITY
WO/2021/000067	CELL-BINDING MOLECULE-TUBULYSIN DERIVATIVE CONJUGATE AND PREPARATION METHOD THEREFOR	HANGZHOU DAC BIOTECH CO., LTD.
WO/2021/003687	COMPOSITIONS AND METHODS OF USING A HUMANIZED ANTI-DKK2 ANTIBODY	YALE UNIVERSITY
WO/2021/007741	AQUEOUS-BASED NON-AEROSOL DRY SHAMPOO COMPOSITION	HENKEL AG & CO. KGAA
WO/2021/007800	ANTI-INFECTION EFFECTS OF HNRNPA2B1 AND USE THEREOF	INSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/012065	APPLICATION OF BEZOAR SEDATIVE PILL IN PREPARING DRUG FOR TREATING DEPRESSION	BEIJING TONG REN TANG CHINESE MEDICINE CO., LTD.
WO/2021/012138	USE OF DIAMINOGUANIDINE DERIVATIVE AND FEED COMPOSITION THEREOF IN PREPARATION OF VETERINARY DRUG	GUANGZHOU INSIGHTER BIOTECHNOLOGY CO.,LTD
WO/2021/012269	ANTI-INFLAMMATORY AND ANTI-SWELLING PHARMACEUTICAL COMPOSITION, AND USE THEREOF	HU, Ping
WO/2021/016729	COMPOSITION FOR CLEANSING AND/OR REMOVING MAKEUP FROM KERATIN MATERIALS	L'OREAL
WO/2021/016924	CATIONIC POLYMER AND PARTICLES USABLE TO TREAT PSORIASIS	SUN YAT-SEN UNIVERSITY
WO/2021/016941	UTILIZING STRUCTURE AND MECHANOGATING MECHANISM OF PIEZO CHANNELS FOR PREPARATION OF MEDICAMENTS AND TECHNOLOGIES	TSINGHUA UNIVERSITY
WO/2021/022466	MEDICAMENT FOR TREATING STROKE CAUSED BY DEEP FUNGAL INFECTIONS	XIAO, Mingchun
WO/2021/022562	PURE NATURAL COMPOUND ESSENTIAL OIL HAVING BROAD-SPECTRUM BACTERICIDAL ACTIVITY AND PREPARATION AND APPLICATION THEREOF	INSTITUTE OF MEDICINAL PLANT DEVELOPMENT, CHINESE ACADEMY OF MEDICAL SCIENCE
WO/2021/007899	INJECTABLE HYDROGEL MATERIAL AND PREPARATION METHOD THEREFOR AND USE THEREOF	ZHEJIANG UNIVERSITY OF TECHNOLOGY
WO/2021/030932	PHARMACEUTICAL COMPOSITIONS COMPRISING ONCOLYTIC HERPES SIMPLEX VIRUS FOR SYSTEMIC ADMINISTRATION	IMMVIRA CO., LTD
WO/2021/030978	USE OF NICLOSAMIDE ETHANOLAMINE SALT IN PREPARATION OF DRUGS FOR TREATING CHEMOTHERAPY-REALATED MUSCLE INJURY	SHENZHEN TRADITIONAL CHINESE MEDICINE HOSPITAL
WO/2021/031102	CRYSTAL FORM OF DAPRODUSTAT, PREPARATION METHOD THEREFOR AND USE THEREOF	SHENZHEN RENTAI PHARMATECH LTD.
WO/2021/026949	PHASE-INVERTED EMULSION AND PREPARATION METHOD	ZHONGSHANSHI BOSHEN CHEMICAL CO., LTD.
WO/2021/031200	CD8+T CELL AND/OR B CELL REGULATION	TONGJI HOSPITAL, TONGJI MEDICAL COLLEGE OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/035378	METHOD TO INCORPORATE OLEANOLIC ACID INTO ORAL CARE COMPOSITIONS AND ORAL CARE COMPOSITIONS BASED THEREOF	COLGATE-PALMOLIVE COMPANY
WO/2021/035386	SUNSCREEN COMPOSITION WITHOUT CYCLOMETHICONES	BEIERSDORF DAILY CHEMICAL (WUHAN) CO. LTD.
WO/2021/035390	MEDICINE FOR TREATING PULMONARY MYCOSIS	XIAO, Mingchun
WO/2021/035498	ANTI-TUMOR PLATINUM-BASED DRUG MINERALIZED PROTEIN NANOPARTICLE, PREPARATION METHOD THEREFOR AND USE THEREOF	SOOCHOW UNIVERSITY
WO/2021/035655	MEDICINE FOR INJECTION AND PREPARATION METHOD THEREFOR	SICHUAN CREDIT PHARMACEUTICAL CO., LTD
WO/2021/000417	USE OF PALMITOLEIC ACID FOR PREPARING COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES	REVAISSANT (SHENZHEN) BIOSCIENCES CO., LTD.
WO/2021/042274	TRADITIONAL CHINESE AND WESTERN MEDICINE COMPOSITION FOR TREATING OSTEOARTHRITIS	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/042275	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING OSTEOARTHRITIS	LUNAN PHARMACEUTICALGROUP CORPORATION
WO/2021/042276	COMBINATION DRUG FOR TREATING OSTEOARTHRITIS	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/042278	MULTI-UNIT SUSTAINED-RELEASE ACIPIMOX PELLET TABLET AND PREPARATION METHOD THEREFOR	LUNAN BETTER PHARMACEUTICAL CO., LTD.
WO/2021/007933	APPLICATION OF MAGGOTS IN TREATMENT OF DIABETES	HUA, Xiangrong
WO/2021/007934	APPLICATION OF LIQUOR PRODUCT WITH SOAKED LUCILIA SERICATA FOR TREATING DIABETES	HUA, Xiangrong
WO/2021/042325	COMPOSITION OF TEMPORARY DENTAL MATERIAL	TAIPEI UNIVERSITY OF TECHNOLOGY
WO/2021/042369	NANOPARTICLE HAVING CGAS-STING PATHWAY ACTIVATION FUNCTION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
WO/2021/046706	A SUNSCREEN FORMULATION	SUN, Yimin
WO/2021/046765	AN ANTICANCER COMBINATION OF CHIDAMIDE AND CELECOXIB	GNT BIOTECH & MEDICALS CORPORATION
WO/2021/017115	APPARATUS AND METHOD FOR PRODUCING FREEZE-DRIED FACIAL MASK	BEIJING BENZHENGONGFANG BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/051260	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING TRAUMATIC INJURY AND USE THEREOF	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/051261	NOVEL USE OF CHINESE MEDICINE COMPOSITION	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/051262	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREPARING DRUGS FOR TREATING EDEMA	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/051271	USE OF PICEATANNOL IN PREPARING A DRUG FOR PREVENTING AND TREATING NEURODEGENERATIVE DISEASES	SHENZHEN UNIVERSITY
WO/2021/051272	USE OF BISMUTH POTASSIUM CITRATE IN PREPARING DRUG FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES	SHENZHEN UNIVERSITY
WO/2021/031270	BACTERIAL MEMBRANE VESICLES, AND SEPARATION AND PREPARATION SYSTEM AND METHOD THEREFOR	SICHUAN UNIVERSITY
WO/2021/051352	ISOLATED ANTIGEN-BINDING PROTEIN AND USE THEREOF	SPH BIOTHERAPEUTICS (HK) LIMITED
WO/2021/056231	KIT FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/056248	TECHNOLOGY FOR FACIAL FAT DEGRADATION AND FIRMING AND APPLICATION OF TECHNOLOGY	SHANGHAI TONGBAI BIOTECHNOLOGY CO., LTD
WO/2021/056412	TWO-PART COMPOSITION FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/056431	NON-DRUG HELICOBACTER PYLORI BACTERICIDAL COMPOSITION	ECO-GEO BIO-TECHNOLOGY COMPANY LIMITED
WO/2021/007957	MESOPOROUS SPONGE SPICULE AND PREPARATION METHOD AND USE THEREFOR	XIAMEN UNIVERSITY
WO/2021/056522	COSMETIC COMPOSITION FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/062607	ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACID AND AMINO ACID	THE PROCTER & GAMBLE COMPANY
WO/2021/062611	DENTIFRICE COMPOSITIONS COMPRISING BICARBONATE SALT AND NEUTRAL AMINO ACID	THE PROCTER & GAMBLE COMPANY
WO/2021/062621	ORAL CARE COMPOSITIONS COMPRISING STANNOUS ION SOURCE, NEUTRAL AMINO ACID, AND POLYPHOSPHATE	THE PROCTER & GAMBLE COMPANY
WO/2021/062623	DENTIFRICE COMPOSITIONS FOR TREATMENT OF DENTAL BIOFILM	THE PROCTER & GAMBLE COMPANY
WO/2021/062631	DENTIFRICE COMPOSITIONS FOR TREATMENT OF DENTAL BIOFILM	THE PROCTER & GAMBLE COMPANY
WO/2021/003864	USE OF GLYCINE IN PREPARATION OF DRUG DELIVERY REINFORCER AND CELL TRANSPLANTATION REAGENT	TIANJIN MEDICAL UNIVERSITY
WO/2021/056609	SEQUENCE OF STRUCTURALLY SENSITIVE POLYPEPTIDE ANTIGEN OF VON WILLEBRAND FACTOR	SOOCHOW UNIVERSITY
WO/2021/068188	WS-635 USES THEREOF IN MEDICINE	WATERSTONE PHARMACEUTICALS(WUHAN) CO., LTD.
WO/2021/068196	METHODS OF USING IL-33 PROTEIN IN TREATING CANCERS	GENERAL REGENERATIVES (SHANGHAI) LIMITED
WO/2021/068203	USE OF CHLOROQUINE OR DERIVATIVE HYDROXYCHLOROQUINE	THE FIRST AFFILIATED HOSPITAL OF SUN YAT-SEN UNIVERSITY
WO/2021/068239	VAGINAL SLOW-RELEASE ADMINISTRATION SYSTEM FOR LUTEAL SUPPORT, PREPARATION METHOD THEREFOR AND USE THEREOF	NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING
WO/2021/068242	AN AGENT THAT ENABLES SIRT7 GENE EXPRESSION AND THE USE THEREOF	SHENZHEN UNIVERSITY
WO/2021/072595	MEDICAL USE OF MESENCHYMAL STEM CELLS IN TREATMENT OF HEARING IMPAIRMENT	MARIA VON MED-BIOTECHNOLOGY CO., LTD.
WO/2021/072642	USE OF PHENYLQUINOLINONES AND FLAVONOID DERIVATIVES FOR TREATING NEUROPATHIC PAIN	HANGZHOU BIO-SINCERITY PHARMA-TECH CO., LTD.
WO/2021/072661	ELECTROACTIVE AND DEGRADABLE SUPRAMOLECULAR MICROGEL AND DRUG-LOADED SUPRAMOLECULAR MICROGEL, AND PREPARATION METHOD AND USE THEREOF	NANJING FORESTRY UNIVERSITY
WO/2021/072683	TWO-PART COMPOSITION FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/031320	NANO-PARTICLE BASED ON DNA PHOTOTHERMAL MELTING, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	QINGDAO UNIVERSITY
WO/2021/031321	MULTI-COLOR UP-CONVERSION NANOPROBE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	QINGDAO UNIVERSITY
WO/2021/042451	DUAL DRUG DELIVERY SYSTEM BASED ON TARGETING NUCLEOLIN, PREPARATION METHOD THEREFOR AND USE THEREOF	QINGDAO UNIVERSITY
WO/2021/072747	COMPOSITION AND METHOD FOR TREATMENT OF DIABETES	SHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/072773	ORLISTAT CAPSULE AND PREPARATION METHOD THEREFOR	SHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/072780	METHODS AND COMPOSITIONS FOR IMPROVING BONE MARROW HEMATOPOIETIC FUNCTIONS	SUN YAT-SEN UNIVERSITY
WO/2021/022678	ANTIBODY-DRUG CONJUGATE AND APPLICATION THEREOF	MABPLEX INTERNATIONAL CO., LTD.
WO/2021/077320	COMPOSITION FOR CARING FOR THE SKIN	L'OREAL
WO/2021/046976	APPLICATION OF CAS13A IN ANTAGONIZING VIRUSES	INSTITUTE OF PATHOGEN BIOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/017222	SUPERMOLECULAR FORMULATIONS OF RETINOL AND DERIVATIVES THEREOF AND PREPARATION METHODS THEREFOR	PROYA COSMETICS CO., LTD.
WO/2021/081782	SUN CARE COMPOSITIONS WITH HOLLOW MESOPOROUS SILICA NANOSPHERES	DOW GLOBAL TECHNOLOGIES LLC
WO/2021/081859	SOLID ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS	L'OREAL
WO/2021/081876	SOLID ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS	L'OREAL
WO/2021/012460	MEDICINE FOR PREVENTING AND TREATING BACTERIAL ENTERITIS OF EELS, AND PREPARATION METHOD THEREFOR	JIMEI UNIVERSITY
WO/2021/031371	APPLICATION OF TYROSINE KINASE INHIBITOR AS THERAPEUTIC DRUG FOR ACUTE KIDNEY INJURY	SHANDONG UNIVERSITY
WO/2021/087838	TUMOR-SPECIFIC POLYPEPTIDE SEQUENCE AND USE THEREOF	SHENZHEN GINO BIOTECHNOLOGY CO., LTD.
WO/2021/017255	PROTEIN PEPTIDE MOISTURIZING LIQUID DISSOLVED IN WEAK ALKALINE WATER AND PREPARATION METHOD THEREFOR	SUZHOU LVZHONGYUAN TEXTILE TECHNOLOGY CO. LTD
WO/2021/092802	A HAIR STYLING PREPARATION	BEIERSDORF DAILY CHEMICAL (WUHAN) CO. LTD.
WO/2021/092892	APPLICATION OF QUINOLINE OR QUINAZOLINE COMPOUND IN PREPARATION OF ANTITUMOR DRUGS	PEKING UNIVERSITY SHENZHEN GRADUATE SCHOOL
WO/2021/092893	USE OF DIARYL ETHER COMPOUND IN PREPARATION OF ANTI-TUMOR DRUG	PEKING UNIVERSITY SHENZHEN GRADUATE SCHOOL
WO/2021/097651	PHARMACEUTICAL COMPOSITION COMPRISING ORLISTAT AND PLANT-DERIVED LIPASE INHIBITOR	ZHONGSHAN WANHAN PHARMACEUTICAL CO., LTD
WO/2021/097652	ORLISTAT NANOSPHERES AND USE THEREOF IN PREPARATION OF MEDICINES FOR TREATMENT OF OBESITY	ZHONGSHAN WANHAN PHARMACEUTICAL CO., LTD
WO/2021/097684	NEW ANTI-SOLUBLE CD14 SUBTYPE ANTIBODY AND USE THEREOF	SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
WO/2021/097691	POROUS DISSOLVABLE SOLID STRUCTURE	THE PROCTER & GAMBLE COMPANY
WO/2021/022718	APPLICATION OF PYRAZOLOPYRIMIDINE COMPOUND IN PREPARATION OF DRUGS FOR PREVENTING/TREATING TUMORS	WEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/102624	COVALENT PROTEIN DRUGS DEVELOPED VIA PROXIMITY-ENABLED REACTIVE THERAPEUTICS (PERX)	HANGZHOU BRANCH OF TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY, CHINESE ACADEMY OF SCIENCES
WO/2021/027181	USE OF IRON-CONTAINING MATERIAL IN PREPARATION OF PRODUCT FOR INHIBITING TRANSMISSION OF DENGUE VIRUS	TSINGHUA UNIVERSITY
WO/2021/017335	PREPARATION METHOD FOR XANTHAN GUM COPOLYMER NANOMICELLES AND APPLICATION THEREOF	JIANGNAN UNIVERSITY
WO/2021/102674	APPLICATION OF COMBINATION OF AMPK-TARGETING INHIBITOR/SIRNA AND PROTEASOME INHIBITOR IN ANTICANCER	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/017339	APPLICATION OF HYDROXYSAFFLOR YELLOW A IN PREPARATION OF MEDICATION FOR TREATMENT OR ADJUVANT TREATMENT OF OBESITY DISEASE	BEIJING SHIJITAN HOSPITAL, CAPITAL MEDICAL UNIVERSITY
WO/2021/102714	A CONDITIONING COMPOSITION	BEIERSDORF DAILY CHEMICAL (WUHAN) CO., LTD.
WO/2021/102715	A CONDITIONING COMPOSITION	BEIERSDORF DAILY CHEMICAL (WUHAN) CO. LTD.
WO/2021/056805	WILD JUJUBE SEED FLAVONE AND PHOSPHOLIPID COMPOSITE AS WELL AS PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	TAIZHOU GUOKEHUAWU BIOMEDICAL TECHNOLOGIES CO., LTD
WO/2021/036058	TERIPARATIDE SUSTAINED RELEASE GEL INJECTION SOLUTION AND PREPARATION METHOD THEREFOR	HYBIO PHARMACEUTICAL CO., LTD.
WO/2021/003961	SKIN CARE COMPOSITION CONTAINING PLANT EXTRACT, AND PREPARATION METHOD THEREFOR	ZHEJIANG KANGMANJIA DAILY NECESSITIES CO., LTD.
WO/2021/003962	SKINCARE COMPOSITION FOR REPAIRING SKIN, AND PREPARATION METHOD THEREFOR	ZHEJIANG KANGMANJIA DAILY NECESSITIES CO., LTD.
WO/2021/003963	SKINCARE COMPOSITION FOR TIGHTENING SKIN, AND PREPARATION METHOD THEREFOR	ZHEJIANG KANGMANJIA DAILY NECESSITIES CO., LTD.
WO/2021/102873	AN OIL-IN-WATER SUNSCREEN COMPOSITION	BEIERSDORF DAILY CHEMICAL (WUHAN) CO., LTD.
WO/2021/102874	AN OIL-IN-WATER SUNSCREEN COMPOSITION	BEIERSDORF DAILY CHEMICAL (WUHAN) CO., LTD.
WO/2021/102886	COMPOSITION FOR CARING FOR/MAKING UP KERATAIN FIBERS	L'OREAL
WO/2021/102897	TWO-PHASE COMPOSITION FOR TOPICAL APPLICATION	L'OREAL
WO/2021/102935	FLEXIBLE, POROUS, DISSOLVABLE SOLID SHEET ARTICLES HAVING LARGE PORES AND METHOD OF MAKING SAME	THE PROCTER & GAMBLE COMPANY
WO/2021/103018	METHOD FOR PREPARING RED POMEGRANATE EXTRACT AND SKINCARE CREAM COMPRISING SAME	CHEN, Bohao
WO/2021/103019	METHOD FOR PREPARING COMPOSITION COMPRISING RICE WASHING WATER AND SHAMPOO COMPRISING COMPOSITION COMPRISING RICE WASHING WATER	CHEN, Bohao
WO/2021/056815	CHEMOTHERAPEUTIC IMMUNE DRUG COMPOSITION AND PREPARATION METHOD THEREOF	SUZHOU INNOVATIVE BIOMATERIALS & PHARMACEUTICS CO., LTD.
WO/2021/109132	COMPOSITE MATERIAL AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	BIOMODI BIOTECH (SUZHOU) CO., LTD
WO/2021/103119	APPLICATIONS OF MACELIGNAN IN PREPARING MEDICAMENT FOR PREVENTING AND TREATING NEURODEGENERATIVE DISEASES	SHENZHEN UNIVERSITY
WO/2021/114020	PHARMACEUTICAL COMPOSITION OF ALKYNYL-CONTAINING COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/114024	COMPOSITION FOR BRIGHTENING AND/OR WHITENING KERATIN MATERIALS	L'OREAL
WO/2021/077566	APPLICATION OF DIVALENT MANGANESE IN PREPARING IMMUNITY ENHANCING DRUG OR ANTITUMOR DRUG	PEKING UNIVERSITY
WO/2021/114089	METHODS OF USING CROCETIN IN TREATING SOLID TUMORS	HANGZHOU MENGLANRUISI BIOTECHNOLOGY CO., LTD.
WO/2021/017365	CRA4S1 GENE, ENCODED CRA4S1 PROTEIN, AND APPLICATION	ZHENJIANG YANGTZE GREEN BIOTECHNOLOGY CO. LTD
WO/2021/114125	USE OF LEVISTOLIDE A IN PREPARATION OF DRUGS FOR TREATING OR PREVENTING RENAL DISEASES	LIAONING SHUANGSHILI PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/068401	TWO-DOSAGE-FORM ESSENCE AND PREPARATION METHOD THEREFOR	GUANGZHOU BIOHOPE CO., LTD.
WO/2021/114159	SPECIAL NON-WOVEN FABRIC FOR FACIAL MASK FOR SENSITIVE SKIN	JIANGSU AIKOP NEW MATERIALS CO., LTD.
WO/2021/114218	MYCOSPORINE-LIKE AMINO ACIDS PORPHYRA-334 AND SHINORINE AND METHOD FOR EXTRACTING PORPHYRA-334 AND SHINORINE FROM SEAWEEDS	LE, Zhanxian
WO/2021/114256	DRUG FOR TREATING PULMONARY FIBROSIS	THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIVERSITY
WO/2021/114315	USE OF HETEROCYCLIC DERIVATIVES WITH CARDIOMYOCYTE PROLIFERATION ACTIVITY FOR TREATMENT OF HEART DISEASES	SHANGHAI EAST HOSPITAL
WO/2021/119902	USE OF NAPHTHYLUREA COMPOUND	SUZHOU RAYMON PHARMACEUTICALS COMPANY, LTD.
WO/2021/119966	DRUG FOR TREATING DIGESTIVE SYSTEM MYCOSIS	XIAO, Mingchun
WO/2021/012589	PREPARATION METHOD AND APPLICATION OF STANDARD LILY BULB AND REHMANNIA DECOCTION HAVING ANTIDEPRESSANT EFFECT	SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
WO/2021/051685	COMPOUND FORMULATION FOR REMOVING HPV	JIANGXI SHANXING BIOTECHNOLOGY CO., LTD.
WO/2021/109251	ESSENTIAL OIL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF	GAIN SURE LIMITED
WO/2021/120084	SOLID COMPOSITION IN THE FORM OF WATER-IN-OIL EMULSION	L'OREAL
WO/2021/093087	TRADITIONAL CHINESE MEDICINE COMPOSITION HAVING EFFECT OF IMPROVING COGNITION, PREPARATION METHOD THEREFOR, AND TRADITIONAL CHINESE MEDICINE PREPARATION	CHENLAND NUTRITIONALS, INC.
WO/2021/088219	APPLICATION OF TRPC1 PEPTIDE MOLECULE IN PREPARATION OF DRUG FOR TREATING INFLAMMATION CAUSED BY VIRAL INFECTION	JIANGNAN UNIVERSITY
WO/2021/047099	METHOD FOR SYNTHESIZING NOVEL FERRIHYDRITE NANO-PHOTOSENSITIZER AND USE THEREOF IN COUNTERACTING CANCER AND BACTERIA	NORTHWESTERN POLYTECHNICAL UNIVERSITY
WO/2021/093090	TRADITIONAL CHINESE MEDICINE EXTRACT COMPOSITION HAVING FUNCTION OF REGULATING DEPRESSION, PREPARATION METHOD THEREFOR, AND CHINESE MEDICINE PREPARATION	CHENLAND NUTRITIONALS, INC.
WO/2021/120213	DEEP BEAUTY-TREATMENT MASSAGE CREAM AND PREPARATION METHOD AND APPLICATION METHOD	TANGSHAN HARBIN SHIP TECHNOLOGY CO., LTD.
WO/2021/109276	COMPLEX, TISSUE REPAIR MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF	SHAANXI BIO REGENERATIVE MEDICINE CO., LTD
WO/2021/127814	PHOTO-NANOVACCINE FOR CANCER TREATMENT, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHENZHEN PEOPLE'S HOSPITAL
WO/2021/103232	PREPARATION METHOD FOR CORE-SHELL NANOPARTICLES BASED ON LIPID MEMBRANE AND METAL ORGANIC FRAMEWORK	SHANGHAI NATIONAL ENGINEERING RESEARCH CENTER FOR NANOTECHNOLOGY LTD.
WO/2021/128027	TACI-FC FUSION PROTEIN AND USE THEREOF	REMEGEN CO., LTD.
WO/2021/008084	ADRENALINE INJECTION AND PREPARATION METHOD THEREFOR	HYBIO PHARMACEUTICAL CO., LTD.
WO/2021/103238	TRADITIONAL CHINESE MEDICINE COMPOUND PREPARATION FOR PREVENTING AND TREATING PORCINE DIARRHEA AND PREPARATION METHOD THEREFOR	GUANGDONG RONGDA BIOLOGY CO., LTD.
WO/2021/103239	COLISTIN SULPHATE PREMIX AND PREPARATION METHOD THEREFOR	GUANGDONG RONGDA BIOLOGY CO., LTD.
WO/2021/103240	SOLUBLE GRANULE FOR IMPROVING PIG IMMUNITY AND METHOD FOR PREPARATION THEREOF	GUANGDONG RONGDA BIOLOGY CO., LTD.
WO/2021/128045	COMPOSITION FOR CONDITIONING KERATAIN FIBERS	L'OREAL
WO/2021/128054	COMPOSITION FOR CONDITIONING KERATAIN FIBRES	L'OREAL
WO/2021/128055	COMPOSITION FOR CONDITIONING KERATAIN FIBERS	L'OREAL
WO/2021/128119	KIT FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/120268	MUPIROCINE OINTMENT AND PREPARATION METHOD THEREFOR	FRONT PHARMACEUTICAL PLC.
WO/2021/128232	OPHIOPOGONIS RADIX DEGRADATION EXTRACT AND USE THEREOF IN PREPARATION OF HYPOGLYCEMIC DRUGS	GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE
WO/2021/128292	COMPOSITION AND METHOD FOR TREATMENT OF MULTIPLE SCLEROSIS	WUHAN VAST CONDUCT SCIENCE FOUNDATION CO., LTD.
WO/2021/128307	FLAVOR COMPOSITION AND ELECTRONIC CIGARETTE LIQUID CONTAINING FLAVOR COMPOSITION	SHENZHEN RELX TECHNOLOGY CO., LTD.
WO/2021/098011	METHOD FOR COMPREHENSIVELY EXTRACTING AUTOLOGOUS LEUKOCYTES AND PLATELET PLASMA	SICHUAN I LOVE WOLAI AUTOMOBILE CLUB CO., LTD
WO/2021/134171	COMPOSITION FOR BRIGHTENING OR WHITENING KERATIN MATERIALS	L'OREAL
WO/2021/134194	ANHYDROUS COMPOSITION FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/134394	COMPOSITION COMPRISING PHENOLIC COMPOUNDS AND HYDROTROPES	L'OREAL
WO/2021/134420	COMPOSITION FOR CARING FOR KERATIN MATERIALS AND USE THEREOF	L'OREAL
WO/2021/134454	COMPOSITION FOR COSMETIC PRODUCTS	L'OREAL
WO/2021/134458	COMPOSITION FOR CONDITIONING KERATIN MATERIALS	L'OREAL
WO/2021/134460	COMPOSITION FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/134463	COMPOSITION FOR CONDITIONING KERATIN MATERIALS	L'OREAL
WO/2021/134469	COMPOSITION FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/134482	DIRECT COMPRESSED ACTIVATED CARBON TABLET FORMULATION	FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
WO/2021/062960	APPLICATION OF PEG INTERFERON AND PROTO-ONCOGENE PRODUCT TARGETING INHIBITOR IN SYNERGISTIC TREATMENT OF RENAL CARCINOMA	SHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD.
WO/2021/062961	APPLICATION OF PEG-INTERFERON AND PROTOONCOGENE PRODUCT TARGETING INHIBITOR IN SYNERGISTIC INHIBITION OF TUMORS	SHANGHAI INSTITUTE OF BIOLOGICAL PRODUCTS CO., LTD.
WO/2021/134623	TERTIARY AMINE PHARMACEUTICAL COMPOSITION AND INDUSTRIAL BATCH PREPARATION METHOD THEREFOR	AC PHARMACEUTICALS CO., LTD
WO/2021/134647	SUSTAINED RELEASE COMPOSITION AND PREPARATION METHOD THEREFOR	DIQI PHARMACEUTICALS CO., LTD.
WO/2021/000558	ACTIVATING AGENT FOR SIMULTANEOUSLY ACTIVATING OXIDATIVE PHOSPHORYLATION PATHWAY AND INHIBITING GLYCOLYTIC PATHWAY AND APPLICATION THEREOF	LANZHOU UNIVERSITY
WO/2021/008100	SYNERGISTIC EFFECT OF COBRA NEUROTOXIN POLYPEPTIDE ON INHIBITING OPIOID HYPERALGESIA AND TOLERANCE AND ALLEVIATING PAIN ASSOCIATED THEREWITH	QI, Zhankai
WO/2021/042645	APPLICATION OF COBRA NEUROTOXIN PEPTIDE MOLECULE IN TREATING NEPHRITIS PROTEINURIA	QI, Zhankai
WO/2021/051720	CLASS OF ANTI-HUMAN EGFR ANTIBODY DRUG CONJUGATE AND PREPARATION METHOD AND APPLICATION THEREOF	INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/068432	APPLICATION OF ELAPIDAE SNAKE POSTSYNAPTIC NEUROTOXIN MONOMER MOLECULE IN TREATMENT OF ALZHEIMER'S DISEASE	QI, Zhankai
WO/2021/093134	USE OF GROUP OF SNAKE NERVE GROWTH FACTORS AND SNAKE NERVE GROWTH FACTOR PRECURSORS IN TREATMENT OF SENILE DEMENTIA	QI, Zhankai
WO/2021/103288	CELL CAPABLE OF BEING TRACED IN ORGANISM, PREPARATION METHOD THEREFOR, AND USE THEREOF IN CELL PHARMACOKINETICS RESEARCH	SHANGHAI HEXAELL BIOTECH CO., LTD.
WO/2021/138759	PREPARATION METHOD FOR AND USE OF COMBINATION OF ANTIBODY TARGETING TUMOR ANTIGEN AND INKT CELLS	SHANGHAI SINOBAY BIOTECHNOLOGY CO., LTD.
WO/2021/138824	A COSMETIC CLEANSING COMPOSITION	BEIERSDORF DAILY CHEMICAL (WUHAN) CO., LTD.
WO/2021/031519	ASCIDIAN EXTRACT RICH IN VARIOUS PLASMALOGENS AND PREPARATION AND ANALYSIS METHODS THEREFOR	TIAN, Bing
WO/2021/109319	BATH MOISTURIZER HAVING HIGH MOISTURE RETENTION EFFECT AND PREPARATION METHOD THEREFOR	JOMOO KITCHEN&BATH CO., LTD
WO/2021/142577	ARYLAMIDE COMPOUND BASED ON BENZENE RING SUPRAMOLECULAR INTERACTION, SELF-ASSEMBLY MORPHOLOGY, AND USE	YI, Tianqi
WO/2021/047137	MEDICINE FOR TREATING PERIODONTAL DISEASE CAUSED BY PERIODONTAL PATHOGEN INFECTION	HOSPITAL OF STOMATOLOGY, SUNYAT-SEN UNIVERSITY
WO/2021/017434	APPLICATION OF ACANTHOPANAX TRIFOLIATUS POLYSACCHARIDE ATP1-1 IN PREPARATION OF MEDICINES FOR TREATING DIABETES	GUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/142733	COMBINATIONAL THERAPY COMPRISING GLP-1 AND/OR GLP-1 ANALOGS, AND INSULIN AND/OR INSULIN ANALOGS	SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/142736	DOSING REGIMEN OF GLP-1	SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/142737	COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH)	SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/134842	USE OF ZC3H12B GENE OR PROTEIN AND ESTABLISHMENT METHOD FOR LIVER DISEASE ANIMAL MODEL	SHANGHAI OCEAN UNIVERSITY
WO/2021/142815	BERBERINE AND COPTISINE, OR ACTIVE METABOLITES THEREOF, AND APPLICATION OF SALTS THEREOF IN MEDICATION FOR PREVENTING AND/OR TREATING URIC ACID NEPHROPATHY	INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/017448	EXTERNAL COMPOSITION FOR SKIN HAVING ITCHING RELIEVING EFFECT	YANGSHENGTANG (ANJI) COSMETICS CO., LTD.
WO/2021/068439	SYNERGISTIC ANTI-SKIN-AGING PREPARATION COMPRISING EXOSOME AND SPONGE SPICULE OR ANALOGUE THEREOF	SHENZHEN PEOPLE'S HOSPITAL
WO/2021/056946	APPLICATION OF ANTI-LCN2 ANTIBODY IN PREPARATION OF DRUG FOR TREATING LUPUS NEPHRITIS	NANJING DRUM TOWER HOSPITAL
WO/2021/151251	TREATING TREATMENT-RESISTANT DIABETES WITH GLUCOKINASE ACTIVATOR	HUA MEDICINE (SHANGHAI) LTD.
WO/2021/151259	USE OF 3-(4-HYDROXYPHENYL)PROPIONIC ACID IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING RESPIRATORY TRACT INFECTION	SUN YAT-SEN UNIVERSITY
WO/2021/155580	COMBINATION THERAPIES AND BIOMARKERS FOR TREATING CANCER	COTHERA BIOSCIENCE, INC.
WO/2021/082298	COMPOSITION CAPABLE OF RELIEVING ECZEMA SKIN CONDITION, AND PREPARATION METHOD THEREFOR	SHENZHEN YUANGUANGZHOUTECHNOLOGY CO., LTD.
WO/2021/120376	COMPOSITE PROBIOTIC COMPOSITION HAVING ANTI-AGING EFFECT AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	YANG, Bo
WO/2021/159547	POLYPEPTIDE DRUG FOR PREVENTING AND/OR TREATING OVARIAN CANCER AND USE THEREOF	ZHUHAI TENGBAI PHARMACEUTICAL CO., LTD.
WO/2021/031536	USE OF NADH AND/OR NMN IN PREPARING MEDICAMENTS AND HEALTH CARE PRODUCTS FOR BRAIN FUNCTION RECOVERY	HOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/163874	RECOMBINANT VIRAL VECTOR, IMMUNOGENIC COMPOSITION COMPRISING SAME, AND USES	VACDIAGN BIOTECHNOLOGY CO., LTD.
WO/2021/163897	PHARMACEUTICAL COMPOSITION CONTAINING METHYLENE BLUE DYE, NUTRIENT OR/AND CONVENTIONAL ANTITUMOR DRUG, AND APPLICATION THEREOF	CHENGDU KUACHANGAOPU MEDICAL TECHNOLOGY CO., LTD.
WO/2021/163915	MILD CLEANSING COMPOSITION CONTAINING NEARLY SATURATED, SATURATED OR SUPERSATURATED ACTIVE INGREDIENTS AND PREPARATION METHOD THEREFOR	HUANG, Yaokun
WO/2021/163965	FLEXIBLE, POROUS, DISSOLVABLE SOLID SHEET ARTICLES CONTAINING CATIONIC SURFACTANT	THE PROCTER & GAMBLE COMPANY
WO/2021/163980	SUBSTANCE TARGETING MASP-2 AND N PROTEIN OR BINDING THEREOF FOR PREVENTING AND/OR TREATING CORONAVIRUS INFECTION	ACADEMY OF MILITARY MEDICAL SCIENCE, ACADEMY OF MILITARY SCIENCE, PLA.
WO/2021/164037	MEDICATION FOR TREATING INFLUENZA OR INFECTIOUS DISEASE	XIAO, Mingchun
WO/2021/142884	USE OF ASPIRIN IN PREPARATION OF PLATELET-TARGETED DRUG DELIVERY SYSTEM	SOUTHEAST UNIVERSITY
WO/2021/138979	PROBIOTIC MINERAL MATERIAL COMPOSITE PREPARATION AND APPLICATION OF MINERAL MATERIALS IN PREPARATION OF DRUGS FOR INHIBITING MALIGNANT TUMOR GROWTH	NANJING UNIVERSITY
WO/2021/168684	ORAL CARE COMPOSITIONS FOR GUM HEALTH	THE PROCTER & GAMBLE COMPANY
WO/2021/168696	ORAL CARE COMPOSITIONS FOR GUM HEALTH	THE PROCTER & GAMBLE COMPANY
WO/2021/068452	DNA VACCINE CAPABLE OF EFFECTIVELY TREATING AND/OR PREVENTING TYPE 1 DIABETES AND USE THEREOF	THE FIFTH MEDICAL CENTER OF CHINESE PLA GENERAL HOSPITAL
WO/2021/174406	MEDICAL USE OF ANEMOSIDE B4 IN TREATING ORAL ULCER	LIU, Qi
WO/2021/174416	DETECTION METHOD FOR CIRCULATING TUMOR CELL	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/168876	ANTI-CORONAVIRUS APPLICATION OF ASCORBYL PALMITATE	SUN YAT-SEN UNIVERSITY
WO/2021/164054	APPLICATION OF CANNABIDIOL IN PREPARATION OF SKINCARE PRODUCTS HAVING SOOTHING AND ANTI-IRRITATION EFFECTS	DOCTOR PLANT GUANGDONG BIOTECHNOLOGY CO., LTD.
WO/2021/051750	TRADITIONAL CHINESE MEDICINE FOR TREATING DISEASES OF BODY CAUSED BY BODY DAMPNESS, AND PREPARATION METHOD THEREFOR	YEUNG, Tak Wai Waisees
WO/2021/159570	APPLICATION OF BAICALEIN IN PREPARING DRUG FOR PREVENTING AND/OR TREATING NOVEL CORONOVIRUS INFECTIOUS DISEASE	INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES & PEKING UNION MEDICAL COLLEGE
WO/2021/179106	APPLICATION OF GP73 INHIBITOR IN PREPARATION OF DRUG FOR TREATING DIABETES	BEIJING SUNGEN BIOMEDICAL TECHNOLOGY CO. LTD.
WO/2021/134913	APPLICATION OF HUMAN CRYPTOCHROME PROTEIN I (HCRY1) IN PREPARATION OF ANTI-ULTRAVIOLET RADIATION PREPARATION	GUANGZHOU DOUBLLE BIOPRODUCT CO., LTD
WO/2021/103342	POLYETHYLENE GLYCOL CONJUGATED DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF	CHONGQING UPGRA BIOLOGICAL SCI. & TECH., LTD.
WO/2021/109351	POLYETHYLENE GLYCOL CONJUGATE DRUG, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	CHONGQING UPGRA BIOLOGICAL SCI. & TECH., LTD.
WO/2021/017475	OPHTHALMIC PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSPORINE, PREPARATION METHOD AND USE THEREOF	SHENYANG XINGQI PHARMACEUTICAL CO., LTD.
WO/2021/179214	Methods for enhancing anti-apoptotic pathway to prevent DOX toxicity	SHENZHEN UNIVERSITY
WO/2021/012686	NALOXONE HYDROCHLORIDE INJECTION AND PREPARATION METHOD THEREFOR	GUANGDONG QIFANG MEDICINES CO., LTD.
WO/2021/147151	USE OF FUCOSAN SULFATE IN PROMOTING FOAM CELL AUTOPHAGY TO DECOMPOSE OX-LDL	SHANDONG UNIVERSITY
WO/2021/179319	COMPOSITION CONTAINING HYDROLYZED CHONDROITIN SULFATE FOR PREVENTING AND TREATING OSTEOARTHROPATHY	NANJING HANXIN PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/174581	NEW USE OF INDAZOLE COMPOUND	TARAPEUTICS SCIENCE INC.
WO/2021/008149	APPLICATION OF AKKERMANSIA MUCINIPHILA IN PREPARATION OF ANTIDEPRESSANT DRUG OR HEALTH CARE PRODUCT	JIANGSU PROVINCE HOSPITAL OF CHINESE MEDICINE
WO/2021/168930	TABLET OF REMDESIVIR AND PREPARATION METHOD THEREFOR	GU, Shihai
WO/2021/036230	RANOLAZINE SUSTAINED-RELEASE COMPOSITION AND PREPARATION METHOD THEREFOR	HYBIO PHARMACEUTICAL CO.,LTD.
WO/2021/168931	SUBMICRO EMULSION CONTAINING ACER TRUNCATUM SEED OIL AND PREPARATION METHOD THEREFOR	SHENZHEN JINFENG BIOMEDICAL TECHNOLOGY CO., LTD
WO/2021/142920	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING LUNG CANCER, AND PREPARATION AND USE THEREOF	DONGGUAN HEC CORDYCEPS R&D CO., LTD.
WO/2021/147162	USE OF LACTOBACILLUS REUTERI FROM BREAST MILK IN REGULATING MATERNAL AND INFANT IMMUNE FUNCTION	FINE (HUNAN) BIOTECHNOLOGY CO., LTD.
WO/2021/012694	ETHYL METHYL HYDROXYPYRIDINE MALATE OR PHARMACEUTICAL COMPOSITION THEREOF, AND A USE IN PREVENTING AND/OR TREATING TYPE-II DIABETES	KENO PHARMA LIMITED
WO/2021/073041	APPLICATION OF MULTI-LINEAGE DIFFERENTIATING STRESS ENDURING CELLS, MEDICAMENT FOR TREATING PERIPHERAL NERVE INJURY AND PREPARATION METHOD THEREFOR	NANTONG UNIVERSITY
WO/2021/068459	SUSPENSION CONTAINING LOW METHOXYLATION PECTIN AND MONTMORILLONITE FOR TREATING ACUTE DIARRHEA	AFFILIATED HOSPITAL OF NANTONG UNIVERSITY
WO/2021/073042	USE OF MULTILINEAGE DIFFERENTIATION STRESS-ENDURING CELL, DRUG FOR TREATING DIABETES AND PREPARATION METHOD THEREFOR	NANTONG UNIVERSITY
WO/2021/008161	DRUG FOR ALLEVIATING PSEUDOMONAS KERATITIS	SHANDONG EYE INSTITUTE
WO/2021/142934	APPLICATION OF JAK-1 SIGNALING PATHWAY INHIBITOR IN PREPARATION OF MEDICAMENT FOR TREATING BRAIN INJURY	SOOCHOW UNIVERSITY
WO/2021/189256	USE OF MENTHOL FOR PREPARING EXTERNAL COMPOSITION FOR TREATING NEURODEGENERATIVE DISEASE AND STROKE	CHINA MEDICAL UNIVERSITY
WO/2021/155631	ERYTHROCYTE GEL DELIVERY SYSTEM, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SOOCHOW UNIVERSITY
WO/2021/179351	IMMUNE COMBINATION FOR INDUCING BROAD-SPECTRUM NEUTRALIZING ANTIBODY AGAINST HIV-1	SHANGHAI PUBLIC HEALTH CLINICAL CENTER
WO/2021/189279	METHOD FOR REDUCING BEHAVIORAL ABNORMALITIES	BENED BIOMEDICAL CO., LTD.
WO/2021/184404	COMPOSITION OF NOVEL IMMUNE AGONIST COMPOUND AND USE THEREOF IN MEDICINE CAPABLE OF RESISTING MULTIPLE DISEASES	HANGZHOU XINGAO BIOTECHNOLOGY CO., LTD.
WO/2021/134935	USE OF CANNABIDIOL IN PREPARATION OF DRUGS FOR PROMPTING HEALING OF ORAL MUCOSA	SICHUAN UNIVERSITY
WO/2021/151264	USE OF ACYLATED SPIRAMYCIN IN PREPARATION OF MEDICAMENT FOR TREATING CORONAVIRUS INFECTIOUS DISEASE	SHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/184405	LIPOSOME COMPRISING GULURONIC ACID OLIGOSACCHARIDE, PREPARATION METHOD, AND USE THEREOF FOR PROMOTING IMMUNE ACTIVITY	SHENZHEN UNIVERSITY
WO/2021/189355	AMINO ACID MEDIATED GENE DELIVERY AND ITS USES	CHINESE INSTITUTE FOR BRAIN RESEARCH, BEIJING
WO/2021/031565	Treatment of Neuronal Diseases	CENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/189390	MEDICAMENT FOR PREVENTING/TREATING TYPE 2 DIABETES AND USES	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/189444	USE OF RIFAMYCIN ANTIBIOTICS IN PREPARATION OF DRUGS AGAINST YELLOW FEVER VIRUS INFECTIONS	THE NAVAL MEDICAL UNIVERSITY OF PLA
WO/2021/195820	TWO-PART COMPOSITION FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/155633	USE OF ALKYL RESORCINOL COMPOUND IN PREPARATION OF DRUG FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE	BEIJING TECHNOLOGY AND BUSINESS UNIVERSITY
WO/2021/195877	FORMULATIONS OF HUMAN PARATHYROID HORMONE (PTH) AND METHODS FOR PRODUCING SAME	SICHUAN LUZHOU BUCHANG BIO-PHARMACEUTICAL CO., LTD.
WO/2021/195883	APPLICATION OF TFF2 PROTEIN AND IFN-κ PROTEIN COMBINATION IN TREATMENT OF A NOVEL CORONAVIRUS INFECTION	SHANDONG RUIYING PIONEER PHARMACEUTICAL CO., LTD
WO/2021/195904	USE OF COMPOSITION CONTAINING ASTRAGALI RADIX, PUERARIAE LOBATAE RADIX AND ERIGERONTIS HERBA	CHONGQING TAIJI INDUSTRIAL (GROUP) CO., LTD
WO/2021/195905	COSMETIC COMPOSITION FOR SKIN CARE	L'OREAL
WO/2021/195931	COSMETIC COMPOSITION IN THE FORM OF A GEL	L'OREAL
WO/2021/077681	HYALURONIC ACID GEL COMPOSITION FOR WATER OPTOINJECTION, AND PREPARATION METHOD THEREFOR	BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD.
WO/2021/077683	HYALURONIC ACID GEL FOR HYALURONIC ACID INJECTION AND USE METHOD FOR HYALURONIC ACID GEL	BIOREGEN BIOMEDICAL (CHANGZHOU) CO., LTD
WO/2021/196079	ENERGY-ACTIVATING, ANTI-WRINKLE, ANTI-INFLAMMATORY, AND WHITENING ORCHID EMBRYO TISSUE EXTRACT	LIANG, Chiahua
WO/2021/196086	METHOD FOR INHIBITING CELL ACTIVITY BY MEANS OF INTRACELLULAR POLYMERIZATION AND PRO-DRUG IMPLEMENTING METHOD	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/189517	USE OF MTHFD1 INHIBITOR IN INHIBITING AND KILLING VIRUSES	TSINGHUA UNIVERSITY
WO/2021/057007	RAPAMYCIN NANOSCALE SUSTAINED-RELEASE AGENT AND PREPARATION METHOD THEREOF	YAN, Pengke
WO/2021/196105	ANTI-TUMOR EFFECTIVE COMPONENT OF HEDYOTIS DIFFUSA, PREPARATION METHOD THEREFOR AND USE THEREOF	GUANGDONG NEW EAR LIFE TECHNOLOGY CO., LTD.
WO/2021/164107	NOVEL APPLICATION OF IL-6 RECEPTOR ANTIBODIES	UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA
WO/2021/203236	BAT-DERIVED CORONAVIRUS VACCINE FOR PREVENTION OF COVID-19	SICHUAN CHENGYU BIOLOGICAL PRODUCTS INC.
WO/2021/168996	CATALASE NANOCAPSULES AND METHODS FOR USE	VIVIBABA, INC.
WO/2021/184449	PREPARATION METHOD FOR AND APPLICATION OF GENETICALLY ENGINEERED ANTITUMOR MICROPARTICLE	WUHAN SHENGRUN BIOTECHNOLOGY CO., LTD
WO/2021/031579	ANTI-ACETYLCHOLINESTERASE ACTIVE COMPOSITION IN CAULIS MAHONIAE AND SCREENING METHOD THEREFOR AND APPLICATION THEREOF	SHENZHEN INSTITUTE FOR DRUG CONTROL (SHENZHEN TESTING CENTER OF MEDICAL DEVICES)
WO/2021/203377	BENDAMUSTINE COMPOSITION AND USE THEREOF	BIKA BIOTECH (GUANGZHOU) CO., LTD
WO/2021/203419	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING DERMATITIS OR ECZEMA	LUNAN HOPE PHARMACEUTICAL CO., LTD.
WO/2021/203434	NANO MATERIAL FOR OSTEOCLAST ACIDIC CLOSED REGION AND PREPARATION METHOD THEREFOR	SIR RUN RUN SHAW HOSPITAL ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/196275	APPLICATION OF EMETINE IN PREPARATION OF DRUG FOR TREATING OR PREVENTING NOVEL CORONAVIRUSES SARS-COV-2	HEFEI INSTITUTES OF PHYSICAL SCIENCE, CHINESE ACADEMY OF SCIENCES
WO/2021/179396	NEW APPLICATION OF HUWE1 INHIBITOR BI8622	KUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/208060	GAS SUPPLY DEVICE, USE THEREOF FOR LIGHTENING HAIR COLOR AND METHOD	TO2M CORPORATION
WO/2021/208080	USE OF OVATODIOLIDE AGAINST NOVEL CORONAVIRUS	CNS BIOTEK CORP.
WO/2021/212253	IBRUTINIB GLUCONOLACTONE CO-CRYSTAL AND PREPARATION METHOD THEREFOR	TIANJIN CREATRON BIOTECHNOLOGY CO., LTD.
WO/2021/212267	COMPOSITION FOR CARING FOR THE SKIN	L'OREAL
WO/2021/212269	APPLICATION OF ELLAGIC ACID IN PREVENTING AND TREATING NOVEL CORONAVIRUS INFECTION	YUNNAN AGRICULTURAL UNIVERSITY
WO/2021/212270	APPLICATION OF AMARONOL A IN PREVENTION AND TREATMENT OF NOVEL CORONAVIRUS INFECTION	YUNNAN AGRICULTURAL UNIVERSITY
WO/2021/114540	PEONY FACE MASK FOR CLEANSING PORES AND PREPARATION METHOD THEREFOR	SHANXI LU'AN MINING (GROUP) CO., LTD
WO/2021/068478	POLYPEPTIDE AND POLYPEPTIDE COMPOSITION FOR INHIBITING HELICOBACTER PYLORI FROM FORMING BIOLOGICAL MEMBRANE AND ELIMINATING BIOLOGICAL MEMBRANE FORMED BY HELICOBACTER PYLORI	ANHUI SCIENCE AND TECHNOLOGY UNIVERSITY
WO/2021/036294	VAGINAL ACID-BASE BUFFER GEL AND PREPARATION METHOD	NANJING TIANLANG PHARMACEUTICAL CO., LTD.
WO/2021/051807	PREPARATION CONTAINING HUMAN ALBUMIN AND PREPARATION METHOD THEREFOR	TONGHUA ANRATE BIOPHARMACEUTICAL CO., LTD
WO/2021/212360	TREATING UNTREATED OR TREATMENT-RESISTANT DIABETES WITH GLUCOKINASE ACTIVATOR AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITOR	HUA MEDICINE (SHANGHAI) LTD.
WO/2021/098141	AEROSOL ALCOHOL-FREE NO-WASH ANTIBACTERIAL HAND SANITIZER AND PREPARATION METHOD THEREFOR	ZHEJIANG LUDAO TECHNOLOGY CO., LTD.
WO/2021/212404	TRANSPARENT SHAMPOO BAR AND METHOD FOR PREPARING THE SAME	HENKEL AG & CO. KGAA
WO/2021/088327	TOOTH MINERALIZATION SOLUTION AND MINERALIZATION METHOD THEREOF	ZHEJIANG UNIVERSITY
WO/2021/057022	PEARL PREPARATION AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	OSM BIOLOGY CO., LTD.
WO/2021/208138	TOAD SKIN STERENE TOTAL LACTONE EXTRACT, AND PREPARATION METHOD THEREFOR AND USE THEREOF	HEFEI HUAFANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/174656	CHINESE PATENT MEDICINE FOR TREATING SUB-HEALTH CHRONIC DISEASES	WU, Guanlin
WO/2021/217388	MEMANTINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE AND PREPARATION METHOD THEREFOR	JIANGSU TASLYDIYI PHARMACEUTICAL CO., LTD.
WO/2021/120486	LITHIUM ION COMPOSITION AND APPLICATION THEREOF	QINGDAO DEBAO SHANGJIA HOUSEHOLD PRODUCTS CO. , LTD
WO/2021/169026	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREVENTING EPIDEMICS, AND PREPARATION METHOD THEREFOR AND USE THEREOF	JIANGSU PROVINCE HOSPITAL OF TCM
WO/2021/196334	APPLICATION OF PYR3 IN PREPARATION OF DRUG FOR PROTECTING AGAINST LIVER DAMAGE	THE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY
WO/2021/196335	USE OF PYR3	THE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY
WO/2021/217560	KIT FOR CARING FOR THE SKIN	L'OREAL
WO/2021/217568	ASSEMBLED JADE-ACTIVATING MATERIAL FOR MAINTAINING BEAUTY AND KEEPING YOUNG, AND ASSEMBLING AND SYNTHESIZING METHOD THEREFOR AND USE THEREOF	SICHUAN SANTAI PHARMACEUTICAL TECHNOLOGY CO. LTD
WO/2021/169034	APPLICATIONS OF TRANSFERRIN OR OVEREXPRESSED TRANSFERRIN IN PREPARING MEDICAMENT FOR TREATING AND/OR PREVENTING ULCERATIVE COLITIS	KUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/223143	O/W EMULSION AND W/O EMULSION INVERTED THEREFROM, AND PERSONAL CARE COMPOSITION CONTAINING SAME	MOMENTIVE PERFORMANCE MATERIALS INC.
WO/2021/217693	USE OF SYMBIOTIC FERMENTATION PRODUCT OF HYDROLYZED CANDIDA AND JAPANESE SAKE YEAST	HANGZHOU QIANMEI COSMETIC CO., LTD
WO/2021/004145	USE OF MIR-132 AND 212 IN PREPARATION OF DRUG FOR TREATING ADDICTION	SHENZHEN KANGNING HOSPITAL (SHENZHEN MENTAL HEALTH INSTITUTE, SHENZHEN MENTAL HEALTH CENTER)
WO/2021/226736	TREATMENT OF ADVERSE EFFECTS CAUSED BY ATYPICAL ANTIPSYCHOTICS	SHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/226738	MOLECULAR-LEVEL PHARMACEUTICAL COMPOSITION COMPRISING LENVATINIB AND PREPARATION METHOD THEREFOR AND USE THEREOF	BEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RESEARCH CO. LTD.
WO/2021/217702	MEDICINE AND FOOD FOR PREVENTING OR TREATING COVID-19, AND APPLICATION THEREOF	GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/226762	TUMOR MICROENVIRONMENT RESPONSE-TYPE NANO-COMPOSITE DRUG LOADING SYSTEM, AND PREPARATION METHOD THEREFOR AND USE THEREOF	WANG, Shubin
WO/2021/203515	PREPARATION METHOD FOR MICRORNA MICRO/NANOSPHERES AND APPLICATION THEREOF IN HEALING SPINAL CORD INJURY	YAOSHUNZE BIO-MEDICAL (NANJING) CO., LTD.
WO/2021/082391	COLLAGEN NANO INSTANT FACIAL MASK OF YEAST RECOMBINANT COLLAGEN AND PREPARATION METHOD THEREFOR	NOX BELLCOW COSMETICS CO., LTD.
WO/2021/226849	IMMUNOLOGICALLY ACTIVE PEPTIDE-BILIVERDIN CONJUGATE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	INSTITUTE OF PROCESS ENGINEERING, CHINESE ACADEMY OF SCIENCES
WO/2021/098164	METHOD FOR EXTRACTING KELP POLYPHENOLS	QINGDAO UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/226883	COMPOSITIONS AND METHODS FOR TREATING CANCER SUBMISSION OF SEQUENCE LISTING ON ASCII TEXT FILE	ADAGENE AG
WO/2021/103434	RECOMBINANT VARICELLA-ZOSTER VIRUS VACCINE	BEIJING LUZHU BIOTECHNOLOGY CO., LTD.
WO/2021/008215	POLYMER COMPOSITE MICROSPHERE, PREPARATION METHOD THEREFOR AND USE THEREOF	GUANGDONG INSTITUTE OF MEDICAL INSTRUMENTS
WO/2021/217740	COMPOSITIONS AND METHODS FOR INHIBITING VIRUS INFECTION	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/227077	AMINO ACID COMPOSITION AND METHOD FOR CATALYTIC SYNTHESIS OF AMINO ACID BY MEANS OF ENERGY RADIATION	BEIJING GUANGHE ORIGINAL TECHNOLOGY CO., LTD.
WO/2021/057042	DRUG COMPOSITION CONTAINING ABIRATERONE ACETATE, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	HUNAN HUIZE BIO-PHARMACEUTICAL CO., LTD
WO/2021/232334	TRADITIONAL CHINESE MEDICINE COMPOSITION HAVING ANTI-ACNE EFFECT, PREPARATION METHOD THEREFOR, AND USE THEREOF	JOHNSON BIOTECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/237456	ANTI-TUMOR PHARMACEUTICAL COMPOSITION AND USE THEREOF	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/237609	NOVEL USE OF ORIDONIN OR ORIDONIN DERIVATIVE	TSINGHUA UNIVERSITY
WO/2021/047210	IMMUNIZATION-PURPOSE SUSPENDING AGENT, VACCINE SUSPENSION PREPARATION METHOD AND SPRAY-DROP IMMUNIZATION METHOD	FOSHAN STANDARD BIO-TECH CO., LTD.
WO/2021/159636	USE OF COMPOUND ZZ-8 IN PREPARING DRUG FOR TREATMENT OF OBESITY	KEY LABORATORY OF SOUTH SUBTROPICAL PLANT DIVERSITY, FAIRY LAKE BOTANICAL GARDEN, SHENZHEN & CHINESE ACADEMY OF SCIENCES
WO/2021/012789	PHARMACEUTICAL COMPOSITION CONTAINING LYSOZYME AND USE THEREOF	GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/237691	DEFORMABLE SOLID COMPOSITION FOR CLEANSING THE SKIN	L'OREAL
WO/2021/237697	COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS	L'OREAL
WO/2021/042777	MULTI-COMPONENT GEL SUSTAINED-RELEASE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF TUMORS	SUZHOU INNOVATIVE BIOMATERIALS & PHARMACEUTICS CO., LTD.
WO/2021/042778	TEMPERATURE-SENSITIVE GEL PHARMACEUTICAL COMPOSITION FOR TREATMENT OF TUMORS	SUZHOU INNOVATIVE BIOMATERIALS & PHARMACEUTICS CO., LTD.
WO/2021/155651	USE OF 4-AMINOQUINOLINE COMPOUND IN TREATMENT OF CORONAVIRUS INFECTION	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/212617	SEAWEED MASK, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHANDONG UNIVERSITY
WO/2021/008265	ANTI-AGING SOFT CAPSULE FOR MENOPAUSAL WOMEN AND PREPARATION METHOD THEREFOR	ZAOZHUANG UNIVERSITY
WO/2021/068533	DRUG FOR ANTAGONIZING REPLICATION OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS AND APPLICATION THEREOF	NANJING AGRICULTURAL UNIVERSITY
WO/2021/135071	USE OF PIPERAZINE FERULATE TABLETS	SHENZHAN TRADITIONAL CHINESE MEDICINE HOSPITAL
WO/2021/227156	COMPOSITIONS AND METHODS FOR TREATING CANCER	ADAGENE AG
WO/2021/243645	GLUCOKINASE ACTIVATOR FOR TREATING DIABETES WITH RENAL IMPAIRMENT	HUA MEDICINE (SHANGHAI) LTD.
WO/2021/243646	GLUCOKINASE ACTIVATOR FOR TREATING DIABETES WITH HEPATIC IMPAIRMENT	HUA MEDICINE (SHANGHAI) LTD.
WO/2021/243658	TREATMENT OR PREVENTION OF CORONAVIRIDAE INFECTION	WATERSTONE PHARMACEUTICALS (WUHAN) CO., LTD.
WO/2021/243669	USE OF A COMPOUND CONTAINING TWO OR MORE ALCOHOLIC HYDROXYL GROUPS OR PHENOLIC HYDROXYL GROUPS AS A MICROBIOME REGULATOR ON SCALP	HENKEL AG & CO. KGAA
WO/2021/093315	COMPOSITION FOR PROTECTING LIVER, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	JIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/063016	COMPOSITION WITH HYPOLIPIDEMIC FUNCTION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	JIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/057089	COMPOSITION WITH CHLOASMA REMOVAL FUNCTION, PREPARATION METHOD THEREFOR AND USE THEREOF	JIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/022891	COMPOSITION HAVING IMMUNITY-ENHANCING FUNCTION AND PREPARATION METHOD THEREFOR	JIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/109509	COMPOSITION HAVING IMMUNITY-ENHANCING FUNCTION AND PREPARATION METHOD THEREFOR	JIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/109510	COMPOSITION HAVING DIGESTION PROMOTING FUNCTION, PREPARATION METHOD AND APPLICATION THEREOF	JIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/109511	ANTI-FATIGUE COMPOSITION AND PREPARATION METHOD THEREFOR	JIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/114586	IMMUNE RESPONSE-IMPROVING COMPOSITION, PREPARATION METHOD AND APPLICATION THEREOF	JIANGSU KANGREN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO. LTD.
WO/2021/196402	PHARMACEUTICAL COMPOSITION AND USE THEREOF	DONGGUAN HEC CORDYCEPS R&D CO., LTD.
WO/2021/217788	METHOD FOR PREPARING COMPOUND-TYPE TABLETS FOR PROTECTING LIVER AND DISPELLING EFFECTS OF ALCOHOL	JIANG SU ZHONGXING PHARM.CO., LTD
WO/2021/227166	APPLICATION OF SUCCINYLATION MODIFICATION OF PROTEIN IN PREPARATION OF TUMOR CELL METABOLISM REGULATOR	TANG, Bo
WO/2021/174714	MELANIN-BASED SUNSCREEN COMPOSITION AND PREPARATION METHOD THEREFOR	JIANGNAN UNIVERSITY
WO/2021/174715	PERSONAL CARE SUNSCREEN COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF	JIANGNAN UNIVERSITY
WO/2021/073131	MEDICAMENT FOR EFFICIENTLY KILLING DRUG-RESISTANT DISEASE BACTERIA AND APPLICATION THEREOF IN INHIBITING DRUG-RESISTANT DISEASE BACTERIA	OCEAN UNIVERSITY OF CHINA
WO/2021/073132	APPLICATION OF HIGH PURITY NERVONIC ACID IN WHITENING AND PREPARATION METHOD FOR HIGH PURITY NERVONIC ACID	NANJING KANGQI BIOLOGICAL TECHNOLOGY CO., LTD
WO/2021/004229	NEW APPLICATION OF CHEMOKINE RECEPTOR CCR6 INHIBITOR IN PREVENTING RECURRENCE OF PSORIASIS	RUIJIN HOSPITAL, SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/253147	METHOD FOR PREPARING CELL-MEDIATED SARS-COV-2 VACCINES	YIN, Xiushan
WO/2021/114596	PHENYLETHANOID GLYCOSIDE EXTRACT FROM ACANTHUS ILICIFOLIUS, AND PREPARATION METHOD THEREOF AND APPLICATION AS DRUG FOR RESISTING LIVER DAMAGE	OCEAN UNIVERSITY OF CHINA
WO/2021/143042	PHARMACEUTICAL COMPOSITION FOR TREATING SEVERE BURNS AND SKIN GANGRENE AND APPLICATION THEREOF	BEIJING GUANGJIE-YOUNG HEALTH SCIENCE AND TECHNOLOGY CO. LTD
WO/2021/189678	WHOLE-CELL CONSTITUENT TRANSPORT SYSTEM AND APPLICATION THEREOF	SOOCHOW UNIVERSITY
WO/2021/217816	COMPOSITION FOR PREVENTING AND TREATING PNEUMONIA, AND PREPARATION METHOD THEREFOR AND USE THEREOF IN PREPARATION OF DRUG FOR PREVENTING AND TREATING PNEUMONIA	INSTITUTE OF SCIENCE AND TECHNOLOGY, GUANGDONG UNIVERSITY OF CHINESE MEDICINE
WO/2021/077770	MINI COMBINED ADJUVANT NANOPARTICLE, PREPARATION METHOD THEREFOR AND APPLICATION THEREFOR	INSTITUTE OF BIOMEDICAL ENGINEERING, CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/248532	VORICONAZOLE PREPARATION FOR EXTERNAL USE AND PREPARATION METHOD THEREFOR	ZHEJIANG POLY PHARM CO., LTD
WO/2021/217823	DIHYDROMYRICETIN HAVING FUNCTION OF DISPELLING EFFECTS OF ALCOHOL	SONG, Kunyuan
WO/2021/243756	PHARMACEUTICAL USE OF MYRICETIN IN INHIBITION OF NOVEL CORONAVIRUS	SHANGHAI SPARK PHARMACEUTICAL CO., LTD
WO/2021/243757	PHARMACEUTICAL APPLICATION OF GALLIC ACID	SHANGHAI SPARK PHARMACEUTICAL CO., LTD
WO/2021/217826	PHARMACEUTICAL APPLICATION OF DIMYRICETIN-YL-DISELENIDE	SHANGHAI SPARK PHARMACEUTICAL CO., LTD
WO/2021/253338	USE OF ROMIDEPSIN IN PREVENTING AND TREATING CORONAVIRUS-RELATED DISEASES	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES
WO/2021/120562	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING EGFR-TKIS-RELATED SKIN RASH, AND USE THEREOF	LIN, Lizhu
WO/2021/068550	ACTIVE POLYPEPTIDE COMPOUND	SHAANXI MICOT TECHNOLOGY CO., LTD.
WO/2021/253380	ORAL FORMULATIONS AND USES THEREOF	INVENTISBIO CO., LTD.
WO/2021/212635	APPLICATION OF BRUCEA JAVANICA FRUIT FAT-SOLUBLE EXTRACT IN PREPARATION OF DRUG FOR PROMOTING PERIPHERAL NERVE REGENERATION	NANTONG UNIVERSITY
WO/2021/212638	CONJUGATES OF A CELL-BINDING MOLECULE WITH CAMPTOTHECIN ANALOGS	HANGZHOU DAC BIOTECH CO., LTD.
WO/2021/227200	ORAL CAVITY CLEANING COMPOSITION AND APPLICATION THEREOF	GUANGZHOU ZHONGYU BIOTECHNOLOGY CO., LTD.
WO/2021/147235	APPLICATION OF FAVIPIRAVIR IN TREATING CORONAVIRUS INFECTION	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/147236	USE OF SUBSTITUTED AMINOPROPIONATE COMPOUND IN TREATMENT OF SARS-COV-2 INFECTIONS	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/114605	LIVER-TARGETED THERAPEUTIC DRUG BASED ON SUGAR-BASED METAL FRAMEWORK MATERIAL AND PREPARATION METHOD THEREOF	JIANGNAN UNIVERSITY
WO/2021/208237	APPLICATION OF HEPTOSE CHAIN-CONTAINING OLIGOSACCHARIDE COMPOUND IN PREPARATION OF HELICOBACTER PYLORI VACCINE	JIANGNAN UNIVERSITY
WO/2021/109549	JOINT APPLICATION OF QUERCETIN AND ANTIBACTERIAL MEDICAMENT	CHINA AGRICULTURAL UNIVERSITY
WO/2021/000770	HETEROCYCLIC COMPOUND CAPABLE OF ENHANCING IMMUNE ACTIVITY, PREPARATION METHOD THEREFOR AND APPLICATION IN MEDICINE	CAMPHOR PHARMACEUTICALS LIMITED
WO/2021/169100	APPLICATION OF TRISACCHARIDE REPEATING UNIT OLIGOSACCHARIDE CHAIN IN PREPARATION OF STAPHYLOCOCCUS AUREUS VACCINES	JIANGNAN UNIVERSITY
WO/2021/258326	APPLICATION OF MIDAZOLAM NANOCRYSTALS IN PREPARING DRUG FOR IMPROVING BLOOD-BRAIN BARRIER PERMEABILITY	MILITARY MEDICAL INSTITUTE, ACADEMY OF MILITARY SCIENCES, PLA
WO/2021/258337	HUMAN MONOCLONAL ANTIBODIES AGAINST TIGIT FOR IMMUNE RELATED DISEASES	HUAHUI HEALTH LTD.
WO/2021/258341	BARNYARD GRASS EXTRACT, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	LEITON FUTURE RESEARCH INSTITUTION JIANGSU CO., LTD.
WO/2021/258342	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR DRUG WITHDRAWAL, AND APPLICATION THEREOF	LEITON FUTURE RESEARCH INSTITUTION JIANGSU CO., LTD.
WO/2021/042830	RECOMBINANT HUMAN PAPILLOMA VIRUS VACCINE COMPOSITION AND USE THEREOF	IMMUNE-PATH BIOTECHNOLOGY (SUZHOU) CO., LTD.
WO/2021/063047	USE OF EXTRACT OF OVERGROUND PART OF SCUTELLARIAE RADIX IN AQUACULTURE	THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/012886	ANTI-NEOPLASTIC COMBINED PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF	GUANGZHOU CAS LAMVAC BIOTECH CO., LTD
WO/2021/179482	TRADITIONAL CHINESE MEDICINE COMPOUND COMPOSITION HAVING EFFECT OF PROMOTING BONE HEALTH AS WELL AS PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	CHENLAND NUTRITIONALS, INC.
WO/2021/227214	STERILIZATION AND DISINFECTION COMPOSITION	NANJING GREEN INTERFACE NEW MATERIALS RESEARCH INSTITUTE CO., LTD
WO/2021/143060	MAGNOLIA OFFICINALIS PLANT PRESERVATIVE AND BACTERIOSTATIC COMPOSITION, PREPARATION PROCESS THEREFOR, AND APPLICATION THEREOF	YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO., LTD.
WO/2021/057152	KIT FOR CARING FOR KERATIN MATERIALS	L'OREAL
WO/2021/027425	ANTI-INFLAMMATORY TARGETED DELIVERY SYSTEM AND PREPARATION METHOD THEREFOR	SOOCHOW UNIVERSITY
WO/2021/179494	DRUG FOR PREVENTING AND/OR TREATING BRAIN TUMOR AND APPLICATION THEREOF	GUANGZHOU CAS LAMVAC BIOTECH CO., LTD
WO/2021/000899	A PHARMACEUTICAL COMBINATION CONTAINING mTOR INHIBITOR AND USE THEREOF	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/000926	USE OF GINSENOSIDE M1 FOR TREATING CANCER	LEE, Sheau-Long
WO/2021/000950	PHARMACEUTICAL COMPOSITION FOR EXTERNAL USE AND PREPARATION METHOD THEREFOR	SHENZHEN RADAK BIO CORPORATION
WO/2021/000953	SUBSTANCE AND METHOD FOR TREATING TUMOR	JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD.
WO/2021/237879	USE OF AITC	THE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY
WO/2021/004422	MICROMOLECULE PI4KIIIα INHIBITOR COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF	NUO-BETA PHARMACEUTICAL TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/114647	APPLICATION OF SODIUM P-HYDROXYBENZOATE IN PREPARATION OF DRUGS FOR TREATMENT OR PREVENTION OF INFLAMMATORY BOWEL DISEASE	GUILIN MEDICAL UNIVERSITY
WO/2021/082512	USE OF BLUE-LIGHT ACTIVATED BLEBBISTATIN ANALOGUES IN KILLING DRUG-RESISTANT BACTERIA	SHENZHEN THIRD PEOPLE'S HOSPITAL
WO/2021/243797	USE OF DROSOPHILA MELANOGASTER HSP22 PROTEIN IN PREPARATION OF ANTI-TUMOR DRUG	AFFILIATED HOSPITAL OF GUILIN MEDICAL UNIVERSITY
WO/2021/174738	BIONIC NANOPARTICLE COATED WITH MESENCHYMAL STEM CELL MEMBRANE HAVING SURFACE OVEREXPRESSING PD-L1 MOLECULE, AND PREPARATION THEREFOR AND APPLICATION THEREOF	SOOCHOW UNIVERSITY
WO/2021/248601	USE OF LYCHEE PEEL EXTRACT MAINLY CONTAINING MULTIMERIC POLYPHENOL IN PREPARATION OF α-AMYLASE INHIBITOR	GUANGXI ZHUANG AUTONOMOUS REGION AND CHINESE ACADEMY OF SCIENCE, GUANGXI INSTITUTE OF BOTANY
WO/2021/042865	ORAL DRUG DOSAGE FORMS HAVING A DESIRED PK PROFILE AND METHODS OF DESIGNING AND PRODUCING THEREOF	TRIASTEK, INC.
WO/2021/004477	MITOCHONDRIA-BASED DRUG DELIVERY SYSTEM AND USE THEREOF	TANG, Lingfeng
WO/2021/243804	TRADITIONAL CHINESE MEDICINE EPIDEMIC-PREVENTION BAG	BEIJING GUORUN JIUHE HEALTH TECHNOLOGY CO., LTD
WO/2021/036537	USE OF KOUMINE IN PREPARATION OF DRUGS FOR TREATING INFLAMMATORY BOWEL DISEASE	FUJIAN MEDICAL UNIVERSITY
WO/2021/004524	PEGYLATED SYNTHETIC KL4 PEPTIDE, COMPOSITIONS AND METHODS THEREOF	THE UNIVERSITY OF HONG KONG
WO/2021/088399	MOISTURIZING AND HYDRATING FACIAL MASK COMPOSITION, FACIAL MASK, AND PREPARATION METHOD FOR FACIAL MASK COMPOSITION	HUBEI CHUANGJIE BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/184610	GALANTAMINE PAMOATE SUSTAINED-RELEASE MICROPARTICLES FOR INJECTION, AND PREPARATION METHOD THEREFOR	SHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/196443	LIQUID PREPARATION OF RECOMBINANT HUMANIZED ANTI-PD-1 MONOCLONAL ANTIBODY	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/184611	TABLET OF STEROID CYP17 INHIBITOR SOLID DISPERSION AND PREPARATION METHOD THEREFOR	SHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/217889	USE OF COMBINATION OF SMALL MOLECULE COMPOUND MLN4924 AND IFNα IN RESISTING HBV	ZHEJIANG UNIVERSITY
WO/2021/174741	APPLICATION OF DIMETHYL BERBAMINE COMPOUND IN INHIBITION OF SARS-COV-2	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/253545	CHITOSAN OLIGOSACCHARIDE COMPOSITION, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	GUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/008501	ENGINEERED VACCINIA VIRUS	SHENZHEN HUA YAO KANG MING BIOPHARMACEUTICAL CO., LTD.
WO/2021/169149	CATALASE NANOPARTICLES AND METHODS FOR USE	VIVIBABA, INC.
WO/2021/098240	USE OF RECOMBINANT SECRETED DDRGK1	SHANGHAI NINTH PEOPLE'S HOSPITAL, SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/008520	STABLE AST-3424 INJECTION PREPARATION AND PREPARATION METHOD	ASCENTAWITS PHARMACEUTICALS, LTD.
WO/2021/179505	FORSYTHIA SUSPENSA AND ASTRAGALUS MEMBRANACEUS COMPOUND PREPARATION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	YAOSHUNZE BIO-MEDICAL (NANJING) CO., LTD.
WO/2021/073178	AVIAN EGG DROP SYNDROME VIRUS TFIBER PROTEIN FRAGMENT, VACCINE COMPOSITION PREPARED THEREFROM, PREPARATION METHOD, AND APPLICATION	PULIKE BIOLOGICAL ENGINEERING, INC.
WO/2021/022984	AZO CALIXARENE PHARMACEUTICAL ADJUVANT AND USE THEREOF	TANGSHAN TIANQUAN TECHNOLOGY CO. LTD.
WO/2021/147272	USE OF BENZOATE COMPOUND IN TREATMENT OF SARS-COV-2 INFECTIONS	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/208280	APPLICATION OF DRIED FLY LARVA IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING BREAST HYPERPLASIA	HANGZHOU YIKETANG BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/155654	APPLICATION OF RITONAVIR IN TREATING SARS-COV-2 INFECTION	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/147273	APPLICATION OF NITAZOXANIDE AND ACTIVE FORM THEREOF, TIZOXANIDE, IN TREATMENT OF SARS-COV-2 INFECTION	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/017833	ANTI-AGING COSMETIC COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/017834	SKIN COMPOSITION FOR EXTERNAL USE HAVING ANTI-INFLAMMATORY EFFECT	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/017835	ENHANCED WHITENING COSMETIC COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/008565	USE OF ACETYLCHOLINE PATHWAY MODULATORS IN TREATMENT OF CANCER	TSINGHUA UNIVERSITY
WO/2021/031750	MIXED BIRCH SAP AND APPLICATION THEREOF IN SKIN CARE COSMETIC COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/017838	TOPICAL SKIN COMPOSITION WITH ANTI-ECZEMA EFFECT	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/017839	EXTERNAL SKIN COMPOSITION HAVING ANTI-ACNE EFFECT	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/013028	PHARMACEUTICAL COMBINATION AND USE THEREOF	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/017844	EXTERNAL COMPOSITION FOR SKIN HAVING ENHANCED ANTI-ECZEMA EFFECT	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/017845	ANTI-HAIR LOSS HAIR GROWTH COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/017846	ENHANCED ANTI-AGING COSMETIC COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/017877	WHITENING COSMETIC COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/017878	COMPOSITION WITH ACNE REMOVAL EFFECT FOR EXTERNAL APPLICATION TO SKIN	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/103581	SKIN TOPICAL COMPOSITION HAVING EFFICACY OF PROMOTING WOUND HEALING AND/OR SCAR REPAIR	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/063076	APPLICATION OF ALBIZIAE CORTEX LIGNAN COMPOUND IN IMPROVING STEATOSIS	JIANGNAN UNIVERSITY
WO/2021/063078	LIGNAN GLYCOSIDE COMPOUND FROM BARK OF ALBIZIA JULIBRISSIN FOR PROMOTING ENDOTHELIAL CELL PROLIFERATION AND USE THEREOF	JIANGNAN UNIVERSITY
WO/2021/008600	CATIONIC POLYMER NANOPARTICLE/HIL-22BP GENE COMPOUND FOR PREVENTING AND TREATING CANCER AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SICHUAN UNIVERSITY
WO/2021/036572	COMPOSITION FOR PREVENTING OR TREATING URIC ACID-RELATED DISEASE	GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/017910	EXTERNAL SKIN TREATMENT COMPOSITION WITH ENHANCED ANTI-INFLAMMATORY EFFECT	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/017911	ENHANCED HAIR LOSS PREVENTION AND HAIR GROWTH PROMOTION COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/008622	APPLICATION OF CARBON-BASED NANOMATERIAL IN PREPARATION OF DRUG FOR RELIEVING OR TREATING HD	SOOCHOW UNIVERSITY
WO/2021/017912	MOISTURIZING COSMETIC COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/017913	ENHANCED MOISTURE-RETAINING COSMETIC COMPOSITION	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/017925	APPLICATION OF RADIX PSEUDOSTELLARIAE CYCLIC PEPTIDE B IN IMPROVING MEMORY AND/OR PREVENTING AND TREATING ALZHEIMER’S DISEASE	GUANGDONG OCEAN UNIVERSITY
WO/2021/027509	PROTON-TRIGGERING-BASED NANODRUG SYSTEM HAVING HYDROPHILIC-HYDROPHOBIC-SIZE DOUBLE CONVERSION CHARACTERISTICS AND PREPARATION METHOD THEREFOR AND USE THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/212678	ORAL MSCS LIQUID-FILLED CAPSULE FOR TREATING INFLAMMATORY BOWEL DISEASES AND OTHER INTESTINAL DISEASES	NANJING DRUM TOWER HOSPITAL
WO/2021/208284	METHOD FOR PREPARING ORAL MICROSPHERE LOADED WITH MSCS-DERIVED EXOSOMES AND APPLICATION THEREOF	NANJING DRUM TOWER HOSPITAL
WO/2021/013204	METHOD FOR TREATING DISEASES BASED ON INTERFERON	XIAMEN AMOYTOP BIOTECH CO., LTD.
WO/2021/013207	MULTIVARIABLE DOSING METHOD FOR USE IN TREATING HIGH-EGFR EXPRESSION CANCER	SINOCELLTECH LTD
WO/2021/013214	USE OF NEUTROPHILIC GRANULOCYTES IN PREPARATION OF DRUGS FOR TREATING AND/OR PREVENTING AUTOIMMUNE HEPATITIS	SICHUAN UNIVERSITY
WO/2021/031791	DEXIBUPROFEN FAT EMULSION INJECTION AND PREPARATION METHOD THEREFOR	SOOCHOW UNIVERSITY
WO/2021/013232	AIE-ACTIVE PHOTOSENSITIZER FOR SELECTIVE BACTERIAL ELIMINATION AND CANCER CELL ABLATION	THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/018026	LIQUID PREPARATION AND APPLICATION THEREOF	ZHANG, Jinyu
WO/2021/018032	PHARMACEUTICAL COMPOSITION OF MDM2 INHIBITOR AND USE THEREOF FOR PREVENTING AND/OR TREATING DISEASE	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/018046	SGLTS/DPP4 INHIBITOR AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/013262	NANO-MICELLE PREPARATION OF ICARITIN AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	BEIJING SHNOGEN PHARMA GROUP LTD
WO/2021/013270	PHARMACEUTICAL COMPOSITION FOR TREATING POLYP	NANJING SANTONG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/143096	WHITENING, ACNE-REMOVING, BLACKHEAD-REMOVING AND ANTI-AGING COMPOSITION, AND USE AND PREPARATION THEREOF	GUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/031810	APPLICATION OF PTBP1 INHIBITOR IN PREVENTING AND/OR TREATING NERVOUS SYSTEM DISEASE RELATED TO FUNCTIONAL NEURONAL DEATH	CENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/023069	APPLICATION OF TPK AS A TARGET IN ALZHEIMER'S DISEASE	SHANGHAI RIXIN BIOTECHNOLOGY CO., LTD.
WO/2021/036654	GRAPHENE ALKALI TARGETING DNA MAJOR GROOVE AND INHIBITING TOPOISOMERASE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHANGHAI UNIVERSITY
WO/2021/036656	ODOR-MASKING COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF	LUNAN HOPE PHARMACEUTICAL CO., LTD.
WO/2021/208290	USE OF GPHB5 GLYCOPROTEIN HORMONE IN LOWERING LIPID AND IMPROVING INSULIN SENSITIVITY	GUANGZHOU HUAZHEN PHARMACEUTICAL CO., LTD.
WO/2021/093376	USE OF PHOSPHODIESTERASE 5 INHIBITOR IN PREPARATION OF MEDICAMENT FOR RESISTING FIBROTIC DISEASES	GUANGZHOU HUAZHEN PHARMACEUTICAL CO., LTD.
WO/2021/184636	SHOUHUI TONGBIAN MICROCAPSULE PREPARATION AND PREPARATION METHOD THEREFOR	LUNAN HOPE PHARMACEUTICAL CO., LTD.
WO/2021/027576	COMBINATION PRODUCT COMPRISING LIMONOIDS AND SGLT-2 INHIBITORS	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/027577	COMBINATION PRODUCT CONTAINING LIMONOID AND α-GLUCOSIDASE INHIBITOR	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/189743	APPLICATION OF CHINESE THOROWAX ROOT-HONEYSUCKLE FLOWER FORMULATION IN PREPARING ANTI-CORONAVIRUS DRUG AND PREPARATION METHOD FOR CHINESE THOROWAX ROOT-HONEYSUCKLE FLOWER FORMULATION	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/196469	USE OF PREPARATION FOR REMOVING FOOD RETENTION AND RELIEVING COUGH IN CHILDREN IN PREPARATION OF DRUG FOR TREATING FEVER SYNDROMES AND PREPARATION METHOD THEREFOR	LUNAN HOPE PHARMACEUTICAL CO., LTD.
WO/2021/027581	COMBINATION PRODUCT COMPRISING LIMONOID AND DPP-4 INHIBITORS	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/027582	COMBINATION PRODUCT CONTAINING LIMONIN COMPOUND AND THIAZOLIDINEDIONE	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/184639	MICROCAPSULE PREPARATION FOR ELIMINATING FOOD STAGNATION AND RELIEVING COUGHS IN CHILDREN AND PREPARATION METHOD THEREFOR	SHANDONG NEW TIME PHARMACEUTICAL CO., LTD.
WO/2021/027583	COMBINATION PRODUCT CONTAINING LIMONIN COMPOUND AND SULFONYLUREA DRUG	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/018237	DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/018240	COMBINATION PRODUCT OF A BCL-2/BCL-XL INHIBITOR AND A CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/212686	METHOD FOR RHO-ADRP BASED ON GENE EDITING, AND COMPOSITION	CHIGENOVO CO., LTD.
WO/2021/004549	USE FOR DUAL TARGET VASCULAR INHIBITOR IN PREPARING DRUGS FOR PREVENTING OR TREATING FIBROSIS	BINZHOU MEDICAL UNIVERSITY
WO/2021/068614	APPLICATION OF HONOKIOL AND MAGNOLOL IN PREPARING MCR-1 ENZYME INHIBITOR	UNIV JILIN
WO/2021/023099	BRUCINE GEL FORMULATION AND PREPARATION METHOD THEREFOR	BEIJING INCREASEPHARM CORPORATION LIMITED
WO/2021/103632	SAFE AND ENVIRONMENTALLY FRIENDLY IRIDESCENT NAIL POLISH	JINHUA KVS CHEMICAL CO., LTD.
WO/2021/208294	APPLICATION OF PDE4 INHIBITOR IN PREPARATION OF DRUG FOR INHIBITING PROLIFERATION IN GLIOMA	GUANGZHOU HUAZHEN PHARMACEUTICAL CO., LTD.
WO/2021/208295	USE OF PDE4 INHIBITOR IN PREPARATION OF DRUG FOR TREATING LEUKEMIA	GUANGZHOU HUAZHEN PHARMACEUTICAL CO., LTD.
WO/2021/023108	ANTI-PD-1 ANTIBODY AND MEDICAL USE THEREOF	CTTQ-AKESO (SHANGHAI) BIOMED. TECH. CO., LTD.
WO/2021/023118	USE OF 5-METHYLTETRAHYDROFOLIC ACID AND COMPOSITION OF 5-METHYLTETRAHYDROFOLIC ACID	LIANYUNGANG JINKANG HEXIN PHARMACEUTICAL CO., LTD.
WO/2021/139147	BIVALENT ADENOVIRUS VACCINE	GUANGZHOU N BIOMED LTD.
WO/2021/018310	AMINOPYRIDINE DERIVATIVES FOR TREATMENT OF NON-SMALL CELL LUNG CANCER	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/031839	TARGETED POLYPEPTIDE-MODIFIED DRUG-LOADED LIPOPROTEIN NANO-DRUG DELIVERY SYSTEM, AND PREPARATION AND APPLICATION THEREOF	SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/023178	USE OF PYRROLO-FUSED SIX-MEMBERED HETEROCYCLIC COMPOUND IN PREPARATION OF MEDICAMENT FOR TREATING FGFR2 GENE MUTATION TUMOR	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/164210	APPLICATION OF GALLIC ACID DERIVATIVE IN PREVENTION AND TREATMENT OF ATHEROSCLEROSIS DISEASE	QILU UNIVERSITY OF TECHNOLOGY
WO/2021/023231	PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE, NITROXOLINE ORAL SOLID TABLET, PREPARATION METHOD THEREFOR AND USE THEREOF	JIANGSU YAHONG MEDITECH CO., LTD.
WO/2021/023237	METHOD FOR TREATING ALZHEIMER'S DISEASE BY REGULATING INTESTINAL MICROORGANISMS	SHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023238	METHOD FOR TREATING ALZHEIMER’S DISEASE BY INHIBITING UPTAKE OF AMINO ACIDS BY T CELLS	SHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023239	USE OF MANNURONIC ACID OLIGOSACCHARIDES OR COMPOSITION COMPRISING SAME IN TREATMENT OF TH1-DOMINANCE RELATED DISEASES	SHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023240	METHOD FOR IDENTIFYING CARBOHYDRATE DRUG-SENSITIVE PATIENT IN PATIENTS HAVING ALZHEIMER'S DISEASE	SHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023241	METHOD FOR TREATING ALZHEIMER'S DISEASE BY REGULATING AMINO ACID LEVEL	SHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/023263	PHARMACEUTICAL COMPOSITION PRODUCING SAFE AMOUNT OF NITRIC OXIDE IN BODY AND USE THEREOF	LIANYUNGANG JINKANG HEXIN PHARMACEUTICAL CO., LTD.
WO/2021/023264	PHARMACEUTICAL COMPOSITION FOR TREATING AFRICAN SWINE FEVER AND USE THEREOF	LIANYUNGANG JINKANG HEXIN PHARMACEUTICAL CO., LTD.
WO/2021/189753	PHARMACEUTICAL COMPOSITION FOR STRENGTHENING BODY AND TREATING LUNG DISEASES AND APPLICATION THEREOF	GUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/023267	PREPARATION COMPRISING ANTI-PD-1/HER2 BISPECIFIC ANTIBODY, AND PREPARATION METHOD THEREFOR AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/023290	APPLICATION OF ZINC PYRITHIONE IN TREATMENT OF LUNG CANCER	XIAMEN UNIVERSITY
WO/2021/023291	USE OF PROFLAVINE IN TREATMENT OF LUNG CANCERS	XIAMEN UNIVERSITY
WO/2021/027704	APPLICATION OF POLYPEPTIDE OR DERIVATIVE THEREOF	CHENGDU HUITAI BIOMEDICINE CO., LTD.
WO/2021/036752	HYPOXIC-TUMOR-TARGETING SHORT-CHAIN POLYPEPTIDE MICROMOLECULE SELF-ASSEMBLY NANOMETER MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF	NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
WO/2021/077856	SIRNA AND NANO DELIVERY SYSTEM CAPABLE OF SILENCING PCSK9 PROTEIN, AND APPLICATION OF NANO DELIVERY SYSTEM	GUANGZHOU MEDICAL UNIVERSITY
WO/2021/031893	PROSTATITIS TREATMENT	NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING
WO/2021/248674	ANTIBACTERIAL NANOZYME AND PREPARATION METHOD THEREFOR	QINGDAO UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/088446	METHOD FOR STAGGERED POWERING-ON OF SERVER HARD DISKS, DEVICE, AND MEDIUM	CHENGDU QINGZHIXIN BIOTECHNOLOGY CO., LTD
WO/2021/212700	PHARMACEUTICAL COMPOSITION FOR IMPROVING MOTION SICKNESS OF PETS, PREPARATION METHOD THEREFOR AND USE METHOD THEREOF	JIANGSU NANJING AGRICULTURAL UNIVERSITY ANIMAL PHARMACEUTICAL CO., LTD
WO/2021/036793	PYROPTOSIS-INDUCED IMMUNOTHERAPY	NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING
WO/2021/036803	USE OF LONG-ACTING PROTEIN PREPARATION FOR IMPROVING SEXUAL DYSFUNCTION	XINTRUM PHARMACEUTICALS, LTD.
WO/2021/027912	CHIDAMIDE-CONTAINING ANTI-TUMOR PHARMACEUTICAL COMPOSITION AND USE THEREOF	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/031991	COMPOSITION AND METHOD FOR TREATING HORMONE-DEPENDENT DISEASES AND REDUCING DRUG TOLERANCE OF PATIENTS WITH HORMONE-DEPENDENT DISEASES	CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES
WO/2021/169194	APPLICATION OF TETRAHYDROPALMATINE IN PREPARATION OF DRUGS AGAINST OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITY	ZHEJIANG UNIVERSITY
WO/2021/027971	FAT EXTRACT WITHOUT ADDED INGREDIENTS, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI SEME CELL TECHNOLOGY CO., LTD
WO/2021/203605	COMPOUND AMINO ACID INJECTION FOR LIVESTOCK AND PREPARATION METHOD THEREFOR	HEBEI KEXING PHARMACEUTICAL CO., LTD
WO/2021/032073	IN-SITU GEL CONTAINING CYCLOSPORINE MICELLES AS SUSTAINED OPHTHALMIC DRUG DELIVERY SYSTEM	IVIEW THERAPEUTICS (ZHUHAI) CO., LTD.
WO/2021/032078	NOVEL ANTI-SIRPA ANTIBODIES	ELPISCIENCE (SUZHOU) BIOPHARMA, LTD.
WO/2021/203606	PREPARATION METHOD FOR COMPOUND AMINO ACID INJECTION FOR LIVESTOCK	HEBEI KEXING PHARMACEUTICAL CO., LTD
WO/2021/203607	METHOD FOR PREPARING COMPOUND AMINO ACID INJECTION FOR LIVESTOCK	HEBEI KEXING PHARMACEUTICAL CO., LTD
WO/2021/248688	APPLICATION OF ITPP IN PREPARATION OF DRUGS FOR PREVENTING AND/OR TREATING HYPOXIC-ISCHEMIC INJURY AND LUNG INJURY	SYMEPILIN PHARMACEUTICALS CO., LTD.
WO/2021/036884	APPLICATION OF HERNANDEZINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN DRUGS FOR DIABETES OR DIABETIC COMPLICATIONS	EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/032128	APPLICATION OF FLUORO-SUBSTITUTED 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDE	HUNAN WARRANT PHARMACEUTICAL CO., LTD
WO/2021/073249	USE OF β-NMN IN PREPARATION OF DRUG FOR TREATING AND PREVENTING SEPSIS-INDUCED ORGAN DAMAGE	SOOCHOW UNIVERSITY
WO/2021/036896	PLANT EXTRACTION METHOD	BEIJING WEHAND-BIO PHARMACEUTICAL CO., LTD
WO/2021/196505	USES OF CYCLOCARYA PALIURUS LEAF FLAVONE EXTRACT IN PREPARATION OF ANTIBACTERIAL MEDICAMENTS AND/OR ANTIBACTERIAL AGENTS	WEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/032179	APPLICATION OF PSEUDOMONAS AERUGINOSA VACCINE IN TREATING INFECTION ASSOCIATED WITH BURN OR SCALD INJURY	SICHUAN UNIVERSITY
WO/2021/036922	COMPOUND INHIBITING AND INDUCING DEGRADATION OF EGFR AND ALK	BEIJING TIDE PHARMACEUTICAL CO., LTD.
WO/2021/036923	SILVER-/GOLD-COMPOUNDS AND METHODS THEREOF	THE UNIVERSITY OF HONG KONG
WO/2021/103679	LIPODISSOLVE	SHANGHAI NINTH PEOPLE'S HOSPITAL, SHANGHAI JIAOTONG UNIVERSTIY SCHOOL OF MEDICINE
WO/2021/036937	APPLICATION OF PDE3 INHIBITOR AND CYTOKINE IN TREATMENT OF TUMOR	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/036975	PEPTIDE AMIDE COMPOSITION AND PREPARATION METHOD THEREFOR	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/032212	ANTI-AGING MEDICINE D/A TARGETING AGING CELLS IN TISSUE MICROENVIRONMENT AND USE THEREOF	SHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF SCIENCES
WO/2021/032213	ANTI-AGING MEDICINE D/S TARGETING AGING CELLS IN TISSUE MICROENVIRONMENT AND USE THEREOF	SHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF SCIENCES
WO/2021/077889	PARACETAMOL SUSTAINED-RELEASE PREPARATION AND 3D PRINTING PREPARATION METHOD THEREFOR	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/037013	NOVEL APPLICATION OF PHENOTHIAZINES OR COMPOUND HAVING SIMILAR STRUCTURE IN PHARMACEUTICS	GUANGZHOU VIROTECH PHARMACEUTICAL CO., LTD.
WO/2021/037077	PATENTIFLORIN A ANALOGS AS ANTIVIRAL AGENTS	HONG KONG BAPTIST UNIVERSITY
WO/2021/037091	CHIDAMIDE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/082683	USE OF TRAMETINIB IN PREPARATION OF MEDICINE FOR PREVENTING AND/OR TREATING NON-ALCOHOLIC HEPATITIS AND/OR NON-ALCOHOLIC FATTY LIVER DISEASE	BEIJING GIGACEUTICALS TECH. CO., LTD
WO/2021/037122	STABLE GEL COMPOSITION HAVING HIGH OIL CONTENT, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SIRIO PHARMA CO., LTD.
WO/2021/037128	CHIDAMIDE-CONTAINING PHARMACEUTICAL COMPOSITION AND USE THEREOF	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/223346	APPLICATION OF YAM PROTEIN EXTRACT IN PREPARATION OF MEDICATION FOR TREATING ERECTILE DYSFUNCTION	ZHAO, Daqing
WO/2021/037188	PHARMACEUTICAL USE OF PYRIMIDO[5,4-B]PYRROLIZINE COMPOUND	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/057380	COMPOSITION AND APPLICATION THEREOF IN PREPARATION OF SKIN CARE PRODUCTS FOR REGULATING SKIN BIORHYTHM	HUNAN YUJIA COSMETICS MANUFACTURING CO., LTD
WO/2021/037199	TRANSDERMAL AMIDE LOCAL ANESTHETIC-CONTAINING PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/217982	FOOT-AND-MOUTH DISEASE VIRUS-LIKE PARTICLE ANTIGEN AND VACCINE COMPOSITION THEREOF, AND PREPARATION METHOD AND APPLICATION OF VACCINE COMPOSITION	PULIKE BIOLOGICAL ENGINEERING, INC.
WO/2021/037212	COMPOSITION USED FOR COMBATING METABOLIC DISEASES AND USES OF COMPOSITION	INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/037230	USE OF ANNEXIN A5	SUZHOU YABAO PHARMACEUTICAL R&D CO., LTD.
WO/2021/128919	APPLICATION OF CST1 IN PREVENTION AND/OR TREATMENT OF LIVER IMMUNE DYSREGULATION DISEASES	CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES
WO/2021/037244	PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/052153	APPLICATION OF CYCLIC ADENOSINE MONOPHOSPHATE, DERIVATIVES THEREOF OR PRODRUGS THEREOF IN PREPARATION OF DRUGS FOR PREVENTING AND/OR TREATING DEPRESSIVE DISORDER	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/203614	PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CORONAVIRUS DISEASES AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
WO/2021/057391	COMPOSITION AND APPLICATION THEREOF IN PREPARATION OF SKINCARE PRODUCTS FOR NIGHT OWLS	HUNAN YUJIA COSMETICS MANUFACTURING CO., LTD.
WO/2021/037265	SIRNA CAPABLE OF INHIBITING EXPRESSION OF MCM7 GENE, COMPOSITION, AND APPLICATION THEREOF	ENZHI (GUANGZHOU) PHARMACEUTICALS, LTD.
WO/2021/253643	APPLICATION OF SULPHATED POLYSACCHARIDES AGAINST NOVEL CORONAVIRUS	DALIAN POLYTECHNIC UNIVERSITY
WO/2021/043120	COMPOUND AMINO ACID DIPEPTIDE INJECTION AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	ZHONGSHAN HOSPITAL, FUDAN UNIVERSITY
WO/2021/232614	CHITOOLIGOSACCHARIDE ORAL LIQUID AND APPLICATION THEREFOR IN PREPARATION OF WEIGHT LOSS DRUGS	GUANGDONG PHARMACEUTICAL UNIVERSITY
WO/2021/043145	CATIONIC NANODRUG, PREPARATION METHOD THEREFOR, AND DRUG-LOADED IMPLANTABLE MEDICAL DEVICE	SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.
WO/2021/093425	ROOT OF MEMBRANOUS MILKVETCH-PAECILOMYCES CICADAE FERMENTATIVE BACTERIUM FERMENTATION SUBSTANCE AND APPLICATION THEREOF	BINZHOU MEDICAL UNIVERSITY
WO/2021/047437	PHARMACEUTICAL COMPOSITION FOR TREATING VIRAL INFLUENZA AND PREPARATION THEREOF	GUANGDONG RAYNOVENT BIOTECH CO., LTD.
WO/2021/043196	USE OF 5-METHYLTETRAHYDROFOLATE	LIANYUNGANG JINKANG HEXIN PHARMACEUTICAL CO., LTD.
WO/2021/212721	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR DISPELLING DAMPNESS AND CLEARING LUNG AND APPLICATION THEREOF	GUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/208334	QI-TONIFYING, DAMPNESS-ELIMINATING AND SORE-THROAT-RELIEVING DIETARY THERAPY FORMULA, AND PREDATION METHOD THEREFOR AND APPLICATION THEREOF	GUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/208335	TRADITIONAL CHINESE MEDICINE COMPOSITION CAPABLE OF REMOVING TOXINS, DISPELLING DAMPNESS, AND DISINHIBITING THROAT, AND APPLICATION THEREOF	GUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/208336	TRADITIONAL CHINESE MEDICINE COMPOSITION AND USE THEREOF	GUANGDONG PROVINCIAL HOSPITAL OF TCM
WO/2021/043227	COATED GRANULE, SOLID DISPERSION, AND PREPARATION CONTAINING VORTIOXETINE HYDROBROMIDE FOR ORAL TASTE MASKING	SEASONS BIOTECHNOLOGY (TAIZHOU) CO., LTD.
WO/2021/043231	DUAL-TARGETING MATERIAL AND USE THEREOF IN DRUG DELIVERY	SHENYANG PHARMACEUTICAL UNIVERSITY
WO/2021/043234	USE OF BERBAMINE OR ITS ANALOGUE FOR PREVENTING OR TREATING RNA VIRUS INFECTION	CITY UNIVERSITY OF HONG KONG
WO/2021/253647	USE OF SMALL MOLECULE INHIBITOR IN TREATMENT OF RESPIRATORY VIRAL PNEUMONIA	INSTITUTE OF BASIC MEDICAL SCIENCES, CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/047451	DNA NANOVACCINE, PREPARATION METHOD THEREFOR AND USE THEREOF	NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
WO/2021/047464	USE OF 4-[9-(6-AMINOPURINYL)]-2(S)-HYDROXYMETHYL BUTYRATE FOR PREPARING OPHTHALMIC PREPARATIONS	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/184699	MOXIFLOXACIN HYDROCHLORIDE AND SODIUM CHLORIDE INJECTION AND PREPARATION METHOD THEREFOR	SHIJIAZHUANG NO. 4 PHARMACEUTICAL CO., LTD
WO/2021/139193	SUSTAINED-RELEASE LONG-LASTING ANTIBACTERIAL HAND SANITIZER AND PREPARATION METHOD THEREFOR	ZHEJIANG SHENYING TECHNOLOGY CO., LTD.
WO/2021/139194	NANO-SCALE PLANT ANTIBACTERIAL AGENT FOR HAND SANITIZER AND PREPARATION METHOD THEREFOR	ZHEJIANG SHENYING TECHNOLOGY CO., LTD.
WO/2021/047573	USE OF MEK INHIBITOR IN COMBINATION WITH CDK4/6 INHIBITOR IN PREPARATION OF DRUGS FOR TREATING TUMORS	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/159704	17β-ESTRADIOL AND VITAMIN C MOLECULAR COMPLEX, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	ZHEJIANG MEDICINE CO., LTD.XINCHANG PHARMACEUTICAL FACTORY
WO/2021/047607	APPLICATION OF NON-IGF1R-BINDING SUBSTANCE IN PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASES	SHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF SCIENCES
WO/2021/047623	TREATMENT OF CANCER USING A COMBINATION COMPRISING MULTI-TYROSINE KINASE INHIBITOR AND IMMUNE CHECKPOINT INHIBITOR	BEIGENE, LTD.
WO/2021/047629	COMPOSITION FOR LIGHTENING SPOTS, MICRONEEDLE PATCH COMPRISING COMPOSITION, AND PREPARATION METHOD THEREFOR	BEIJING CAS MICRONEEDLE TECHNOLOGY LTD.
WO/2021/052269	WATER-SOLUBLE COMPOSITION, PREPARATION METHOD AND APPLICATION THEREOF	GUANGDONG HEJI BIOTECH CO., LTD
WO/2021/052274	CEFUROXIME AXETIL PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR	SINOPHARM ZHIJUN (SHENZHEN) PHARMACEUTICAL CO., LTD
WO/2021/052305	USE OF EIGHT-TREASURE PILL IN PREPARATION OF MEDICINE FOR PREVENTING OR TREATING DISEASES RELATED TO IL-6 INFLAMMATORY CYTOKINE STORM	XIAMEN TRADITIONAL CHINESE MEDICINE CO., LTD.
WO/2021/052386	COMBINATION OF SMALL MOLECULE INHIBITOR OF THE PD-1/PD-L1 INTERACTION AND ANTI-PD-1 ANTIBODY FOR TREATING CANCER	GUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD.
WO/2021/052398	GEL COMPOSITION WITH HIGH OIL CONTENT, THE PREPARATION METHOD AND THE USE OF THE SAME	BASF SE
WO/2021/227326	COMPOSITIONS AND METHODS FOR TREATING CANCER	ADAGENE AG
WO/2021/057599	APPLICATION OF PIRFENIDONE IN PREPARING MEDICAMENT FOR PREVENTING AND TREATING RHEUMATOID ARTHRITIS	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/052440	USE OF CHIGLITAZAR AND DERIVATIVES THEREOF IN TREATING TYPE 2 DIABETES ACCOMPANIED BY ABNORMAL LIPIDS METABOLISM	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/052441	USES OF COMPLEX OF ANGIOTENSIN II RECEPTOR ANTAGONIST METABOLITE AND NEP INHIBITOR IN TREATING HEART FAILURE	SHENZHEN SALUBRIS PHARMACEUTICALS CO. LTD
WO/2021/218004	APPLICATION OF PRUSSIAN BLUE NANOPARTICLES IN PREPARATION OF DRUG FOR PREVENTING, DELAYING OR TREATING NERVOUS SYSTEM DEGENERATIVE DISEASE	TIANJIN UNIVERSITY
WO/2021/043319	TRANSDERMAL PENETRATION ENHANCING COMPOSITION AND APPLICATION THEREOF IN TIMOLOL PREPARATION	WUHAN CONFORM PHARMACEUTICAL CO., LTD.
WO/2021/052450	REVERSED PHASE CHROMATOGRAPHY ISOLATION OF ACTIVE COMPONENT IN AMNIOTIC FLUID OF NON-HUMAN ANIMAL	ZHEJIANG HYGEIANCELLS BIOMEDICAL CO. LTD
WO/2021/258565	APPLICATION OF CARNOSIC ACID IN PREPARATION OF ANTI-PHOTOAGING PRODUCTS	CENTRAL SOUTH UNIVERSITY
WO/2021/103777	SPRAYING AGENT FOR PREVENTING AND TREATING ALLERGIC ASTHMA COMBINED WITH ALLERGIC RHINITIS IN CHILDREN AND TEENAGERS	LEITON FUTURE RESEARCH INSTITUTION JIANGSU CO., LTD.
WO/2021/052496	IMMUNE EFFECTOR CELL IN WHICH EXPRESSION IS REGULATED BY CYTOKINES	CARSGEN THERAPEUTICS CO., LTD.
WO/2021/057661	PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD SUGAR	SHENZHEN SALUBRIS PHARMACEUTICALS CO. LTD
WO/2021/057680	APPLICATION OF 2,4-DIHYDROXYBENZOIC ACID OR ISOMER THEREOF IN RELATED DISEASES OR CONDITIONS CAUSED BY IRON OVERLOAD	ZHANG, Jianguo
WO/2021/057694	LOW-CONTENT FLURBIPROFEN AXETIL PHARMACEUTICAL COMPOSITION, AND APPLICATION THEREOF	BEIJING PODCONLEY MEDICAL TECHNOLOGY DEVELOPMENT CO., LTD.
WO/2021/128995	WHITENING AND MOISTURIZING HAND MASK AND PREPARATION METHOD THEREFOR	GUANGDONG GEECHING BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/128996	NATURAL PLANT BACTERIOSTATIC OINTMENT CONTAINING ARTEMISIA ARGYI EXTRACT AND PREPARATION METHOD THEREFOR	GUANGDONG GEECHING BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/128997	NATURAL PLANT EYE SPRAY AND PREPARATION METHOD THEREFOR	GUANGDONG GEECHING BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/179567	CHINESE MUGWORT LEAF COMPOSITE ESSENTIAL OIL FOR RELIEVING SORE THROAT AND PREPARATION METHOD THEREFOR	GUANGDONG GEECHING BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/057721	SPECIFIC ANTIDOTAL DRUG FOR TREATING PARAQUAT ACUTE POISONING	ENVIRONMENT AND PLANT PROTECTION INSTITUTE, CHINESE ACADEMY OF TROPICAL AGRICULTURAL SCIENCES
WO/2021/018318	PHARMACEUTICAL COMPOSITION CONTAINING CHIDAMIDE AND SURFACTANT	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/057764	USE OF PD-1 ANTIBODY IN COMBINATION WITH TAXOID COMPOUND IN PREPARATION OF DRUGS FOR TREATING TRIPLE-NEGATIVE BREAST CANCER	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/057881	OSELTAMIVIR PREPARATION	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/169273	USE OF ALBIFLORIN IN TREATMENT OF CORONAVIRUS PNEUMONIA	ZHANG, Zuoguang
WO/2021/057906	IMMUNE EFFECTOR CELL EXPRESSING IL-15	CARSGEN THERAPEUTICS CO., LTD.
WO/2021/057942	GENE-ENGINEERED MESENCHYMAL STEM CELLS AND APPLICATIONS THEREOF	CHINA MEDICAL UNIVERSITY
WO/2021/057955	METHOD FOR TREATING MOOD DISORDERS	JIANGSU NUO-BETA PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/077990	USE OF VITAMIN E COMPOUND	HUIYU HEALTH (HANGZHOU) PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/058005	PHARMACEUTICAL COMPOSITION CONTAINING HUMANIZED ANTI-HUMAN IL-17A MONOCLONAL ANTIBODY	HUABO BIOPHARM (SHANGHAI) CO., LTD.
WO/2021/058014	ORNIDAZOLE PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD AND USE THEREOF	YANGTZE RIVER PHARMACEUTICAL GROUP NANJING HAILING PHARMACEUTICAL CO., LTD.
WO/2021/063331	USE OF COMBINATION OF EZH2 INHIBITOR AND TGF-β RECEPTOR-CONTAINING FUSION PROTEIN IN PREPARATION OF DRUGS FOR TREATING TUMORS	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/063332	USE OF EZH2 INHIBITOR COMBINED WITH CDK4/6 INHIBITOR IN PREPARATION OF DRUG FOR TREATING TUMOR	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/058021	DRUG COMBINATION CONTAINING TLR7 AGONIST	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/063340	USE OF EZH2 INHIBITOR IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITOR AND TYROSINE KINASE INHIBITOR IN PREPARATION OF MEDICATION FOR TREATING TUMOR	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/253681	FAVIPIRAVIR COMPOSITION AND PREPARATION METHOD THEREOF	ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD.
WO/2021/068802	APPLICATION OF NADH AND SALT AND/OR NMN THEREOF IN PREPARATION OF DRUG OR HEALTH CARE PRODUCT FOR ENHANCING MUSCLE OR INHIBITING MUSCLE VOLUME REDUCTION	HOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/073426	APPLICATION OF NADH AND SALT THEREOF IN PREPARATION OF SKIN PIGMENT INHIBITOR	HOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/078000	APPLICATION OF NADH AND SALT THEREOF IN PREPARATION OF DRUGS OR HEALTH FOOD FOR PREVENTING AND TREATING PHARYNGITIS	HOBOOMLIFE BIO-TECHNOLOGY (SHENZHEN) CO., LTD.
WO/2021/109704	CHRONIC WOUND HEALING COMPOSITION AND APPLICATION THEREOF	LO, Hsu En
WO/2021/063366	DRUG FOR TREATING ARTERY-RELATED DISEASES, AND USE THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/143208	METHOD FOR PREPARING HAND WASH HAVING ULTRA-STRONG DECONTAMINATION EFFECT	ZHEJIANG SHENYING TECHNOLOGY CO., LTD.
WO/2021/143209	METHOD FOR PREPARING HAND SANITIZER SUITABLE FOR INFANT SKIN	ZHEJIANG SHENYING TECHNOLOGY CO., LTD.
WO/2021/063376	UV LIGHT-RESPONSIVE HYPERBRANCHED POLY-β-AMINO ESTER HAVING HIGH-EFFICIENCY GENE DELIVERY ABILITY AND PREPARATION METHOD AND APPLICATION THEREOF	SOOCHOW UNIVERSITY
WO/2021/063378	ORAL CARE COMPOSITIONS COMPRISING HOPS BETA ACID AND AMINO ACID	THE PROCTER & GAMBLE COMPANY
WO/2021/063384	DENTIFRICE COMPOSITIONS COMPRISING BICARBONATE SALT AND NEUTRAL AMINO ACID	THE PROCTER & GAMBLE COMPANY
WO/2021/103816	USE OF UTERINE CAVITY FLUID-DERIVED EXOSOME IN PREPARATION OF THERAPEUTIC DRUGS AND ADJUVANT THERAPEUTIC AGENTS FOR TREATING INFERTILITY-RELATED DISEASES	PHARCHOICE THERAPEUTICS INC
WO/2021/063387	USE OF COMPOSITION OF IMATINIB AND DERIVATIVE THEREOF IN PREPARATION OF DRUG FOR PREVENTING, TREATING AND CONTROLLING ADDICTION RELAPSE	WUHAN UNIVERSITY
WO/2021/063391	CORNU GORAIS KERATIN, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF	INSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/063408	PREPARATION OF DRUG FOR TREATING ALZHEIMER'S DISEASE	PLANTARX LIMITED
WO/2021/063414	USE OF VALERIC ACID DERIVATIVE IN TREATMENT OF DOWN'S SYNDROME	XIAMEN UNIVERSITY
WO/2021/068868	COMBINATION THERAPY FOR CANCERS WITH KRAS MUTATION	COTHERA BIOSCIENCE, INC.
WO/2021/218039	BIOMIMETIC AND CAMELLIA EXTRACT-CONTAINING SKIN BARRIER REPAIR COMPOSITION AND APPLICATION THEREOF	SHANGHAI FOREST CABIN BIOLOGICAL-TECH CO., LTD.
WO/2021/088585	PARATHYROID HORMONE 1-34 NASAL SPRAY, PREPARATION METHOD AND APPLICATION THEREOF	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/068879	ANTIBODY COMPLEX MODIFIED BY TARGETED FUNCTIONAL MOLECULE, COMPOSITION AND USE THEREOF	FUDAN UNIVERSITY
WO/2021/027977	USE FOR ULVA POLYSACCHARIDE IN SUPPRESSING β-AMYLOID PROTEIN AGGREGATION	TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/068890	LYSOSOME-TARGETING ANTIBODY-DRUG CONJUGATE AND APPLICATION THEREOF	SUN YAT-SEN UNIVERSITY
WO/2021/082882	METHOD FOR ANCHORING AND MODIFYING NANO-DRUG ON SURFACE OF LIVING CELL	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/068909	AMERICAN COCKROACH EXTRACT, PREPARATION THEREOF, PREPARATION METHODS THEREFOR AND APPLICATIONS THEREOF	LIANGSHAN JIANENGDA BIOMATERIALS BREEDING CO., LTD.
WO/2021/203648	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREVENTING GINGIVAL ATROPHY AND/OR TREATING GINGIVITIS	SICHUAN GREEN HERB TECHNOLOGY DEVELOPMENT CO., LTD
WO/2021/068951	MEDICAL USE OF BENZENESULFONAMIDE COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/068957	TREATMENT AND PREVENTION OF NEPHROTOXIN-INDUCED KIDNEY INJURIES	FARSIGHT MEDICAL TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/082889	ENVIRONMENTALLY-FRIENDLY METHOD OF PREPARING COMPOSITION CONTAINING ANTI-INFLAMMATORY ACTIVE INGREDIENT AND APPLICATION THEREOF	SHANGHAI JAKA BIOTECH CO., LTD.
WO/2021/068961	INHALATION SOLUTION PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/068971	ANTI-CD20 ANTIBODY FORMULATION AND USE OF ANTI-CD20 ANTIBODY FOR TREATMENT OF CD20 POSITIVE DISEASES	BIO-THERA SOLUTIONS, LTD.
WO/2021/073518	USE OF INHIBITOR OF PLASMIN INHIBITORY FACTOR FOR PREVENTING OR TREATING PRE-ECLAMPSIA OR ECLAMPSIA	INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/073535	METHOD FOR PREVENTING OR TREATING DISEASES ASSOCIATED WITH ADMINISTRATION OF VEGFR AND/OR VEGF INHIBITOR	ONQUALITY PHARMACEUTICALS CHINA LTD.
WO/2021/073547	APPLICATION OF BORTEZOMIB IN PREPARATION OF DRUGS FOR TREATMENT OF OSTEOSARCOMA	XI'AN JIAOTONG UNIVERSITY
WO/2021/073548	PHARMACEUTICAL COMPOSITION	SUNSHINE LAKE PHARMA CO., LTD.
WO/2021/073563	COMPOSITION AND METHOD FOR TREATMENT OF DIABETES	SHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/103833	MOLECULARLY IMPRINTED POLYMERS FOR SEQUESTERING ACETATE AND OTHER MOLECULES	CLAVES LIFE SCIENCES LIMITED
WO/2021/073586	DECOQUINATE LIPOSOME, PREPARATION METHOD THEREFOR AND USE THEREOF	BLUELIGHT PHARMATECH CO ., LTD
WO/2021/073610	METHODS AND COMPOSITIONS FOR IMPROVING BONE MARROW HEMATOPOIETIC FUNCTIONS	SUN YAT-SEN UNIVERSITY
WO/2021/073620	USE OF ACELLULAR ADIPOSE TISSUE EXTRACT IN PROMOTING HAIR GROWTH AND RETENTION	SHANGHAI SEME CELL TECHNOLOGY CO., LTD.
WO/2021/232667	STARCH-BASED COLON-TARGETING CONTROLLED-RELEASE CRYSTAL INCLUSION COMPLEX AND PREPARATION METHOD THEREFOR	SOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/078087	TRADITIONAL CHINESE MEDICINE PILL REALIZING TARGETED RELEASE, AND PREPARATION METHOD THEREFOR	RONGCHANG PHARMACEUTICAL (ZIBO) CO., LTD.
WO/2021/073643	DRUG FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/135520	SUNFLOWER SEED COMPOSITION RICH IN PLEASANT HORMONE PRECURSOR AND ANTIDEPRESSANT USE THEREOF	CHACHA FOOD CO., LTD.
WO/2021/078110	DRUG COMBINATION FOR PREVENTING OR TREATING IRRITABLE BOWEL SYNDROME	GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/078126	METHOD FOR TREATING CANCERS	ACURA NANOMEDICINE CORPORATION
WO/2021/174868	CHLORIN NANOMETER PHOTOSENSITIZER, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SOOCHOW UNIVERSITY
WO/2021/143243	USE OF IGF1 IN COMBINATION WITH IGF1EC24 IN PREPARATION OF MEDICINE FOR PROMOTING TISSUE REPAIR AND REGENERATION	CHONGQING UNIVERSITY
WO/2021/088645	CRYSTAL FORM OF APROCITENTAN, PREPARATION METHOD THEREFOR AND USE THEREOF	CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD.
WO/2021/243925	APPLICATION OF ZIF-8 NANO MATERIAL IN DEGRADATION OF BROAD-SPECTRUM MUTANT P53 PROTEIN	SOUTH CHINA UNIVERSITY OF TECHNOLOGY
WO/2021/179616	NOVEL USE OF XIAOCHAIHU GRANULES IN COMBINATION WITH CHLOROQUINE PHOSPHATE	GUANGZHOU BAIYUNSHAN GUANGHUA PHARMACEUTICAL CO., LTD
WO/2021/078246	PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING SEPSIS, KIT, USE THEREOF AND TREATMENT METHOD THEREOF	SHENZHEN MYTANG BIOTECHNOLOGY CO., LTD.
WO/2021/093553	NOVEL THERAPEUTIC DRUG FOR ISCHEMIC BRAIN DAMAGE	CENTER FOR EXCELLENCE IN BRAIN SCIENCE AND INTELLIGENCE TECHNOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/078252	USE OF LIRIODENDRON CHINENSE (HEMSL.) SARG OR EXTRACT THEREOF IN PREPARATION OF MEDICINE FOR REDUCING SERUM URIC ACID LEVEL AND PREVENTING AND TREATING URIC ACID NEPHROPATHY	SICHUAN CREATION PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/078288	ACTIVATED INSULIN, COMPOUND MOMORDICA CHARANTIA PEPTIDE ORAL MEDICINE FOR TREATMENT OF DIABETES, AND PREPARATION METHOD	LI, Yubao
WO/2021/078295	BOTANICAL MEDICINE FOR TREATING HYPERLIPIDEMIA AND CORONARY HEART DISEASE AND METHOD FOR PREPARATION THEREOF	GUOZHONGXINGHE BIOMEDICINE TECHNOLOGY CO., LTD.
WO/2021/058038	USE OF CD200 PROTEIN AND CD200 FUSION PROTEIN IN PREPARING A DRUG FOR TREATING PSORIASIS	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/088672	COMPOSITION CONTAINING LEGOAMODIPINE BESYLATE HYDRATE AND PREPARATION METHOD THEREFOR	SHIHUIDA PHARMACEUTICALS GROUP (JILIN) LTD.
WO/2021/078301	PROTEIN DEGRADING AGENT AND USE THEREOF IN TREATMENT OF DISEASES	SHANGHAITECH UNIVERSITY
WO/2021/083089	PHARMACEUTICAL COMPOSITION CONTAINING ALGINATE OLIGOSACCHARIDE DIACID	SHANGHAI GREEN VALLEY PHARMACEUTICAL CO., LTD.
WO/2021/258590	APPLICATION OF β-GLUCAN AS ADHESIVE IN PREPARATION OF TABLET OR GRANULE	YICHUN WANSHEN PHARMACEUTICAL MACHINERY CO. LTD
WO/2021/114909	PHOTODYNAMIC THERAPY SYSTEM, PREPARATION METHOD THEREFOR, AND USE THEREOF IN PHOTODYNAMIC THERAPY	SHENZHEN HANGUANG TECHNOLOGY CO., LTD.
WO/2021/169345	METHOD AND APPLICATION FOR IMPROVING MITOCHONDRIAL FUNCTION OF PERIPHERAL BLOOD MONONUCLEAR CELLS	INSTITUTE OF ENVIRONMENTAL AND OPERATIONAL MEDICINE, ACADEMY OF MILITARY MEDICAL SCIENCE, ACADEMY OF MILITARY SCIENCE
WO/2021/184762	GOLD CLUSTERS (AuCs), COMPOSITION AND METHOD FOR TREATMENT OF LIVER CIRRHOSIS	WUHAN VAST CONDUCT SCIENCE FOUNDATION CO., LTD.
WO/2021/243932	USE OF PHOSPHATIDYLSERINE IN PREPARATION OF DRUG FOR TREATING INFLAMMATORY BOWEL DISEASE	JIANGSU TARGET BIOMEDICAL RESEARCH INSTITUTE CO. , LTD.
WO/2021/083290	RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN INHIBITOR COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF RSV DISEASES USING THE SAME	SHANGHAI ARK BIOPHARMACEUTICAL CO. LTD.
WO/2021/083306	GLP-1/GCG DUAL-ACCEPTOR AGONIST POLYPEPTIDE	DONGGUAN HEC BIOPHARMACEUTICAL R&D CO., LTD.
WO/2021/083315	ORALLY ADMINISTERED SOLID DOSAGE FORM DRUG	ASCENTAWITS PHARMACEUTICALS, LTD.
WO/2021/083336	USE OF BILE ACIDS AND DERIVATIVES THEREOF IN PREPARATION OF GPR39 AGONIST	PEKING UNIVERSITY
WO/2021/083346	PHARMACEUTICAL COMPOSITION COMPRISING QUINAZOLINE DERIVATIVE OR SALT THEREOF	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/088739	METHOD AND DEVICE FOR DETERMINING INTESTINAL PROBIOTIC SUPPLEMENT FORMULA, STORAGE MEDIUM, AND PROCESSOR	SHENZHEN DIGITAL LIFE INSTITUTE
WO/2021/083370	PREPARATION AND USE OF NANOMATERIAL SPECIFICALLY ACTIVATING IMMUNE SYSTEM	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/083372	SOLID COMPOSITION CONTAINING ANGIOTENSIN II, PREPARATION METHOD AND USE METHOD THEREFOR AND USE THEREOF	NANJING HAIWEI PHARMACEUTICAL TECHNOLOGIES CO., LTD.
WO/2021/109771	METHOD FOR PREPARING MICROPOWDER MIXTURE OF ACTIVE PHARMACEUTICAL INGREDIENTS OF GLYCOPYRRONIUM BROMIDE AND INDACATEROL	CF PHARMTECH, INC.
WO/2021/129160	NANOCONJUGATE OF PEGYLATED ICD INDUCER-IDO INHIBITOR, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	SHANDONG UNIVERSITY
WO/2021/208410	SKIN WHITENING, FIRMING AND MOISTURIZING FACE CREAM AND PREPARATION METHOD THEREFOR	YUHUAN ZITI COSMETICS CO., LTD.
WO/2021/208411	WHITENING MOISTURIZING FACE MASK IN FORM OF PASTE, AND PREPARATION METHOD THEREFOR	YUHUAN ZITI COSMETICS CO., LTD.
WO/2021/093632	ACTIVE ESSENCE COMPOUNDED WITH POSTBIOTICS AND PREPARATION METHOD	BIO-RACE BIOTECH HANGZHOU CO., LTD.
WO/2021/129166	APPLICATION OF MONASCINOL IN PREPARATION OF FAT-REDUCING PRODUCT	TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/088846	FGFR4/PD-1 COMBINATION TREATMENTS	CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD.
WO/2021/088853	DRUG COMBINATION OF QUINOLINE DERIVATIVE AND PD-1 MONOCLONAL ANTIBODY	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/174894	NANOBOWL-SUPPORTED DRUG-LOADED LIPOSOME, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/088927	ANTIBODY-DRUG CONJUGATES TARGETING CLAUDIN 18.2	LANOVA MEDICINES LIMITED COMPANY
WO/2021/088957	AROMATIC HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF	GUANGZHOU HENOVCOM BIOSCIENCE CO. LTD
WO/2021/109796	ANTI-TUMOR DRUG SENSITIZER EMPLOYING 5-CARBOXY-8-HYDROXYQUINOLINE, AND APPLICATION THEREOF	ZHEJIANG UNIVERSITY
WO/2021/088975	USE OF COMPOUND IN PREVENTING OR TREATING GRAFT VERSUS HOST DISEASE	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/088983	7,8-DIHYDROXYFLAVONE COMPOSITE NANO-BIOMATERIAL WITH HIGH BIOAVAILABILITY, PREPARATION METHOD, AND APPLICATION THEREOF	HANGZHOU U-MATE TECHNOLOGY CO., LTD.
WO/2021/089005	USE OF FGFR INHIBITOR	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD.
WO/2021/089038	USE OF MULTI-TARGET PROTEIN KINASE INHIBITOR	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD.
WO/2021/143313	ACTIVE GENE MODIFIED PORCINE SKIN FOR COVERING AND REPAIRING HUMAN SKIN WOUNDS AND USE THEREOF	GENEO MEDICINE CO., LTD.
WO/2021/089053	NANO COMPLEX FOR TARGETED REPAIRING OF NEUROVASCULAR LESION, AND PREPARATION AND USE THEREOF	SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/227405	ETAMSYLATE INJECTION AND PREPARATION METHOD THEREFOR	SHANDONG FANGMING PHARMACEUTICAL GROUP CO., LTD
WO/2021/135654	USE OF DISULFIRAM IN PREPARATION OF MEDICAMENT FOR PREVENTION AND TREATMENT OF DISEASES RELATED TO NLRP3 INFLAMMASOME	GUANGZHOU MEDICAL UNIVERSITY
WO/2021/098557	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING PSORIASIS, PREPARATION METHOD THEREFOR AND USE THEREOF	TASLY PHARMACEUTICAL GROUP CO., LTD.
WO/2021/258614	VAGINAL GEL PREPARATION AND PREPARATION METHOD THEREFOR	ZHUHAI SHU TONG MEDICAL TECHNOLOGY CO., LTD.
WO/2021/093764	PHARMACEUTICAL COMBINATION AND USE THEREOF	CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD.
WO/2021/109823	CANNABINOID NANOMICELLE PREPARATION AND METHOD FOR PREPARING SAME	HANYI BIOTECHNOLOGY (BEIJING) CO., LTD
WO/2021/135665	APPLICATION OF TETRAHYDROCANNABIVARIN IN PREVENTION AND/OR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION	HANYI BIOTECHNOLOGY (BEIJING) CO., LTD
WO/2021/104034	USE OF 4-HYDROXYBENZALDEHYDE IN TREATING INFLAMMATORY BOWEL DISEASE	MEDICAL AND PHARMACEUTICAL INDUSTRY TECHNOLOGY AND DEVELOPMENT CENTER
WO/2021/120937	APPLICATION OF TRANSTHYRETIN IN ENTERING EYE AND PREPARING DROP	TONGYAN (SHANGHAI) MEDICAL DEVICE CO., LTD.
WO/2021/196628	NATURAL EDIBLE SHAMPOO AND PREPARATION METHOD THEREFOR	NINGBO YUFANGTANG BIOLOGICAL SCIENCE AND TECHNOLOGY CO., LTD.
WO/2021/098606	LIPID NANO DRUG DELIVERY SYSTEM TARGETING BRAIN LESION AND PREPARATION METHOD AND APPLICATION THEREOF	SHANGHAI JIAOTONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/135682	MICROBUBBLE DISPERSION SYSTEM USED FOR EFFICIENTLY SUPPLYING OXYGEN TO VEINS AND STABILIZED BY POLYDOPAMINE NANOPARTICLES AND PREPARATION METHOD FOR MICROBUBBLE DISPERSION SYSTEM	ZHEJIANG UNIVERSITY
WO/2021/223397	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING NOVEL CORONAVIRUS PNEUMONIA, PREPARATION METHOD, DETECTION METHOD, AND USE THEREOF	BEIJING HANDIAN PHARMACEUTICAL CO., LTD.
WO/2021/093864	USE OF HETEROLOGOUS TISSUE CELL COMPOSITION FOR TREATING CANCERS	CHINA MEDICAL UNIVERSITY
WO/2021/098621	IMMUNOADJUVANT-ENCAPSULATED NANOPARTICLE AND USE THEREOF	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/093881	COMPOSITION FOR REGULATING IMMUNE RESPONSE IN ACIDIC ENVIRONMENT, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI SINOBAY BIOTECHNOLOGY CO., LTD.
WO/2021/104086	METHOD FOR OVERCOMING TUMOR DRUG RESISTANCE	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/104088	NANOPARTICLE DRUG DELIVERY SYSTEM, PREPARATION METHOD THEREFOR AND USE THEREOF	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/203701	APPLICATION OF SOFOSBUVIR IN PREPARATION OF DRUG FOR PREVENTING AND TREATING CORONAVIRUS	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES
WO/2021/203702	USE OF PYROGLUTAMIC ACID IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING NOVEL CORONAVIRUS OF NOVEL CORONAVIRUS PNEUMONIA	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES
WO/2021/203703	USE OF CARGLUMIC ACID IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING CORONAVIRUSES	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES
WO/2021/203704	USE OF BACITRACIN A IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING CORONAVIRUSES	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES
WO/2021/203706	USE OF FOSCARNET SODIUM IN PREPARATION OF MEDICINES FOR PREVENTING AND TREATING CORONAVIRUSES	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCES
WO/2021/098679	USE OF FAK INHIBITOR IN PREPARATION OF DRUG FOR TREATING TUMORS HAVING NRAS MUTATION	INXMED (NANJING) CO., LTD.
WO/2021/164344	TRADITIONAL CHINESE MEDICINE COMPOSITION AND USE THEREOF IN PREVENTION AND TREATMENT OF VIRAL PNEUMONIA	GUANGZHOU EIGHTH PEOPLE'S HOSPITAL
WO/2021/227417	METHOD AND DRUG FOR TREATING SPINAL MUSCULAR ATROPHY	TALENGEN INTERNATIONAL LIMITED
WO/2021/098686	PREPARATION METHOD FOR THERAPEUTIC DRUG DELIVERY SYSTEM CAPABLE OF CROSSING BLOOD-BRAIN BARRIER AND SPECIFICALLY TARGETING GLIOMA	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/098688	LIVING ORGANISM OXYGEN SELF-PRODUCING PHOTOSENSITIZER AND USE THEREOF	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/104112	NOVEL METHOD FOR IMPROVING TUMOR HYPOXIA	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/115070	INDOCYANINE GREEN LIPOSOME FOR NEAR-INFRARED REGION II FLUORESCENCE DETECTION, PREPARATION METHOD THEREFOR AND USE THEREOF	SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY
WO/2021/098692	APPLICATION OF CHERRY PLUM PRODUCT IN INHIBITING THROMBOSIS	ZHEJIANG YANGSHENGTANG INSTITUTE OF NATURAL MEDICATION CO., LTD.
WO/2021/104120	POLYETHYLENE GLYCOL CONJUGATE MEDICAMENT, PREPARATION METHOD THERFOR AND USE THEREOF	CHONGQING UPGRA BIOLOGICAL SCI. & TECH., LTD.
WO/2021/120966	SHEEP HORN KERATIN, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF	INSTITUTE OF MATERIA MEDICA ,CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/098755	NEW APPLICATION OF BIFIDOBACTERIUM LACTIS BL-99 IN INHIBITING INTESTINAL INFLAMMATION	INNER MONGOLIA YILI INDUSTRIAL GROUP CO., LTD.
WO/2021/196654	USE OF GLYCOSYL POLYETHER COMPOUND IN PREPARATION OF ANTI-RNA VIRUS DRUGS	WUHAN UNIVERSITY
WO/2021/184807	COPPER CLUSTERS, COMPOSITION, AND METHOD FOR TREATMENT OF LIVER CIRRHOSIS	WUHAN VAST CONDUCT SCIENCE FOUNDATION CO., LTD.
WO/2021/098769	TREATMENT OF CANCER WITH ANTI-OX40 ANTIBODIES AND MULTI-KINASE INHIBITORS	BEIGENE, LTD.
WO/2021/098771	TREATMENT METHOD WITH IAP INHIBITOR	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/120972	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING DEFICIENCY OF BOTH QI AND BLOOD, PREPARATION METHOD THEREFOR AND USE THEREOF	SICHUAN NEO-GREEN PHARMACEUTICAL TECHNOLOGY DEVELOPMENT CO., LTD
WO/2021/098791	TRANSDERMAL PATCH CONTAINING MEMANTINE	CHENGDU KANGHONG PHARMACEUTICAL CO.LTD.
WO/2021/232717	CONJUGATE CONTAINING MONO-PHOSPHORYLATED LIPID A AND GLYCOANTIGEN, AND PREPARATION METHOD THEREFOR AND USE THEREOF	GUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU INSTITUTE OF TRADITIONAL CHINESE MEDICINE)
WO/2021/232718	CONJUGATE AND PREPARATION METHOD THEREFOR AND USE THEREOF	GUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU INSTITUTE OF TRADITIONAL CHINESE MEDICINE)
WO/2021/232719	CONJUGATE CONTAINING α-GALACTOSYL CERAMIDE ANALOGUE AND CARBOHYDRATE ANTIGEN AND PREPARATION METHOD THEREFOR AND USE THEREOF	GUANGZHOU UNIVERSITY OF CHINESE MEDICINE(GUANGZHOU INSTITUTE OF TRADITIONAL CHINESE MEDICINE)
WO/2021/104155	HYDROGEL TABLET FOR DISPELLING EFFECT OF ALCOHOL AND PROTECTING LIVER, AND PREPARATION METHOD THEREFOR AND USE THEREOF	GUANGDONG OCEAN UNIVERSITY
WO/2021/109879	COMPOSITION HAVING WHOLESOME PERSONALIZED INTESTINAL FLORA DIVERSITY FUNCTION AND APPLICATION	NII, Keni
WO/2021/196659	GLYCOSYL POLYETHER COMPOUND LIPOSOME, PREPARATION METHOD THEREFOR AND MEDICINE THEREOF	WUHAN UNIVERSITY
WO/2021/109880	PHARMACEUTICAL COMPOSITION, COMPLEMENTARY KIT AND APPLICATION THEREOF	SHANGHAI PHARMACEUTICALS HOLDING CO., LTD.
WO/2021/098826	USE OF ALBIFLORIN OR PAEONIFLORIN IN THE PREVENTION AND/OR TREATMENT OF RENAL ANEMIA	ZHANG, Zuoguang
WO/2021/115100	NOVEL USE OF SULFORAPHANE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	ZHEJIANG UNIVERSITY OF TECHNOLOGY
WO/2021/098874	HAIR CARE COMPOSITION AND PREPARATION METHOD THEREFOR	BIORIGHT WORLDWIDE COMPANY LIMITED.
WO/2021/196666	USE OF HOMOHARRINGTONINE IN PREPARATION OF HUMAN BODY BETA-CORONAVIRUS REPLICATION INHIBITOR	SUN YAT-SEN UNIVERSITY
WO/2021/104208	ENDOGENOUS SMALL RNA MOLECULAR TARGET FOR PREVENTING SKIN AGING AND PREMATURE AGING AND APPLICATION THEREOF	SHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF SCIENCES
WO/2021/104213	APPLICATION OF FU TEA EXTRACT IN PREPARING ANTIFUNGAL DRUG	PHARCHOICE THERAPEUTICS INC
WO/2021/104214	USE OF EXOSOME DERIVED FROM CARCASS IN SKIN REGULATION PRODUCT	PHARCHOICE THERAPEUTICS INC
WO/2021/218129	COPPER @ RHUBARB ANTHRAQUINONE METAL ORGANIC FRAMEWORK COMPOSITE AND USE THEREOF	GUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU INSTITUTE OF CHINESE MEDICINE)
WO/2021/104253	IBUPROFEN PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI BOCIMED PHARMACEUTICAL CO., LTD.
WO/2021/104276	USES OF FU TEA EXTRACT IN PREPARING SKIN-CONDITIONING PRODUCT	PHARCHOICE THERAPEUTICS INC
WO/2021/104319	COMBINED PHARMACEUTICAL COMPOSITION OF QUINAZOLINE DERIVATIVE OR SALT THEREOF AND USE THEREOF	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/104340	SUBSTITUTED CROTONAMIDE PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR	JIANGSU SUZHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/104341	APPLICATION OF SUBSTITUTED CROTONAMIDE	JIANGSU SUZHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/104363	COMPOSITION CONTAINING AROMATIC HETEROCYCLIC COMPOUND IN AMORPHOUS FORM, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/104371	ANTIBODIES TO CD3 AND BCMA, AND BISPECIFIC BINDING PROTEINS MADE THEREFROM	SHANGHAI EPIMAB BIOTHERAPEUTICS CO., LTD.
WO/2021/109924	USE OF MYRICETIN IN THE PREPARATION OF SALMONELLA TYPE Ⅲ SECRETION SYSTEM INHIBITOR	JILIN UNIVERSITY
WO/2021/104442	METHOD AND COMPOSITIONS FOR PREDICTING ANTI-CANCER EFFICACY OF COMPOUNDS TARGETING APOPTOSIS PATHWAY	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/104454	USE OF BI853520 IN CANCER TREATMENT	INXMED (NANJING) CO., LTD.
WO/2021/104460	PREPARATION METHOD FOR PALIPERIDONE PALMITATE SUSPENSION	NHWA PHARMA. CORPORATION
WO/2021/258642	USE OF GCS INHIBITOR IN PREPARING DRUG FOR TREATING COCAINE ADDICTION	WEST CHINA HOSPITAL, SICHUAN UNIVERSITY
WO/2021/104487	COMPOSITION INCLUDING RILPIVIRINE AND USE THEREOF FOR TREATING TUMORS OR CANCER	APTORUM THERAPEUTICS LIMITED
WO/2021/109945	WEAKLY ACIDIC DERIVATIVE OF POORLY SOLUBLE DRUG, AND LIPOSOME PREPARATION THEREOF	SHENYANG PHARMACEUTICAL UNIVERSITY
WO/2021/104511	APPLICATION OF CAR T-CELLS IN PREPARING DRUG FOR TREATING CANCER	SUZHOU NOVA THERAPEUTICS CO. LTD
WO/2021/109970	XANTHINE DERIVATIVE PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR	CHENGDU EASTON BIOPHARMACEUTICALS CO., LTD
WO/2021/258643	SOAP/AMINO ACID-TYPE FACIAL CLEANSING PRODUCT AND PREPARATION METHOD THEREFOR	HUNAN YUJIA COSMETICS MANUFACTURING CO., LTD.
WO/2021/110049	APPLICATION OF MANGANESE-TYPE HIGH-STABILITY SUPEROXIDE DISMUTASE IN PREVENTION OR TREATMENT OF STROKE	CARRY HEALTH BIOPHARMACEUTICALS (HANGZHOU) CO., LTD.
WO/2021/121038	EXOSOME FORMULATION FOR TREATING DRUG-RESISTANT BACTERIAL INFECTIONS	NANJING UNIVERSITY
WO/2021/110064	NEW MULTI-FUNCTIONAL OLIGOPEPTIDES	JIANGYIN USUN BIOCHEMICAL TECHNOLOGY CO., LTD.
WO/2021/110071	METHODS FOR INDUCING INTERMITTENT FASTING AND MODULATING AUTOPHAGY	THE HONG KONG POLYTECHNIC UNIVERSITY
WO/2021/110073	PHARMACEUTICAL COMPOSITION CONTAINING ELEMENE, PREPARATION METHOD THEREFOR, AND USE THEREOF	CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/135798	APPLICATION OF MULBERROSIDE A AND DERIVATIVES THEREOF IN PREPARATION OF DRUGS FOR PROTECTING INTESTINAL BARRIER	NANJING UNIVERSITY
WO/2021/110097	N-(PHENYLSULFONYL)BENZAMIDES AND RELATED COMPOUNDS AS BCL-2 INHIBITORS	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/129340	TANDOSPIRONE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF	SICHUAN CREDIT PHARMACEUTICAL CO., LTD
WO/2021/110105	USE OF NEUREGULIN-1 IN PREPARATION OF PRODUCT FOR ENHANCING TRPC6 CHANNEL ACTIVITY	GUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU RESEARCH INSTITUTE OF CHINESE MEDICINE)
WO/2021/253742	APPLICATION OF WUBI CHINESE YAM PILLS IN PREPARATION OF DRUG FOR TREATMENT OF PREMATURE OVARIAN INSUFFICIENCY	HANGZHOU HUQINGYUTANG PHARMACEUTICAL CO., LTD.
WO/2021/110120	ANTI-TUMOR VACCINE MOLECULE, PREPARATION METHOD THEREFOR AND USE THEREOF	CENTRAL CHINA NORMAL UNIVERSITY
WO/2021/110121	HDAC6 SELECTIVE INHIBITOR AND COMBINATION THERAPY THEREOF	CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD.
WO/2021/110127	METHOD OF TREATING INFLAMMATORY BOWEL DISEASE	CHEER GLOBAL LIMITED
WO/2021/110134	THREE-LAYER HAIR CARE COMPOSITION, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	GUANGZHOU UNIASIA COSMETIC TECHNOLOGY CO., LTD.
WO/2021/110136	PHARMACEUTICAL COMBINATION AND USE THEREOF	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/218154	DRUG, FOOD AND APPLICATION OF ANTI-CORONAVIRUS INFECTION	GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD
WO/2021/110148	SIRNA CONJUGATE, DOUBLE-STRANDED SIRNA CONJUGATE, SALT THEREOF AND APPLICATION THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/212858	APPLICATION OF HETEROCYCLIC COMPOUND CONTAINING AT LEAST TWO SULFUR ATOMS IN PREPARING NANO-VACCINE AND PREPARED NANO-VACCINE	FUZHOU UNIVERSITY
WO/2021/110164	LIQUID PREPARATION CONTAINING ANTI-IL-17 ANTIBODY	LIVZON MABPHARM INC.
WO/2021/143392	DRUG FOR REGULATING IMMUNE FUNCTION OR TREATING IMMUNE-RELATED DISEASES	SHENZHEN YUANJIAN LIFE TECHNOLOGY CO., LTD.
WO/2021/129362	USE OF AMHR2 RECOMBINANT PROTEIN OR FUSION PROTEIN IN PREPARATION OF DRUGS FOR TREATING AMH SIGNAL AXIS ABNORMAL ACTIVATION RELATED DISEASES	PHARCHOICE THERAPEUTICS INC
WO/2021/258654	SILVER ION ANTIBACTERIAL HAND SANITIZER, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	GUANGZHOU HWASUEN HEALTH INDUSTRY CO., LTD
WO/2021/110173	LIPOSOME FORMULATION OF FLUTICASONE PROPIONATE	ANOVENT PHARMACEUTICALS CO., LTD
WO/2021/253746	USE OF DALBAVANCIN IN PREPARATION OF MEDICAMENT FOR INHIBITING BINDING OF SARS-COV-2 TO ACE2	KUNMING INSTITUTE OF ZOOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/115272	CALCIUM-SENSING RECEPTOR AGONIST COMPOUND AND APPLICATION THEREOF	BEIJING TUO JIE BIOPHARMACEUTICAL CO. LTD.
WO/2021/121082	SCAVENGER RECEPTOR-A TARGETED DRUG CARRIER, AND PREPARATION METHOD AND APPLICATION THEREOF	SICHUAN UNIVERSITY
WO/2021/115321	PHARMACEUTICAL TACI-FC FUSION PROTEIN FORMULATION	REMEGEN CO., LTD.
WO/2021/212865	COMPOUND ALLICIN SOFT CAPSULE AND METHOD FOR PREPARING AND PACKAGING SAME	GUANGZHOU HONGKANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/115389	FULVESTRANT PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	SHANGHAI BOCIMED PHARMACEUTICAL CO., LTD.
WO/2021/169484	NANOVACCINE AND PREPARATION METHOD THEREFOR	ZHEJIANG UNIVERSITY
WO/2021/115408	PHARMACEUTICAL COMPOSITION AND USE THEREOF	JIANGSU THERAVAC BIO-PHARMACEUTICAL CO., LTD.
WO/2021/115409	PHARMACEUTICAL COMPOSITION AND USE THEREOF	JIANGSU THERAVAC BIO-PHARMACEUTICAL CO., LTD.
WO/2021/115410	IMMUNOSTIMULATORY COMPOSITION AND USE THEREOF	JIANGSU THERAVAC BIO-PHARMACEUTICAL CO., LTD.
WO/2021/115412	USE OF NITRIC OXIDE SYNTHASE PATHWAY INHIBITOR IN PREPARATION OF MEDICINE	ZHUJIANG HOSPITAL, SOUTHERN MEDICAL UNIVERSITY
WO/2021/115415	METHODS FOR TREATING BACTERIAL INFECTIONS	MICROBIOTA I - CENTER (MAGIC) LIMITED
WO/2021/115425	PHARMACEUTICAL COMPOSITION CONTAINING BPI-7711 AND PREPARATION METHOD THEREOF	BETA PHARMA (SUZHOU) , LTD.
WO/2021/115426	ANTI-CLAUDIN ANTIBODY-DRUG CONJUGATE AND PHARMACEUTICAL USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/073659	VACCINE VECTOR PREPARED ON BASIS OF ANIONIC POLYMERS AND DERIVATIVES THEREOF	SICHUAN UNIVERSITY
WO/2021/073660	LYOPHILIZED PREPARATION OF VACCINE CONTAINING ALUMINUM ADJUVANT AND PREPARATION METHOD AND USE THEREFOR	SICHUAN UNIVERSITY
WO/2021/258668	METHOD FOR PREPARING P/H MICROSPHERES WITH HYDROPHOBIC SOLID POWDER WRAPPED THEREIN	ZHEJIANG UNIVERSITY
WO/2021/196734	CONTROLLED-RELEASE BRIVARACETAM PREPARATION AND PREPARATION METHOD THEREFOR	JIANGSU ALICORN PHARMATECH CO., LTD.
WO/2021/244004	ZEOLITE ENERGY MASK AND PREPARATION METHOD THEREFOR	JIANGSU FULE BIOLOGICAL ENVIRONMENTAL PROTECTION TECHNOLOGY CO., LTD
WO/2021/164399	APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION OF DRUGS FOR TREATING OR PREVENTING CORONAVIRUS INFECTION	JIANGSU KANION PHARMACEUTICAL CO., LTD.
WO/2021/227493	USE OF FGF21 IN PREPARATION OF MEDICINE FOR TREATING COLORECTAL CANCER	JIANGNAN UNIVERSITY
WO/2021/121277	A METHOD AND COMPOSITION FOR TREATMENT OF A CANCER	TUAN, Mei-Nan
WO/2021/164401	USE OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION OF DRUGS FOR TREATING OR PREVENTING CORONAVIRUS INFECTION	JIANGSU KANION PHARMACEUTICAL CO.,LTD.
WO/2021/135980	SOLVENT SYSTEM CAPABLE OF EFFECTIVELY DISSOLVING ORNIDAZOLE OR LEVORNIDAZOLE, AND APPLICATION THEREOF	CHONGQING DIANSUO MEDICAL TECHNOLOGY CO., LTD
WO/2021/121366	LONG-ACTING INJECTABLE FORMULATIONS OF KETAMINE PAMOATE SALTS	ALAR PHARMACEUTICALS INC.
WO/2021/258683	APPLICATION OF BERBERINE-ORYZANOL TABLET IN TREATMENT OF DIABETES	YICHUN WANSHEN PHARMACEUTICAL MACHINERY CO., LTD
WO/2021/121387	APPLICATION OF COMPOUND IN DRUG PREPARATION	MEDSHINE DISCOVERY INC.
WO/2021/121388	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR TREATING EGFR-TKIS RELATED SKIN RASH AND USE THEREOF	YANGTZE RIVER PHARMACEUTICAL GROUP GUANGZHOU HAIRUI PHARMACEUTICAL CO., LTD.
WO/2021/232777	AEROSOL	YUNNAN HEMPSON BIO-TECH CO., LTD.
WO/2021/129600	JAK KINASE INHIBITOR PHARMACEUTICAL COMPOSITION	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/129616	PHARMACEUTICAL COMBINATION OF ANTI-PD-1 ANTIBODY AND HISTONE DEACEYLASE INHIBITOR, USE THEREOF, AND USAGE METHOD THEREFOR	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/129635	SUSTAINED-RELEASE DRUG DELIVERY SYSTEM	NANJING DELOVA BIOTECH CO. LTD.
WO/2021/129649	USE OF α-KETOGLUTARATE IN PREPARATION OF DRUG	TONGJI UNIVERSITY
WO/2021/129658	APPLICATION OF FUSION PROTEIN IN TREATING AGE-RELATED MACULAR DEGENERATION	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/129673	ANTI-CSF1R MOLECULES AND USE THEREOF	ADAGENE (SUZHOU) LIMITED
WO/2021/129678	CONJUGATE WITH RADIATION-RESPONSIVE GROUP AND USE THEREOF	PEKING UNIVERSITY
WO/2021/129735	SOLID PREPARATION, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SINOTHERAPEUTICS INC.
WO/2021/129744	COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND CANCERS BY TARGETING IGSF8	SHANGHAI XBH BIOTECHNOLOGY CO., LTD.
WO/2021/129775	ANTI-CTLA-4 MONOCLONAL ANTIBODY, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	BIO-THERA SOLUTIONS, LTD.
WO/2021/129796	EASILY CLEANSING MAKEUP BASE COSMETIC FOR SKIN	SHISEIDO COMPANY, LTD.
WO/2021/143485	CURCUMIN COMPLEX, PREPARATION METHOD THEREFOR AND DETECTION METHOD THEREFOR	CHENLAND NUTRITIONALS INC.
WO/2021/136089	ANTI-TUMOR PHARMACEUTICAL COMPOSITION AND METHOD FOR INCREASING SOLUBILITY OF COMPOUND	BEIJING KONRUNS PHARMACEUTICAL CO., LTD.
WO/2021/212892	BROAD-SPECTRUM ANTIVIRAL DRUG AND USE THEREOF	METHYCURE BIOTECH CORP.
WO/2021/136169	FILM-FORMING COMPOSITION CONTAINING GELLAN GUM AND STARCH, AND APPLICATION IN SOFT CAPSULE	SIRIO PHARMA CO., LTD.
WO/2021/136226	APPLICATIONS OF IMINOSTILBENE IN TERMS OF PREVENTING AND TREATING CARDIAC CEREBRAL ISCHEMIA/REPERFUSION INJURY	CHINESE ACADEMY OF MEDICAL SCIENCES INSTITUTE OF MEDICINAL PLANT DEVELOPMENT
WO/2021/136262	TWO-DIMENSIONAL NANO COMPOSITE MATERIAL, PREPARATION METHOD THEREFOR AND USE THEREOF	NINGBO INSTITUTE OF MATERIALS TECHNOLOGY & ENGINEERING, CHINESE ACADEMY OF SCIENCES
WO/2021/136274	FORMULATION CONTAINING ANTI-TROP2 ANTIBODY-DRUG CONJUGATE AND PREPARATION METHOD AND APPLICATION THEREOF	BIO-THERA SOLUTIONS, LTD.
WO/2021/136275	MULTI-STAGE FAT-PROTECTING SKINCARE COMPOSITION FOR PROTECTING SKIN BARRIER OF INFANTS	LUNALER HEALTH TECHNOLOGY (GUANGZHOU) CO LTD
WO/2021/136381	PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE, NITROXOLINE TABLET, PREPARATION METHOD THEREFOR AND USE THEREOF	JIANGSU YAHONG MEDITECH CO., LTD.
WO/2021/184918	USE OF EPHB4 AS TARGET IN SCREENING OF DRUGS OR MODELS FOR INCREASING INSULIN SENSITIVITY	INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/136405	ANTI-INFECTION USE OF CLASS OF THIAZOLE-CONTAINING COMPOUNDS	INSTITUTE OF MEDICINAL BIOTECHNOLOGY, CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/136488	CRYSTAL FORM OF PYRIDOPYRIMIDINE DERIVATIVE AND PREPARATION METHOD THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/136492	GASTRIC RETENTION TABLET	GUANGZHOU BOSTAL DRUG DELIVERY CO., LTD.
WO/2021/136494	GASTRIC RETENTION TABLET	GUANGZHOU BOSTAL DRUG DELIVERY CO., LTD.
WO/2021/136507	PHARMACEUTICAL COMPOSITION OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD.
WO/2021/253803	PREPARATION METHOD FOR FIRE-PURGING TABLET	HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD.
WO/2021/136513	METHOD FOR PREPARING PH-RESPONSIVE INTESTINE-TARGETED ACTIVE FACTOR TRANSPORTATION SYSTEM BASED ON ANIONIC SODIUM ALGINATE	DALIAN POLYTECHNIC UNIVERSITY
WO/2021/136520	NEW METHOD FOR TARGETED EDITING OF RNA	EDIGENE INC.
WO/2021/136523	PHARMACEUTICAL COMBINATION FOR TREATING TUMORS AND APPLICATION THEREOF	FUKANG (SHANGHAI) HEALTH TECHNOLOGY CO., LTD
WO/2021/174995	USE OF JQ-1 IN PREPARATION OF MEDICINE FOR TREATING PANCREATIC CANCER AND METHOD FOR VERIFYING INHIBITION OF JQ-1 ON EXOSOME SECRETION OF PANCREATIC CANCER	AFFILIATED HOSPITAL OF NANTONG UNIVERSITY
WO/2021/196808	NOVEL THERAPEUTIC VACCINE AGAINST NOVEL CORONAVIRUS, PREPARATION METHOD THEREFOR, AND USE THEREOF	HANGZHOU XINGAO BIOTECHNOLOGY CO., LTD
WO/2021/253807	ANTI-NOVEL CORONAVIRUS COMPLEX AND PREPARATION METHOD THEREFOR	HANGZHOU XINGAO BIOTECHNOLOGY CO., LTD
WO/2021/136541	APPLICATION OF A REAGENT DOWN-REGULATING CIRCULAR GENE EXPRESSION IN PREPARATION OF A DRUG TO PREVENT AND/OR TREAT PULMONARY FIBROSIS, AND DRUG	BINZHOU MEDICAL UNIVERSITY
WO/2021/203769	USE OF ANTI-PD-1 ANTIBODY IN PREPARATION OF DRUGS FOR TREATING ACRAL LENTIGINOUS MELANOMA	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/244027	APPLICATION OF COBRA POSTSYNAPTIC NEUROTOXIN IN TREATMENT OF DISEASES RELATED TO INFLAMMATORY CYTOKINE OVEREXPRESSION	SHEN, Zhejing
WO/2021/203779	COMPOUND FOR TREATMENT OF PULMONARY ARTERIAL HYPERTENSION, AND APPLICATION THEREOF	EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/136549	APPLICATION OF CINEPAZIDE MALEATE IN PREPARATION OF DRUGS FOR PREVENTION AND TREATMENT OF STROKE	BEIJING SIHUAN PHARMACEUTICAL CO., LTD.
WO/2021/139642	PROGRAMMED CELL DEATH RECEPTOR 1 ANTIBODY FORMULATION AND USE THEREOF	SHANGHAI HENLIUS BIOTECH, INC.
WO/2021/139661	APPLICATION OF GENE EXPRESSION INHIBITOR POU2F1 IN PREPARATION OF DRUG FOR TREATING TISSUE FIBROSIS DISEASES	PEKING UNIVERSITY THIRD HOSPITAL
WO/2021/139697	APPLICATION OF SUPERNATANT OF TUMOR CELLS AFTER ACTION OF CHEMOTHERAPEUTIC DRUG	ZHUKANG BIOTECHNOLOGY CO. , LTD.
WO/2021/159892	HEMOSTATIC AGENT FOR CENTRAL HEMANGIOMA HEMORRHAGE OF JAW, PREPARATION METHOD THEREFOR AND USE THEREOF	NANTONG UNIVERSITY
WO/2021/139739	CANNABIDIOL DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF	CHENGDU BAIYU PHARMACEUTICAL CO., LTD.
WO/2021/238232	PRAMIPEXOLE HYDROCHLORIDE ORAL SOLUTION	CHANGZHOU NO.4 PHARMACEUTICAL FACTORY CO. LTD
WO/2021/227541	TRADITIONAL CHINESE MEDICINAL COMPOSITION FOR TREATING DEMENTIA AND PREPARATION METHOD THEREFOR	WEST CHINA HOSPITAL OF SICHUAN UNIVERSITY
WO/2021/143671	PHARMACEUTICAL COMPOSITION OF ANTI-PD-1 ANTIBODY AND QUINAZOLINE DERIVATIVE, USES OF COMPOSITION, AND METHOD FOR USING SAME	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/147740	USE OF MAPK/ERK PATHWAY INHIBITOR IN ANTAGONIZING SKIN AGING AND RADIATION-INDUCED PREMATURE AGING	SHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF SCIENCES
WO/2021/143736	COMPOSITIONS AND METHODS FOR CONTROLLED RELEASE OF TARGET AGENT	THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/143741	TARGETING POLYPEPTIDE-DRUG CONJUGATE AND USE THEREOF	BEIJING HOPE PHARMACEUTICAL CO. LTD.
WO/2021/143745	LONG-ACTING ROPIVACAINE PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/143746	NON-AQUEOUS SUSTAINED RELEASE DRUG DELIVERY SYSTEM	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/143751	INJECTABLE LONG-ACTING ANALGESIC PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/143754	COMBINATION FOR THE TREATMENT OF CANCER AND APPLICATION THEREOF	EVERFRONT BIOTECH INC.
WO/2021/143767	PREPARATION OF BISPECIFIC ANTIBODY COMBINING PD-1 AND PD-L1 AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/143785	PHARMACEUTICAL COMPOSITION OF AEROSOL INHALANT CONTAINING INDACATEROL AND PREPARATION METHOD THEREOF	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/143791	PHARMACEUTICAL USE OF ESRRA GENE ENCODING FOR ESTROGEN-RELATED RECEPTOR α	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/143799	USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH FRUQUINTINIB IN PREPARATION OF MEDICAMENTS FOR TREATING CANCER	GENOR BIOPHARMA CO. LTD
WO/2021/143806	APPLICATION OF WIDE-SPECTRUM FLAVIVIRUS-AGAINST ACTIVITY OF HSP70 INHIBITOR	ACADEMY OF MILITARY MEDICAL SCIENCES
WO/2021/143826	RECOMBINANT ANTI-PROGRAMMED CELL DEATH PROTEIN 1 AND ANTI-CLUSTER OF DIFFERENTIATION ANTIGEN 137 BISPECIFIC ANTIBODY PREPARATION AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO. LTD.
WO/2021/143861	COMPOSITIONS AND METHODS FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH)	SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/143879	COMBINATIONAL THERAPY COMPRISING GLP-1 AND/OR GLP-1 ANALOGS, AND INSULIN AND/OR INSULIN ANALOGS	SHANGHAI BENEMAE PHARMACEUTICAL CORPORATION
WO/2021/143906	METHOD FOR TREATMENT OF NERVE INJURY AND RELATED DISEASE	TALENGEN INTERNATIONAL LIMITED
WO/2021/143912	THERAPEUTIC ACTION OF CELL-FREE FAT EXTRACT ON FATTY LIVER AND COMPLICATIONS THEREOF	SHANGHAI SEME CELL TECHNOLOGY CO., LTD.
WO/2021/151366	HEALTH FOOD OR TRADITIONAL CHINESE MEDICINE MEDICINAL FORMULA FOR IMPROVING MALE SEXUAL FUNCTION, AND ULTRASONIC WAVE PREPARATION METHOD	JIANGSU UNIVERSITY
WO/2021/143919	PHARMACEUTICAL COMPOSITION AND USE THEREOF	HENAN TAIFENG BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/147854	RECOMBINANT FULLY HUMAN ANTI-TIGIT MONOCLONAL ANTIBODY PREPARATIONS, PREPARATION METHOD THEREFOR AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO., LTD.
WO/2021/143928	QUINOLINE DERIVATIVE FOR TREATING RHEUMATOID ARTHRITIS	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/208551	APPLICATION OF THYROID HORMONE AND ANALOGUE THEREOF IN PREPARATION OF DRUG FOR TREATING SICKLE-CELL DISEASE	RUIJIN HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/208552	USE OF THYROID HORMONE AND ANALOGUE THEREOF IN PREPARATION OF DRUGS FOR TREATING ALPHA-THALASSEMIA	RUIJIN HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE
WO/2021/232836	CANNABINOID COMPOUNDS AND APPLICATION THEREOF IN TREATMENT OF PARKINSON'S DISEASE	HANYI BIOTECHNOLOGY (BEIJING) CO., LTD
WO/2021/238242	USE OF FULL-SPECTRUM HEMP OIL IN TREATMENT OF EPILEPSY	HANYI BIOTECHNOLOGY (BEIJING) CO., LTD
WO/2021/169682	TRADITIONAL CHINESE MEDICINE COMPOSITION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	BEIJING REGEN-PHARMATECH CO., LTD.
WO/2021/147922	EXTRACELLULAR VESICLE AND USE THEREOF IN SKIN PRODUCTS	EV CELL BIOTECH (GUANGZHOU) CO., LTD.
WO/2021/148003	DRUG CONJUGATE OF ERIBULIN DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE	SHANGHAI SENHUI MEDICINE CO., LTD.
WO/2021/203798	USE OF SPLICING FACTOR PRPF31 INHIBITOR IN PREPARING DRUG	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/244044	EYE DROP SUITABLE FOR LIMBAL STEM CELL DEFICIENCY AND PREPARATION	QINGDAO HAIER BIOTECH CO.LTD
WO/2021/218249	SPINOSYN DERIVATIVE AS ARGININOSUCCINATE SYNTHETASE ACTIVATOR AND APPLICATION THEREOF	CENTRAL SOUTH UNIVERSITY
WO/2021/155748	INHIBITORS OF MALARIAL AND PLASMODIUM FALCIPARUM HEXOSE TRANSPORTER AND USES THEREOF	TSINGHUA UNIVERSITY
WO/2021/179817	PROGESTERONE EMULSION INJECTION AND PREPARATION METHOD THEREFOR	JIANGSU JIAERKE PHARMACEUTICAL GROUP CO., LTD.
WO/2021/155751	TRADITIONAL CHINESE MEDICINE COMPOUND WITH FUNCTIONS OF CLEARING LUNGS AND DETOXIFICATION, AND APPLICATION THEREOF	INSTITUTE OF BASIC RESEARCH IN CLINICAL MEDICINE,CHINA ACADEMY OF CHINESE MEDICAL SCIENCES
WO/2021/179828	USE OF PHARMACEUTICAL COMPOSITION IN PREPARATION OF DRUG FOR TREATING ACUTE LUNG INJURY	SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/151387	PHARMACEUTICAL USE OF KETOAMIDE-BASED COMPOUND	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/169724	SUSTAINED-RELEASE DOSAGE FORM OF TOFACITINIB, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHANGHAI BOCIMED PHARMACEUTICAL CO., LTD.
WO/2021/164523	AKKERMANSIA MUCINIPHILA COMPOSITION	SHANGHAI INSTITUTE OF ENDOCRINE AND METABOLIC DISEASES
WO/2021/155764	COMBINATION OF BI853520 WITH CHEMOTHERAPEUTIC DRUGS	INXMED (NANJING) CO., LTD.
WO/2021/129890	MEDICATION FOR BLOCKING MICROBIAL INFECTION, REDUCING CHOLESTEROL, AND PREVENTING AND TREATING ASSOCIATED TUMORS, AND USE THEREOF	CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES
WO/2021/151391	APPLICATION OF ISOVALERYLSPIRAMYCIN COMPOUND AND COMPOSITION THEREOF IN PREPARATION OF ANTIVIRAL DRUG	SHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/179843	ANTI-TUMOR NANO ADJUVANT BASED ON VESICLE FORMED BY CROSS-LINKED BIODEGRADABLE POLYMER, PREPARATION METHOD THEREFOR AND USE THEREOF	SOOCHOW UNIVERSITY
WO/2021/155777	USE OF PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING NOVEL CORONAVIRUS PNEUMONIA	SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/184987	AD7 VECTOR VACCINE FOR PREVENTING SARS-COV-2 INFECTION	GUANGZHOU N BIOMED LTD.
WO/2021/184988	AD35 VECTOR VACCINE FOR PREVENTING SARS-COV-2 INFECTION	GUANGZHOU N BIOMED LTD.
WO/2021/155795	PHARMACEUTICAL COMPOSITION AND USE THEREOF	QIN, Caidong
WO/2021/155798	USE OF IMMUNE POLYPEPTIDE IN ANTIVIRAL DRUG	CHENG, Yun
WO/2021/184990	SENSITIZER DRUG, DRUG COMBINATION AND USE	SUN YAT-SEN MEMORIAL HOSPITAL, SUN YAT-SEN UNIVERSITY
WO/2021/227572	USE OF MICRO-NANO MGH<sb>2</sb> COMPOUND PARTICLES IN INHIBITION OF LEISHMANIA INFECTION AND TREATMENT OF LEISHMANIASIS	SHANGHAI JIAO TONG UNIVERSITY
WO/2021/196884	USE OF CATECHOL AND DERIVATIVES IN PREPARATION OF DRUGS FOR TREATING SLEEP DISTURBANCES	XI'AN LIBANG ZHAOXIN BIOTECHNOLOGY CO., LTD.
WO/2021/155825	USE OF PAX6 GENE OR EXPRESSION PRODUCT THEREOF IN PREPARATION OF DRUG FOR INHIBITING FIBROSIS	PEKING UNIVERSITY THIRD HOSPITAL
WO/2021/155840	USE OF ANTI-PD-1 ANTIBODY IN TREATMENT OF MALIGNANT TUMORS	SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/155846	PREPARATION METHOD FOR NOVEL CORONAVIRUS PNEUMONIA BIVALENT VACCINE	WENG, Binghuan
WO/2021/160049	BACTERIOSTATIC COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF	SHENZHEN EULIKAN BIOTECHNOLOGY CO., LTD
WO/2021/203828	USE OF INHIBITOR IN PREPARATION OF DRUGS FOR TREATING SARS-COV-2 PNEUMONIA AND COMPLICATIONS THEREOF	ACADEMY OF MILITARY MEDICAL SCIENCES, PLA
WO/2021/223480	CONTROLLED-RELEASE TICAGRELOR TABLET AND PREPARATION METHOD THEREFOR	JIANGSU ALICORN PHARMATECH CO., LTD.
WO/2021/164600	USE OF COMPOSITION IN TREATING ATHEROSCLEROSIS	INNOLIFE CO., LTD.
WO/2021/155867	METHOD AND DRUG FOR PREVENTING AND TREATING MULTIPLE SCLEROSIS	TALENGEN INTERNATIONAL LIMITED
WO/2021/185006	LENVATINIB PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	SHANGHAI BOCIMED PHARMACEUTICAL CO., LTD.
WO/2021/160092	METHOD AND DRUG FOR TREATING VIRAL PNEUMONIA	TALENGEN INTERNATIONAL LIMITED
WO/2021/160104	FOLIUM APOCYNI VENETI EXTRACT, AND PREPARATION METHOD THEREFOR AND USE THEREOF	XIAMEN UNIVERSITY
WO/2021/179878	3CLPRO-TARGETING PHILLYRIN, DERIVATIVE THEREOF, AND USE THEREOF AGAINST NOVEL CORONAVIRUS	DALIAN FUSHENG NATURAL MEDICINE DEVELOPMENT CO., LTD.
WO/2021/160115	USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME FOR TREATING BREAST CANCER	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD
WO/2021/160120	OPTIMIZATION OF CHIMERIC ANTIGEN RECEPTOR	BEIJING IMMUNOCHINA PHARMACEUTICALS CO., LTD.
WO/2021/160124	OPTIMIZATION OF CHIMERIC ANTIGEN RECEPTOR	BEIJING IMMUNOCHINA PHARMACEUTICALS CO., LTD.
WO/2021/160131	FIBROTIC DISEASE MECHANISM AND THERAPEUTIC DRUG THEREFOR	GUANGZHOU WOMEN AND CHILDREN'S MEDICAL CENTER
WO/2021/179881	APPLICATION OF HERBAL MEDICINE COMPOSITION IN PREPARATION OF MEDICINE FOR PREVENTING AND TREATING CORONAVIRUS COMPLICATED WITH LUNG INJURY	GUANGDONG LEIYUNSHANG PHARMACEUTICAL CO., LTD.
WO/2021/169812	USE OF PAX4 INHIBITOR IN PREPARATION OF DRUG FOR INHIBITING FIBROSIS	PEKING UNIVERSITY THIRD HOSPITAL
WO/2021/160139	9,10-DIHYDROPHENANTHRENE COMPOUNDS AND USE THEREOF IN TREATMENT OF LIVER INJURY	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/164672	ANTI-RNA VIRUS DRUG AND APPLICATION THEREOF	EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/160144	METHOD FOR PREVENTING OR TREATING THROMBOEMBOLISMS BY MEANS OF APIXABAN INJECTION	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/160151	USE OF ANTI-PD-1 ANTIBODY IN TREATMENT OF TUMORS	SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/160152	USE OF ANTI-PD-1 ANTIBODY IN TREATING NEUROENDOCRINE TUMORS	SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/232864	TREATING TUMOR USING IMMUNE EFFECTOR CELL	CAFA THERAPEUTICS LIMITED
WO/2021/160163	METHODS FOR PREVENTION OR TREATMENT OF VIRUS-INDUCED ORGAN INJURY OR FAILURE WITH IL-22 DIMER	EVIVE BIOTECHNOLOGY (SHANGHAI) LTD
WO/2021/164685	GROUP OF PEPTIDE COMPOUNDS OMICSYNIN HAVING ANTIVIRAL ACTIVITY AND APPLICATION THEREOF	INSTITUTE OF MEDICINAL BIOTECHNOLOGY CHINESE ACADEMY OF MEDICAL SCIENCES
WO/2021/160170	METHODS OF USE OF SOLUBLE CD24 FOR TREATING SARS-COV-2 INFECTION	ONCOIMMUNE, INC.
WO/2021/160173	METHODS OF USE OF SOLUBLE CD24 FOR TREATING VIRAL PNEUMONIA	ONCOIMMUNE, INC.
WO/2021/164689	APPLICATION OF NELFINAVIR IN PREPARATION OF DRUG FOR PREVENTING AND TREATING NOVEL CORONAVIRUS PNEUMONIA	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/160183	ORAL CARE COMPOSITION AND DEVICES FORMED THEREWITH	RANIR, LLC
WO/2021/164706	PHARMACEUTICAL COMPOSITION CONTAINING METHYLENE BLUE DYE AND APPLICATION THEREOF	CHENGDU KUACHANGAOPU MEDICAL TECHNOLOGY CO., LTD.
WO/2021/169845	METHOD FOR PREVENTING, TREATING OR DELAYING HEART FAILURE BY USING NEUREGULIN, AND COMPOSITION	ZENSUN (SHANGHAI) SCIENCE & TECHNOLOGY, CO., LTD.
WO/2021/164717	ANTI-TNF-α ANTIBODY PREPARATION, PREPARATION METHOD THEREFOR AND USE THEREOF	BIO-THERA SOLUTIONS, LTD.
WO/2021/164723	GINSENOSIDE M1 AS A MODULATOR OF ANGIOTENSIN REGULATING ENZYMES AND ITS USE FOR TREATING DISEASES OR CONDITIONS INCLUDING SYMPTOMS CAUSED BY CORONAVIRUS	LEE, Sheau-Long
WO/2021/164728	PHARMACEUTICAL COMPOSITION CONTAINING ANTI-IL-4R ANTIBODY AND USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/164740	USE OF INTERFERON IN PREPARING DRUG FOR PREVENTING CORONAVIRUS INFECTION OR PREVENTING DISEASE CAUSED BY CORONAVIRUS INFECTION	SHANGHAI GANYI MEDICAL BIOTECHNOLOGY INC.
WO/2021/164744	METHODS FOR TREATING GRAFT VERSUS HOST DISEASE	EVIVE BIOTECHNOLOGY (SHANGHAI) LTD
WO/2021/164755	OLAPARIB PHARMACEUTICAL COMPOSITION, PREPARATION THEREOF, PREPARATION METHOD THEREFOR AND USE THEREOF	SINOTHERAPEUTICS INC.
WO/2021/169861	USE OF NUCLEOSIDE COMPOUND IN TREATMENT OF CORONAVIRUS INFECTIOUS DISEASES	GENUINE BIOTECH CO., LTD.
WO/2021/169884	USE OF RAPAMYCIN AND DERIVATIVES THEREOF IN PREPARATION OF DRUGS FOR PREVENTING AND TREATING ADE CAUSED BY VIRUSES	ZHENG, Yunfeng
WO/2021/179902	USE OF CORYDALIS SAXICOLA AND PREPARATION THEREOF IN PREPARATION OF DRUG FOR TREATING NON-ALCOHOLIC FATTY LIVER DISEASES	NANJING ZHONGSHAN PHARMACEUTICAL CO., LTD.
WO/2021/169957	APPLICATION OF N-SUBSTITUTED PYRIDYL BENZISOSELENAZOLONE COMPOUND	SHANGHAITECH UNIVERSITY
WO/2021/212995	ANTI-AGEING COMPOSITION, DRUG AND HEALTHCARE PRODUCT COMPRISING SAME, AND APPLICATION THEREFOR	BIORIGHT WORLDWIDE COMPANY LIMITED.
WO/2021/169974	COMBINED PHARMACEUTICAL COMPOSITION FOR RESISTING DOUBLE-HIT LYMPHOMAS, AND USE THEREOF	THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY
WO/2021/169978	USE OF RECOMBINANT CYTOKINE GENE DERIVED PROTEIN OR FRAGMENT THEREOF	GENOVA INC.
WO/2021/169984	ANTI-CORONAVIRUS APPLICATION OF POLY ADP RIBOSE POLYMERASE INHIBITOR	FUKANG (SHANGHAI) HEALTH TECHNOLOGY CO., LTD
WO/2021/227597	USE FOR CORDYCEPS SINENSIS EXTRACT IN PREPARING DRUG FOR PROMOTING ANGIOGENESIS AND/OR TREATING ISCHEMIC CARDIOVASCULAR AND CEREBROVASCULAR DISEASES	INSTITUTE OF ZOOLOGY, GUANGDONG ACADEMY OF SCIENCES
WO/2021/170045	METHODS OF TREATING DLBCL USING BTK INHIBITORS AND COMBINATIONS THEREOF	BEIGENE SWITZERLAND GMBH
WO/2021/170060	PURIFICATION OF BISPECIIFC ANTIBODIES	WUXI BIOLOGICS (SHANGHAI) CO., LTD.
WO/2021/170064	ORAL CARE COMPOSITIONS FOR GUM HEALTH	THE PROCTER & GAMBLE COMPANY
WO/2021/170065	ORAL CARE COMPOSITIONS FOR GUM HEALTH	THE PROCTER & GAMBLE COMPANY
WO/2021/170073	USE OF SMALL MOLECULE COMPOUNDS IN TREATING DISEASES MEDIATED BY LUNG EPITHELIAL CELL INJURY AND/OR VASCULAR ENDOTHELIAL CELL INJURY	GUANGZHOU CELLPROTEK PHARMACEUTICAL CO., LTD.
WO/2021/170078	USE OF CSF-1R KINASE INHIBITOR	SHANGHAI RUNSHI MEDICAL TECHNOLOGY CO., LTD
WO/2021/170093	APPLICATION OF DISULFIRAM IN CORONAVIRUS RESISTANCE	SHANGHAITECH UNIVERSITY
WO/2021/170099	METHOD AND DRUG FOR PREVENTING AND TREATING ABNORMAL BLOOD PRESSURE CONDITION	TALENGEN INTERNATIONAL LIMITED
WO/2021/175175	PHARMACEUTICAL FORMULATION COMPRISING BEVACIZUMAB	SHANGHAI HENLIUS BIOTECH, INC.
WO/2021/170137	ANTI-TUMOR COMPOSITION	SPH SINE PHARMACEUTICAL LABORATORIES CO., LTD
WO/2021/170138	ANTI-TUMOR COMPOSITION	SPH SINE PHARMACEUTICAL LABORATORIES CO., LTD
WO/2021/175186	USE OF SMALL MOLECULE SHORT PEPTIDE IN PREPARATION OF PRODUCT FOR TREATING ACNE	JINAN UNIVERSITY
WO/2021/175192	TREATMENT METHODS AND BIOMARKERS FOR MDM2 INHIBITORS	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/175200	FERROPTOSIS INHIBITORS–DIARYLAMINE PARA-ACETAMIDES	SIRONAX LTD
WO/2021/179947	USE OF PHARMACEUTICAL COMPOSITION IN PREPARING ANTIBACTERIAL DRUG	SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/179950	USE OF PHARMACEUTICAL COMPOSITION IN PREPARING ANTI-VIRAL DRUG	SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/179952	APPLICATION OF GW8510 IN PREPARATION OF DRUGS FOR PROLONGING LIVES, IMPROVING COGNITIVE ABILITY, AND THE LIKE OF MAMMALS IN NATURAL AGING	PEKING UNIVERSITY
WO/2021/185071	COMPOSITIONS OF ANTI-VIRAL PEPTIDES AND METHODS OF USE THEREOF	THE UNIVERSITY OF HONG KONG
WO/2021/179959	PHARMACEUTICAL COMPOSITION COMPRISING JAK3/JAK1/TBK1 INHIBITOR AND METHOTREXATE AND USE THEREOF	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/175240	APPLICATION OF FULLERENE AND DERIVATIVE THEREOF IN REGULATING INTESTINAL FLORA	XIAMEN FUNANO NEW MATERIAL TECHNOLOGY CO., LTD.
WO/2021/179967	APPLICATION OF IFN-γ IN PREPARING ANTI-TUMOR ADJUVANT DRUG	WEST CHINA HOSPITAL OF SICHUAN UNIVERSITY
WO/2021/175250	COMPOUNDS AND METHODS FOR TREATING DISEASES AND/OR CONDITIONS CAUSED BY CORONAVIRUS	APTORUM THERAPEUTICS LIMITED
WO/2021/175274	OLAPARIB DISSOLUTION ENHANCING COMPOSITION	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/175275	HYDROPHOBICALLY MODIFIED ALBUMIN, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	KUNSHAN XINYUNDA BIOTECH CO., LTD.
WO/2021/175279	APPLICATION OF PHYSICAL TRANSDERMAL TECHNOLOGY IN SUPPLEMENTARY NUTRITION SUPPLEMENTING	SUZHOU NASHENG MICROELECTRONICS CO., LTD
WO/2021/175295	APPLICATION OF MYRICETIN COMPOUND IN PREPARATION OF DRUGS FOR PREVENTION AND TREATMENT OF NOVEL CORONAVIRUS PNEUMONIA	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/227614	PHARMACEUTICAL COMPOSITION FOR CLEARING LUNG AND PULMONARY FIBROSIS AND USE THEREOF	ZHANG, Yingwen
WO/2021/175311	PHARMACEUTICAL COMPOSITION CONTAINING GINKGOLIDE AND CANNABINOID COMPOUNDS AND USE THEREOF IN MEDICINE	CHENGDU BAIYU PHARMACEUTICAL CO., LTD.
WO/2021/175326	COMBINED USE OF CTB006 AND PONATINIB	BEIJING SINOTAU BIO-PHARMACEUTICALS TECHNOLOGY CO., LTD.
WO/2021/196982	ANTI-ARRHYTHMIC PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR	JIANGSU KANION PHARMACEUTICAL CO.,LTD.
WO/2021/180027	PHARMACEUTICAL COMBINATION OF ANTI-PD-1 ANTIBODY AND MULTI-RECEPTOR TYROSINE KINASE INHIBITOR AND METHOD FOR USING SAME	HUTCHISON MEDIPHARMA LIMITED
WO/2021/180032	Novel Therapeutic Methods	GUANGZHOU MAXINOVEL PHARMACEUTICALS CO., LTD.
WO/2021/175333	SCUTELLARIAE RADIX COMPOUNDS AND USE THEREOF FOR INHIBITING OXIDATIVE PHOSPHORYLATION PATHWAY OF MITOCHONDRIA	NANJING SHIJIANG MEDICINE TECHNOLOGY CO., LTD
WO/2021/180055	USE OF BRD4 INHIBITOR	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD.
WO/2021/180068	METHOD AND DRUG FOR TREATING DISEASES CAUSED BY 2019 NOVEL CORONAVIRUS	TALENGEN INTERNATIONAL LIMITED
WO/2021/180087	MEDICAL USE OF ANYHDROICARITIN	LUNAN PHARMACEUTICAL GROUP CORPORATION
WO/2021/180110	USE OF ANTI-BASIGIN HUMANIZED ANTIBODY FOR PREPARING MEDICAMENT FOR TREATING NOVEL CORONAVIRUS PNEUMONIA	THE FOURTH MILITARY MEDICAL UNIVERSITY
WO/2021/218422	APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION OF DRUGS FOR TREATING OR PREVENTING CORONAVIRUS INFECTION	JIANGSU KANION PHARMACEUTICAL CO.,LTD.
WO/2021/213058	APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION OF DRUGS FOR TREATING OR PREVENTING INFECTION WITH CORONAVIRUSES	JIANGSU KANION PHARMACEUTICAL CO., LTD.
WO/2021/213059	USE OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION OF DRUG FOR TREATING OR PREVENTING CORONAVIRUS INFECTION	JIANGSU KANION PHARMACEUTICAL CO., LTD.
WO/2021/180184	USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOMES	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD
WO/2021/185154	PHARMACEUTICAL COMPOSITION COMPRISING TIZOXANIDE AND PHARMACEUTICAL USE THEREOF	BEIJING JUNKE HUAYUAN MED TECH CO., LTD.
WO/2021/180196	COMPOSITION OF PIPERAZINE-BASED DRUGS	DONGGUAN HEC GENERIC DRUG R&D CO., LTD.
WO/2021/180205	PVRIG BINDING PROTEIN AND ITS MEDICAL USES	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/223514	HOUSING-LIKE DENTAL INSTRUMENT HAVING ANTICARIES FUNCTION AND MANUFACTURING METHOD THEREFOR	WUXI EA BIOTECHNOLOGY LIMITED
WO/2021/180219	ANTI-CORONAVIRUS EFFECT AND APPLICATION OF PI4K INHIBITOR	NUO-BETA PHARMACEUTICAL TECHNOLOGY (SHANGHAI) CO. LTD
WO/2021/180225	NEW APPLICATION OF C60 AND METHOD FOR MEASURING ACTIVITY OF PRODUCTS THEREOF	QINGDAO AGRICULTURAL UNIVERSITY
WO/2021/203914	PERAMIVIR DRY POWDER INHALANT AND PREPARATION METHOD THEREFOR	GUANGZHOU NUCIEN PHARMACEUTICAL CO., LTD
WO/2021/143951	COLCHICINE SOLUBLE MICRONEEDLE PATCH AND PREPARATION METHOD THEREFOR	NANJING UNIVERSITY
WO/2021/180237	ATOMIZED INHALATION FORMULATION CONTAINING HUMAN CELL-DERIVED EXTRACELLULAR VESICLES, PREPARATION METHOD AND USE THEREOF	CELLULAR BIOMEDICINE GROUP (SHANGHAI) LTD.
WO/2021/185234	COMBINED PHARMACEUTICAL COMPOSITION OF COMPOUND AS C-MET KINASE INHIBITOR AND USE THEREOF	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/213086	DEXTRAN-DOCOSAHEXAENOIC ACID COUPLING POLYMER, SYNTHESIS METHOD THEREFOR AND APPLICATION THEREOF	SHANDONG UNIVERSITY
WO/2021/185265	ORAL PHARMACEUTICAL COMPOSITION	SICHUAN HAISCO PHARMACEUTICAL CO LTD
WO/2021/213089	A CONTROLLED DRUG RELEASE SYSTEM OF PHOTORESPONSIVE NANOCARRIERS, METHODS OF MAKING AND USING THEREOF	THE UNIVERSITY OF HONG KONG
WO/2021/203933	TRADITIONAL CHINESE MEDICINE FOR DISPERSING LUNG QI AND DETOXICATION	SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.
WO/2021/185292	USE OF ASTRAGALUS MEDICINAL COMPOSITION FOR PREPARING DRUG FOR ENHANCING CANCER THERAPY	PHYTOHEALTH CORPORATION
WO/2021/185340	USE OF MITOCHONDRIA FOR PROMOTING WOUND REPAIR AND/OR WOUND HEALING	TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185341	USE OF MITOCHONDRIAL EXTRACT FOR TREATMENT OR/AND PREVENTION OF KIDNEY INJURY-RELATED DISEASES	TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185342	USE OF MITOCHONDRIA FOR TREATMENT AND/OR PREVENTION OF TENDON DAMAGE OR RELATED DISEASES	TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185343	GLYBURIDE LIPOSOME COMPOSITION AND PREPARATION METHOD THEREFOR	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/185344	METHOD FOR TREATING CHOLESTEROL-RELATED DISEASES	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/185356	USE OF BUTYLPHTHALIDE AND DERIVATIVE THEREOF	CSPC NBP PHARMACEUTICAL CO., LTD
WO/2021/185359	Modified red blood cells and uses thereof for delivering agents	WESTLAKE THERAPEUTICS (HANGZHOU) CO. LIMITED
WO/2021/185364	CELL CULTURE COMPOSITION AND USE THEREOF	TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185373	MICROPARTICLE FOR DRUG LOADING, DRUG LOADING MICROPARTICLE, PARTICLE CONTAINING TUBE, AND IMPLANTATION SYSTEM FOR MICROPARTICLE	SUZHOU YIBEN LIFE TECHNOLOGY CO., LTD
WO/2021/185376	COMPOSITION CONTAINING MITOCHONDRIA AND USE THEREOF FOR REPAIRING CARTILAGE DAMAGE OR AMELIORATING DEGENERATIVE ARTHRITIS	TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185377	COMPOSITION FOR PROMOTING HAIR REGENERATION THAT CONTAINS PLASMA RICH IN MITOCHONDRIA, AND MANUFACTURING METHOD THEREFOR AND USE THEREOF	TAIWAN MITOCHONDRION APPLIED TECHNOLOGY CO., LTD.
WO/2021/185382	METHOD FOR IMPROVING THE STABILITY OF A PHARMACEUTICAL COMPOSITION COMPRISING A HIGH PENETRATION DRUG, AND THE PHARMACEUTICAL COMPOSITION OBTAINED THEREFROM	YU, Chongxi
WO/2021/238367	APPLICATION OF MITOXANTRONE PREPARATION IN PREPARATION OF DRUG FOR DIAGNOSING AND TREATING DISEASE RELATED TO THYROIDECTOMY	SHENZHEN CHINA RESOURCES JIUCHUANG MEDICAL AND PHARMACEUTICAL CO., LTD
WO/2021/203959	HEPARIN NANO DRUG CARRIER SYSTEM FOR LOADING AMINO ANTI-TUMOR DRUG, AND PREPARATION METHOD THEREFOR	NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL CO., LTD.
WO/2021/190495	PEGYLATED HEPARIN NANO-MICELLE LOADED WITH CARBOXYLIC ACID ANTI-TUMOR DRUG AND PREPARATION METHOD THEREFOR	KINDOS PHARMACEUTICALS CO., LTD.
WO/2021/190546	PHARMACEUTICAL COMPOSITION COMPRISING PROTEIN KINASE INHIBITOR AND CHEMOTHERAPEUTIC DRUG AND USE THEREOF	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/190553	ANTI-IL-1β ANTIBODY, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF	AKESO BIOPHARMA, INC
WO/2021/190558	METHOD AND DRUG FOR TREATING ALZHEIMER DISEASE	TALENGEN INTERNATIONAL LIMITED
WO/2021/190561	METHOD AND DRUG FOR TREATING PARKINSON'S DISEASE	TALENGEN INTERNATIONAL LIMITED
WO/2021/190562	METHOD AND DRUG FOR PROMOTING DEGRADATION OF MISFOLDED PROTEIN AND AGGREGATE THEREOF	TALENGEN INTERNATIONAL LIMITED
WO/2021/190563	METHOD AND MEDICINE FOR TREATING HUNTINGTON'S DISEASE	TALENGEN INTERNATIONAL LIMITED
WO/2021/190573	MAGNETIC NANOCOMPOSITE MATERIAL AND PREPARATION METHOD THEREFOR AND USE THEREOF	NINGBO INSTITUTE OF MATERIALS TECHNOLOGY & ENGINEERING, CHINESE ACADEMY OF SCIENCES
WO/2021/190581	PHARMACEUTICAL COMPOSITION COMPRISING ANTIBODY DRUG CONJUGATE AND USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/190582	ANTI-OX40 ANTIBODY PHARMACEUTICAL COMPOSITION AND USE THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/218506	APPLICATION OF PROGESTIN IN PREPARATION OF DRUG INHIBITING CYTOKINE STORM	SHENZHEN EVERGREEN THERAPEUTICS CO., LTD.
WO/2021/190588	HERBA LYCOPI EXTRACT AND PREPARATION METHOD THEREFOR AND USE THEREOF	XIAMEN UNIVERSITY
WO/2021/190611	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR RECOVERY PHASE OF EXOGENOUS FEVER, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF	BEIJING UNIVERSITY OF CHINESE MEDICINE THIRD AFFILIATED HOSPITAL
WO/2021/190616	METHODS FOR INHIBITING CASEIN KINASES	GRITSCIENCE BIOPHARMACEUTICALS CO., LTD.
WO/2021/190624	PHARMACEUTICAL COMPOSITIONS, METHOD OF MAKING AND METHOD OF USING THEREOF	GANNEX PHARMA CO., LTD.
WO/2021/190631	METHOD FOR DISPLAYING BISPECIFIC ANTIBODY ON SURFACE OF MAMMALIAN CELL AND VECTOR	DDBIO.CO, LTD., (SHANG HAI)
WO/2021/190637	COMBINATION OF ANTI-HER2 ANTIBODY AND CDK INHIBITIOR FOR TUMOR TREATMENT	JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD.
WO/2021/190641	METHODS FOR TREATING CYTOKINE STORM SYNDROME AND RELATED DISEASES	FU, Xin-Yuan
WO/2021/190647	USE OF BERBERINE ANALOG AND JAK INHIBITOR IN TREATMENT OF INFLAMMATORY DISEASES OF GASTROINTESTINAL TRACT	ENNOVABIO (ZHEJIANG) PHARMACEUTICALS CO., LTD.
WO/2021/197254	USE OF MICROORGANISMS IN REGULATION OF BODYWEIGHT AND CHOLESTEROL LEVEL	MICROBIOTA I - CENTER (MAGIC) LIMITED
WO/2021/208711	APPLICATION OF TYLOPHORA ALKALOID OR SALT THEREOF IN RESISTING CORONAVIRUS	NANKAI UNIVERSITY
WO/2021/197285	SEMI-DRY NASAL AND ORAL CAVITY NURSING TOWEL, NURSING MASK AND PREPARATION METHOD	YANG LING ANDIYUAN BIOTECHNOLOGY CO., LTD.
WO/2021/197290	NOVEL APPLICATION OF ACETYLCHOLINESTERASE ACTIVITY INHIBITOR	THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
WO/2021/197297	PHARMACEUTICAL COMPOSITION CONTAINING GINSENOSIDES RH3, PPD, AND RH2	SHAANXI GIANT BIOTECHNOLOGY CO., LTD
WO/2021/197333	PHARMACEUTICAL COMBINATION AND USE THEREOF	NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD.
WO/2021/197334	PHARMACEUTICAL COMBINATION AND USE THEREOF	NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD.
WO/2021/197335	ANTIBODIES BINDING CD40 AND USES THEREOF	BIOSION INC.
WO/2021/197346	VACCINE ADJUVANT CONTAINING TRPV2 AGONIST AND USE THEREOF	TSINGHUA UNIVERSITY
WO/2021/197372	ANTI-TUMOR COMPOSITION CONTAINING RARE GINSENOSIDES RK2, CK, AND PPT	SHAANXI GIANT BIOTECHNOLOGY CO., LTD
WO/2021/197376	A FEBUXOSTAT TABLET	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/244120	SARS-COV-2 VACCINE	CANSINO BIOLOGICS INC.
WO/2021/208749	MEDICAL USE OF RIBOSOMAL PROTEIN SA ANTIBODIES IN IMMUNOREGULATION	JILIN UNIVERSITY
WO/2021/197430	COMPOSITIONS AND METHODS FOR REDUCING GRAFT REJECTION IN ALLOGENEIC CELL THERAPY	NANJING LEGEND BIOTECH CO., LTD.
WO/2021/204060	COMBINATIONS OF BCL-2/BCL-XL INHIBITORS AND RELATED USES	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/197451	MULTIPLE FORMULATION OF TICAGRELOR	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/227700	ANTI-DRY AND ANTI-SENSITIVITY COMPOSITION AND PREPARATION METHOD THEREFOR	GUANGZHOU KENENG COSMETICS RESEARCH CO. LTD
WO/2021/197492	BREAST MILK OLIGOSACCHARIDES FOR IMPROVING RESISTANCE OF ORGANISM AGAINST STAPHYLOCOCCUS AUREUS INFECTION	INNER MONGOLIA YILI INDUSTRIAL GROUP CO., LTD.
WO/2021/204179	NUCLEIC ACID VACCINES FOR CORONAVIRUS	SUZHOU ABOGEN BIOSCIENCES CO., LTD.
WO/2021/204188	UTIDELONE SEMI-HYDRATED SINGLE CRYSTAL AND PREPARATION METHOD THEREFOR AND USE THEREOF	BEIJING BIOSTAR PHARMACEUTICALS CO., LTD.
WO/2021/204192	USE OF COMPOUND AS SIRT1 RECEPTOR AGONIST	CATCH BIO-SCIENCE & TECHNOLOGY CO., LTD.
WO/2021/204197	APPLICATION OF ACRIDINEDIONE COMPOUND IN PREPARATION OF ANTI-DIABETIC DRUGS	THE FOURTH MILITARY MEDICAL UNIVERSITY
WO/2021/204223	PHARMACEUTICAL COMPOSITION INCLUDING NICOTINAMIDE	YANGTZE RIVER PHARMACEUTICAL GROUP NANJING HAILING PHARMACEUTICAL CO., LTD.
WO/2021/218594	REAGENT AND METHOD FOR REGULATING INTEGRIN β SUBUNIT	CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES
WO/2021/204279	PROBIOTIC COMPOSITION FOR TREATING RAPID EYE MOVEMENT SLEEP BEHAVIOR DISORDER, FORMULATION AND USE	BEIJING FRIENDSHIP HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIVERSITY
WO/2021/208842	USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD
WO/2021/160192	USE OF KAURANE COMPOUNDS IN PREPARATION OF DRUG FOR PREVENTION AND TREATMENT OF SEPSIS AND MULTIPLE ORGAN DAMAGE	KEY-PHARMA BIOMEDICAL INC.
WO/2021/208860	MICROEMULSION-BASED VACCINE DELIVERY SYSTEM, PREPARATION METHOD THEREFOR AND USE THEREOF	SICHUAN UNIVERSITY
WO/2021/208910	POLYMER PREPARATION FOR TREATING VIRUS INFECTION, AND PREPARATION METHOD THEREFOR AND USE THEREOF	SHANDONG HUBBLE KISEN BIOLOGICAL TECHNOLOGY CO., LTD
WO/2021/249009	RSV VACCINE COMPOSITIONS, METHODS, AND USES THEREOF	SICHUAN CLOVER BIOPHARMACEUTICALS, INC.
WO/2021/208947	COFFEE SILVERSKIN EXTRACT, PREPARATION METHOD THEREFOR AND USE THEREOF	INGREDI BIOTECH CO., LTD.
WO/2021/208976	SOLID PHARMACEUTICAL PREPARATION, PREPARATION METHOD THEREFOR AND USE THEREOF	SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/218638	DRUG COMBINATION FOR TREATING DIABETES MELLITUS AND COMPLICATIONS THEREOF AND PHARMACEUTICAL COMPOSITION OF DRUG COMBINATION	SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.
WO/2021/213230	APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION OF DRUG FOR TREATING OR PREVENTING FATTY LIVER DISEASE	NG, Tit
WO/2021/213232	APPLICATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARING DRUG FOR TREATING OR PREVENTING HYPERLIPIDEMIA	NG, Tit
WO/2021/208984	APPLICATION OF ABELMOSCHI COROLLA EXTRACT AS TRPC ION CHANNEL INHIBITOR	JIANGSU SUZHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/208985	USE OF QUERCETIN-3'-O-β-D-GLUCOSIDE AS CALCIUM CHANNEL INHIBITOR	JIANGSU SUZHONG PHARMACEUTICAL GROUP CO., LTD.
WO/2021/209003	PREVENTION AND TREATMENT OF ORGAN INJURIES	FARSIGHT MEDICAL TECHNOLOGY (SHANGHAI) CO., LTD.
WO/2021/209007	ANTIBODY-DRUG CONJUGATE	SHENZHEN ENDURING BIOTECH, LTD.
WO/2021/209010	METHOD AND DRUG FOR TREATING HURLER SYNDROME	EDIGENE INC.
WO/2021/209017	PREPARATION SPECIFICALLY BOUND WITH CD137 AND USE THEREOF	DINGFU BIOTARGET, CO., LTD.
WO/2021/175339	ROLE OF HUMAN SYMBIOTIC FLORA IN IMPROVING TUMOR IMMUNOTHERAPY RESPONSE	SHENZHEN XBIOME BIOTECH CO., LTD.
WO/2021/209025	PHARMACEUTICAL COMPOSITIONS	SHENZHEN PHARMACIN CO., LTD
WO/2021/209028	METHODS OF TREATING VIRAL INFECTIONS USING ARGINASE	BIO-CANCER TREATMENT INTERNATIONAL LIMITED
WO/2021/213287	USE OF IRAK4 INHIBITOR IN TREATMENT OF ACUTE LUNG INJURY ALI/ARDS	SHANGHAI LEADINGTAC PHARMACEUTICAL CO., LTD.
WO/2021/213327	COMPOSITION CONTAINING 7-ETHYL-10-HYDROXYCAMPTOTHECIN, PREPARATION METHOD THEREFOR AND USE THEREOF	KUNSHAN XINYUNDA BIOTECH CO., LTD.
WO/2021/209070	GINSENOSIDE COMPOSITION HAVING ALCOHOLIC FATTY LIVER-PREVENTING AND -TREATING FUNCTION	SHAANXI GIANT BIOTECHNOLOGY CO., LTD
WO/2021/218687	STEM CELL DRUG FOR TREATING DIABETES	SOOCHOW UNIVERSITY
WO/2021/213455	DRUG COMBINATION AND USE THEREOF	NATURAL MEDICINE INSTITUTE OF ZHEJIANG YANGSHENGTANG CO., LTD.
WO/2021/218763	PERIPLOSIDE COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF IN PREPARATION OF DRUG FOR TREATMENT OF AUTOIMMUNE DISEASES	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/180250	PREPARATION FOR INHIBITING CANDIDA ALBICANS	NORTHWEST UNIVERSITY
WO/2021/213483	APPLICATION OF COMPOUNDS IN CONTROLLING OR KILLING MITES	ZHUHAI QIWEI BIO-TECHNOLOGY LTD.
WO/2021/213484	APPLICATION OF RADIX GENTIANAE MACROPHYLLAE AND MONOMER COMPOUND THEREOF IN KILLING MITES	ZHUHAI QIWEI BIO-TECHNOLOGY LTD.
WO/2021/213485	USE OF DANDELION AND MONOMER COMPOUNDS THEREOF FOR KILLING MITES	ZHUHAI QIWEI BIO-TECHNOLOGY LTD.
WO/2021/213492	DRUG-CARRYING MACROMOLECULE AND PREPARATION METHOD THEREFOR	SHANGHAI SENHUI MEDICINE CO., LTD.
WO/2021/238529	TECHNETIUM CARBON MICROSPHERE INJECTION, PREPARATION METHOD THEREFOR AND USE THEREOF	CHENGDU NEW RADIOMEDICINE TECHNOLOGY CO., LTD.
WO/2021/218802	ISOLATED RECOMBINANT ONCOLYTIC POXVIRUS CAPABLE OF BEING REGULATED AND CONTROLLED BY MICRORNA AND USE THEREOF	HANGZHOU CONVERD CO., LTD.
WO/2021/213502	SLEEP-IMPROVING PHARMACEUTICAL COMPOSITION CONTAINING RARE GINSENOSIDES RG6 AND F4	SHAANXI GIANT BIOTECHNOLOGY CO., LTD
WO/2021/213504	USE OF VEGF INHIBITOR IN PREPARATION OF MEDICAMENT FOR TREATING HYPOXIA-RELATED DISEASES	QILU HOSPITAL OF SHANDONG UNIVERSITY
WO/2021/213512	A FORMULATION FOR TREATING OPHTHALMIC CONDITIONS	GUANGZHOU KANGRUI BIOLOGICAL PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/213520	ANTI-SARS CORONAVIRUS-2 SPIKE PROTEIN ANTIBODIES	SINGLE CELL TECHNOLOGY, INC.
WO/2021/213523	USES OF COMBINATION OF ANTI-PD-1 ANTIBODY AND ANTI-CTLA-4 ANTIBODY IN PREVENTING OR TREATING CANCER	INNOVENT BIOLOGICS (SUZHOU) CO. LTD.
WO/2021/218884	USE OF ARYL GUANIDINE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/227868	PHARMACEUTICAL COMPOSITION PREPARATION	WANG, Zhaolin
WO/2021/218945	ANTIBACTERIAL ANTIVIRAL PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF	YUNNAN BAIYAO GROUP CO., LTD
WO/2021/218964	EXTRACT FROM CORIOLUS VERSICOLOR FOR TREATING VAGINAL OR CERVICAL DISORDERS CAUSED BY INFECTIOUS AGENTS	PROCARE HEALTH IBERIA, S.L.
WO/2021/218965	APPLICATION OF RUBIACEAE TYPE CYCLIC PEPTIDE COMPOUNDS IN PREPARATION OF DRUGS AS CGAS-STING SIGNAL PATHWAY ACTIVATORS	CHINA PHARMACEUTICAL UNIVERSITY
WO/2021/218974	USES OF ANTRODIA CINNAMOMEA EXTRACT IN MANUFACTURING PRODUCTS FOR REDUCING EXPRESSION AND TREATING ASSOCIATED DISEASES OF ANGIOTENSIN CONVERTING ENZYME 2	ALPS BIOTECH CO., LTD.
WO/2021/219001	COMPOSITION FOR IMPROVING IMMUNITY	THE CHINESE UNIVERSITY OF HONG KONG
WO/2021/219009	DIAGNOSIS AND TREATMENT OF CANCERS SHOWING HIGH EXPRESSION OF PIWI AND/OR NMD COMPLEX PROTEIN	SHANGHAITECH UNIVERSITY
WO/2021/219029	SARS-COV-2 VIRAL PROTEINS AND USE THEREOF	VERSITECH LIMITED
WO/2021/219031	TRADITIONAL CHINESE MEDICINE COMPOSITION, AND APPLICATION OF PREPARATION OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARING MEDICINE FOR PREVENTING AND/OR TREATING ‎CORONAVIRUS DISEASE 2019	TASLY PHARMACEUTICAL GROUP CO., LTD.
WO/2021/219040	HISTONE DEACETYLASE INHIBITORS FOR IMMUNOMODULATION IN TUMOR MICROENVIRONMENT	GNT BIOTECH & MEDICALS CORPORATION
WO/2021/219047	METHOD FOR IMPROVING IMMUNOGENICITY OF PROTEIN/PEPTIDE ANTIGEN	SINOCELLTECH LIMITED
WO/2021/227887	COMPOUND FOR TREATING AND/OR PREVENTING DISEASES CAUSED BY CORONAVIRUS AND USE THEREOF	SHANGHAITECH UNIVERSITY
WO/2021/223652	COSMETIC PRODUCT AND MAKING-UP METHOD	MOMENTIVE PERFORMANCE MATERIALS INC.
WO/2021/219077	PROTEOLYSIS TARGETING COMPOUND HAVING TISSUE TARGETING CAPABILITY AND USE THEREOF	TAI BI DI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO. LTD
WO/2021/258851	PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES AND PREPARATION METHOD THEREFOR	GUANGZHOU LIXIN PHARMACEUTICAL CO., LTD
WO/2021/223659	EXTRACELLULAR VESICLES TARGETING CANCER CELLS AND USES THEREOF	NANJING IASO BIOTHERAPEUTICS CO., LTD.
WO/2021/223664	METHODS FOR TREATING CORONAVIRUS INFECTIONS	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/219112	ISOVALERYL SPIRAMYCIN COMPOUND OR APPLICATION OF ISOVALERYL SPIRAMYCIN COMPOSITION IN PREPARATION OF DRUG FOR TREATING SEPSIS DISEASE	SHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/219113	USE OF ISOVALERYL SPIRAMYCIN COMPOUND OR COMPOSITION THEREOF IN PREPARATION OF MEDICAMENT FOR TREATING IMMUNE DISORDERS	SHENYANG FUYANG PHARMACEUTICAL TECHNOLOGY CO., LTD.
WO/2021/219137	AMINOPYRIDINE DERIVATIVE FOR TREATING DISEASES CAUSED BY MET GENETIC ABNORMALITIES	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/219138	COMBINATION DRUG FOR TREATING KIDNEY CANCER	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/223713	APPLICATION OF SMS2 INHIBITOR IN PREPARATION OF DRUG FOR TREATMENT OF HIGHLY INVASIVE BREAST CANCER	SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.
WO/2021/227937	METHOD FOR ENHANCING IMMUNOGENICITY OF PROTEIN/PEPTIDE ANTIGEN BY MEANS OF FORMING FUSION PROTEIN WITH MODIFIED FC FRAGMENT	SINOCELLTECH LIMITED
WO/2021/223732	BLOOD PURIFICATION CONCENTRATE	XIA, Yongbiao
WO/2021/180251	CROSS-LINKED MEDICATION FOR TREATMENT OF CORONAVIRAL INFECTION AND METHOD OF TREATMENT	1GLOBE BIOMEDICAL CO., LTD.
WO/2021/228037	COMPOSITIONS AND METHODS FOR BROAD SPECTRUM ANTI-VIRAL THERAPY	VERSITECH LIMITED
WO/2021/228044	DRUG CONJUGATES CONTAINING ALPHA-ENOLASE ANTIBODIES AND USES THEREOF	HUNILIFE BIOTECHNOLOGY, INC.
WO/2021/228069	USE OF COMBINATION OF ANTI-VEGF ANTIBODY AND ANTI-PD-1 ANTIBODY FOR PREVENTING OR TREATING DISEASE	INNOVENT BIOLOGICS (SUZHOU) CO. LTD.
WO/2021/244235	APPLICATION OF POLYINOSINIC ACID AND SARS-COV-2 SPIKE PROTEIN IN CONSTRUCTION OF MOUSE ARDS MODEL	CHINA-US (HENAN) HORMEL CANCER INSTITUTE
WO/2021/228086	METHOD AND DRUG FOR TREATING SPINAL MUSCULAR ATROPHY	TALENGEN INTERNATIONAL LIMITED
WO/2021/228106	ONCOLYTIC VIRUS IN COMBINATION WITH IMMUNE CHECKPOINT INHIBITOR FOR TREATING TUMORS	JOINT BIOSCIENCES (SH) LTD.
WO/2021/180252	NOVEL APPLICATION AND MANUFACTURING METHOD FOR HYALURONIC ACID FRAGMENT	QINGDAO AGRICULTURAL UNIVERSITY
WO/2021/228113	PREPARATION COMPRISING ANTI-IL-23P19 ANTIBODY, PREPARATION METHOD THEREFOR AND USE THEREOF	INNOVENT BIOLOGICS (SUZHOU) CO. LTD.
WO/2021/228141	ANTIBODY DRUG CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
WO/2021/228146	USE OF LSD1 INHIBITOR	CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD.
WO/2021/228178	COMPOSITIONS AND METHODS FOR TREATING CANCER	ADAGENE AG
WO/2021/254054	VACCINE FOR PREVENTING DISEASE CAUSED BY CORONAVIRUS	ACADEMAY OF MILITARY MEDICAL SCIENCES, AMS, PLA
WO/2021/228213	COMBINATION COMPRISING TRICYCLE COMPOUND AND USE THEREOF IN PREPARATION OF MEDICAMENT FOR TREATING HBV	FUJIAN COSUNTER PHARMACEUTICAL CO., LTD.
WO/2021/228222	COMBINATION FOR TREATING HEPATITIS B	FUJIAN COSUNTER PHARMACEUTICAL CO., LTD.
WO/2021/238689	CHINESE MEDICINE COMPOSITION FOR SOOTHING NERVES AND AIDING SLEEP, AND CHINESE MEDICINE SACHET AND APPLICATION	CHENG, Yawei
WO/2021/238690	TRADITIONAL CHINESE MEDICINE COMPOSITION AND TRADITIONAL CHINESE MEDICINE SACHET USED FOR PREVENTING COLDS AND APPLICATION THEREOF	CHENG, Yawei
WO/2021/233237	TUMOR VACCINE, PREPARATION METHOD THEREFOR AND USE THEREOF	NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY
WO/2021/233239	APPLICATION OF ACTIVE INGREDIENT OF ROOT OF LIGULILOBE SAGE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF IN PREPARING ANTIVIRAL DRUG	SOUTHERN MEDICAL UNIVERSITY
WO/2021/238695	TRADITIONAL CHINESE MEDICINE COMPOSITION FOR PREVENTING AND TREATING COLD IN SPRING AND GRANULES AND APPLICATION THEREOF	CHENG, Yawei
WO/2021/238698	TRADITIONAL CHINESE MEDICINE COMPOSITION AND TRADITIONAL CHINESE MEDICINE SACHET HELPING TO BOOST MOOD AND APPLICATION THEREOF	CHENG, Yawei
WO/2021/228260	PHARMACEUTICAL USE OF IRIDOID GLYCOSIDE COMPOUND	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/233346	TARGETEDLY MODIFIED EXOSOME LOADED WITH DRUG, AND PREPARATION METHOD AND USE THEREFOR	BEIJING TIANTAN HOSPITAL, CAPITAL MEDICAL UNIVERSITY
WO/2021/238752	PROBIOTIC PREPARATION BASED ON W<sb>1</sb>/O/W<sb>2</sb> TYPE DUAL EMULSION STRUCTURE, AND PREPARATION METHOD THEREFOR AND USE THEREOF	HUAZHONG AGRICULTURAL UNIVERSITY
WO/2021/238761	THERAPEUTIC COMPOSITION AND METHOD FOR TREATING CORONAVIRUS INFECTION	BEIJING BJUT SCIENCE AND TECHNOLOGY PARK CO., LTD
WO/2021/233402	BREXPIPRAZOLE-CONTAINING PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREFOR	JIANGSU SIMCERE PHARMACEUTICAL CO., LTD.
WO/2021/197507	RECOMBINANT NEWCASTLE DISEASE VIRUS AND PREPARATION METHOD, RECOMBINANT PLASMID, AND USE THEREFOR	JIANGSU KANIONREAL BIOMEDICAL TECHNOLOGY CO., LTD
WO/2021/233432	BLOOD-PURIFICATION MOLECULAR CONCENTRATE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF	XIA, Yongbiao
WO/2021/238836	CANTHARIDIN ANTIVIRAL AND ANTIBACTERIAL PREPARATION, PREPARATION METHOD THEREFOR, AND USE THEREOF FOR PREVENTING AND TREATING NOVEL CORONAVIRUS INFECTION	GANSU YUANMEI PHARMACEUTICAL CO., LTD.
WO/2021/238957	USE OF FAMITINIB IN PREPARATION OF MEDICATION FOR TREATING TUMOR HAVING C-KIT OR PDGFRA MUTATION	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/238978	PHARMACEUTICAL COMPOSITION CONTAINING NITROXOLINE PRODRUG, AND PREPARATION METHOD AND APPLICATION THEREFOR	JIANGSU YAHONG MEDITECH CO., LTD.
WO/2021/238982	PHARMACEUTICAL COMPOSITION COMPRISING POLYNUCLEOTIDES AND USE THEREOF FOR PREVENTION OR TREATMENT OF COVID-19	LIAONING YISHENG BIOPHARMA CO., LTD.
WO/2021/254118	APPLICATIONS OF HPK1 KINASE INHIBITOR IN PREVENTING AND/OR TREATING ANIMAL PATHOGEN INFECTION	ZHUHAI YUFAN BIOTECHNOLOGIES CO., LTD
WO/2021/244421	ANTIBODIES SPECIFICALLY RECOGNIZING PSEUDOMONAS PCRV AND USES THEREOF	STAIDSON (BEIJING) BIOPHARMACEUTICALS CO., LTD.
WO/2021/239106	APPLICATION OF ATP POTASSIUM CHANNEL MODIFIER IN PREPARATION OF ANTI-DIABETIC NEPHROPATHY DRUG	HANGZHOU QIAN BIOTECHNOLOGY LTD
WO/2021/239130	PHARMACEUTICAL PREPARATION AND PREPARATION METHOD THEREFOR	SICHUAN HAISCO PHARMACEUTICAL CO., LTD.
WO/2021/239134	LIPOSOME CONTAINING ETHYLENEDIAMINE TETRAACETIC ACID OR SALT THEREOF AND ERIBULIN OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF	JIANGSU HENGRUI MEDICINE CO., LTD.
WO/2021/244460	BIOMARKER RELATED TO ORAL SQUAMOUS CELL CARCINOMA AND DIAGNOSIS AND TREATMENT METHODS	QINGDAO MEDINTELL BIOMEDICAL CO., LTD
WO/2021/254132	ANTI-SIGLEC15 ANTIBODY AND USE THEREOF	SHENGHE (CHINA) BIOPHARMACEUTICAL CO., LTD.
WO/2021/249228	CAMPTOTHECIN DRUG HAVING HIGH-STABILITY HYDROPHILIC CONNECTING UNIT AND CONJUGATE THEREOF	SICHUAN BAILI PHARM CO., LTD
WO/2021/244481	COMPOSITIONS AND METHODS FOR TREATING A SARS-COV-2 INFECTION	THE UNIVERSITY OF HONG KONG
WO/2021/239147	β-CORONAVIRUS ANTIGEN, β-CORONAVIRUS BIVALENT VACCINE, PREPARATION METHODS THEREFOR, AND APPLICATIONS THEREOF	INSTITUTE OF MICROBIOLOGY, CHINESE ACADEMY OF SCIENCES
WO/2021/249236	USE OF 12,15-DIOXO-α-SELENENE IN PHARMACEUTICALS	KUNMING INSTITUTE OF BOTANY, CHINESE ACADEMY OF SCIENCES
WO/2021/249240	USE OF PALOVAROTENE IN TREATMENT AGAINST HBV VIRUS	YANG SHENG TANG COMPANY, LTD.
WO/2021/244515	PHARMACEUTICAL COMPOSITION FOR IMPROVING RESPIRATORY SYSTEM DAMAGE AND A USE IN PREPARATION OF PHARMACEUTICAL COMPOSITION FOR IMPROVING RESPIRATORY SYSTEM DAMAGE	BUFFALO BIOMEDICAL TECHNOLOGY CO., LTD.
WO/2021/244547	APPLICATION OF NATURAL COMPOUND AND DERIVATIVE THEREOF IN TREATING ARTERIAL LESIONS	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/244551	COMBINED PHARMACEUTICAL COMPOSITION OF C-MET KINASE INHIBITOR AND ANTI-PD-L1 ANTIBODY	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/249250	NOVEL IMMUNOLOGIC ADJUVANT, COMPOUND AND APPLICATION THEREOF	WANG, Zhulin
WO/2021/244597	METHOD FOR PREPARING FATTY ACID-BASED VC LIPOSOME	JIANGNAN UNIVERSITY
WO/2021/244606	GLUCOKINASE ACTIVATOR FOR TREATING DIABETES WITH HEPATIC IMPAIRMENT	HUA MEDICINE (SHANGHAI) LTD.
WO/2021/249286	NEW DRUG FORMULA FOR IMMUNOTHERAPY AND TABLET STRUCTURE THEREOF	XU, Xinpeng
WO/2021/249288	VORICONAZOLE EXTERNAL PREPARATION AND PREPARATION METHOD THEREFOR	HAINAN POLY PHARM CO., LTD.
WO/2021/249289	APPLICATION OF NORHARMANE IN IMPROVEMENT OF ANTIBIOTIC ANTIBACTERIAL ACTIVITY	ZHEJIANG UNIVERSITY OF TECHNOLOGY
WO/2021/244627	ISOLATED ANTIGEN BINDING PROTEIN AND USE THEREOF	LONGBIO PHARMA (SUZHOU) CO., LTD.
WO/2021/244628	PHARMACEUTICAL COMPOSITION OF ENZYMES AND VIRUSES AND APPLICATION THEREOF	SHANGHAI BAO PHARMACEUTICALS CO., LTD.
WO/2021/249352	CONJUGATE OF DOUBLE-STRANDED SIRNA ANALOGUE	CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
WO/2021/249373	STABLE HIGH-CONCENTRATION ANTI-HUMAN IL-5 MONOCLONAL ANTIBODY LIQUID PREPARATION	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/249376	USE OF TLR4 PATHWAY INHIBITOR AND/OR ANTAGONIST IN PREPARATION OF DRUG	ZHUJIANG HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY
WO/2021/249402	EFFECTS OF CELL-FREE FAT LIQUID EXTRACT ON MACROPHAGE POLARIZATION MODULATION AND DISEASE TREATMENT	SHANGHAI SEME CELL TECHNOLOGY CO., LTD.
WO/2021/254221	STABLE LIQUID PREPARATION OF ANTI-IL-4Rα MONOCLONAL ANTIBODIES	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/249420	USE OF KADSURA HETEROCLITA (ROXB.) CRAIB AGENT IN PREPARATION OF MEDICAMENT FOR RESISTING RHEUMATOID ARTHRITIS	HUNAN UNIVERSITY OF CHINESE MEDICINE
WO/2021/249445	PHARMACEUTICAL COMPOSITION OF ANTI-IL-17A ANTIBODIES AND USE THEREOF	SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/249452	RSV VACCINE COMPOSITIONS, METHODS, AND USES THEREOF	SICHUAN CLOVER BIOPHARMACEUTICALS, INC.
WO/2021/249484	CONJUGATE GROUP AND CONJUGATE	MEDSHINE DISCOVERY INC.
WO/2021/249492	METHYL-SUBSTITUTED BENZOBISOXAZOLE COMPOUND AND USE THEREOF	MEDSHINE DISCOVERY INC.
WO/2021/249501	ANTIVIRAL PREPARATION	SUNTRAP LIFE TECHNOLOGIES LTD.
WO/2021/254265	USE OF COMPOUND IN PREVENTION AND/OR TREATMENT OF PATHOGEN INFECTION IN ANIMALS	GARGAMEL (ZHUHAI) BIOTECH LTD.
WO/2021/249548	PHARMACEUTICAL COMPOSITION OF NOVEL CORONAVIRUS ANTIBODY AND USE THEREOF	SHANGHAI JUNSHI BIOSCIENCES CO., LTD.
WO/2021/254277	MICROSUSPENSION OF AN MDM2 INHIBITOR AND THERAPEUTIC APPLICATIONS THEREOF	ASCENTAGE PHARMA (SUZHOU) CO., LTD.
WO/2021/249551	LIQUID PREPARATION OF ANTI-PD-1 MONOCLONAL ANTIBODIES	SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
WO/2021/254287	NOVEL CORONAVIRUS TANDEM EPITOPE POLYPEPTIDE VACCINE AND USE THEREOF	SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
WO/2021/249561	THERAPEUTIC USE OF OF CELL-FREE FAT EXTRACT FOR PULMONARY DISEASES	SHANGHAI SEME CELL TECHNOLOGY CO., LTD.
WO/2021/254296	BIOACTIVE SUBSTANCE COMPOSITION, SERUM-FREE CULTURE MEDIUM COMPRISING THE COMPOSITION, AND USES THEREOF	ZHEJIANG UNIVERSITY
WO/2021/254299	USE OF BACTERIA IN CHILDREN DEVELOPMENT ASSESSMENT AND TREATMENT	THE CHINESE UNIVERSITY OF HONG KONG
WO/2021/254327	ENVELOPE REPLACEMENT-TYPE VIRAL VECTOR VACCINE AND CONSTRUCTION METHOD THEREFOR	FANTASIA BIOPHARMA (ZHEJIANG) CO. LTD
WO/2021/254337	NEW USE OF ACTIVE INGREDIENT WGX50 IN ZANTHOXYLUM BUNGEANUM MAXIM. EXTRACT	SHANGHAI JIAO TONG UNIVERSITY
WO/2021/254360	CARBOHYDRATE MOLECULAR CLUSTER AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF	TUOJIE BIOTECH (SHANGHAI) CO., LTD.
WO/2021/254447	STABLE FORMULATION FOR RECOMBINANT ANTI-PD-1 MONOCLONAL ANTIBODY	SINOCELLTECH LIMITED
WO/2021/259143	PHARMACEUTICAL USE OF (E)-3-ARYLHETEROCYCLYL PROP-2-ENOIC ACID DERIVATIVES	MEDCURIUS INC.
WO/2021/254471	ORAL FORMULATIONS AND USES THEREOF	INVENTISBIO CO., LTD.
WO/2021/259195	COMBINED DRUG FOR TREATING CORONAVIRUS DISEASE 2019	SICHUAN UNIVERSITY WEST CHINA HOSPITAL
WO/2021/259211	ANTISEPTIC COMPOSITIONS	RHT LIMITED
WO/2021/259215	ANTISEPTIC COMPOSITIONS	RHT LIMITED
WO/2021/259288	AGONIST OF DEACETYLASE AND USE THEREOF	GUANGZHOU UNIVERSITY OF CHINESE MEDICINE (GUANGZHOU RESEARCH INSTITUTE OF CHINESE MEDICINE)
WO/2021/259334	SELF-REGULATING CHIMERIC ANTIGEN RECEPTOR AND APPLICATION THEREOF IN TUMOR IMMUNITY	NANJING BOWANG PHARMACEUTICAL TECHNOLOGY CO., LTD
WO/2021/244676	NOVEL COMPOSITION FOR ENAMEL REMINERALIZATION	IBRITE SUZHOU TECHNOLOGY CO., LTD.
WO/2021/254537	USE OF CYCLOVIROBUXINE	SOUTHWEST UNIVERSITY
WO/2021/249578	MEDICATION FOR THE PREVENTION AND TREATMENT OF ASTHMA, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, OR ALLERGIC DISEASES	LIU, Li
WO/2021/249579	MEDICATION FOR THE PREVENTION AND TREATMENT OF COLD OR VIRAL DISEASES	LIU, Li
WO/2021/043345	HUMAN RECOMBINANT HYPOSIALYLATED ERYTHROPOIETIN, METHODS OF PURIFICATION AND THERAPEUTIC USES THEREOF	CENTRO DE INMUNOLOGIA MOLECULAR
WO/2021/129897	PROTEIN-BASED PHARMACEUTICAL COMPOSITION WITH NEUROPROTECTIVE, IMMUNOMODULATING, ANTI-INFLAMMATORY AND ANTIMICROBIAL ACTIVITY	CENTRO NACIONAL DE BIOPREPARADOS
WO/2021/155871	ORAL SUSPENSION WITH ANTI-ULCEROUS AND CHEMOPROTECTIVE EFFECT ON COLON CANCER AND PREPARATION METHOD THEREOF	CENTRO NACIONAL DE INVESTIGACIONES CIENTIFICAS
WO/2021/209080	PEPTIDE FOR THE TREATMENT OF CYTOKINE STORM SYNDROME	CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA
WO/2021/233484	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF RESPIRATORY DISEASES OF VIRAL ORIGIN	CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA
WO/2021/239165	PEPTIDE FOR TREATING CORONAVIRUS INFECTIONS	CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA
WO/2021/098892	DEVICE FOR THE PREPARATION OF FUNCTIONALISED SUBSTANCES	GRADE MEDICAL S.R.O.
WO/2021/110185	PHENOLIC DIHYDROBENZOFURANE DERIVATIVES, MEDICAL AND COSMETIC PREPARATIONS CONTAINING THESE DERIVATIVES, AND USE THEREOF	UNIVERZITA PALACKEHO V OLOMOUCI
WO/2021/233486	MESYLATE SALT OF <i>PARA</i>-TOPOLIN, COMPOSITIONS CONTAINING SAID SALT AND USE THEREOF	USTAV EXPERIMENTALNI BOTANIKY AV ČR, V. V. I.
WO/2021/047699	GLYCOPOLYMER, METHOD OF PREPARATION THEREOF, USE THEREOF AS MEDICAMENT	USTAV MAKROMOLEKULARNI CHEMIE AV CR, V. V.I.
WO/2021/073667	METHOD FOR THE PREPARATION OF POLYMERIC CARRIERS FOR PH- CONTROLLED DRUG RELEASE AND THEIR CONJUGATES WITH DRUGS	USTAV MAKROMOLEKULARNI CHEMIE AV CR, V.V.I.
WO/2021/115502	N-(FURAN-2-YLMETHYL)-7H-PURIN-6-AMINE FOR TREATMENT OF CIRCADIAN RHYTHM DISEASES, DISORDERS AND DYSFUNCTIONS	UNIVERZITA PALACKEHO V OLOMOUCI
WO/2021/115503	LIPOPHOSPHONOXINS, THEIR PREPARATION AND USE	USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I.
WO/2021/121446	COPOLYMER WITH HYDROLYTIC RELEASE OF CANCEROSTATIC AGENT CYTARABINE, METHOD OF ITS PREPARATION AND USE THEREOF	USTAV MAKROMOLEKULARNI CHEMIE AV CR, V.V.I.
WO/2021/249581	METHOD OF PREPARATION OF THE TRANSFER FACTOR MEDICINE, TRANSFER FACTOR MEDICINE, METHOD OF TESTING ITS BIOLOGICAL ACTIVITY, PHARMACEUTICAL FORM AND ITS USE	AUMED, A.S.
WO/2021/148065	A METHOD OF TRANSFORMATION OF GENES INTO BACTERIAL CELLS	UNIVERZITA KARLOVA, LEKARSKA FAKULTA V PLZNI
WO/2021/148066	DENTAL PREPARATION COMPRISING FIBERS BASED ON HYALURONIC ACID WITH REGULATED BIODEGRADABILITY	CONTIPRO A.S.
WO/2021/013283	ORAL HYGIENE AGENTS CONTAINING CAFFEINE AND L-LYSIN AS BITTER BLOCKING AGENTS	DR. KASCHNY HEALTHCARE GMBH
WO/2021/027984	PROTEOPHOSPHOLIPOSOMES HAVING HDL-TYPE VESICLES	KORTH, Ruth-Maria
WO/2021/093912	NEW FORMULATION OF LACTOBACILLUS STRAINS FOR THE TREATMENT AND PREVENTION OF <i>HELICOBACTER PYLORI</i> COLONISATION IN THE UPPER AIRWAYS AND THE DIGESTIVE SYSTEM	BELANO MEDICAL AG
WO/2021/008652	NANOSTRUCTURED IBUOPROFEN COMPOSITIONS, METHODS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITION CONTAINING THEM	MYBIOTECH GMBH
WO/2021/032252	ADHESIVE PLASTER CONTAINING A SPECIALLY DESIGNED RESERVOIR FOR A PHARMACEUTICAL PREPARATION	ABU-GHAZALEH, Adrian
WO/2021/143962	PROVISION OF BACTERIOPHAGES IN VARIOUS DOSAGE FORMS AND BACTERIOPHAGE APPLICATION DEVICE	JUNGHANS, Simon Frank
WO/2021/209093	TREATMENT OF NON-TRANSMISSIBLE INFLAMMATORY DISEASES WITH A SUBSTANCE THAT INHIBITS TRANSCRIPTION OF THE CEBPB GENE OR THE FUNCTION OF THE CEBPB PROTEIN	DERMAGNOSTIX R&D GMBH
WO/2021/213587	COMBINATION WHICH CAN BE USED FOR THE TREATMENT AND PROPHYLAXIS OF CORONAVIRUS-INDUCED PULMONARY DYSFUNCTION AND DAMAGE	KIESEWETTER, Holger
WO/2021/259423	USE OF COENZYME ANTAGONISTS IN ORDER TO SLOW DOWN A METABOLIC PROCESS	TAVARGENIX GMBH
WO/2021/259425	BISPHOSPHONATE-MODIFIED LIPOSOMES CONTAINING NANOPARTICLES	PHARMA DEVELOPMENT HOLDING GMBH
WO/2021/069036	COMPRESSED NICOTINE LOZENGE	FERTIN PHARMA A/S
WO/2021/001006	A SKIN CARE COMPOSITION	COLOPLAST A/S
WO/2021/023351	TOPICAL FORMULATIONS COMPRISING CANNABIDIOL, METHOD OF PREPARING THE COMPOSITION AND USE THEREOF	CS GROUP APS
WO/2021/069044	AN ION-EXCHANGE COMPOSITION WITH WATER-SOLUBLE MUCOADHESIVE POLYMERS	FERTIN PHARMA A/S
WO/2021/069046	A VAGINAL CONTRACEPTIVE COMPOSITION FOR REINFORCEMENT OF MUCUS BARRIER PROPERTIES	CIRQLE BIOMEDICAL CONTRACEPTION ApS
WO/2021/083467	ADMINISTRATION OF CD22, CD33 AND/OR TIM-3 ANTIBODIES USING OMMAYA RESERVOIRS FOR THE TREATMENT OF CNS CANCER OR NEURODEGENERATIVE DISEASES	Y-MABS THERAPEUTICS, INC.
WO/2021/151442	METHOTREXATE DOSAGE FORM	ROS THERAPEUTICS APS
WO/2021/164832	STARCH PROPIONATE USED AS A FOOD ADDITIVE AND/OR DIETARY SUPPLEMENT FOR PREVENTION OF OVERWEIGHT AND OBESITY	ABILDGAARD, Ole
WO/2021/170193	COMPOSITION COMPRISING EGG YOLK AND BURNT CERAL POWDER FOR WOUND HEALING	SAHEBI, Sükrüye
WO/2021/213601	B7H3 ANTIBODIES WITH CHELATORS	Y-MABS THERAPEUTICS, INC.
WO/2021/223824	FLOWPACK FOR ORAL DELIVERY OF ACTIVE INGREDIENTS	FERTIN PHARMA A/S
WO/2021/223825	ORAL POWDER MIXTURE WITH SMALL SIZED PARTICLES	FERTIN PHARMA A/S
WO/2021/223826	MOUTHWASH FOR ORAL CARE BENEFITS	FERTIN PHARMA A/S
WO/2021/244721	ANTI-B7H3 ANTIBODIES FOR THE TREATMENT OF CANCER	Y-MABS THERAPEUTICS, INC.
WO/2021/259434	METHOD FOR MANUFACTURING A MULTI-LAYERED FILM STRUCTURE AND METHOD FOR MANUFACTURING MULTI-LAYERED MICROSTRUCURES	MLMC THERAPEUTICS APS
WO/2021/078349	PHARMACEUTICAL COMPOSITION BASED ON PLANT EXTRACTS FOR THE TREATMENT OF FIBROMYALGIA, RHEUMATOID ARTHRITIS, LUPUS AND OTHER AUTOIMMUNE DISEASES	PORTILLO ROSADO, Rosa Maria
WO/2021/037322	COMPOSITION FOR DELAYING AND DYEING GREY HAIR	PORTILLO ROSADO, Rosa Maria
WO/2021/180293	A COMPOSITION FOR NORMALIZING BLOOD LIPID LEVEL	DIKOVSKIY, Aleksander Vladimirovich
WO/2021/043382	NOVEL BIOLOGICAL ENTERIC DIALYSIS METHOD FOR CKD AND ESRD	HESEN, Sherif Salah Abdulaziz
WO/2021/028005	A MEDICAMENT COMPRISING ANABASINE FOR TREATMENT OF ASTHMA, CHEST ALLERGY AND ATOPIC DERMATITS	ELKAZAZ, Mohamed, Fadly, Abd el Ghany
WO/2021/151450	TARGETED DRUG DELIVERY SYSTEM USING BACTERIAL GHOSTS OF SALMONELLA TOWARD HEPATIC CANCER CELLS	AHMED, Sameh Rabea Mohamed
WO/2021/254582	EFFICACY OF (SOFOSBUVIR PLUS LEDIPASVIR) IN EGYPTIAN PATIENTS WITH COVID-19COMPARED TO STANDARD OF CARE TREATMENT.	ALMAZA MILITARY FEVER HOSPITAL
WO/2021/013315	OINTMENT FOR DIABETIC FOOT ULCER TREATMENT	MOSTAFA, Mariam Mohamed Kamel
WO/2021/259441	A NEW AND SAFE PHARMACEUTICAL PREPARATION FOR PROPHYLAXIS AND TREATMENT OF RESPIRATORY VIRAL INFECTIONS, ESPECIALLY CORONA VIRUSES	KHALIL, Ibrahim Taha Ibrahim
WO/2021/063468	STABLE PARENTERAL PHARMACEUTICAL COMPOSITION CONTAINING TIGECYCLINE AND PROCESS FOR THE PREPARATION THEREOF	ANFARM HELLAS S.A.
WO/2021/008668	PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC ADMINISTRATION CONTAINING CYCLOSPORINE	PHARMATHEN S.A.
WO/2021/001023	RNA FORMULATIONS SUITABLE FOR THERAPY	BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/001029	BLEND OF BEESWAX AND A LACTYLATE ESTER	SYMRISE AG
WO/2021/008669	PHARMACEUTICAL COMPOSITIONS COMPRISING INHIBITORS OF OPA1 FOR USE IN THE TREATMENT OF CANCER	UNIVERSITA' DEGLI STUDI DI PADOVA
WO/2021/008678	USE OF N-ACYLHYDROXY AMINO ACID ESTER FOR INDUCING THE EXPRESSION OF SUPEROXIDE-DISMUTASE AND/OR HEM OXYGENASE	SYMRISE AG
WO/2021/018377	COSMETIC COMPOSITION WITH COMBINED FILLER AND SKIN REGENERATIVE EFFECT	GIULIANI S.P.A.
WO/2021/018387	DIFFERENT FORMS OF 6-CHLORO-2-ETHYL-N-(4-(4-(4-(TRIFLUOROMETHOXY)PHENYL)PIPERIDINE-1-YL)BENZYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBOXAMIDE	QURIENT CO., LTD.
WO/2021/028024	IMPROVED DOSAGE OF BALOXAVIR MARBOXIL FOR PEDIATRIC PATIENTS	F. HOFFMANN-LA ROCHE AG
WO/2021/032271	INDUCTION OF FUNCTIONAL ASTROCYTES FROM PLURIPOTENT STEM CELLS	LU LICENSE AB
WO/2021/037383	COSMETIC USE OF β-L-ASPARTYL-L-ARGININE	SYMRISE AG
WO/2021/043389	GINSENG COMPOSITION AND USE THEREOF AS A MEDICAMENT FOR TREATMENT OR PREVENTION OF AN IMPAIRED COGNITION	BOTALYS SA
WO/2021/043392	ANTIPERSPIRANT EMULSION	BEIERSDORF AG
WO/2021/043394	ANTIPERSPIRANT ACTIVE EMULSION	BEIERSDORF AG
WO/2021/047783	VS-6063 IN COMBINATION WITH CH5126766 FOR THE TREATMENT OF CANCER	THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
WO/2021/052597	SKIN-CARE PRODUCT CONTAINING HYALURONIC ACID (OR A SALT THEREOF) AND A PLANT STEM CELL EXTRACT	PM-INTERNATIONAL AG
WO/2021/058091	TREATMENT INVOLVING THERAPEUTIC ANTIBODY AND INTERLEUKIN-2 (IL2)	BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/037387	PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE VIRUS	ELANCO US INC.
WO/2021/058117	METHOD OF TREATMENT OF HEMATOPOIETIC STEM CELL TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY (HSCT-TMA)	VOLUTION IMMUNO PHARMACEUTICALS SA
WO/2021/073742	AGONIST OF TACR2	UNIVERSITY OF COPENHAGEN
WO/2021/078359	USE OF INHIBITORS OF CUBILIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASES	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/073761	COMPOSITIONS WITH ANTIMICROBIAL PROPERTIES	SYMRISE AG
WO/2021/073762	COMBINATION DRUG FOR MEDICAL USE FOR THE TREATMENT OF A DISORDER CAUSED BY DAMAGE TO RENAL TUBULAR FUNCTION	PROSALIX AG
WO/2021/104639	USE OF 2-PHENYL-6-(1H-IMIDAZOL-1-YL) QUINAZOLINE FOR THE PREVENTION OF ABUSE AND OF SIDE EFFECTS OF AT LEAST ONE OPIOID	ROTTAPHARM BIOTECH S.R.L.
WO/2021/110239	STAINLES STEEL CAN FOR PRESSURISED METERED DOSE INHALERS	CHIESI FARMACEUTICI S.P.A.
WO/2021/013372	LIQUID ANTIBODY FORMULATION	ICHNOS SCIENCES SA
WO/2021/115601	BIODEGRADABLE MICROCAPSULE SYSTEMS	PAPIERFABRIK AUGUST KOEHLER SE
WO/2021/115610	METHOD FOR PREPARING A COMPOSITION AND USE OF THE COMPOSITION FOR TREATMENT OR PROPHYLAXIS OF DISEASE	QUANTUM PHARMACEUTICALS SA
WO/2021/121566	UTILIZATION OF A COMPOSITION COMPRISING ORGANIC SILICA FOR THE IMPROVEMENT OF THE QUALITY OF CARTILAGENOUS TISSUES	AA HEALTHCARE SàRL
WO/2021/063526	NOVEL SKIN CARE COMPOSITION	S-BIOMEDIC
WO/2021/063527	NOVEL SKIN CARE COMPOSITION	S-BIOMEDIC
WO/2021/063528	NOVEL SKIN CARE COMPOSITION	S-BIOMEDIC
WO/2021/063529	NOVEL SKIN CARE COMPOSITION	S-BIOMEDIC
WO/2021/063530	NOVEL SKIN CARE COMPOSITION	S-BIOMEDIC
WO/2021/063531	NOVEL SKIN CARE COMPOSITION	S-BIOMEDIC
WO/2021/063532	NOVEL SKIN CARE COMPOSITION	S-BIOMEDIC
WO/2021/121627	IMPROVED PERTUSSIS VACCINE COMPOSITION	UNIVERSITé D'AIX-MARSEILLE
WO/2021/151452	OIL-IN-WATER-TYPE EMULSION COSMETIC	L V M H RECHERCHE
WO/2021/129927	TREATMENT WITH IMMUNE EFFECTOR CELLS ENGINEERED TO EXPRESS AN ANTIGEN RECEPTOR	BIONTECH CELL & GENE THERAPIES GMBH
WO/2021/129945	<i>IN VITRO</i> AND <i>IN VIVO</i> GENE DELIVERY TO IMMUNE EFFECTOR CELLS USING NANOPARTICLES FUNCTIONALIZED WITH DESIGNED ANKYRIN REPEAT PROTEINS (DARPINS)	BIONTECH CELL & GENE THERAPIES GMBH
WO/2021/121645	A TOPICAL ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION COMPRISING ZILEUTON	QURIENT CO., LTD.
WO/2021/013384	SKINCARE COMPOSITIONS	THE BOOTS COMPANY PLC
WO/2021/018414	PHARMACEUTICAL COMPOSITION COMPRISING DABIGATRAN ETEXILATE	ZAKLADY FARMACEUTYCZNE POLPHARMA S.A.
WO/2021/037396	DENTAL COMPOSITION	DENTSPLY SIRONA INC.
WO/2021/078412	FRACTAL FORMULATIONS	MESSADEK, Jallal
WO/2021/139872	SOLUBLE MELATONIN TRIPARTATE ADDUCT FOR THE PREVENTION AND TREATMENT OF RARE AND SEVERE EYE SIGHT-THREATENING CONDITIONS AND NEURO-OPHTHALMIC DISORDERS	WORPHMED SRL
WO/2021/139874	COGNITIVE DISORDER PREVENTION AND THERAPY	ANIMA
WO/2021/144020	ANTIGEN BINDING PROTEINS SPECIFICALLY BINDING PRAME	IMMATICS BIOTECHNOLOGIES GMBH
WO/2021/073775	ARTICLES FOR INDIRECT TRANSFER OF COSMETIC ACTIVES TO SKIN	SYMRISE AG
WO/2021/013385	PROCESSES FOR OBTAINING A HIGHLY CONCENTRATED ANTIBODY SOLUTION	ICHNOS SCIENCES SA
WO/2021/148124	COMPOSITIONS FOR REMOVING NECROTIC OR INFECTED TISSUES FROM BODY SURFACE LESIONS	DEBX MEDICAL BV
WO/2021/155916	TREATMENT INVOLVING ANTIGEN VACCINATION AND BINDING AGENTS BINDING TO PD-L1 AND CD137	BIONTECH SE
WO/2021/164848	NOVEL 6-SUBSTITUTED 7-DEAZAPURINES AND CORRESPONDING NUCLEOSIDES AS MEDICAMENTS	KATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/170218	STABLE, LIQUID EMULSIFIERS ON THE BASIS OF CITRATE ESTERS AND THEIR USE	SYMRISE AG
WO/2021/170223	ANTIPERSPIRANT ACTIVE EMULSION	BEIERSDORF AG
WO/2021/175405	COMPOSITE RNA PARTICLES	BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/175432	METHOD FOR ADMINISTRATION OF AN ANTI CANCER AGENT	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/175450	COMPOSITION OR OAT EXTRACT COMPRISING AVENANTHRAMIDE AND ß-GLUCAN	SYMRISE AG
WO/2021/175451	COSMETIC OR PHARMACEUTICAL USE OF AVENANTHRAMIDE L	SYMRISE AG
WO/2021/175452	COMPOSITION COMPRISING AN AVENANTHRAMIDE OR AN ANALOGUE THEREOF WITH IMPROVED SKIN PENETRATION	SYMRISE AG
WO/2021/175453	COMPOSITION COMPRISING AN AVENTHRAMIDE OR AN ANALOGUE THEREOF WITH IMPROVED STABILITY	SYMRISE AG
WO/2021/175454	AVENANTHRAMIDE COMPOSITIONS WITH IMPROVED SOLUBILITY COMPRISING 4-HYDROXYPHENONE	SYMRISE AG
WO/2021/037400	METHODS OF TREATING HEART FAILURE WITH REDUCED EJECTION FRACTION WITH DAPAGLIFLOZIN	ASTRAZENECA AB
WO/2021/139901	PEPTIDE-CONTAINING COMPOSITION FOR USE FOR TREATING NEOPLASTIC LESIONS	CYTOVATION AS
WO/2021/047798	VS-6063 IN COMBINATION WITH CH5126766 FOR THE TREATMENT OF CANCER	THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
WO/2021/083555	ALK INHIBITORS FOR TREATMENT OF ALK-NEGATIVE CANCER AND PLASMA CELL-MEDIATED DISEASES	UNIVERSITETET I OSLO
WO/2021/190735	COSMETIC COMPOSITION FOR MAKING UP OR CARING FOR KERATIN MATERIALS COMPRISING A FLUORESCENT COMPOUND FROM THE FAMILY OF 4-BORA-3A,4A-DIAZA-S-INDACENES, AND/OR FROM THE FAMILY OF DIFLUOROBORANE BETA-DIKETONATES	CRIME SCIENCE TECHNOLOGY
WO/2021/190770	INHIBITORS OF C5A FOR THE TREATMENT OF CORONA VIRUS Infection	INFLARX GMBH
WO/2021/197589	TREATMENT INVOLVING NON-IMMUNOGENIC RNA FOR ANTIGEN VACCINATION	BIONTECH SE
WO/2021/148143	TREATMENT OF CARDIAC REMODELLING	UNIVERSITETET I OSLO
WO/2021/197639	COMPOSITIONS COMPRISING 15-HEPE FOR TREATING OR PREVENTING HEMATOLOGIC DISORDERS, AND/OR RELATED DISEASES	AFIMMUNE LIMITED
WO/2021/204371	ANTI-POLLUTION COMPOSITION	BEIERSDORF AG
WO/2021/073778	COMPOSITIONS AND METHODS FOR VACCINATING PIGLETS AGAINST <i>STREPTOCOCCUS</i>	CEVA SANTE ANIMALE
WO/2021/209134	ANTIMICROBIAL SILVER COORDINATION COMPLEXES	PENTA SCIENCE INDUSTRIES HOLDING B.V.
WO/2021/136602	ORAL SOLUTIONS COMPRISING LISDEXAMFETAMINE SALTS	LABOSERVE PHARMACEUTICAL COMPANY S.A.
WO/2021/180338	COMBINATION TREATMENT WITH A P53 REACTIVATOR AND AN INHIBITOR OF DNA METHYLTRANSFERASE POST STEM CELL TRANSPLANT	APREA THERAPEUTICS AB
WO/2021/219202	VISUALIZATION OF HER2 EXPRESSION IN HUMAN PATIENTS	HOBER BIOTECH AB
WO/2021/004673	SOLID HAIR CONDITIONING COMPOSITIONS	HENKEL AG & CO. KGAA
WO/2021/004674	SOLID HAIR CONDITIONING COMPOSITIONS	HENKEL AG & CO. KGAA
WO/2021/094000	DOSING REGIMEN FOR ANTI-BCMA AGENTS	AMGEN RESEARCH (MUNICH) GMBH
WO/2021/228358	A SOLID MUCOADHESIVE COMPOSITION	SYMRISE AG
WO/2021/228363	PREVENTION OF INFECTIOUS DISEASES BY MODULATING THE IMMUNE SYSTEM	VAKZINE PROJEKT MANAGEMENT GMBH
WO/2021/228365	USES AND FORMULATIONS OF CANNABINOIDS	ADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/228366	USES AND FORMULATIONS OF CANNABINOIDS	ADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/228414	METHODS OF TREATING SMALL CELL LUNG CANCER WITH LURBINECTEDIN FORMULATIONS	PHARMA MAR, S.A.
WO/2021/098991	COMPOSITIONS COMPRISING BACTERIAL STRAINS	4D PHARMA RESEARCH LIMITED
WO/2021/233534	USE OF SUBSTANCE AND PHARMACEUTICAL COMPOSITION THEREOF, AND MEDICAL TREATMENTS OR USES THEREOF	PVAC MEDICAL TECHNOLOGIES LTD
WO/2021/233549	CLEAVABLE POLYMER DRUG CONJUGATES FOR VIRAL DISEASES	RS ARASTIRMA EGITIM DANISMANLIK ILAC SANAYI TICARET ANONIM SIRKETI
WO/2021/233551	OLIGONUCLEOTIDES FOR SPLICE MODULATION OF CARD9	F.HOFFMANN-LA ROCHE AG
WO/2021/098992	METHODS OF TREATING SMALL CELL LUNG CANCER WITH LURBINECTEDIN FORMULATIONS	PHARMA MAR, S.A.
WO/2021/001104	LIPID MIXTURE CONSISTING OF LIQUID OILS, HYDROGENATED VEGETABLE OILS, AND SHEA BUTTER	BEIERSDORF AG
WO/2021/244733	HYPOXIA-RESISTANT NATURAL KILLER CELLS	ONK THERAPEUTICS LIMITED
WO/2021/004711	FATTY ACID POLYGLYCERYL ESTER-CONTAINING CLEANSING PREPARATION	BEIERSDORF AG
WO/2021/004712	CLEANSING EMULSION CONTAINING FATTY ACID POLYGLYCERYL ESTERS	BEIERSDORF AG
WO/2021/018443	METHOD FOR TREATING KERATIN MATERIAL, COMPRISING THE USE OF AN ORGANIC C1-C6 ALKOXY-SILANE AND AN AMINO ACID AND/OR AN AMINO ACID DERIVATIVE	HENKEL AG & CO. KGAA
WO/2021/013419	INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL	HENKEL AG & CO. KGAA
WO/2021/018444	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN ORGANIC C1-C6-ALKOXY-SILANE AND AN ALKALISING AGENT	HENKEL AG & CO. KGAA
WO/2021/018445	OXIDANT-FREE METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE APPLICATION OF AN ORGANIC C1-C6-ALKOXY SILANE AND AN OXIDANT-FREE DYE PRECURSOR	HENKEL AG & CO. KGAA
WO/2021/018446	METHOD FOR TREATING KERATIN MATERIAL, COMPRISING THE APPLICATION OF AN ORGANIC C1-C6-ALKOXY-SILANE AND AN AMINO ACID AND/OR AMINO ACID DERIVATIVE	HENKEL AG & CO. KGAA
WO/2021/013420	INCREASING THE STABILITY OF AGENTS FOR TREATING KERATIN MATERIAL	HENKEL AG & CO. KGAA
WO/2021/028093	METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS BEEN DYED USING AN ORGANOSILICON COMPOUND AND A PIGMENT	HENKEL AG & CO. KGAA
WO/2021/018447	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN ORGANIC C1-C6-ALKOXY-SILANE AND AN ALKALISING AGENT	HENKEL AG & CO. KGAA
WO/2021/028094	METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS BEEN DYED USING AN ORGANOSILICON COMPOUND AND A PIGMENT	HENKEL AG & CO. KGAA
WO/2021/028095	METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS BEEN DYED USING AN ORGANOSILICON COMPOUND AND A PIGMENT	HENKEL AG & CO. KGAA
WO/2021/023415	COMESTIC NANOEMULSION	BEIERSDORF AG
WO/2021/249641	PHARMACEUTICAL COMPOSITIONS CONTAINING ENTEROKINE-RELEASING SUBSTANCES IN MULTIPLE DOSAGE FORMS IN COMBINATION WITH GELLING AGENTS	APHAIA PHARMA IP AG
WO/2021/254588	SOLID CLEANSING COMPOSITION	BEIERSDORF AG
WO/2021/004736	REDUCING THE VIRAL ACTIVITY OF ELAFIBRANOR WITH RIBOFLAVIN OR DHA	DSM IP ASSETS B.V.
WO/2021/254628	FRAGRANCE MIXTURES CONTAINING 1-(4,4-DIMETHYLCYCLOHEXEN-1-YL) ETHANON	SYMRISE AG
WO/2021/254637	ASSOCIATION OF NATURAL ACTIVES INGREDIENTS TO FIGHT SKIN AGING	TOMCAT INTERNATIONAL LIMITED
WO/2021/004770	HAIR CARE COMPOSITION COMPRISING ANTIDANDRUFF AGENT	UNILEVER N.V.
WO/2021/018479	PROCESS AND APPARATUS FOR PRODUCTION OF A GRANULAR CANNABINOID MATERIAL ESSENTIALLY SOLUBLE IN AQUEOUS MEDIUM	ADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/259454	TINTED SUNSCREEN	BEIERSDORF AG
WO/2021/013452	TSG6 POLYPEPTIDE FRAGMENT FOR DRY EYE DISEASE	THE UNIVERSITY OF MANCHESTER
WO/2021/008822	TOPICAL COMPOSITIONS AND METHODS OF USING SAME AGAINST MITOCHONDRIAL FRAGMENTATION	UNILEVER PLC
WO/2021/008823	STABILIZATION OF RESORCINOL COMPOUNDS IN COSMETIC COMPOSITIONS	UNILEVER PLC
WO/2021/008824	BIOENERGETIC COMBINATIONS AND METHODS OF USING SAME	UNILEVER PLC
WO/2021/259471	DERMAL FILLER WITH HIF-1α ACTIVITY MODULATORS	THOR, Dominik
WO/2021/259472	MICELLAR DOCETAXEL FOR USE IN THE TREATMENT OF CANCER	OASMIA PHARMACEUTICAL AB
WO/2021/001281	METHOD OF DEPOSITING A SUBSTANCE ON A SUBSTRATE	DBV TECHNOLOGIES
WO/2021/001286	A SUBSTITUTED TETRAHYDROISOQUINOLINE DERIVATIVE AS A D1 POSITIVE ALLOSTERIC MODULATOR	UCB BIOPHARMA SRL
WO/2021/001288	A SUBSTITUTED TETRAHYDROISOQUINOLINE DERIVATIVE AS A D1 POSITIVE ALLOSTERIC MODULATOR	UCB BIOPHARMA SRL
WO/2021/001290	COMPOSITION COMPRISING STABILIZED PHYCOCYANIN AND ITS USES	CALICEA
WO/2021/001306	METHYLTHIONINIUM AS ENHANCERS OF THE COGNITIVE FUNCTION	WISTA LABORATORIES LTD.
WO/2021/013476	HAIR CARE COMPOSITION	UNILEVER N.V.
WO/2021/001326	METHYLTHIONINIUM FOR USE IN THE TREATMENT OF SYNAPTOPATHIES	WISTA LABORATORIES LTD.
WO/2021/001332	METHOD FOR OBTAINING A BOTANICAL THERMAL INFUSION	LABORATOIRES LéA
WO/2021/013479	MUCIN ISOFORMS IN DISEASES CHARACTERIZED BY BARRIER DYSFUNCTION	UNIVERSITEIT ANTWERPEN
WO/2021/001349	INHALABLE COMPOSITION COMPRISING CYCLODEXTRIN FOR USE IN THE TREATMENT OF NASAL INFLAMMATIONS	AQUILON PHARMACEUTICALS
WO/2021/001356	CD5 SPECIFIC T CELL RECEPTOR CELL OR GENE THERAPY	MAX-DELBRüCK-CENTRUM FüR MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT
WO/2021/001360	PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USES THEREOF	ADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/121677	RETINOL-BASED SERUM	L'OREAL
WO/2021/001362	PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) LIGANDS AND USES THEREOF	ADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/001365	PROPHYLAXIS AND TREATMENT OF A HUMAN PAPILLOMAVIRUS (HPV) INFECTION OF THE CERVIX	EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTÄT
WO/2021/001366	METHOD FOR STABILIZING THE PH OF AN AQUEOUS COMPOSITION COMPRISING A DRUG	OCULIS SA
WO/2021/001374	PHARMACEUTICAL COMPOSITIONS FOR GLUCAGON AND GLP-1 CO-AGONIST PEPTIDES	MEDIMMUNE LIMITED
WO/2021/001377	cPLA2e INDUCING AGENTS AND USES THEREOF	FUNDACION PARA LA INVESTIGACION MEDICA APLICADA
WO/2021/001380	THERAPEUTIC INTERACTIONS OF LEUCOMETHYLTHIONINIUM	WISTA LABORATORIES LTD.
WO/2021/001393	COSMETIC COMPOSITION COMPRISING SILICONES BEARING A CARBOXYLIC GROUP AND ANIONIC DIRECT DYES, AND COSMETIC TREATMENT PROCESS	L'OREAL
WO/2021/008870	Cosmetic composition comprising anionic and amphoteric surfactants, cationic polysaccharides and unsaturated fatty alcohols, and cosmetic treatment process	L'OREAL
WO/2021/001405	COMPOUND AND COMPOSITIONS FOR MULTITARGET TREATMENT OF TAU PROTEIN-RELATED DISORDERS	FONDAZIONE IRCCS ISTITUTO NEUROLOGICO CARLO BESTA
WO/2021/001417	RNA FORMULATIONS SUITABLE FOR THERAPY	BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/001427	METHODS FOR THE PROPHYLACTIC TREATMENT OF CANCER IN PATIENTS SUFFERING FROM PANCREATITIS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/001431	USE OF PI3KA-SELECTIVE INHIBITORS FOR TREATING METASTATIC DISEASE IN PATIENTS SUFFERING FROM PANCREATIC CANCER	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/001457	CRYSTALLINE (R)-2-AMINO-3-PHENYLPROPYLCARBAMATE ACID ADDITION SALTS	SANDOZ AG
WO/2021/001458	ANTI-CD154 ANTIBODIES AND USES THEREOF	TONIX PHARMA HOLDINGS LIMITED
WO/2021/001461	ORAL THIN FILM	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/001462	CONJUGATED DEOXYNIVALENOL TO PROTECT AGAINST MYCOTOXICOSIS	INTERVET INTERNATIONAL B.V.
WO/2021/001464	COMBINATION THERAPY METHODS, COMPOSITIONS AND KITS	BIONURE FARMA, S.L.
WO/2021/001508	METHODS OF TREATING HIV IN PEDIATRIC PATIENTS WITH RILPIVIRINE	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/004910	COMBINATION FOR THE TREATMENT OF INFECTIONS CAUSED BY MYCOPLASMA GENITALIUM	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/001518	PXR LIGANDS FOR THE PREVENTION OR TREATMENT OF METABOLIC DISORDERS	MEDIZINISCHE UNIVERSITÄT GRAZ
WO/2021/004913	COMPOSITIONS AND METHODS USING TRIGONELLINE AND HIGH PROTEIN FOR PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLE	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/004915	COMPOSITIONS AND METHODS USING TRIGONELLINE AND MINERALS FOR PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLE	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/004919	COMPOSITIONS AND METHODS USING TRIGONELLINE AND VITAMINS FOR PREVENTING OR TREATING CONDITIONS OR DISORDERS IN SKELETAL MUSCLE	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/004922	COMPOSITIONS AND METHODS USING TRIGONELLINE TO PRODUCE INTRACELLULAR NICOTINAMIDE ADENINE DINUCLEOTIDE (NAD+) FOR TREATING OR PREVENTING PHYSIOLOGICAL DISORDERS OR STATES	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/001528	NOVEL GALACTOSIDE INHIBITOR OF GALECTINS	GALECTO BIOTECH AB
WO/2021/001538	NOVEL GALACTOSIDE INHIBITOR OF GALECTINS	GALECTO BIOTECH AB
WO/2021/001540	DETOXIFICATION OF PROTEINS	PROXI BIOTECH APS
WO/2021/004942	DRY COSMETIC AND/OR SKIN CARE COMPOSITION	OMYA INTERNATIONAL AG
WO/2021/004945	COMPOSITION COMPRISING A NATURAL DYE, AN ANTHRAQUINONE CATIONIC DIRECT DYE AND AN AROMATIC COMPOUND	L'OREAL
WO/2021/004948	COMPOSITION COMPRISING A NATURAL DYE, A HYDRAZONO AND/OR AZO CATIONIC SYNTHETIC DIRECT DYE AND AN AROMATIC COMPOUND	L'OREAL
WO/2021/004950	COMPOSITION COMPRISING A NATURAL DYE, A TRIARYLMETHANE DIRECT DYE AND AN AROMATIC COMPOUND	L'OREAL
WO/2021/004958	COMPOSITIONS COMPRISING BACTERIAL STRAINS	4D PHARMA RESEARCH LIMITED
WO/2021/001567	MODULATION OF T CELL CYTOTOXICITY AND RELATED THERAPY	CANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/001568	METHODS OF TREATING HIV IN PEDIATRIC PATIENTS WITH RILPIVIRINE	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/013509	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A COLORED EFFECT PIGMENT AND A FILM-FORMING POLYMER II	HENKEL AG & CO. KGAA
WO/2021/013510	COATED EFFECT PIGMENTS AND PRODUCTION THEREOF	HENKEL AG & CO. KGAA
WO/2021/013511	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A COLORED EFFECT PIGMENT AND A FILM-FORMING POLYMER IV	HENKEL AG & CO. KGAA
WO/2021/013512	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A COLORED EFFECT PIGMENT AND A SEALING REAGENT III	HENKEL AG & CO. KGAA
WO/2021/013513	COLOURING EFFECT PIGMENTS AND PRODUCTION THEREOF	HENKEL AG & CO. KGAA
WO/2021/013516	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A COATED EFFECT PIGMENT AND A FILM-FORMING POLYMER II	HENKEL AG & CO. KGAA
WO/2021/052647	SKIN LIGHTENING COMPOSITION	BELLA AURORA LABS, S.A.
WO/2021/052648	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A COATED EFFECT PIGMENT AND A SEALING REAGENT I	HENKEL AG & CO. KGAA
WO/2021/013517	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A COLORED EFFECT PIGMENT AND A SEALING REAGENT I	HENKEL AG & CO. KGAA
WO/2021/005011	TABLETING OF SPECIFIC POLYMER STABILIZERS	BASF SE
WO/2021/005059	MODIFIED ESCHERICHIA COLI STRAIN NISSLE AND TREATMENT OF GASTROINTESTINAL DISORDER	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/005064	A COMPOSITION, A KIT AND USE THEREOF	THERAVET SA
WO/2021/005069	A METHOD FOR THE PREPARATION OF A GEL-FORMING COMPOSITION	THERAVET SA
WO/2021/005071	A COMPOSITION, A KIT AND USE THEREOF	THERAVET SA
WO/2021/098996	OLIGOPEPTIDE THAT INHIBITS ANGIOGENESIS AND VASCULAR FUNCTION	UNIVERSIDAD NACIONAL AUTONOMA DE MEXICO
WO/2021/005077	PHARMACEUTICAL PREPARATION	MERCK PATENT GMBH
WO/2021/013546	A WATER-IN-OIL EMULSION COMPOSITION FOR ENHANCED DELIVERY OF WATER SOLUBLE SKIN BENEFIT AGENTS	UNILEVER N.V.
WO/2021/005101	PHARMACEUTICAL COMPOSITION COMPRISING A TETRAHYDROPYRAZOLOPYRIMIDINONE COMPOUND	IDORSIA PHARMACEUTICALS LTD
WO/2021/005104	COSMETIC COMPOSITION OF LIQUID CRYSTAL LIPID PARTICLES FOR HAIR CARE COMPOSITION	BASF SE
WO/2021/005117	TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING AN ACTIVE AGENT-CONTAINING LAYER COMPRISING A SILICONE-CONTAINING POLYMER AND A SKIN CONTACT LAYER COMPRISING A SILICONE GEL ADHESIVE	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/005118	TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING AN ACTIVE AGENT-CONTAINING LAYER COMPRISING AN ACRYLIC POLYMER AND A SKIN CONTACT LAYER COMPRISING A SILICONE GEL ADHESIVE	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/005129	COMBINATION OF IBUPROFEN AND TRAMADOL FOR RELIEVING PAIN	FARMALíDER, S.A.
WO/2021/259506	COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND A SAPONIN OR A LIGAND-SAPONIN CONJUGATE	SAPREME TECHNOLOGIES B.V.
WO/2021/259507	CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION	SAPREME TECHNOLOGIES B.V.
WO/2021/259508	CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY, PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOF	SAPREME TECHNOLOGIES B.V.
WO/2021/005147	COMBINATION	GENESIS PHARMA SA
WO/2021/005153	SELF-ASSEMBLING PEPTIDES IN THE PREVENTION AND TREATMENT OF CAVITATED CARIOUS LESIONS	CREDENTIS AG
WO/2021/005169	TREATMENT OF PATIENTS UNDER ANTIPLATELET MEDICATION EXPERIENCING BLEEDING	FÄLKER, Knut
WO/2021/005176	TREATMENT OF GLYCOGEN STORAGE DISEASE (GSD)	GENETHON
WO/2021/005183	INHIBITOR OF MAP KINASE INTERACTING SERINE/THREONINE KINASE 1 (MNK1) AND MAP KINASE INTERACTING SERINE/THREONINE KINASE 2 (MNK2), CANCER THERAPY AND THERAPEUTIC COMBINATIONS	FUNDACIó HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA
WO/2021/005189	NOVEL PFAR-INHIBITING COMPOUNDS	UNIVERSITE DE BRETAGNE OCCIDENTALE (UBO)
WO/2021/047804	IN VITRO METHOD FOR TRANSDUCTION OF T CELLS IN THE PRESENCE OF MALIGNANT CELLS	MILTENYI BIOTEC B.V. & CO. KG
WO/2021/009020	EXCIPIENT FOR BIOTHERAPEUTICS	LUDWIG-MAXIMILIANS-UNIVERSITÄT MüNCHEN
WO/2021/009027	HIGH CONCENTRATION INSULIN FORMULATION	NOVO NORDISK A/S
WO/2021/009029	TRYPTOPHAN- AND PHENYLETHYLAMINE-DERIVED BETAXANTHINS FOR USE IN THE TREATMENT AND/OR PREVENTION OF CANCER	UNIVERSIDAD DE MURCIA
WO/2021/009040	PROCESS FOR PRODUCING MICROPARTICLES LADEN WITH A VOLATILE ORGANIC ACTIVE	BASF SE
WO/2021/009050	REDUCING MALARIA TRANSMISSION	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/009083	PROCESS FOR TREATING KERATIN FIBERS, COMBINING A COMPOSITION COMPRISING A WATER-SOLUBLE SILICATE AND A COMPOSITION COMPRISING AN AMINO ACID AND/OR AN OLIGOPEPTIDE	L'OREAL
WO/2021/009091	METHODS FOR PREDICTING AND TREATING CARDIAC DYSFUNCTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/058157	KIT AND METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF AMINOSILICONE AND A CHROMOPHORIC COMPOUND	HENKEL AG & CO. KGAA
WO/2021/009110	COSMETIC PREPARATIONS COMPRISING NATURAL ACTIVATORS	ETH ZURICH
WO/2021/058158	PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, A CHROMOPHORIC COMPOUND AND ETHOXYLATED FATTY ACID ESTER	HENKEL AG & CO. KGAA
WO/2021/058159	PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, A CHROMOPHORIC COMPOUND AND AN ORGANIC CARBONIC ACID ESTER	HENKEL AG & CO. KGAA
WO/2021/009126	SIRNA SEQUENCES TARGETING THE EXPRESSION OF HUMAN GENES JAK1 OR JAK3 FOR A THERAPEUTIC USE	COMMISSARIAT à L'éNERGIE ATOMIQUE ET AUX éNERGIES ALTERNATIVES
WO/2021/009142	COMPOSITION COMPRISING AT LEAST ONE OXAZOLINE FOR INHIBITING THE GROWTH OF MALASSEZIA YEASTS INVOLVED IN CRADLE CAP, IN PARTICULAR	LABORATOIRES EXPANSCIENCE
WO/2021/018565	SKIN CARE OIL IN WATER EMULSION	BEIERSDORF AG
WO/2021/009177	ACTIVE AGENT FOR USE IN HAIR GROWTH REGULATION	MONASTERIUM LABORATORY SKIN & HAIR RESEARCH SOLUTIONS GMBH
WO/2021/073788	NATURAL NON-PATHOGENIC MICROORGANISMS CAPABLE OF ASSOCIATING GLYCOLIPIDS OR LIPOPEPTIDES AND USE THEREOF	ACARYON GMBH
WO/2021/009197	DOSE DUMPING RESISTANT PHARMACEUTICAL COMPOSITIONS COMRISING VERINURAD	ASTRAZENECA AB
WO/2021/009219	A RECEPTOR-TARGETING CONJUGATE WITH AN EFFECTIVE PHARMACOKINETIC PROFILE	FLUOGUIDE A/S
WO/2021/009237	A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE	RIGSHOSPITALET
WO/2021/018596	LIQUID ORAL CARE COMPOSITION	MEDA PHARMA S.P.A.
WO/2021/009266	PHARMACEUTICAL COMPOSITION FOR SUBCUTANEOUS ADMINISTRATION	ZEALAND PHARMA A/S
WO/2021/009267	ANTI-PD-L1 ANTIBODIES	CAPELLA BIOSCIENCE LTD
WO/2021/013693	ANTIBODY DRUG CONJUGATES (ADCS) WITH NAMPT INHIBITORS	BAYER PHARMA AKTIENGESELLSCHAFT
WO/2021/009288	COMBINATION COMPRISING ALPHA-1 ANTITRYPSIN FOR USE IN TREATING ISCHAEMIA IN A SUBJECT	FUNDACIó HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA
WO/2021/018619	STABILIZING THERAPEUTIC PROTEINS WITH PIPERAZIN- OR MORPHOLINE-CONTAINING ZWITTERIONIC BUFFERING SUBSTANCES	LUDWIG-MAXIMILIANS-UNIVERSITÄT MüNCHEN
WO/2021/009331	IMPROVED TREATMENT USING EYP001	ENYO PHARMA
WO/2021/009332	METHOD FOR DECREASING ADVERSE-EFFECTS OF INTERFERON	ENYO PHARMA
WO/2021/009333	SYNERGISTIC EFFECT OF EYP001 AND IFN FOR THE TREATMENT OF HBV INFECTION	ENYO PHARMA
WO/2021/009336	METHODS FOR INDUCING FULL ABLATION OF HEMATOPOIESIS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/013712	POLYAROMATIC UREA DERIVATIVES AND THEIR USE IN THE TREATMENT OF MUSCLE DISEASES	ANAGENESIS BIOTECHNOLOGIES S.A.S.
WO/2021/013713	MESNA COMPOSITION, KIT COMPRISING MESNA AND METHOD FOR VISUALIZATION OF A MESNA COMPOSITION APPLIED TO TISSUES	AUXIN SURGERY SA
WO/2021/013714	COMPOSITION AND INSTRUMENT COMPRISING MESNA FOR USE IN A METHOD OF ROBOT-ASSISTED SURGERY	AUXIN SURGERY SA
WO/2021/009355	SOLID FORMULATION OF A 1,2,4-OXADIAZOLE DERIVATIVE	ABAXYS THERAPEUTICS
WO/2021/009358	ANTIBODY COMBINATIONS FOR TREATMENT OF CANCER IN SPECIFIC PATIENTS	BIOINVENT INTERNATIONAL AB
WO/2021/009362	BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE DERIVATIVES FOR THE MODULATION OF STING	CTXT PTY LIMITED
WO/2021/009363	MEDICAL USES, METHODS AND USES	AOUADI, Myriam
WO/2021/009365	BENZOTHIOPHENE, THIENOPYRIDINE AND THIENOPYRIMIDINE DERIVATIVES FOR THE MODULATION OF STING	CTXT PTY LIMITED
WO/2021/009367	GLYCOPEPTIDES INCREASING LIPID SYNTHESIS	TFCHEM
WO/2021/013764	P21 EXPRESSING MONOCYTES FOR CANCER CELL THERAPY	INSTITUT GUSTAVE ROUSSY
WO/2021/013771	FERROPORTIN-INHIBITORS FOR THE USE IN THE TREATMENT OF TRANSFUSION-DEPENDENT BETA-THALASSEMIA (TDT)	VIFOR (INTERNATIONAL) AG
WO/2021/013772	FERROPORTIN-INHIBITORS FOR THE USE IN THE PREVENTION AND TREATMENT OF KIDNEY INJURIES	VIFOR (INTERNATIONAL) AG
WO/2021/013798	THERAPEUTIC VIRAL VACCINE	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/009384	NOVEL PYRAZOLONE DERIVATIVES AS PD-1/PD-L1 INTERACTION INHIBITORS	CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LILLE
WO/2021/013815	METHODS OF TREATING MULTIPLE SCLEROSIS	ACTELION PHARMACEUTICALS LTD
WO/2021/013825	SOFT CHEWABLE VETERINARY DOSAGE FORM	INTERVET INTERNATIONAL B.V.
WO/2021/013861	SUSTAINED RELEASE TREPROSTINIL-COMPOUND MICROPARTICLE COMPOSITIONS	NANOMI, B.V.
WO/2021/018682	HYBRID MINERAL-ORGANIC COMPLEX, AND USE THEREOF FOR MAINTAINING THE MICROBIOLOGICAL BALANCE OF THE SKIN AND/OR OF A COSMETIC AND/OR DERMOPHARMACEUTICAL COMPOSITION	BIONUCLEI
WO/2021/023512	BIFUNCTIONAL COMPOUND AND ITS USE IN IMMUNOTHERAPY	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS (CSIC)
WO/2021/013884	INHIBITORS OF CHI3L1 AND THEIR USES	HUMANITAS MIRASOLE S.P.A.
WO/2021/013903	NEW USE OF TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES	UNIVERSITé DE LIèGE
WO/2021/013904	ANTIBODY AGAINST THE OPRF PROTEIN OF <i>PSEUDOMONAS AERUGINOSA</i>, USE THEREOF AS A MEDICAMENT AND PHARMACEUTICAL COMPOSITION CONTAINING SAME	UNIVERSITé GRENOBLE ALPES
WO/2021/028180	AN ANTIPERSPIRANT COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/013911	INHIBITORS OF THE STING PATHWAY FOR THE TREATMENT OF HIDRADENITIS SUPPURATIVA	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/013921	THE SERPINB3 INHIBITOR PIPERIDINPROPIONIC ACID FOR TUMOR TREATMENT	UNIVERSITA' DEGLI STUDI DI PADOVA
WO/2021/013931	ANTIMYCOTIC	KARL-FRANZENS-UNIVERSITÄT GRAZ
WO/2021/013942	USE OF MYELOPEROXIDASE INHIBITORS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES IN PATIENTS SUFFERING FROM MYELOPROLIFERATIVE NEOPLASMS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/013944	FAECALIBACTERIUM PRAUSNITZII AND CHRISTENSENELLA BACTERIAL STRAINS FOR THE TREATMENT AND PREVENTION OF BOWEL INFLAMMATION	INSTITUT NATIONAL DE RECHERCHE POUR L’AGRICULTURE, L’ALIMENTATION ET L’ENVIRONNEMENT
WO/2021/013950	IMMUNE CELLS DEFECTIVE FOR SUV39H1	MNEMO THERAPEUTICS
WO/2021/013951	VETERINARY COMPOSITIONS COMPRISING MELATONIN AND THEIR USES FOR RUMINANTS	CEVA SANTE ANIMALE
WO/2021/018747	HAIR TREATMENT COMPOSITION	UNILEVER GLOBAL IP LIMITED
WO/2021/018750	OPHTHALMIC COMPOSITIONS COMPRISING VISCOSIFYING POLYMERS AND NUCLEIC ACIDS	PROQR THERAPEUTICS II B.V.
WO/2021/018754	AN ANTIDANDRUFF COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/018755	AN ANTIDANDRUFF COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/013973	COSMETIC COMPOSITIONS COMPRISING PLANT EXTRACTS AND USES THEREOF	ALUMIER EUROPE LIMITED
WO/2021/013981	CRYSTALLINE FORM OF TELMAPITANT OR (5R,8S)-8-[[(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY]METHYL]-8-PHENYL-1,3,7-TRIAZASPIRO[4.5]DECANE-2,4-DIONE	INTERVET INTERNATIONAL B.V.
WO/2021/013999	RECEPTOR-TARGETING PEPTIDE-DRUG CONJUGATES	ONTOCHEM GMBH
WO/2021/018786	USE OF FFAR2 AGONISTS FOR THE TREATMENT OF BACTERIAL SUPERINFECTIONS POST-VIRAL INFECTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/018792	OSTEOCRIN, LEBETIN OR ANP FOR DESTROYING BACTERIAL BIOFILMS	UNIVERSITé DE ROUEN-NORMANDIE
WO/2021/014014	TREATMENT AND/OR PREVENTION OF LESIONS IN THE CENTRAL AUDITORY NERVOUS SYSTEM	SENSORION
WO/2021/018798	COMPOSITION COMPRISING STEROL DERIVATIVES FOR USE IN THE TREATMENT OF A NEURONAL PATHOLOGY RELATED TO HYPOXIA, HYPOGLYCEMIA AND/OR HYPERGLYCEMIA	DENDROGENIX
WO/2021/014019	SAPONIN DERIVATIVES WITH IMPROVED THERAPEUTIC WINDOW	SAPREME TECHNOLOGIES B.V.
WO/2021/018806	IGG-DEPLETED PORCINE SERUM AND THE USES THEREOF	CEVA SANTE ANIMALE
WO/2021/018816	ALGINATE-BASED FACIAL MASK	BEIERSDORF AG
WO/2021/018824	USE OF (R)-9-(2,5-DIFLUOROPHENETHYL)-4-ETHYL-2-METHYL-1-OXA-4,9-DIAZASPIRO[5.5]UNDECAN-3-ONE FOR THE TREATMENT OF NOCICEPTIVE PAIN, NEUROPATHIC PAIN, OSTEOARTHRITIS PAIN AND CANCER PAIN, WHILE HAVING REDUCED SIDE EFFECTS COMPARED TO OPIOIDS	ESTEVE PHARMACEUTICALS, S.A.
WO/2021/037455	ACRYLATE AND SILICON-FREE COSMETIC O/W EMULSION	BEIERSDORF AG
WO/2021/037456	ACRYLATE AND SILICON-FREE COSMETIC O/W EMULSION	BEIERSDORF AG
WO/2021/023547	PREPARATION AND FULLY COMPOUNDED STOCK FOR USE IN MEDICAL OR DENTAL APPLICATIONS, MEDICAL OR DENTAL PRODUCT AND USE AND PREPARATION THEREOF	GEBR. BRASSELER GMBH & CO. KG
WO/2021/018839	ISOQUINOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PARASITIC INFECTIONS	BAYER ANIMAL HEALTH GMBH
WO/2021/014026	BIOACTIVE SAPONIN LINKED TO A FUNCTIONAL MOIETY	SAPREME TECHNOLOGIES B.V.
WO/2021/014027	PHOSPHOLIPASE-A2 INHIBITORS FOR THE PREVENTION OF CANCER METASTASIS	COEGIN PHARMA AS
WO/2021/018859	ANTIBODIES BINDING TO GPRC5D	F. HOFFMANN-LA ROCHE AG
WO/2021/018862	SS-31 FOR THE PREVENTION AND/OR TREATMENT OF ANEURYSM	FUNDACIó INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU
WO/2021/018866	MEK INHIBITOR FOR TREATMENT OF STROKE	EDVINCE AB
WO/2021/018879	PEPTIDES FOR USE AS SENOTHERAPEUTIC AGENTS	FUNDACIóN PROFESOR NOVOA SANTOS
WO/2021/018898	METHODS FOR TREATING TUMORS	NH THERAGUIX
WO/2021/018899	USE OF GDF15 AS A MARKER FOR EXERCISE MANAGEMENT	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/018917	PROCESS FOR PREPARING ADHESIVE COMPOUNDS FOR USE IN A TRANSDERMAL THERAPEUTIC SYSTEM	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/018923	PEPTIDES AS INHIBITORS OF FIBROTIC MATRIX ACCUMULATION	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/018928	NEW PHARMACEUTICAL FORMULATION	F. HOFFMANN-LA ROCHE AG
WO/2021/018931	COMPOSITIONS FOR THE TREATMENT OF ATOPIC DERMATITIS	DERMOPHISIOLOGIQUE S.R.L. SOCIETà BENEFIT
WO/2021/018934	TREATMENT OF SEBACEOUS GLAND DISORDERS	ECHO PHARMACEUTICALS B.V.
WO/2021/018935	TREATMENT OF AGING OR UV-DAMAGED SKIN	ECHO PHARMACEUTICALS B.V.
WO/2021/018936	TREATMENT OF INFLAMMATORY SKIN CONDITIONS	ECHO PHARMACEUTICALS B.V.
WO/2021/018950	COSMETIC COMPOSITION WITH COMBINED FILLER AND SKIN REGENERATIVE EFFECT	GIULIANI S.P.A.
WO/2021/018965	ACTIVATORS OF SIRTUINS AND USES THEREOF	EPI-C S.R.L.
WO/2021/018967	SEROTONERGIC AGENT AND 5-HT1A-RECEPTOR ANTAGONIST	ATLAS PHARMACEUTICALS BV
WO/2021/023600	COMBINATION PRODUCT FOR HELPING MAINTAIN THE NATURAL DEFENSES OF THE ORGANISM AND AIDING WITH RECOVERY	URGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/018990	PREVENTION AND REDUCTION OF CORNIFICATION DISORDERS AND RELATED COSMETIC AGENTS	MERCK PATENT GMBH
WO/2021/023609	COMBINATION OF A TYPE I PROTEIN ARGININE METHYLTRANSFERASE (TYPE I PRMT) INHIBITOR AND A METHIONINE ADENOSYLTRANSFERASE II ALPHA (MAT2A) INHIBITOR	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/023616	ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS FOR USE IN EPILEPSY OR SEIZURES	H. LUNDBECK A/S
WO/2021/023617	ALCOHOL DERIVATIVES AS KV7 POTASSIUM CHANNEL OPENERS	H. LUNDBECK A/S
WO/2021/019023	COMPOUNDS FOR USE IN A METHOD OF TREATING OR PREVENTING NEUROLOGICAL AND/OR PSYCHIATRIC DISORDERS	THE BECKLEY FOUNDATION
WO/2021/019033	DOSAGE AND ADMINISTRATION REGIMEN FOR THE TREATMENT OR PREVENTION OF C5-RELATED DISEASES BY THE USE OF THE ANTI-C5 ANTIBODY CROVALIMAB	F. HOFFMANN-LA ROCHE AG
WO/2021/019036	DOSAGE AND ADMINISTRATION REGIMEN FOR THE TREATMENT OR PREVENTION OF C5-RELATED DISEASES BY THE USE OF THE ANTI-C5 ANTIBODY CROVALIMAB	F. HOFFMANN-LA ROCHE AG
WO/2021/023631	NOVEL FORM OF A DEPILATORY COMPOSITION , AND PREPARATION METHOD THEREFOR	L.C.M. LABORATOIRE DE COSMéTOLOGIE MODERNE
WO/2021/023644	NEUTRALIZING GRANZYME B FOR PROVIDING CARDIOPROTECTION IN A SUBJECT WHO EXPERIENCED A MYOCARDIAL INFARCTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/023646	MELANOCYTE-REGULATING PEPTIDES	IDP DISCOVERY PHARMA, S.L.
WO/2021/019067	VETERINARY COMPOSITIONS FOR THE PREVENTION AND/OR TREATMENT OF CRYPTOSPORIDIOSIS	CEVA SANTE ANIMALE
WO/2021/023649	BI-FUNCTIONALIZED NANOPARTICLES, PROCESS FOR ITS PREPARATION AND USES THEREOF	FUNDACIó HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA
WO/2021/023662	PYRAZOLO[4,3-C]PYRIDINE COMPOUNDS FOR USE IN THE TREATMENT OF HBV INFECTION	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/019078	LIPOSOMES AND USES THEREOF	UNIVERSITà DEGLI STUDI DI MILANO - BICOCCA
WO/2021/019081	C3/C5 CONVERTASE ASSAYS	UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF
WO/2021/019092	TOPICAL COMPOSITIONS	BAUSCH HEALTH IRELAND LIMITED
WO/2021/023673	PROCESS FOR PREVENTING AND/OR TREATING TRANSPIRATION AND ASSOCIATED COMPOSITION	L'OREAL
WO/2021/023675	LACOSAMIDE FOR THE TREATMENT OF ADD/ADHD	SANCHEZ, Hector Mario
WO/2021/019097	MEMBRANE FILTRATION OF PLANT EXTRACTS BY MEANS OF CYCLODEXTRIN	BIONORICA SE
WO/2021/023691	IMMUNOGENIC COMPOSITION	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/023692	PROCESS FOR PREPARING A COMPOSITION COMPRISING A PROTEIN D POLYPEPTIDE	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/023695	COMBINATIONS OF OLIGOSACCHARIDES AND XYLITOL FOR DERMATOLOGICAL TREATMENT	MEDA PHARMA S.P.A.
WO/2021/023698	ANGIOTENSIN TYPE 2 (AT2) RECEPTOR AGONISTS FOR USE IN THE TREATMENT OF CANCER	LANTHIOPEP B.V
WO/2021/019102	A METHOD OF ELICITING AN IMMUNE RESPONSE BY ADMINISTERING A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ANTIGEN TOGETHER WITH A POPULATION OF POLYMERSOMES HAVING AN ASSOCIATED ADJUVANT AS WELL AS COMPOSITIONS COMPRISING THE TWO POPULATIONS OF POLYMERSOMES	ACM BIOLABS PTE LTD
WO/2021/069126	CLEANSING PREPARATION CONTAINING CAESALPINIA SPINOSA GUM	BEIERSDORF AG
WO/2021/023733	TARGETED NANOPARTICLES OF WELL-DEFINED AND REPRODUCIBLE SIZES	STAMS DIAGNOSTICS GMBH
WO/2021/023796	COMPOSITIONS FOR TRANSFECTING A NUCLEIC ACID MOLECULE INTO A CELL COMPRISING HETEROCYCLIC COMPOUNDS GRAFTED TO A CATIONIC POLYMER, AND THEIR APPLICATIONS	POLYPLUS TRANSFECTION
WO/2021/023798	COMPOSITIONS FOR TRANSFECTING A NUCLEIC ACID MOLECULE INTO A CELL COMPRISING TRIAZOLE COMPOUNDS GRAFTED TO A CATIONIC POLYMER, AND THEIR APPLICATIONS	POLYPLUS TRANSFECTION
WO/2021/037511	SUNSCREEN COMPOSITION WITHOUT CYCLOMETHICONES	BEIERSDORF AG
WO/2021/028299	VIRAL PARTICLES FOR USE IN TREATING SYNUCLEINOPATHIES SUCH AS PARKINSON'S DISEASES BY GENE THERAPY	FUNDACION PARA LA INVESTIGACION MEDICA APLICADA
WO/2021/023805	COMPOUND FOR COMBINATION TREATMENT	INITIATOR PHARMA A/S
WO/2021/023809	ETIFOXINE FOR USE IN THE TREATMENT OF DISEASES RELATED TO ACTIVATED MAST CELLS	MC SCIENCES UG
WO/2021/023811	SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID	NOVO NORDISK A/S
WO/2021/023817	SOLID COMPOSITION COMPRISING A PYY COMPOUND AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID	NOVO NORDISK A/S
WO/2021/023820	EXTRACT OF SILYBUM MARIANUM (L.) GAERTN. AKENES FOR PROMOTING HAIR GROWTH	PIERRE FABRE DERMO-COSMETIQUE
WO/2021/023837	INHIBITION OF METASTASIS DEVELOPMENT BY NANGPTL-4	DEUTSCHES KREBSFORSCHUNGSZENTRUM
WO/2021/028328	TOPICAL COMPOSITION COMPRISING A PROSTAGLANDIN ANALOGUE	NOVALIQ GMBH
WO/2021/023848	METHOD OF PREPARING A SOLID DOSAGE FORM AND A LUBRICANT	EVONIK OPERATIONS GMBH
WO/2021/023849	DOWN STREAMING PROCESS FOR THE PRODUCTION OF POLYUNSATURATED FATTY ACID SALTS	EVONIK OPERATIONS GMBH
WO/2021/023850	METHOD OF PREPARING A SOLID DOSAGE FORM AND A BINDER	EVONIK OPERATIONS GMBH
WO/2021/023855	SOLID COMPOSITIONS COMPRISING AN EGF(A) DERIVATIVE AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID	NOVO NORDISK A/S
WO/2021/023857	SOLUBILITY ENHANCEMENT OF POORLY SOLUBLE ACTIVES	EVONIK OPERATIONS GMBH
WO/2021/028336	(HETERO)ARYL-METHYL-THIO-BETA-D-GALACTOPYRANOSIDE DERIVATIVES	IDORSIA PHARMACEUTICALS LTD
WO/2021/028337	PEPTIDE ANTIGENS AND USES THEREOF	HUMANITAS MIRASOLE S.P.A.
WO/2021/028347	HLA-DR/CII PEPTIDE COMPLEXES FOR TREATING ARTHRITIS	FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
WO/2021/028350	PRODUCTION OF MHC II/CII COMPLEXES	FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
WO/2021/023876	GNRH ANTAGONISTS FOR THE TREATMENT OF ESTROGEN-DEPENDENT DISORDERS	OBSEVA S.A.
WO/2021/023877	COMPOSITIONS AND METHODS FOR THE TREATMENT OF ESTROGEN-DEPENDENT DISORDERS	OBSEVA S.A.
WO/2021/023885	LIQUID DRESSING COMPOSITIONS AND THEIR USES	CAMBRIDGE ENTERPRISE LIMITED
WO/2021/023886	LIQUID DRESSING COMPOSITIONS AND THEIR VETERINARY USES	CAMBRIDGE ENTERPRISE LIMITED
WO/2021/037532	METHOD FOR TRAINING PATIENTS WITH THERAPEUTIC GAS MIXTURES	EGOROV, Egor
WO/2021/028382	[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINES	BAYER AKTIENGESELLSCHAFT
WO/2021/028402	IMMUNOGENIC COMPOSITION	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/028406	CHIKUNGUNYA VACCINE FORMULATIONS	VALNEVA SE
WO/2021/028407	SINGLE SHOT CHIKUNGUNYA VIRUS VACCINE	VALNEVA SE
WO/2021/028415	PERSONAL HYGIENE PRODUCT	CRODA INTERNATIONAL PLC
WO/2021/028438	TARGETING WNK1 IN BLOOD CANCERS	KØBENHAVNS UNIVERSITET
WO/2021/028456	HOLLOW THREE-DIMENSIONAL UNIT MADE FROM RETINAL TISSUE AND USE THEREOF IN THE TREATMENT OF RETINOPATHIES	TREEFROG THERAPEUTICS
WO/2021/028469	COMPOSITIONS AND METHODS FOR TREATING CYTOKINE RELEASE SYNDROME AND NEUROTOXICITY	SITOKINE LIMITED
WO/2021/028479	COMPOSITIONS COMPRISING TIGOLANER FOR CONTROLLING PARASITES	VETOQUINOL S.A.
WO/2021/028502	IMPLANTABLE CAPSULE	MAXIVAX SA
WO/2021/028512	ARYLSULFONAMIDE DERIVATIVES AS MGLUR4 NEGATIVE ALLOSTERIC MODULATORS	F. HOFFMANN-LA ROCHE AG
WO/2021/032582	PYRAZOLO[4,3-C]PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS	GALAPAGOS NV
WO/2021/028529	NON-OXIDATIVE HAIR DYE COMPOSITION AND METHOD	KAO CORPORATION
WO/2021/028530	DYEING COMPOSITION, METHOD, USE, AND KIT-OF-PARTS THEREOF	KAO CORPORATION
WO/2021/028532	KIT-OF-PARTS AND COMPOSITION FOR DYEING OF KERATIN FIBERS, METHOD, AND USE THEREOF	KAO CORPORATION
WO/2021/028538	MIRABEGRON COMPOSITION AND USES THEREOF	BIOHORM S.L.
WO/2021/063581	AN ORAL CARE SPRAY COMPOSITION COMPRISING HEXAMETAPHOSPHATE	UNILEVER GLOBAL IP LIMITED
WO/2021/028559	METHOD FOR OBTAINING EFFICIENT COMPOSITIONS COMPRISING VIRAL VECTORS FOR VACCINATION OR GENE THERAPY	LEUKOCARE AG
WO/2021/032611	HETEROAROMATIC COMPOUNDS USEFUL IN THERAPY	CUROVIR AB
WO/2021/028578	FILM FORMULATION COMPRISING CARRIERS	KLARIA PHARMA HOLDING AB
WO/2021/032643	COMPOUNDS SUITABLE FOR THE TREATMENT AND PROPHYLAXIS OF MUSCLE WASTING AND OTHER CONDITIONS	ADAMS, Volker
WO/2021/032646	STABILIZING BUFFER FOR FACTOR VIII AND VWF	OCTAPHARMA AG
WO/2021/028585	BACTERIUM COMPRISING MYO-INOSITOL TO PROPIONATE PATHWAY	WAGENINGEN UNIVERSITEIT
WO/2021/028587	PHARMACEUTICAL COMPOSITIONS COMPRISING BISPECIFIC ANTIBODIES DIRECTED AGAINST CD3 AND CD20 AND THEIR USES	GENMAB A/S
WO/2021/032648	COMPOUNDS FOR USE IN THE TREATMENT OF LIVER DISEASE	THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIV. TRINITY OF QUEEN
WO/2021/032650	PEPTIDES FOR TREATING MUSCLE ATROPHY	NURITAS LIMITED
WO/2021/032657	COSMETIC O/W EMULSION CONTAINING SUCCINOGLUCAN AND LIPOPHILIC UV FILTER SUBSTANCES	BEIERSDORF AG
WO/2021/037597	ISAVUCONAZONIUM SALTS AND PROCESS FOR PREPARING THEREOF	SYNTHON B.V.
WO/2021/032687	ANTIMALARIAL HEXAHYDROPYRIMIDINE ANALOGUES	UCB BIOPHARMA SRL
WO/2021/028598	REDUCTION OF BONE RESORPTION, ESPECIALLY IN CHRONIC JOINT DISEASES	TECHNISCHE UNIVERSITÄT DARMSTADT
WO/2021/032700	COSMETIC O/W EMULSION CONTAINING SUCCINOGLUCAN	BEIERSDORF AG
WO/2021/032777	OLIGONUCLEOTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE	MINA THERAPEUTICS LIMITED
WO/2021/037629	COMPOSITION, PROCESS AND KIT FOR SEMI-PERMANENT STRAIGHTENING AND CURLING OF KERATIN FIBERS	KAO CORPORATION
WO/2021/032784	PLATINUM ISOTOPE COMBINED WITH BONE-TARGETING AGENTS FOR USE IN ANTICANCER DRUGS	NUCLEAR RESEARCH AND CONSULTANCY GROUP
WO/2021/032807	COMBINATION OF A CHEMOTHERAPEUTIC AGENT AND ALPHA-LACTOGLUBULIN-OLEIC ACID COMPLEX FOR CANCER THERAPY	HAMLET PHARMA AB
WO/2021/037656	SOLUBILIZED FOLIC ACID	AQUANOVA AG
WO/2021/032844	FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES	MüHLBAUER TECHNOLOGY GMBH
WO/2021/037676	HAIR TREATMENT COMPOSITION IN FOAM FORMAT	UNILEVER GLOBAL IP LIMITED
WO/2021/037679	USE OF HAIR TREATMENT COMPOSITION IN FOAM FORMAT	UNILEVER GLOBAL IP LIMITED
WO/2021/058206	KIT AND METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF AMINOSILICONE AND A CHROMOPHORIC COMPOUND	HENKEL AG & CO. KGAA
WO/2021/032861	COMBINATION OF AN UROLITHIN WITH AN IMMUNOTHERAPY TREATMENT	AMAZENTIS SA
WO/2021/037702	PHARMACEUTICAL COMBINATION OF A SPECIFIC THIENOPYRIDONE DERIVATIVE WITH AN FXR AGONIST FOR THE TREATMENT OF LIVER DISEASES	POXEL
WO/2021/032873	COMPOSITION COMPRISING AT LEAST ONE ALKOXYSILANE OF FORMULA (I), AT LEAST ONE ALKOXYSILANE OF FORMULA (II), AT LEAST ONE NONAMINO SILICONE, AND OPTIONALLY PIGMENTS AND/OR DIRECT DYES	L'OREAL
WO/2021/037713	OIL SUBSTITUTE FOR COSMETIC PREPARATIONS	BEIERSDORF AG
WO/2021/037714	PARTICULARLY NATURAL OIL SUBSTITUTE FOR COSMETIC PREPARATIONS	BEIERSDORF AG
WO/2021/037716	PARTICULARLY NATURAL OIL SUBSTITUTE FOR COSMETIC PREPARATIONS	BEIERSDORF AG
WO/2021/037717	ETHYL-CELLULOSE-CONTAINING SUNSCREEN SPRAY	BEIERSDORF AG
WO/2021/037719	HYDROXYPROPYLCELLULOSE-CONTAINING SUNSCREEN SPRAY	BEIERSDORF AG
WO/2021/037733	TROPOELASTIN FOR USE IN TREATMENT OF ACNE SCARRING	ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
WO/2021/037750	NOVEL COMPOUNDS FOR SKIN LIGHTENING	UNILEVER GLOBAL IP LIMITED
WO/2021/032883	COMBINATION THERAPY OF A PATIENT SUBGROUP	BERGENBIO ASA
WO/2021/032891	BINDING MOLECULES TO ARGINASE II (ARG2)	CANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/180342	COMPOSITION FOR THE TREATMENT OF LESIONS OF THE RESPIRATORY SYSTEM	ORGANES TISSUS REGENERATION REPARATION REMPLACEMENT
WO/2021/032894	NANOPARTICLE COMPOSITION COMPRISING CHITOSAN AND CLATHRIN	BIOCYTO LIMITED
WO/2021/052720	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, AN EFFECT PIGMENT AND A FILM-FORMING POLYMER	HENKEL AG & CO. KGAA
WO/2021/052721	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, AN EFFECT PIGMENT AND A POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/052722	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND AN ACIDIFIER	HENKEL AG & CO. KGAA
WO/2021/047900	ORAL CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/037871	SOLID ORAL DOSAGE FORM COMPRISING NAPROXEN AND VITAMIN B6	DSM IP ASSETS B.V.
WO/2021/037873	SOLID ORAL DOSAGE FORM COMPRISING NAPROXEN AND VITAMIN B1	DSM IP ASSETS B.V.
WO/2021/037874	SOLID ORAL DOSAGE FORM COMPRISING NAPROXEN AND VITAMIN B12	DSM IP ASSETS B.V.
WO/2021/037933	COMBINATION OF AZD2811 NANOPARTICLES, 5-AZACITIDINE AND VENETOCLAX FOR USE IN THE TREATMENT OF CANCER	ASTRAZENECA AB
WO/2021/043656	COMPOSITIONS CONTAINING DI-SUBSTITUTED TEREPHTHALATES AND LIGHT PROTECTION FILTER SUBSTANCES, DEODORANTS AND/OR ANTIPERSPIRANTS	EVONIK OPERATIONS GMBH
WO/2021/037956	COMBINATIONS OF MEK INHIBITORS WITH CAP-DEPENDENT ENDONUCLEASE INHIBITORS	ATRIVA THERAPEUTICS GMBH
WO/2021/037960	PHARMACEUTICAL FORMULATION	KLARIA PHARMA HOLDING AB
WO/2021/038014	CONTROLLED RELEASE TOFACITINIB COMPOSITIONS	SYNTHON B.V.
WO/2021/043673	P-GP INDUCERS AS PROTECTORS AGAINST CHEMOTHERAPY-INDUCED SIDE EFFECTS, SUCH AS PERIPHERAL NEUROPATHY (CIPN) AND HAIR LOSS	SYDDANSK UNIVERSITET
WO/2021/038022	NEW USE OF CYCLIC DINUCLEOTIDES	HELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/038029	LOADED GRANULES, THEIR PROCESS OF PRODUCTION AND THEIR USES	SAKSO
WO/2021/038035	SCYLLO-INOSITOL AND B-CELL MEDIATED DISORDERS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/038036	B CELL TARGETED PARALLEL CAR (pCAR) THERAPEUTIC AGENTS	KING'S COLLEGE LONDON
WO/2021/038043	TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) AND HEPATOCELLULAR CARCINOMA (HCC) WITH COMPOUNDS BINDING THE ECTODOMAIN OF PLATELET GLYCOPROTEIN IB (GPIB) ALPHA	DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS
WO/2021/038062	T CELL EPITOPES OF HCMV AND USES OF THEREOF	EBERHARD KARLS UNIVERSITÄT TüBINGEN, MEDIZINISCHE FAKULTÄT
WO/2021/038076	USE OF BETA-L-ASPARTYL-L-ARGININE ON SENESCENT SKIN	SYMRISE AG
WO/2021/038078	THERAPY GUIDANCE AND/OR THERAPY MONITORING FOR TREATMENT OF SHOCK	4TEEN4 PHARMACEUTICALS GMBH
WO/2021/038080	TREATMENT	PNEUMAGEN LTD
WO/2021/038084	BIOADHESIVE PARTICLES COMPRISING ACTIVE AGENTS, AND USES THEREOF	SKINOSIVE
WO/2021/038097	METHOD FOR THE TREATMENT OF CHRONIC FATIGUE SYNDROME USING AN INHIBITORY OR CYTOTOXIC AGENT AGAINST PLASMA CELLS	VESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/058230	METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF A PREMIX OF AMINOSILICONE AND A CHROMOPHORIC COMPOUND	HENKEL AG & CO. KGAA
WO/2021/043718	ANTIVIRAL PHARMACEUTICAL COMPOSITION CONTAINING 6-AMINONICOTINAMIDE	UNIVERSITE DE PICARDIE JULES VERNE
WO/2021/043719	ANTIVIRAL PHARMACEUTICAL COMPOSITION CONTAINING THIONICOTINAMIDE	UNIVERSITE DE PICARDIE JULES VERNE
WO/2021/043721	USE OF COSMETIC PREPARATIONS FOR IMPROVING THE VISIBILITY OF SUBEPIDERMAL PIGMENTS	BEIERSDORF AG
WO/2021/043723	METHODS AND COMPOSITIONS FOR TREATING PAX6- DEFICIENCY RELATED DISEASE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/043724	USE OF PYRVINIUM FOR THE TREATMENT OF A RAS PATHWAY MUTATED ACUTE MYELOID LEUKEMIA	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/043726	OXYTOCIN ANTAGONIST DOSING REGIMENS FOR PROMOTING EMBRYO IMPLANTATION AND PREVENTING MISCARRIAGE	OBSEVA S.A.
WO/2021/063609	BISMUTH OXYCHLORIDE-CONTAINING SUNSCREEN FOR PROTECTION FROM BLUE LIGHT	BEIERSDORF AG
WO/2021/063610	NOVEL SUN PROTECTIVE AGENT CONTAINING BISMUTH OXYCHLORIDE FOR PROTECTION AGAINST BLUE LIGHT	BEIERSDORF AG
WO/2021/043757	FACTOR VIII PROTEIN WITH INCREASED HALF-LIFE	BIOTEST AG
WO/2021/058240	PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, A CHROMOPHORIC COMPOUND AND ESTER OIL	HENKEL AG & CO. KGAA
WO/2021/058241	KIT AND METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF AMINOSILICONE AND A CHROMOPHORIC COMPOUND	HENKEL AG & CO. KGAA
WO/2021/043771	FORMULATIONS AND TREATMENT METHODS	CAMURUS AB
WO/2021/052753	RECOMBINANT ONCOLYTIC NEWCASTLE DISEASE VIRUSES WITH INCREASED ACTIVITY	THALLER, Arno
WO/2021/047971	METHOD FOR REMINERALIZING AND/OR REDUCING SENSITIVITY OF TEETH	UNILEVER IP HOLDINGS B.V.
WO/2021/043799	COSMETIC COMPOSITION FOR COATING KERATINIC FIBERS COMPRISING A L-BETA LAMMELLAR PHASE, A CYCLIC CARBONATE AND AN ACID DYE	L'OREAL
WO/2021/043803	PROCESS FOR PRODUCING A TABLET COMPRISING GLP-1 PEPTIDES	NOVO NORDISK A/S
WO/2021/043804	IMMUNOTHERAPY TARGETING TUMOR NEOANTIGENIC PEPTIDES	INSTITUT CURIE
WO/2021/043813	PHENAZINE DERIVATIVE AND USE THEREOF FOR THE TREATMENT OF CANCER	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/043835	REBAMIPIDE FOR USE IN PROPHYLAXIS AND TREATMENT OF CELIAC DISEASE	SQUARE POWER LTD
WO/2021/043840	REBAMIPIDE FOR USE IN PROPHYLAXIS AND TREATMENT OF CANCER	SQUARE POWER LTD
WO/2021/043846	REBAMIPIDE FOR USE IN PREVENTION AND TREATMENT OF CROHN'S DISEASE	SQUARE POWER LTD
WO/2021/043862	THIORIDAZINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER	UNIVERSITA' DEGLI STUDI DI PADOVA
WO/2021/043864	COSMETIC COMPOSITION FOR COATING KERATINIC FIBERS COMPRISING A L-BETA LAMMELLAR PHASE, A CYCLIC CARBONATE AND AN ACID DYE	L'OREAL
WO/2021/043869	INFLUENZA VIRUS VACCINES AND USES THEREOF	JANSSEN VACCINES & PREVENTION B.V.
WO/2021/249661	ECOBIOLOGICAL LIPO-ALCOHOLIC COMPOSITION	NAOS INSTITUTE OF LIFE SCIENCE
WO/2021/043905	VAFIDEMSTAT FOR USE IN TREATING AUTISM SPECTRUM DISORDERS	ORYZON GENOMICS, S.A.
WO/2021/047997	ORAL CARE WATER-IN-OIL EMULSIONS	UNILEVER IP HOLDINGS B.V.
WO/2021/043926	MANGANESE CHELATE ISOMERS	GE HEALTHCARE LIMITED
WO/2021/043927	GINSENG COMPOSITION AND USE THEREOF AS A MEDICAMENT	BOTALYS SA
WO/2021/043949	LURBINECTEDIN IN THE TREATMENT OF MALIGNANT MESOTHELIOMA	PHARMA MAR S.A.
WO/2021/043951	DRUG ANTIBODY CONJUGATES	PHARMA MAR, S.A.
WO/2021/048003	CHIMERIC FILOVIRUS VACCINES	KATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/043955	COMPOSITIONS AND METHODS FOR TREATING EXTENSIVE STAGE SMALL CELL LUNG CANCER (ES-SCLC)	ASTRAZENECA AB
WO/2021/043961	DOSING REGIMEN FOR THE TREATMENT OF CANCER WITH AN ANTI ICOS AGONISTIC ANTIBODY AND CHEMOTHERAPY	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/052779	ELECTROSTATICALLY SPRAYABLE COSMETIC FORMULATION	IONIQ SKINCARE GMBH & CO. KG
WO/2021/044009	HERV INHIBITORS FOR USE IN TREATING TAUOPATHIES	DEUTSCHES ZENTRUM FüR NEURODEGENERATIVE ERKRANKUNGEN E.V. (DZNE)
WO/2021/044013	USE OF A COMPOSITION CONTAINING AN EXTRACT OF TULIPA GESNERIANA	FRANCE COSMEPHYL-LAB
WO/2021/044045	OPHTHALMIC COMPOSITION FOR THE TREATMENT OF UVEITIS	NOVALIQ GMBH
WO/2021/069158	SUNSCREEN CONTAINING A NATURAL, FILM-FORMING POLYMER	BEIERSDORF AG
WO/2021/048034	GLUCOCEREBROSIDASE MUTANTS	F. HOFFMANN-LA ROCHE AG
WO/2021/048041	ORAL CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/044058	FAST CONSOLIDATING COMPOUNDS	UNIVERSITÄT INNSBRUCK
WO/2021/044061	TREATMENT OF TUMORS BY A COMBINATION OF AN ONCOLYTIC ADENOVIRUS, A CDK4/6 INHIBITOR AND A FURTHER THERAPEUTICALLY ACTIVE AGENT	KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITÄT MüNCHEN
WO/2021/048081	IMMUNOTHERAPEUTIC COMPOSITIONS	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/052811	NEW ONCOLYTIC NEWCASTLE DISEASE VIRUSES AND RECOMBINANT NDV STRAINS	THALLER, Arno
WO/2021/048129	USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF PAIN, AND CORRESPONDING COMPOSITIONS	NUVAMID SA
WO/2021/048135	PHARMACEUTICAL COMBINATIONS COMPRISING A FURAZANOBENZIMIDAZOLES AND A CD40 AGONIST FOR USE IN THE TREATMENT OF NEOPLASTIC DISEASES	BASILEA PHARMACEUTICA INTERNATIONAL AG
WO/2021/048162	COMPOUND FOR INHIBITING CELL DEATH	CHRISTIAN-ALBRECHTS-UNIVERSITÄT ZU KIEL
WO/2021/048171	METHOD TO IMPROVE PHAGOCYTOSIS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/048172	DELIVERY VEHICLE FOR IN SITU DELIVERING OF PHARMACEUTICAL AGENTS	RIVER STONE BIOTECH APS
WO/2021/048200	NOVEL QUINOLINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE	F. HOFFMANN-LA ROCHE AG
WO/2021/048235	TREATMENT OF HR DEFICIENT CANCER	THE FRANCIS CRICK INSTITUTE LIMITED
WO/2021/048266	TREATMENT OF TYPE 2 DIABETES MELLITUS	SANOFI
WO/2021/048268	USE OF HDL IN THE PROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE	ETABLISSEMENT FRANÇAIS DU SANG
WO/2021/052855	STABLE PERFUMING COMPOSITIONS HAVING GOOD SPRAY PROPERTIES	SOCIéTé D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES - SEPPIC
WO/2021/052856	STABILIZER CONCENTRATES FOR WAX DISPERSIONS	BASF SE
WO/2021/048283	METHOD FOR PROMOTING WEIGHT LOSS BY ADMINISTERING A DIET RICH IN ARABINOXYLAN OLIGOSACCHARIDES	UNIVERSITY OF COPENHAGEN
WO/2021/048313	DENTAL COMPOSITION	DENTSPLY SIRONA INC.
WO/2021/048314	REBAMIPIDE FOR USE IN PREVENTION AND/OR TREATMENT OF ARTERIAL STIFFNESS	SQUARE POWER LTD
WO/2021/048315	USE OF DUOX1 INHIBITORS FOR TREATING CANCER	INSTITUT GUSTAVE ROUSSY
WO/2021/048322	GOLF BALL-LIKE MICROPARTICLES FOR USE IN THE TREATMENT AND PREVENTION OF PULMONARY DISEASES	AQUILON PHARMACEUTICALS
WO/2021/048324	NOVEL MOLECULES FOR DIAGNOSIS	AC IMMUNE SA
WO/2021/223894	PEPTIDE FOR PREVENTION OR TREATMENT OF COVID-19	APEPTICO FORSCHUNG UND ENTWICKLUNG GMBH
WO/2021/052877	PREMIX AND COMPOSITION AND METHODS OF PREPARING THE SAME	UNILEVER IP HOLDINGS B.V.
WO/2021/048338	COMBINATION VACCINE FOR INTRADERMAL ADMINISTRATION	INTERVET INTERNATIONAL B.V.
WO/2021/048339	VS-6063 IN COMBINATION WITH CH5126766 FOR THE TREATMENT OF CANCER	THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
WO/2021/048359	METHODS OF TREATING NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) USING IL-17RA ANTIBODY	BAUSCH HEALTH IRELAND LIMITED
WO/2021/048402	LASSAVIRUS VACCINES	KATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/048412	COMBINATION THERAPIES COMPRISING PANOBINOSTAT FOR THE TREATMENT OF CHOLANGIOCARCINOMA	SEALD AS
WO/2021/048417	COMBINATION THERAPIES COMPRISING DASATINIB FOR THE TREATMENT OF CHOLANGIOCARCINOMA	SEALD AS
WO/2021/048418	COMBINATION THERAPIES COMPRISING BORTEZOMIB FOR THE TREATMENT OF CHOLANGIOCARCINOMA	SEALD AS
WO/2021/048419	COMBINATION THERAPIES COMPRISING TRAMETINIB FOR THE TREATMENT OF CHOLANGIOCARCINOMA	SEALD AS
WO/2021/048430	COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES	AMABIOTICS
WO/2021/048431	COMPOUNDS FOR TREATING ATAXIA	AMABIOTICS
WO/2021/104700	METHOD FOR IMPROVING COLOUR RETENTION OF DYED KERATINOUS MATERIAL, ESPECIALLY HUMAN HAIR	HENKEL AG & CO. KGAA
WO/2021/104701	IMPROVING THE PERFORMANCE OF PIGMENT-BASED DYES BY USING A PRETREAMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/104702	METHOD FOR IMPROVING THE TACTILE SENSATION OF DYED KERATINOUS MATERIAL, ESPECIALLY HUMAN HAIR	HENKEL AG & CO. KGAA
WO/2021/104703	AGENT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, A CHROMOPHORIC COMPOUND AND PHOSPHOROUS-CONTAINING SURFACTANT	HENKEL AG & CO. KGAA
WO/2021/048436	POLYETHYLENE GLYCOL FOR USE IN THE TREATMENT AND PREVENTION OF ABDOMINAL INFLAMMATORY DISEASES AND/OR ASSOCIATED DISEASES	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
WO/2021/104704	PRODUCT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, PIGMENT, POLYSACCHARIDE AND A FATTY CONSTITUENT	HENKEL AG & CO. KGAA
WO/2021/104705	METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS BEEN DYED USING A PIGMENT	HENKEL AG & CO. KGAA
WO/2021/048438	INHIBITOR OF METADHERIN EXPRESSION	SECARNA PHARMACEUTICALS GMBH & CO. KG
WO/2021/048441	METHOD AND APPARATUS FOR CELL ISOLATION AND ISOLATED CELLS FOR WOUND HEALING	VERITACELL
WO/2021/052923	ACTIVE SUBSTANCE DELIVERY SYSTEM WITH DELAYED DELIVERY	CAPNOMED GMBH
WO/2021/052926	AGENT FOR USE IN TREATMENT OR PREVENTION OF OPHTHALMIC DISORDERS	CHIESI FARMACEUTICI S.P.A.
WO/2021/052952	METHODS OF TREATMENT AND/OR PREVENTION OF DISORDERS AND SYMPTOMS RELATED TO BKCA AND/OR SK CHANNELOPHATHIES	UNIVERSITE DE BORDEAUX
WO/2021/052960	STABLE, CONCENTRATED RADIOPHARMACEUTICAL COMPOSITION	ADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/052962	TREATMENT OF SPINAL CORD INJURY	INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES
WO/2021/053001	CAMPHORSULFONIC ACID AND COMBINATIONS THEREOF WITH CATIONIC EXCIPIENTS AS VISCOSITY REDUCING AGENTS IN HIGH CONCENTRATED PROTEIN FORMULATIONS	MERCK PATENT GMBH
WO/2021/053018	TARGETING MISSPLICED TRANSCRIPTS IN GENETIC DISORDERS	UNIQURE IP B.V.
WO/2021/104706	AGENT FOR DYEING KERATINOUS MATERIAL, CONTAINING AMINOSILICONE, PIGMENT AND POLYSACCHARIDE	HENKEL AG & CO. KGAA
WO/2021/063686	AN ORAL CARE COMPOSITION COMPRISING HEXAMETAPHOSPHATE AND A PIGMENT	UNILEVER IP HOLDINGS B.V.
WO/2021/053040	METHODS FOR RADIOLABELLING GRPR ANTAGONISTS AND THEIR KITS	ADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/053047	BIOACTIVE IMPLANTS FOR DRUG DELIVERY	THE QUEEN'S UNIVERSITY OF BELFAST
WO/2021/053058	ALVELESTAT FOR USE IN THE TREATMENT OF GRAFT REJECTION, BRONCHIOLITIS OBLITERANS SYNDROME AND GRAFT VERSUS HOST DISEASE	MEREO BIOPHARMA 4 LIMITED
WO/2021/115648	DOSAGE FORM COMPRISING AN ALKALINE AGENT AND AN ENTERIC COATING LAYER	EVONIK OPERATIONS GMBH
WO/2021/115649	DOSAGE FORM FOR USE IN TREATING OR PREVENTING OF A DISEASE	EVONIK OPERATIONS GMBH
WO/2021/115650	DOSAGE FORM FOR USE IN TREATING OR PREVENTING OF A DISEASE	EVONIK OPERATIONS GMBH
WO/2021/053076	COMBINATION THERAPY WITH VILDAGLIPTIN AND METFORMIN	NOVARTIS AG
WO/2021/053078	NICOTINE POUCH	ENORAMA PHARMA AB
WO/2021/053093	ANTIPERSPIRANT COMPOSITIONS	UNILEVER IP HOLDINGS B.V.
WO/2021/053126	METHOD OF TREATING HBV INFECTION USING A CORE PROTEIN ALLOSTERIC MODULATOR	F. HOFFMANN-LA ROCHE AG
WO/2021/053155	COMBINATION TREATMENT WITH A P53 REACTIVATOR AND AN INHIBITOR OF AN ANTIAPOPTOTIC BCL-2 FAMILY PROTEIN	APREA THERAPEUTICS AB
WO/2021/053163	IMMUNE STIMULATING MICELLE COMPOSITION	DANMARKS TEKNISKE UNIVERSITET
WO/2021/053167	EXTRUDED DEPOT FORM FOR CONTROLLED ACTIVE SUBSTANCE RELEASE	AMW GMBH
WO/2021/053171	EXTRUDED DEPOT FORM FOR CONTROLLED ACTIVE SUBSTANCE RELEASE	AMW GMBH
WO/2021/053173	METHODS FOR TRIGGERING M1 MACROPHAGE POLARIZATION	NH THERAGUIX
WO/2021/053178	PREPARATION FOR REMOVAL AND/OR PREVENTION OF AN INFECTION ASSOCIATED WITH STAPHYLOCOCCUS EPIDERMIDIS	RLS GLOBAL AB
WO/2021/053185	MELFLUFEN FORMULATIONS AND THEIR USE IN THE TREATMENT OR PROPHYLAXIS OF OSTEOSARCOMA	ONCOPEPTIDES AB
WO/2021/053194	KV1.3 BLOCKERS	ZEALAND PHARMA A/S
WO/2021/053198	POLYMER OR POLYCONDENSATE BASED ON PEPTIDE, LINKER AND OPTIONALLY OTHER MONOMERS AND METHOD FOR PREPARING THE SAME	ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
WO/2021/058416	HETEROCYCLIC COMPOUNDS	F. HOFFMANN-LA ROCHE AG
WO/2021/058423	COMPOSITION WITH DRUG MICRO-NANO PARTICLES OF AN ANTI-CANCER AGENT	CAPNOMED GMBH
WO/2021/058428	COMPOSITIONS FOR USE IN REDUCING INFLAMMATION	EVONIK OPERATIONS GMBH
WO/2021/053234	COMPOUNDS AND COMPOSITIONS FOR TREATING KIDNEY DISEASE	JOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN
WO/2021/053240	A NOVEL HUMAN RESPIRATORY SYNCYTIAL VIRUS STRAIN AND ITS USE	UNIVERSITEIT ANTWERPEN
WO/2021/063727	A POUCH PRODUCT SUITABLE FOR APPLICATION IN AN ORAL CAVITY	SCHJÖLIN, Evaggelos
WO/2021/053246	ORAL DELIVERY SYSTEM	UNIVERSITY COLLEGE DUBLIN
WO/2021/063734	CDK4/6 INHIBITORS FOR THE TREATMENT OF PSORIASIS	EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET
WO/2021/063737	AGENT FOR THE TREATMENT OF PSORIASIS	EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET
WO/2021/058454	NOVEL CARRIER PARTICLES FOR DRY POWDER FORMULATIONS FOR INHALATION	CHIESI FARMACEUTICI S.P.A.
WO/2021/058463	A LIPOSOME SYSTEM COMPRISING A LIPID, AN ACTIVE COMPOUND AND A VECTOR PEPTIDE	WESTFÄLISCHE WILHELMS-UNIVERSITÄT MüNSTER
WO/2021/058469	ANHYDROUS COMPOSITIONS	DSM IP ASSETS B.V.
WO/2021/058472	TREATMENT INVOLVING THERAPEUTIC ANTIBODY AND INTERLEUKIN-2 (IL2)	BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/058492	NANOPARTICLE COMPOSITIONS FOR GENE THERAPY	UNIVERSITY COLLEGE DUBLIN
WO/2021/104709	METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS BEEN DYED BY APPLYING A PIGMENT	HENKEL AG & CO. KGAA
WO/2021/104710	METHOD FOR THE DECOLORIZATION OF KERATIN MATERIAL THAT HAS BEEN DYED USING AN AMINO SILICONE AND A PIGMENT	HENKEL AG & CO. KGAA
WO/2021/058514	COMPOSITIONS AND METHODS USING ADENOSYLCOBALAMIN	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/058521	A TOPICAL PLANT EXTRACT FORMULATION COMPRISING URTICA DIOICA AND VITAMIN A	THE CEUTICS COMPANY GESMBH
WO/2021/058548	ANTIBODIES FOR THE DIAGNOSIS AND/OR TREATMENT OF ATHEROSCLEROSIS	CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P.)
WO/2021/058549	RADIOLABELLED GRPR-ANTAGONIST FOR USE AS THERAGNOSTIC	ADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/058604	HYPOCHLORITE COMPOSITION AND SYSTEM AND METHOD FOR PREPARING A HYPOCHLORITE COMPOSITION AND USE OF THE SAME	KONINKLIJKE PHILIPS N.V.
WO/2021/058611	KIT, SYSTEM AND METHOD FOR PREPARING AND USE OF A PEROXIDE-CONTAINING COMPOSITION	KONINKLIJKE PHILIPS N.V.
WO/2021/058628	SCYLLO-INOSITOL AND ITS USE AS INSULIN SENSITIZER	SOCIéTé DES PRODUITS NESTLé SA
WO/2021/058636	ANTI-NRP1A ANTIBODIES AND THEIR USES FOR TREATING EYE OR OCULAR DISEASES	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/058651	HYDROGEL COMPOSITIONS FOR THE CONTROLLED AND CONSTANT RELEASE OF ACTIVE AGENTS	TECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/058656	RIFAXIMIN LIQUID FORMULATIONS	BAUSCH HEALTH IRELAND LIMITED
WO/2021/058670	PHARMACEUTICAL DELIVERY DEVICE AND METHOD OF MANUFACTURE	UNIVERSITY OF ULSTER
WO/2021/058679	POWDER AND PROCESS FOR CLEANING TEETH BY USE OF SUCH POWDER	FERTON HOLDING S.A.
WO/2021/058684	MODIFIED VESICULAR STOMATITIS VIRUS GLYCOPROTEIN AND USES THEREOF FOR THE TREATMENT OF BRAIN TUMORS	UNIVERSITé CATHOLIQUE DE LOUVAIN
WO/2021/058715	HYDROGEL BASED ON ZINC GLUCONATE AND HYALURONIC ACID ESTERS	BMG PHARMA S.P.A.
WO/2021/063813	PROCESS FOR PREPARING NANOPARTICLES IN THE FORM OF A POWDER COMPRISING A BIO-RESORBABLE POLYESTER	EVONIK OPERATIONS GMBH
WO/2021/058735	CANCER TREATMENT WITH ANTI-MET ANTIBODY COMPOSITIONS	SYMPHOGEN A/S
WO/2021/058744	USE OF MüLLERIAN INHIBITING SUBSTANCE INHIBITORS FOR TREATING CANCER	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/058748	FORMULATION FOR TOPICAL APPLICATION TO THE SKIN OR MUCOUS MEMBRANES	SEBBAN, Sandrine
WO/2021/058754	PHARMACEUTICAL COMPOUNDS	SENTINEL ONCOLOGY LIMITED
WO/2021/058758	CELL COMPOSITION COMPRISING RADIOLABLED MESENCHYMAL STEM CELLS, USE THEREOF AND METHOD FOR PREPARING RADIOLABELED MESENCHYMAL STEM CELLS	GLOBAL STEM CELL TECHNOLOGY NV
WO/2021/058794	DOSING REGIMENS FOR TREATMENT OF PATIENTS WITH LOCALLY ADVANCED SQUAMOUS CELL CARCINOMA	DEBIOPHARM INTERNATIONAL S.A.
WO/2021/058798	USE OF FGFR INHIBITORS IN FGFR-GENETICALLY ALTERED CANCERS TO ENHANCE PATIENT RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN SEQUENTIAL TREATMENT SETTINGS	JANSSEN PHARMACEUTICA NV
WO/2021/058804	BINDING MODULES COMPRISING MODIFIED EHD2 DOMAINS	UNIVERSITÄT STUTTGART
WO/2021/058807	TRIVALENT BINDING MOLECULES	UNIVERSITÄT STUTTGART
WO/2021/058810	PEDIATRIC TRAZODONE COMPOSITIONS AND METHOD OF TREATMENT THEREOF	ANGELINI S.P.A.
WO/2021/058811	SHORT-CHAIN FATTY ACID PENTANOATE AS ENHANCER FOR CELLULAR THERAPY AND ANTI-TUMOR THERAPY	PHILIPPS-UNIVERSITÄT MARBURG
WO/2021/058818	NOVEL MEDICAL USES OF THIOL-FUNCTIONALIZED POLYGLYCEROL DERIVATIVES	FREIE UNIVERSITÄT BERLIN
WO/2021/083593	LAG TIME REDUCTION/ICE SPRAY	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/058831	THERAPEUTIC EFFICACY BY PULMONARY DELIVERY OF LIVE ATTENUATED MYCOBACTERIA	UNIVERSIDAD DE ZARAGOZA
WO/2021/058835	CONTROL OF TUMOUR GROWTH AND GUT BLEEDING BY BIOSURFACTANTS	UNIVERSITY OF ULSTER
WO/2021/063917	VACCINE AGAINST CHLAMYDIA IN SWINE	UNIVERSITEIT GENT
WO/2021/069256	SILICA FOR ORAL CARE COMPOSITIONS	RHODIA OPERATIONS
WO/2021/063945	COMBINED THERAPY COMPRISING AN INHIBITOR OF INTERLEUKIN-17 ACTIVITY AND A VITAMIN D RECEPTOR AGONIST	SERVEI DE SALUT DE LES ILLES BALEARS – IBSALUT
WO/2021/063967	NOVEL SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF	SANOFI
WO/2021/064009	PROTEIN BINDERS TO IRHOM2 EPITOPES	SCIRHOM GMBH
WO/2021/064034	A PUNICA GRANATUM EXTRACT AND ITS COSMETIC USES	L'OREAL
WO/2021/064050	IMMUNOGENIC COMPOSITIONS	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/064069	METHODS FOR THE TREATMENT OF ADULT T-CELL LEUKEMIA/LYMPHOMA	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/064072	USE OF RETINOIC ACID RECEPTOR (RAR) AGONISTS FOR REVERSING, PREVENTING, OR DELAYING CALCIFICATION OF AORTIC VALVE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/064076	LIPOSOMES COMPRISING ANTI-LOX ANTIBODY	ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI (I.R.S.T.) S.R.L.
WO/2021/064088	BETA-GLUCANS HAVING SUPERIOR IMMUNO-STIMULATING PROPERTIES	UNIVERSITEIT GENT
WO/2021/064105	EXTRACT OF ORGANIC HUMIFIED MATERIALS	FELLNER, Stefan Johannes
WO/2021/064116	COMPOSITIONS WITH POLYMERIC OR OLIGOMERIC HYDROXY PHENYL TRIAZINE UV FILTER	BASF SE
WO/2021/064123	PHARMACEUTICAL COMPOSITION COMPRISING ENZALUTAMIDE	SYNTHON B.V.
WO/2021/064132	TREATMENT OF MENOPAUSAL SYNDROME AND/OR SYMPTOMS ASSOCIATED WITH MENOPAUSE	BESINS HEALTHCARE IRELAND LIMITED
WO/2021/064142	HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OR AMELIORATION OF CANCER	TOLREMO THERAPEUTICS AG
WO/2021/064151	COMBINATION OF THE ETHYL ESTERS OF DOCOSAHEXAENOIC AND EICOSAPENTAENOIC ACID PLUS VITAMIN D3 FOR PREVENTION OF AGE-RELATED DISEASES	UNIVERSITÄT ZüRICH
WO/2021/064152	HYBRID ANTIBODY	EPSILOGEN LTD
WO/2021/064153	HYBRID ANTIBODY	EPSILOGEN LTD
WO/2021/064159	RETINOID DERIVATIVES FOR USE IN THE TREATMENT OF DISEASES ASSOCIATED WITH SULFATASE DEFICIENCIES	GEORG-AUGUST-UNIVERSITÄT GÖTTINGEN STIFTUNG ÖFFENTLICHEN RECHTS, UNIVERSITÄTSMEDIZIN
WO/2021/064167	COMBINATION PRODUCT FOR RELIEVING THE BRONCHI	URGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/064169	COMBINATION PRODUCT FOR RELIEVING THE BRONCHI AND FACILITATING FALLING ASLEEP	URGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/064173	USE OF LEONTODIUM ALPINUM PLANT CELLS FOR AN ANTI-GLYCATION ANTI-AGEING SKIN TREATMENT	SEDERMA
WO/2021/064180	METHODS AND COMPOSITIONS FOR MODULATING MACROPHAGES POLARIZATION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/064184	METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OVARIAN CANCER, BREAST CANCER OR PANCREATIC CANCER	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/064186	NOVEL PYRIDIN-2(1<i>H</i>)ONE DERIVATIVES, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF PAIN	INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
WO/2021/064188	COMBINATION COMPRISING HDAC INHIBITOR, CTLA-4 INHIBITOR AND A PD-1 INHIBITOR OR PD-L1 INHIBITOR FOR CANCER TREATMENT	4SC AG
WO/2021/064197	ISOLATED POLYPEPTIDE AND POLYPEPTIDE COMPLEXES FOR PREVENTION, ALLEVIATION AND/OR TREATMENT OF HCV INFECTIONS	KØBENHAVNS UNIVERSITET
WO/2021/064217	METHOD FOR TREATING AND/OR PREVENTING A PARASITIC INFECTION IN A TELEOST	PREVIWO AS
WO/2021/064227	SINGLE DOMAIN ANTIBODIES SPECIFICALLY BINDING GLOBO - SERIES GLYCANS	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/069339	HOMOPIPERAZINYL AND HOMOPIPERIDINYL QUINAZOLIN-4(3H)-ONE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN	ESTEVE PHARMACEUTICALS, S.A.
WO/2021/069344	PROCESS FOR THE PREPARATION OF A NANOPARTICULATE ACTIVE INGREDIENT	BAYER AKTIENGESELLSCHAFT
WO/2021/069345	PROCESS FOR PRODUCING NANOPARTICULATE RIVAROXABAN	BAYER AKTIENGESELLSCHAFT
WO/2021/069349	PROCESS FOR PRODUCING A PHARMACEUTICAL FORMULATION COMPRISING CRYSTALLINE AND AMORPHOUS FRACTIONS OF AN ACTIVE SUBSTANCE	BAYER AKTIENGESELLSCHAFT
WO/2021/069350	PROCESS FOR PRODUCING A PHARMACEUTICAL FORMULATION COMPRISING ACTIVE SUBSTANCE, POLYMER AND SURFACTANT	BAYER AKTIENGESELLSCHAFT
WO/2021/083616	HAIR CARE COMPOSITION	GIVAUDAN SA
WO/2021/069426	PEPTIDE BASED COSMETIC OR DERMATOLOGICAL TREATMENT OF THE SKIN AND ITS APPENDAGES	SEDERMA
WO/2021/073961	SOLUTION OF CELLULOSE IN A QUATERNARY AMMONIUM COMPOUND AND A CO-SOLVENT	BASF SE
WO/2021/104728	BIODEGRADABLE BEADS	BASF SE
WO/2021/104729	BIODEGRADABLE BEADS WITH DYES AND PIGMENTS	BASF SE
WO/2021/069486	MEK INHIBITORS FOR THE TREATMENT OF HANTAVIRUS INFECTIONS	ATRIVA THERAPEUTICS GMBH
WO/2021/069496	AN ANHYDROUS PHARMACEUTICAL COMPOSITION FOR MAINTENANCE TREATMENT OF PSORIASIS	LEO PHARMA A/S
WO/2021/069497	SYSTEMIC ADMINISTRATION OF PEPTIDES FOR THE TREATMENT OF SPINAL CORD INJURY AND/OR FOR REMYELINATION	AXOLTIS PHARMA
WO/2021/069523	CALRETICULIN FOR TREATING OR PREVENTING AN ANGIOGENIC EYE DISEASE	UAB BALTYMAS
WO/2021/069527	NON-DEGRADABLE EMBOLISATION MICROSPHERE	GUERBET
WO/2021/069528	NON DEGRADABLE RADIO-OPAQUE EMBOLISATION MICROSPHERE	GUERBET
WO/2021/069533	HAIR TREATMENT COMPOSITIONS	UNILEVER IP HOLDINGS B.V.
WO/2021/073988	ANTIPERSPIRANT EMULSION	UNILEVER IP HOLDINGS B.V.
WO/2021/073989	AN ANTIPERSPIRANT COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/069542	ZAFIRLUKAST DERIVATIVES FOR USE AS CONTRACEPTIVE AGENTS	RIGSHOSPITALET
WO/2021/069553	USE OF LIVER PROGENITOR OR STEM CELLS, LYSATES THEREOF, AND/OR CONDITIONED MEDIUM IN DISORDERS CHARACTERIZED BY VASCULAR HYPERPERMEABILITY	PROMETHERA BIOSCIENCES S.A./N.V.
WO/2021/069558	COMPOSITIONS OF THE OLEA EUROPAEA V. SYLVESTRIS WITH ANTIMICROBIAL EFFICACY	TAPROGGE GMBH
WO/2021/069567	NOVEL HETEROARYL-TRIAZOLE COMPOUNDS AS PESTICIDES	BAYER AKTIENGESELLSCHAFT
WO/2021/069571	POLYMORPH OF LORLATINIB	SANDOZ AG
WO/2021/069576	A PHARMACEUTICAL COMPOSITION COMPRISING CANNABINOID	BLACKHAWK PARTNERS LTD
WO/2021/069578	RIBOFLAVIN FOR USE IN CONTROLLING BLOOD PRESSURE DURING PREGNANCY	DSM IP ASSETS B.V.
WO/2021/069590	GELATIN CAPSULES WITH GROUND CALCIUM CARBONATE	CAPSUGEL FRANCE SAS
WO/2021/069615	IMPROVED ANTI-HANGOVER COMPOSITION, ITS PREPARATION AND USES	ZOBRIUS PHARMA AS
WO/2021/074012	HAIR TREATMENT METHOD	UNILEVER IP HOLDINGS B.V.
WO/2021/074025	USE OF ESCULENTIN AND ITS DERIVATIVES FOR USE IN THE TREATMENT OF CYSTIC FIBROSIS	UNIVERSITà DEGLI STUDI DI ROMA “LA SAPIENZA”
WO/2021/069671	HEXAHYDRO-5,8-EPOXYCYCLOHEPTA[c]PYRAZOLE DERIVATIVES USEFUL AS MODULATORS OF THE CB1 AND/OR CB2 RECEPTORS	JANSSEN PHARMACEUTICA NV
WO/2021/069685	FLUORESCENT VANCOMYCIN ANALOGUE	UNIVERSITE DE STRASBOURG
WO/2021/069686	NOVEL THERAPEUTIC COMBINATIONS COMPRISING DERIVATIVES OF OXAZAPHOSPHORINES FOR THE TREATMENT OF CANCER	INSTITUT GUSTAVE ROUSSY
WO/2021/069698	HEALING AND CONDUCTIVE COMPOSITION COMPRISING COLLAGEN	MONDERNA HEALTH & WELLNESS
WO/2021/204409	OLEYL PHOSPHOCHOLINE CONTAINING GRANULATES	OBLITA THERAPEUTICS BVBA
WO/2021/069705	ISOINDOLINONE COMPOUNDS	MONTE ROSA THERAPEUTICS
WO/2021/069709	ANTI-CHEMOKIN LIKE RECEPTOR 1 HUMANIZED ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS	OSE IMMUNOTHERAPEUTICS
WO/2021/078553	NOVEL PEDIATRIC COMBINATION	CESSATECH A/S
WO/2021/069736	NEW CARBAZOLE DERIVATIVES SENSITIZING CELLS TO ANTI-CANCER AGENTS	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/069740	METHOD FOR PREVENTING HUMAN GLANDS FROM RADIATION DAMAGE	KCM CONSULTING GMBH
WO/2021/083657	COSMETIC PREPARATION COMPRISING ALKALINE EARTH METAL SALTS, CARBOXYLIC ACIDS AND EMULSIFIERS HAVING BRANCHED HYDROPHOBIC CHAINS	BEIERSDORF AG
WO/2021/089278	MICROMETRIC SIZE COMPOSITION AND ITS USE AS A PLANT ALKALOID COADJUVANT AGENT	BEIJING ENBIWO BIOLOGICAL TECHNOLOGY CO., LTD.
WO/2021/074118	LIQUID OMEGA-3 FATTY ACID COMPOSITIONS FOR DIRECT ORAL ADMINISTRATION	HERMES ARZNEIMITTEL GMBH
WO/2021/110306	MULTI-TONE HAIR DYEING METHOD IN THREE STEPS	HENKEL AG & CO. KGAA
WO/2021/115664	HAIR STYLING COMPOSITION I CONTAINING SUGAR	HENKEL AG & CO. KGAA
WO/2021/074158	ORAL CARE COMPOSITION	LACER, S.A.
WO/2021/074159	MEMBRANE-BASED TWO COMPONENT THERAPEUTIC GAS RELEASE SYSTEM FOR ORAL ADMINISTRATION	JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG
WO/2021/074164	ORAL CARE COMPOSITION	LACER, S.A.
WO/2021/074197	THIENOPYRIMIDONES AS TRPA1 INHIBITORS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/074198	NOVEL TETRAZOLES	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/078611	COSMETIC COMPOSITION WITH ENHANCED COLOR STABILITY	UNILEVER IP HOLDINGS B.V.
WO/2021/074261	B-LYMPHOCYTE SPECIFIC AMATOXIN ANTIBODY CONJUGATES	HEIDELBERG PHARMA RESEARCH GMBH
WO/2021/074284	USE OF NICOTINAMIDE MONONUCLEOTIDE (NMN) FOR THE PREVENTION AND/OR TREATMENT OF RHEUMATOID ARTHRITIS, AND CORRESPONDING COMPOSITIONS	NUVAMID SA
WO/2021/074314	AQUEOUS FORMULATIONS COMPRISING BUFFERED TIOTROPIUM BROMIDE FOR TOPICAL TREATMENT OF HYPERHIDROSIS	NOTOXINS IP B.V.
WO/2021/074352	NOVEL VACCINE COMPOSITIONS	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/074357	THIOPHENE DERIVATIVES FOR USE IN TREATING PORTAL INFLAMMATION AND FIBROSIS	ENYO PHARMA
WO/2021/121715	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A HYDROXYCARBOXYLIC ACID ESTER, A COLOURING COMPOUND AND A POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/121716	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, SHELLAC, A DYEING COMPOUND AND A POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/121717	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND A DYEING COMPOUND AND A OLIGOMERESTER	HENKEL AG & CO. KGAA
WO/2021/121718	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND TANNIC ACID	HENKEL AG & CO. KGAA
WO/2021/121719	PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED BY USING THE PIGMENT SUSPENSION	HENKEL AG & CO. KGAA
WO/2021/121720	PIGMENT SUSPENSION AND METHOD FOR DYING KERATINOUS MATERIAL USING THE PIGMENT SUSPENSION	HENKEL AG & CO. KGAA
WO/2021/089300	4-[5-[(RAC)-1-[5-(3-CHLOROPHENYL)-3-ISOXAZOLYL]ETHOXY]-4-METHYL-4<i>H</i>-1,2,4-TRIAZOL-3-YL]PYRIDINE FOR USE IN PREVENTION AND/OR TREATMENT OF SURMENAGE IN A MAMMAL	THULIN, Claes
WO/2021/121721	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A DYEING COMPOUND AND A PRE-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/074368	IRON(III) COMPLEXES HAVING NEW CONTRAST AGENT PROPERTIES, FOR MAGNETIC RESONANCE IMAGING	CHARITé - UNIVERSITÄTSMEDIZIN BERLIN
WO/2021/121722	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A HYDROXYCARBOXYLIC ACID ESTER, C<sb>1</sb>-C<sb>10</sb> ALCOHOL AND A DYEING COMPOUND	HENKEL AG & CO. KGAA
WO/2021/121723	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, AN HYDROXYCARBOXYLIC ACID ESTER, A DIOL AND A DYEING COMPOUND	HENKEL AG & CO. KGAA
WO/2021/121724	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE, A DYEING COMPOUND AND SHELLAC	HENKEL AG & CO. KGAA
WO/2021/121725	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND A COPOLYMER OF (METH)ACRYLIC ACID AND MALEIC ACID (ANHYDRIDE)	HENKEL AG & CO. KGAA
WO/2021/121726	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE, A DYEING COMPOUND AND GALACTOMANNAN	HENKEL AG & CO. KGAA
WO/2021/121727	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN ORGANIC C<sb>1</sb>-C<sb>6</sb> ALKOXY SILANE AND A COPOLYMER OF STYRENE AND MALEIC ACID (ANHYDRIDE)	HENKEL AG & CO. KGAA
WO/2021/074389	IMMUNOGENIC COMPOUNDS FOR TREATMENT OF ADRENAL CANCER	ENTEROME S.A.
WO/2021/074398	A PROCESS FOR PRODUCING MICROPARTICLES FOR USE AS MICROBEADS AND MICROPARTICLES PRODUCED ACCORDING TO THE PROCESS	SEAGREEN BIO LIMITED
WO/2021/074399	CONTROLLED RELEASE FORMULATIONS OF HIGHLY LIPOPHILIC PHYSIOLOGICALLY ACTIVE SUBSTANCES	ADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/074403	CONTROLLED RELEASE FORMULATIONS OF HIGHLY LIPOPHILIC PHYSIOLOGICALLY ACTIVE SUBSTANCES	ADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/074409	COMPOSITION FOR THE TREATMENT OF (PRE)OBESITY AND/OR ASSOCIATED MORBIDITIES THERETO	BASF SE
WO/2021/074414	OXAZOLE AND THIOAZOLE-TYPE CULLIN RING UBIQUITIN LIGASE COMPOUNDS AND USES THEREOF	CEMM - FORSCHUNGSZENTRUM FüR MOLEKULARE MEDIZIN GMBH
WO/2021/074418	CARBAZOLE-TYPE CULLIN RING UBIQUITIN LIGASE COMPOUNDS AND USES THEREOF	CEMM - FORSCHUNGSZENTRUM FüR MOLEKULARE MEDIZIN GMBH
WO/2021/074423	VACCINE PRODUCT	JANSSEN VACCINES & PREVENTION B.V.
WO/2021/074431	MICROBIAL COMPOSITIONS, STRAINS AND METHODS	UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK
WO/2021/110313	METHOD FOR COLOURING KERATIN MATERIAL, COMPRISING THE USE OF AN ORGANIC C1-C6 ALKOXY SILANE AND TWO STRUCTURALLY DIFFERENT CELLULOSE TYPES	HENKEL AG & CO. KGAA
WO/2021/089306	ANTI-INFLAMMATORY COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/110314	METHOD FOR COLOURING KERATIN MATERIAL, COMPRISING THE USE OF AN ORGANIC C1-C6 ALKOXYSILANE AND FIBRES	HENKEL AG & CO. KGAA
WO/2021/078685	METHOD OF REDUCING DENTAL HYPERSENSITIVITY	UNILEVER IP HOLDINGS B.V.
WO/2021/074452	COMBINATION PREPARATIONS OF 3-N-FORMYLHYDROXYLAMINOPROPYL PHOSPHONIC ACID DERIVATIVES OR 3-N-ACETYLHYDROXYLAMINOPROPYL PHOSPHONIC ACID DERIVATIVES WITH CLINDAMYCIN AND ARTESUNATE	DMG DEUTSCHE MALARIA GMBH
WO/2021/078726	PHARMACEUTICAL COMPOSITIONS OF GD-BASED CONTRAST AGENTS	BRACCO IMAGING SPA
WO/2021/197646	AQUEOUS OCTENIDINE-CONTAINING COMPOSITION FOR TREATING AND/OR PREVENTING AN EXACERBATION OF DISEASES CAUSED BY A CORONAVIRUS INFECTION	SCHüLKE & MAYR GMBH
WO/2021/078761	TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF FINGOLIMOD	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/121734	MODIFIED GRPR ANTAGONIST PEPTIDES FOR IMAGING AND THERAPY OF CANCER	TECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/083766	TREATMENT OF PRURITUS IN HORSES	EVAX AG
WO/2021/078810	SCHIZOPHRENIC DISORDER TREATMENT USING COMBINATION THERAPY	CAMBRIDGE COGNITION LTD.
WO/2021/078814	USE OF CYCLODEXTRINS AS A RADIOSTABILIZER	GE HEALTHCARE LIMITED
WO/2021/078835	PHARMACEUTICAL COMPOSITION COMPRISING SELEXIPAG	ACTELION PHARMACEUTICALS LTD
WO/2021/078864	COMPOSITIONS FOR THE TREATMENT OF EPITHELIAL LESIONS	GIELLEPI S.P.A.
WO/2021/078889	METHODS AND COMPOSITIONS FOR TREATING SICKLE CELL DISEASE WITH A FERROPORTIN INHIBITOR (VIT-2763)	VIFOR (INTERNATIONAL) AG
WO/2021/078910	IMMUNOTHERAPY TARGETING TUMOR NEOANTIGENIC PEPTIDES	INSTITUT CURIE
WO/2021/083790	DRY SHAMPOO COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/078912	TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE	NURITAS LIMITED
WO/2021/078920	COMPOSITIONS COMPRISING 2'-FUCOSYLLACTOSE TO PREVENT ASTHMA	FRIESLANDCAMPINA NEDERLAND B.V.
WO/2021/078925	METHODS OF TREATING CANCER	ASTRAZENECA AB
WO/2021/078937	TREATMENT OF STAT3 RELATED DISEASES BY IRON CHELATORS	DEUTSCHES KREBSFORSCHUNGSZENTRUM
WO/2021/078939	RNA OLIGONUCLEOTIDES FOR PREVENTING AGGREGATION OF PROTEINS	UNIVERSITÄT WIEN
WO/2021/078942	COMPOUNDS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE	UNIVERSIDAD DEL PAíS VASCO / EUSKAL HERRIKO UNIBERTSITATEA
WO/2021/078952	ANALOGUES OF N-ACYL-HOMOSERINE LACTONES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME	SORBONNE UNIVERSITE
WO/2021/078958	COMPOUNDS FOR USE (IN PARTICULAR RIPA-56) IN THE PREVENTION AND/OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE	SORBONNE UNIVERSITE
WO/2021/078959	AMH-COMPETITIVE ANTAGONIST ANTIBODY	GAMAMABS PHARMA
WO/2021/078964	ORAL GLIPTIN COMPOSITIONS AND METHOD FOR PREPARATION THEREOF	AUTHENDA PHARMACEUTICALS AG
WO/2021/078982	PRODUCT FOR COSMETIC SKIN CARE	S.I.P.R.E.S. S.R.L.
WO/2021/078987	COMBINATION TREATMENTS FOR CANCER	CELEX ONCOLOGY INNOVATIONS LIMITED
WO/2021/078988	RECOMBINANT L-ASPARAGINASE	JAZZ PHARMACEUTICALS IRELAND LTD.
WO/2021/078991	TREATMENT OF CONDITIONS OF THE NERVOUS SYSTEM	KWOK, Jessica
WO/2021/104770	ACTIVE SUBSTANCE COMBINATIONS OF UBICHINOL UND GLYCERYL STEARATE CITRATE AND COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ACTIVE SUBSTANCE COMBINATIONS	BEIERSDORF AG
WO/2021/104772	ACTIVE SUBSTANCE COMBINATIONS OF UBIQUINOL AND CARRAGEENAN AND COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ACTIVE SUBSTANCE COMBINATIONS	BEIERSDORF AG
WO/2021/104773	ACTIVE SUBSTANCE COMBINATIONS OF UBICHINOL UND HYALURONIC ACID AND COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ACTIVE SUBSTANCE COMBINATIONS	BEIERSDORF AG
WO/2021/104775	ACTIVE SUBSTANCE COMBINATIONS OF UBICHINOL AND CREATINE AND COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SAID ACTIVE SUBSTANCE COMBINATIONS	BEIERSDORF AG
WO/2021/104777	ACTIVE SUBSTANCE COMBINATIONS OF UBIQUINOL AND ONE OR MORE EMULSIFIERS FROM THE GROUP OF PHOSPHATES AND SULFATES, AND COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SUCH ACTIVE SUBSTANCE COMBINATIONS	BEIERSDORF AG
WO/2021/079010	ELECTROPHILIC NITROALKENE BENZOIC ACID DERIVATES AS THERAPEUTIC DRUGS IN AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND OTHER NEURODEGENERATIVE CONDITIONS	INSTITUT PASTEUR DE MONTEVIDEO
WO/2021/099072	HAIR CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/099073	HAIR CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/104780	ANTIMICROBIAL COMPOSITIONS COMPRISING MODIFIED CLAY AND COPOLYMERS	UNILEVER IP HOLDINGS B.V.
WO/2021/083867	PHARMACEUTICAL COMPOSITION INCLUDING A SYNERGISTIC COMBINATION OF IBUPROFEN AND N-ACETYLCYSTEINE	E-PHARMA TRENTO S.P.A.
WO/2021/104781	ACTIVE SUBSTANCE COMBINATIONS OF UBIQUINOL AND UBIQUINONE, COSMETIC OR DERMATOLOGICAL PREPARATIONS CONTAINING SUCH ACTIVE SUBSTANCE COMBINATIONS, AND USE OF UBIQUINOL TO IMPROVE THE EFFICACY OF COSMETIC OR DERMATOLOGICAL PREPARATIONS WITH AN UBIQUINONE CONTENT	BEIERSDORF AG
WO/2021/083879	BROMODOMAIN INHIBITORS	RHEINISCH-WESTFÄLISCHE TECHNISCHE HOCHSCHULE (RWTH) AACHEN
WO/2021/083899	PROCESS FOR PREPARING A DYE COMPOSITION COMPRISING THE MIXING OF SOLID PARTICLES WITH AN AQUEOUS COMPOSITION CONTAINING ARGININE, AND THE USE THEREOF	L'OREAL
WO/2021/083900	METHOD FOR THE TREATMENT OF KERATIN FIBRES BY MEANS OF A COMPOSITION CONTAINING ARGININE AND OF AN OXIDIZING COMPOSITION	L'OREAL
WO/2021/083901	PROCESS FOR PREPARING A DYE COMPOSITION, COMPRISING THE MIXING OF AT LEAST TWO TYPES OF SOLID PARTICLES WITH AN AQUEOUS COMPOSITION, AND USE THEREOF	L'OREAL
WO/2021/083902	ALKALINE COMPOSITION COMPRISING AT LEAST THREE DIFFERENT ALKALINE AGENTS FOR THE TREATMENT OF KERATIN FIBRES, METHODS AND USES	L'OREAL
WO/2021/083903	COATED COLOURING SOLID PARTICLES COMPRISING AT LEAST ONE DIRECT DYE AND/OR ONE OXIDATION DYE PRECURSOR	L'OREAL
WO/2021/083904	PROCESS FOR PREPARING A DYE COMPOSITION BY MIXING SOLID PARTICLES AND AN OXIDIZING COMPOSITION AND AN ALKALINE COMPOSITION	L'OREAL
WO/2021/083910	DRY POWDER FORMULATIONS CONTAINING LEUCINE AND TRILEUCINE	ASTRAZENECA AB
WO/2021/083912	COMBINATION THERAPY HAVING ANTIOXYDANT PROPERTIES	GENFIT
WO/2021/083919	COMPOSITION CONTAINING PREBIOTIC BACTERIA AND LICOCHALCONE A	BEIERSDORF AG
WO/2021/083920	COMPOSITION CONTAINING PREBIOTIC BACTERIA AND PROTECTOR STRAINS	BEIERSDORF AG
WO/2021/104782	USE OF ALKYLAMIDOTHIAZOLES IN COSMETIC OR DERMATOLOGICAL PREPARATIONS FOR THE CARE OF TATTOOED HUMAN SKIN AND IN PARTICULAR FOR INCREASING BRILLIANCY OF TATTOOS ON DARK HUMAN SKIN	BEIERSDORF AG
WO/2021/104785	A CONDITIONING COMPOSITION	BEIERSDORF AG
WO/2021/104786	A CONDITIONING COMPOSITION	BEIERSDORF AG
WO/2021/083958	NOVEL PEPTIDES INDUCING SATIETY	SPECIALITES PET FOOD
WO/2021/083959	METHODS AND COMPOSITIONS FOR TREATING UVEAL MELANOMA	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/083964	NEW MEANS AND METHODS FOR THERAPY AND DIAGNOSIS OF DNA VIRUS INFECTIONS	TECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/083970	MEDICAL COMPOSITIONS AND THEIR USE IN TREATING INFLAMMATORY BOWEL DISEASE	BIOMILLENIA SAS
WO/2021/083989	PROCESS FOR PREPARING NANO- OR MICROPARTICLES COMPRISING A CARRIER-POLYMER AND ONE OR MORE BIOLOGICALLY ACTIVE INGREDIENTS	EVONIK OPERATIONS GMBH
WO/2021/083992	DENTAL COMPOSITE MATERIAL	KULZER GMBH
WO/2021/084007	FOAM PRECURSOR LIQUID AND FOAM CLEANSING COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/084013	NEW TREATMENT REGIMEN FOR THE TREATMENT OF NEUROLOGICAL DISEASES OR CONDITIONS	BIONURE FARMA, S.L.
WO/2021/084022	HYDROPYRAZINO[1,2-D][1,4]DIAZEPINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE	F. HOFFMANN-LA ROCHE AG
WO/2021/099088	HAIR CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/084030	ORAL PHARMACEUTICAL COMPOSITION COMPRISING A MELT-AGGLOMERATED ACTIVE INGREDIENT CORE	HERMES ARZNEIMITTEL GMBH
WO/2021/084055	BLEACHING POWDER COMPOSITION	KAO GERMANY GMBH
WO/2021/084058	COMPOSITION FOR THE PREVENTION AND TREATMENT OF DISEASES OF THE RESPIRATORY SYSTEM	NEILOS S.R.L.
WO/2021/084062	ANTI-CD19 THERAPY IN COMBINATION WITH LENALIDOMIDE FOR THE TREATMENT OF LEUKEMIA OR LYMPHOMA	MORPHOSYS AG
WO/2021/089419	THERAPEUTIC COMBINATIONS OF ACALABRUTINIB AND CAPIVASERTIB TO TREAT B-CELL MALIGNANCIES	ASTRAZENECA AB
WO/2021/084064	SEQUENTIAL ANTI-CD19 THERAPY	MORPHOSYS AG
WO/2021/099089	SUNSCREEN COMPOSITION CONTAINING SILICA FOR PROTECTION FROM BLUE LIGHT	BEIERSDORF AG
WO/2021/084068	COMBINATION OF A CXCR7 ANTAGONIST WITH AN S1P1 RECEPTOR MODULATOR	IDORSIA PHARMACEUTICALS LTD
WO/2021/099090	NOVEL SUNSCREEN COMPOSITION CONTAINING SILICA FOR PROTECTION AGAINST BLUE LIGHT	BEIERSDORF AG
WO/2021/084082	COSMETIC COMPOSITION FOR IMPROVED BLEACHING OR DYEING OF KERATIN FIBERS	KAO CORPORATION
WO/2021/084083	AQUEOUS OXIDATIVE COMPOSITION COMPRISING XANTHINE DERIVATIVES	KAO CORPORATION
WO/2021/084084	AQUEOUS OXIDIZING COMPOSITION COMPRISING AMINO ACIDS	KAO CORPORATION
WO/2021/084085	TWO-PART OXIDATIVE DYEING COMPOSITION	KAO CORPORATION
WO/2021/084087	BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE AGENTS	CIS PHARMA AG
WO/2021/089433	SOLID DISPERSIONS OF URSOLIC ACID POTASSIUM SALT	INDENA S.P.A.
WO/2021/084120	LIQUID ORAL FORMULATION OF BUMETANIDE	NEUROCHLORE
WO/2021/089445	ORAL CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/084124	COMBINED INHIBITION OF PD-1, TGFβ AND ATM TOGETHER WITH RADIOTHERAPY FOR THE TREATMENT OF CANCER	ARES TRADING S.A.
WO/2021/084136	COSMETIC COMPOSITION CONTAINING AN EXTRACT FROM OPUNTIA FICUS INDICA	WELEDA AG
WO/2021/089500	SUNSCREEN COMPOSITION WITH LOW STICKINESS	DSM IP ASSETS B.V.
WO/2021/089501	NOVEL METHOD	DSM IP ASSETS B.V.
WO/2021/089502	SUNSCREEN COMPOSITION WITH LOW STICKINESS	DSM IP ASSETS B.V.
WO/2021/089513	TREATMENT OF CANCER USING A HLA-A2/WT1 X CD3 BISPECIFIC ANTIBODY AND LENALIDOMIDE	F. HOFFMANN-LA ROCHE AG
WO/2021/089554	INTRANASAL ADMINISTRATION OF MEROTOCIN FOR IMPROVING LACTATION	FERRING B.V.
WO/2021/089563	METHODS OF USING IL-33 ANTAGONISTS	MEDIMMUNE LIMITED
WO/2021/089580	ORAL FORMULATION OF X842	CINCLUS PHARMA AG
WO/2021/089581	TOOTH WHITENING COMPOSITION	UNIVERSITAT AUTONOMA DE BARCELONA
WO/2021/110341	WATER-RESISTANT COSMETIC SUNSCREEN	BEIERSDORF AG
WO/2021/089588	HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF CANCER	PIERIS PHARMACEUTICALS GMBH
WO/2021/094156	A FILM AND A KIT FOR WHITENING TEETH	UNILEVER IP HOLDINGS B.V.
WO/2021/104813	SIMULTANEOUS IMAGE REPRESENTATION OF TWO DIFFERENT FUNCTIONAL AREAS	SIEMENS HEALTHCARE GMBH
WO/2021/099117	A COSMETIC COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/089644	METAL COMPLEXES BEARING BISSTYRYL-BIPYRIDINE LIGAND AND THEIR USE AS PHOTOSENSITIZER AGENT IN ONE AND TWO-PHOTON PHOTODYNAMIC THERAPY	PARIS SCIENCES ET LETTRES - QUARTIER LATIN
WO/2021/089649	ANDROGEN RECEPTOR INHIBITORS FOR THE TREATMENT OF NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN SUBJECTS WITH SEVERE HEPATIC IMPAIRMENT	JANSSEN PHARMACEUTICA NV
WO/2021/089651	DIAGNOSTIC METHOD	AMAZENTIS SA
WO/2021/089678	GLP-1 RECEPTOR AGONISTS IN DEMENTIA	NOVO NORDISK A/S
WO/2021/089692	INHIBITOR OF BINDING BETWEEN PODOCIN AND KERATIN 8 FOR USE IN THE TREATMENT OF NEPHROTIC SYNDROME	THE UNIVERSITY OF BRISTOL
WO/2021/094192	SOLID PARTICLES CONTAINING SOLID PRIMARY PARTICLES THAT CONSIST ESSENTIALLY OF NATIVE CELLULOSE	EVONIK OPERATIONS GMBH
WO/2021/089704	COMBINED INHIBITION OF PD-1, TGFB AND TIGIT FOR THE TREATMENT OF CANCER	MERCK PATENT GMBH
WO/2021/089715	USE OF COLCHICINE IN THE TREATMENT AND PREVENTION OF LUNG CANCER	MURRAY AND POOLE ENTERPRISES, LTD.
WO/2021/089721	TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL INFECTION.	HERCULES PHARMACEUTICALS B.V.
WO/2021/089729	BIVALENT LECA INHIBITORS TARGETING BIOFILM FORMATION OF <i>PSEUDOMONAS AERUGINOSA</i>	HELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/089736	COMBINED THERAPY FOR MUSCULAR DISEASES	ASSOCIATION INSTITUT DE MYOLOGIE
WO/2021/089752	SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST, AN SGLT2 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID	NOVO NORDISK A/S
WO/2021/089761	SOLID COMPOSITIONS COMPRISING A PCSK9 INHIBITOR AND A SALT OF N-(8-(2-HYDROXYBENZOYL)AMINO)CAPRYLIC ACID	NOVO NORDISK A/S
WO/2021/094209	SUBSTITUTED PYRROLO TRIAZINE CARBOXAMIDE DERIVATIVES AS PROSTAGLANDIN EP3 RECEPTOR ANTAGONISTS	BAYER AKTIENGESELLSCHAFT
WO/2021/094210	SUBSTITUTED PYRAZINE CARBOXAMIDE DERIVATIVES AS PROSTAGLANDIN EP3 RECEPTOR ANTAGONISTS	BAYER AKTIENGESELLSCHAFT
WO/2021/089768	TREATMENT AND PREVENTION OF A NEURODEGENERATIVE DISORDER	INFLAZOME LIMITED
WO/2021/089769	TREATMENT AND PREVENTION OF NEUROINFLAMMATION OR AN INFLAMMATORY BRAIN DISORDER	INFLAZOME LIMITED
WO/2021/089770	PROTEIN PURIFICATION	JANSSEN VACCINES & PREVENTION B.V.
WO/2021/089776	TREATMENT AND PREVENTION OF A TRAUMATIC BRAIN DISORDER	INFLAZOME LIMITED
WO/2021/089781	TREATMENT OR PREVENTION OF PSYCHIATRIC BRAIN DISORDERS USING THE NLRP3 INHIBITOR N-((1,2,3,5,6,7-HEXAHYDRO-S-INDACEN-4-YL)CARBAMOYL)-1 -ISOPROPYL-1 H-PYRAZOLE-3-SULFONAMIDE	INFLAZOME LIMITED
WO/2021/089782	TREATMENT OF AUTOINFLAMMATORY DISORDERS	INFLAZOME LIMITED
WO/2021/089783	TREATMENT OF ARTHRITIS	INFLAZOME LIMITED
WO/2021/089790	MITROCHONDRIA-TARGETING ANTIOXIDANTS	GIVAUDAN SA
WO/2021/089791	METHODS FOR THE TREATMENT OF CANCERS THAT HAVE ACQUIRED RESISTANCE TO KINASE INHIBITORS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/089794	METHODS OF TREATING CANCER WITH A COMBINATION OF A PLATINUM-BASED AGENT AND AN ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATE	GENMAB A/S
WO/2021/089807	ANTIVIRAL PREPARATION FROM CHESTNUT SHELLS OF <i>CASTANEA SATIVA</i> MILL	MICRONATURE S.R.L.
WO/2021/089824	5-HT2A AGONISTS FOR USE IN TREATMENT OF DEPRESSION	LOPHORA APS
WO/2021/104834	COMBINATION THERAPY	ADC THERAPEUTICS SA
WO/2021/089840	FERMENTATION METHOD FOR THE PRODUCTION OF PHYTOESTROGENS	MRM HEALTH N.V.
WO/2021/089845	CD93 INHIBITORS FOR USE IN THE TREATMENT OF CANCER	UNIVERSITÄT BERN
WO/2021/089848	USE OF SODIUM OCTENYL-SUCCINATE STARCHES AS A BINDER IN CONTINUOUS WET GRANULATION	ROQUETTE FRERES
WO/2021/094259	NPY2 RECEPTOR AGONISTS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/104844	CLEANSING COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/094296	USE OF MAST CELL STABILIZER FOR THE TREATMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/094331	INOSITOL PHOSPHATE COMPOUNDS FOR USE IN TREATING, INHIBITING THE PROGRESSION, OR PREVENTING CARDIOVASCULAR CALCIFICATION	SANIFIT THERAPEUTICS, S.A.
WO/2021/094334	CLEANSING COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/094344	POLYPEPTIDES FOR INDUCING TOLERANCE TO FACTOR VIII	CSL BEHRING LENGNAU AG
WO/2021/094378	TYPE I INTERFERON INHIBITION IN SYSTEMIC LUPUS ERYTHEMATOSUS	ASTRAZENECA AB
WO/2021/094379	EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER	ASTRAZENECA AB
WO/2021/094390	(S)-2-(1-(5-(CYCLOHEXYLCARBAMOYL)-6-(PROPYLTHIO)PYRIDIN-2-YL)PIPERIDIN-3-YL) ACETIC ACID FOR USE IN TREATING WOUNDS	UNIVERSITY OF LEEDS
WO/2021/094396	COMPOSITION FOR ANTIMICROBIAL PHOTODYNAMIC THERAPY	CMS DENTAL A/S
WO/2021/094424	AN INHIBITOR OF AN IRON-CONTAINING HYDROGENASE OF A METHANOGENIC ARCHAEON FOR USE IN THE TREATMENT OR PREVENTION OF A PARKINSONIAN CONDITION	UNIVERSITé DU LUXEMBOURG
WO/2021/094429	DEODORANT COMPOSITIONS	UNILEVER IP HOLDINGS B.V.
WO/2021/094469	ANTI-CLAUDIN-1 MONOCLONAL ANTIBODIES FOR THE PREVENTION AND TREATMENT OF FIBROTIC DISEASES	UNIVERSITé DE STRASBOURG
WO/2021/094561	RINSABLE OILY SOLUTION FOR CONTROLLING LICE	DERMOWAVE
WO/2021/094562	ANTIGENIC PEPTIDES FOR PREVENTION AND TREATMENT OF B-CELL MALIGNANCY	ENTEROME S.A.
WO/2021/094563	TREATMENT AND PREVENTION OF DENGUE DISEASE	JANSSEN PHARMACEUTICALS, INC
WO/2021/129977	PLANT EXTRACTS FOR TREATMENT OF INCREASED FACIAL VASCULARITY	ORIFLAME COSMETICS AG
WO/2021/099241	COMPOSITIONS AND METHODS FOR GLUTATHIONE ENHANCEMENT FOR USE IN BRAIN HEALTH	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/115730	HAIR STYLING COMPOSITION CONTAINING DISACCHARIDES	HENKEL AG & CO. KGAA
WO/2021/115731	MICROPLASTIC-FREE COMPOSITION	HENKEL AG & CO. KGAA
WO/2021/094610	CHITOSAN FOR USE IN A METHOD OF PREVENTING OR TREATING A CARDIOVASCULAR DISEASE	BIOMEDICA PHARMA GMBH
WO/2021/094626	MEDICAL COMPOSITION FOR TREATING CARDIAC WASTING AND CACHEXIA	RELAXERA PHARMAZEUTISCHE GMBH & CO. KG
WO/2021/121823	TINTING CONDITIONER HAVING IMPROVED DYEING PERFORMANCE	HENKEL AG & CO. KGAA
WO/2021/099292	AN ANTIPERSPIRANT COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/099346	PHARMACEUTICAL DELIVERY DEVICE	FERRING B.V.
WO/2021/099402	PHARMACEUTICAL COMPOSITIONS COMPRISING AN INHIBITOR OF A HISTON-DEACETYLASE (HDACI) AND AN AGONIST OF TOLL-LIKE-RECEPTOR 7 AND/OR 8 (TLR7 AND/OR TLR8) AND THEIR USE IN THE TREATMENT OF CANCER	STRUMBERG, Dirk
WO/2021/121843	COMPOSITION COMPRISING THROMBIN DERIVED PEPTIDES AND USE THEREOF	IN2CURE AB
WO/2021/099444	A NOVEL VACCINE AGAINST HEAMOPHILUS PARASUIS	INTERVET INTERNATIONAL B.V.
WO/2021/099446	A NOVEL VACCINE AGAINST HEAMOPHILUS PARASUIS	INTERVET INTERNATIONAL B.V.
WO/2021/099450	INHIBITORS OF HSP70 PROTEIN	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/099453	AQUEOUS LIQUID EXTRACT OF SPIRULINA FOR PREVENTING AND/OR TREATING PERIPHERAL CHEMOTHERAPY-INDUCED NEUROPATHIES AND THE SYMPTOMS THEREOF, AND CORRESPONDING COMPOSITION AND USE	ALGOSOURCE
WO/2021/099458	A NOVEL VACCINE AGAINST HEAMOPHILUS PARASUIS	INTERVET INTERNATIONAL B.V.
WO/2021/099460	CURABLE COMPOSITION FOR DENTAL IMPRESSION	DENTSPLY SIRONA INC.
WO/2021/099462	CURABLE COMPOSITION FOR DENTAL IMPRESSION	DENTSPLY SIRONA INC.
WO/2021/099481	SOLID COMPOSITION CONTAINING RUFINAMIDE	MEDICHEM, S.A.
WO/2021/099515	PROCESS FOR TREATING KERATIN FIBERS, COMPRISING A (POLY)CARBODIIMIDE COMPOUND, AN AQUEOUS DISPERSION OF PARTICLES OF POLYMER(S)AND A COLORING AGENT	L'OREAL
WO/2021/099517	COMPOSITION COMPRISING A (POLY)CARBODIIMIDE COMPOUND AND A COLORING AGENT	L'OREAL
WO/2021/099531	ZONISAMIDE ORODISPERSIBLE TABLETS	BIOHORM, S.L.
WO/2021/121859	HAIR TREATMENT PROCESS	L'OREAL
WO/2021/121860	COSMETIC COMPOSITION COMPRISING A SILICONE RESIN AND A PARTICULAR AMINO SILICONE	L'OREAL
WO/2021/099555	COSMETIC PREPARATION CONTAINING ANISIC ACID AND LEVULINIC ACID, HAVING SELECTIVE ANTIMICRIOBIAL EFFECT	BEIERSDORF AG
WO/2021/099572	MEDICAL USES OF 4-1BBL ADJUVANTED RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA)	BAVARIAN NORDIC A/S
WO/2021/099575	MESENCHYMAL STEM CELL DERIVED EXTRACELLULAR VESICLES LOADED WITH AT LEAST ONE PHOTOSENSITIZER AND USES THEREOF FOR THE TREATMENT OF PERITONEAL CARCINOMATOSIS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/099586	RECOMBINANT MVA VIRUSES FOR INTRATUMORAL AND/OR INTRAVENOUS ADMINISTRATION FOR TREATING CANCER	BAVARIAN NORDIC A/S
WO/2021/099608	METHODS FOR MANUFACTURING TISSUE INTERFACING COMPONENTS	MASSACHUSETTS INSTITUTE OF TECHNOLOGY
WO/2021/099611	INSULINOTROPIC AND GLUCAGONOTROPIC EFFECTS OF BETA-LACTOGLOBULIN	ARLA FOODS AMBA
WO/2021/099616	MASITINIB FOR THE TREATMENT OF SICKLE CELL DISEASE	AB SCIENCE
WO/2021/099624	COMPOSITIONS COMPRISING A BACTERIAL STRAIN OF THE GENUS FUSICATENIBACTER	4D PHARMA RESEARCH LIMITED
WO/2021/105040	MULTIPLE UNIT PELLET SYSTEM TABLET COMPRISING RIBOFLAVIN	DSM IP ASSETS B.V.
WO/2021/105041	MUPS TABLET COMPRISING RIBOFLAVIN	DSM IP ASSETS B.V.
WO/2021/105051	COMPOSITION FOR THE 3D PRINTING OF SEMISOLID DRUGS	FUNDACION IDONIAL
WO/2021/099635	NEW SOLID STATE FORM OF LURBINECTEDIN	PHARMA MAR, S.A.
WO/2021/105059	UK 114 SALMON PROTEINS FOR USE IN THE TREATMENT, DIAGNOSIS AND PREVENTION OF MALIGNANT TUMOURS	BARTORELLI CUSANI, Alberto
WO/2021/099638	COMPOSITION AND FOOD SUPPLEMENT, IN PARTICULAR FOR ORAL AND DENTAL CARE	SMILLEAN
WO/2021/105061	WHOLE CELL VACCINES AND METHODS OF PRODUCTION THEREOF	GOTOVAX AB
WO/2021/105073	BENZOCOUMARIN AMPK ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS AND USES THEREOF	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105074	DIRECT AMPK ACTIVATOR COMPOUNDS COMBINED WITH INDIRECT AMPK ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS AND USES THEREOF	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105075	DIBENZOPYRAN AMPK ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS AND USES THEREOF	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105076	Z-STILBENE AMPK ACTIVATOR COMPOUNDS, COMPOSITIONS, METHODS AND USES THEREOF	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105093	FREEZE-DRIED POWDER CONTAINING 2-[(3-AMINOPROPYL)AMINO]ETHANETHIOL AND ITS USE FOR PREPARING A THERMOGEL	CLEVEXEL PHARMA
WO/2021/121882	HAIR DYEING PROCESS USING AT LEAST ONE SILICONE COMPRISING AT LEAST ONE CARBOXYLIC ACID ANHYDRIDE GROUP, AT LEAST ONE AMINO SILICONE AND AT LEAST ONE PIGMENT AND/OR DIRECT DYE	L'OREAL
WO/2021/105137	TREM-1 INHIBITORS FOR THE TREATMENT OF VASO-OCCLUSIONS AND TISSUE INJURIES IN PATIENTS SUFFERING FROM SICKLE CELL DISEASE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/105164	PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PULMONARY VASCULAR DISEASE AND/OR CARDIAC DYSFUNCTION IN FONTAN-PALLIATED PATIENTS	ACTELION PHARMACEUTICALS LTD
WO/2021/105167	TRIPLE VACCINE AGAINST AVIBACTERIUM PARAGALLINARUM AND AVIAN ENCEPHALOMYELITIS VIRUS AND FOWL POX VIRUS	BOEHRINGER INGELHEIM VETMEDICA GMBH
WO/2021/105217	USE OF RHAMNOSE AND ARABINOSE FOR DENTAL POWDER JET CLEANING	FERTON HOLDING S.A.
WO/2021/105219	PARTHANATOS CELL DEATH INHIBITORS FOR USE IN THE TREATMENT OF PSORIASIS	UNIVERSIDAD DE MURCIA
WO/2021/105224	KDM SUBFAMILY 6 PROTEIN INHIBITOR FOR USE IN THE TREATMENT OF CANCER	FUNDACIó INSTITUT DE RECERCA CONTRA LA LEUCèMIA JOSEP CARRERAS
WO/2021/110544	METHOD FOR MANUFACTURING A SOLID ADMINISTRATION FORM AND SOLID ADMINISTRATION FORM	MERCK PATENT GMBH
WO/2021/110545	DEPOSITION OF NANOSUSPENSIONS OF ACTIVE PHARMACEUTICAL INGREDIENTS ON CARRIERS	MERCK PATENT GMBH
WO/2021/105331	METHODS OF TREATING PULMONARY ARTERIAL HYPERTENSION	ACTELION PHARMACEUTICALS LTD
WO/2021/105339	SHAMPOO VETERINARY COMPOSITIONS	CEVA SANTE ANIMALE
WO/2021/105340	NON-RINSED VETERINARY COMPOSITIONS	CEVA SANTE ANIMALE
WO/2021/115800	TREATMENT OF HEMORRHOIDS WITH ANTICOAGULANT DRUGS	DE KEULENAER, Hendrik
WO/2021/105353	COMPOSITIONS AND METHODS WITH A PROBIOTIC AND A NUTRIENT AND/OR MINERAL FOR THE PREVENTION OR TREATMENT OF MASTITIS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105361	COMPOSITIONS AND METHODS WITH A PROBIOTIC AND A N-3 FATTY ACID FOR THE PREVENTION OR TREATMENT OF MASTITIS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/105368	USE OF NEUROPILIN ANTAGONISTS FOR THE TREATMENT OF ENDOMETRIOSIS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/105371	METHODS FOR STRATIFYING DIABETES PATIENTS	IMCYSE SA
WO/2021/105384	TARGETING THE NLS REGION OF NUPR1 PROTEIN TO TREAT CANCER	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/105391	COMBINATION COMPRISING NUPR1 INHIBITORS TO TREAT CANCER	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/105392	SUSPENSION COMPRISING A PROTEIN PARTICLE SUSPENDED IN A NON-AQUEOUS VEHICLE	NOVALIQ GMBH
WO/2021/105393	PROCESSES FOR OBTAINING STABLE GLP-1 COMPOSITIONS	NOVO NORDISK A/S
WO/2021/105407	miRNA-BASED PHARMACEUTICAL COMPOSITIONS AND USES THEREOF FOR THE PREVENTION AND THE TREATMENT OF TISSUE DISORDERS	NOVADIP BIOSCIENCES
WO/2021/105414	USE OF 2-PHENYL-6-(1H-IMIDAZOL-1-YL) QUINAZOLINE FOR THE PREVENTION OF ABUSE AND OF SIDE EFFECTS OF AT LEAST ONE OPIOID	ROTTAPHARM BIOTECH S.R.L.
WO/2021/105419	(R)-4-(1-(6-(4-(TRIFLUOROMETHYL)BENZYL)-6-AZASPIRO[2.5]OCTANE-5-CARBOXAMIDO)-CYCLOPROPYL) BENZOIC ACID OR ITS SALT ALSO IN POLYMORPHIC FORM A FOR USE IN THE PREVENTION OF HETEROTOPIC OSSIFICATION	ROTTAPHARM BIOTECH S.R.L.
WO/2021/110561	INTERFERON-ASSOCIATED ANTIGEN BINDING PROTEINS FOR USE IN TREATING HEPATITIS B INFECTION	EVOTEC INTERNATIONAL GMBH
WO/2021/105435	PROOXIDATIVE CHAIN-TRANSFER AGENTS FOR USE IN THE TREATMENT OF MALIGNANT TUMOUR OR INFECTIOUS DISEASES	UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ
WO/2021/110562	INTERFERON-ASSOCIATED ANTIGEN BINDING PROTEINS AND USES THEREOF	EVOTEC INTERNATIONAL GMBH
WO/2021/105461	USE OF COMPOUNDS FOR THE PREVENTION AND/OR TREATMENT OF ANKYLOSING SPONDYLITIS, AND CORRESPONDING COMPOSITIONS	NUVAMID SA
WO/2021/105474	NEW COMPOUNDS FOR TREATMENT OF DISEASES RELATED TO DUX4 EXPRESSION	FACIO INTELLECTUAL PROPERTY B.V.
WO/2021/105481	NOVEL COMPOUNDS FOR TREATMENT OF DISEASES RELATED TO DUX4 EXPRESSION	FACIO INTELLECTUAL PROPERTY B.V.
WO/2021/115825	COSMETIC COMPOSITION IN THE FORM OF AN OIL-IN-WATER NANOEMULSION COMPRISING AT LEAST ONE LIQUID FATTY SUBSTANCE, AT LEAST ONE SOLID FATTY SUBSTANCE AND AT LEAST ONE CATIONIC SURFACTANT	L'OREAL
WO/2021/105509	CHIMERIC OPSIN GPCR PROTEINS	UNIVERSITÄT BERN
WO/2021/110608	PEPTIDES AND COMPOSITIONS FOR USE IN COSMETICS AND MEDICINE	LIPOTRUE, S.L.
WO/2021/110625	HAIR TREATMENT PROCESS COMPRISING THE APPLICATION OF A COMPOSITION COMPRISING CATIONIC POLYMERS AND ORGANOSILANES, FOLLOWED BY A WASHING STEP	L'OREAL
WO/2021/110697	SOLID PHARMACEUTICAL FORMULATIONS OF 6-(2-CHLORO-6-METHYLPYRIDIN-4-YL)-5-(-4-FLUOROPHENYL)-1,2,4-TRIAZIN-3-AMINE	ASTRAZENECA AB
WO/2021/110732	METHOD FOR PRODUCING SPRAY-FREEZE-DRIED PARTICLES, AND PARTICLES PRODUCED ACCORDINGLY	RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN
WO/2021/110733	A COSMETIC COMPOSITION AND THE USE THEREOF AND A METHOD FOR IMPROVING SENSORY CHARACTERISTICS	BASF SE
WO/2021/110737	USE OF MASITINIB FOR THE TREATMENT OF EOSINOPHILIC ASTHMA	AB SCIENCE
WO/2021/110748	A DAY-AND-NIGHT AND INSIDE-OUTSIDE COLLAGEN-CONTAINING TREATMENT	LABORATORIO GENOVE, S.A.
WO/2021/122005	DIALIPHATIC KETONE MIXTURES, COMPOSITIONS COMPRISING SAME AND USE THEREOF	SOLVAY SA
WO/2021/110768	COSMETIC CLEANING COMPOSITIONS IN POWDER FORM	YODI SAS
WO/2021/115886	A HEMOSTATIC AGENT AND USES THEREOF	ROYAL COLLEGE OF SURGEONS IN IRELAND
WO/2021/115887	DOT PRINTING METHOD AND DEVICE FOR ADDITIVE MANUFACTURING OF DOSAGE FORMS WHICH CONTAIN ACTIVE SUBSTANCES	DIHESYS DIGITAL HEALTH SYSTEMS GMBH
WO/2021/110782	THE CHOLESTEROL-SYNTHESIS INTERMEDIATES FOR TREATMENT DEMYELINATING DISORDERS	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/130002	FOOD SUPPLEMENT FOR ALZHEIMER	FOLIUM BIOSCIENCES EUROPE B.V.
WO/2021/110796	INHIBITORS OF SHP2	BAYER AKTIENGESELLSCHAFT
WO/2021/110805	COMBINATION OF AN AZETIDINE LPA1 RECEPTOR ANTAGONIST WITH PIRFENIDONE AND/OR NINTEDANIB FOR USE IN THE TREATMENT OF FIBROTIC DISEASES	IDORSIA PHARMACEUTICALS LTD
WO/2021/110817	POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING TNFA AND OX40L	ABLYNX NV
WO/2021/110833	TOOLS AND METHODS TO DETECT AND ISOLATE COLIBACTIN PRODUCING BACTERIA	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
WO/2021/115919	TOPICAL ORAL COMPOSITION	KONINKLIJKE PHILIPS N.V.
WO/2021/122039	COMPOSITION COMPRISING AT LEAST 5% BY WEIGHT OF TITANIUM OXIDES, AN A-CYANODIPHENYLACRYLATE DERIVATIVE AND A 4-HYDROXYBENZYLIDENEMALONATE OR 4-HYDROXYCINNAMATE DERIVATIVE	L'OREAL
WO/2021/122041	COSMETIC COMPOSITION COMPRISING WATER-SOLUBLE OR WATER-DISPERSIBLE UV-SCREENING AGENTS, HYDROPHILIC THICKENERS AND HYDROPHILIC SURFACTANTS	L'OREAL
WO/2021/110860	REACTIVE CONJUGATES	DEBIOPHARM RESEARCH & MANUFACTURING S.A.
WO/2021/110883	BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS	ALBIREO AB
WO/2021/110884	BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS	ALBIREO AB
WO/2021/110885	BENZOTHIADIAZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS	ALBIREO AB
WO/2021/110886	BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS	ALBIREO AB
WO/2021/110887	BENZOTHIAZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS	ALBIREO AB
WO/2021/110915	METHOD FOR TRANSFORMING AN ESSENTIAL OIL	PRANARÔM INTERNATIONAL S.A.
WO/2021/110919	TREATMENT OF DISEASES RELATED TO HEPATITIS B VIRUS	ISA PHARMACEUTICALS
WO/2021/110923	PERSONAL DENTAL CARE PRODUCT FOR PREVENTING DEMINERALISATION	CREDENTIS AG
WO/2021/110942	PHARMACEUTICAL COMPOSITION COMPRISING ELTROMBOPAG BIS(MONOETHANOLAMINE)	SYNTHON B.V.
WO/2021/110959	PHARMACEUTICAL COMPOSITION COMPRISING ELTROMBOPAG BIS(MONOETHANOLAMINE)	SYNTHON B.V.
WO/2021/110968	MACROCYCLES COMPRISING A 4-AMIDO-2,4-PENTADIENOATE MOIETY FOR THE TREATMENT OF HYPOXIC CANCERS	AARHUS UNIVERSITET
WO/2021/110976	PEPTIDE COMPOSITIONS AND METHODS FOR TREATING TAUOPATHIES	AXOLTIS PHARMA
WO/2021/110978	DEEP-LAYER REMINERALIZATION OF HYDROXYLAPATITE	DR. KURT WOLFF GMBH & CO. KG
WO/2021/110979	LIPID VESICLES AS OXIDATIVE STRESS SENSORS	MEDIZINISCHE UNIVERSITÄT WIEN
WO/2021/110983	CO-AMORPHOUS FORMS OF BETA-LACTOGLOBULIN AND A DRUG SUBSTANCE	ZERION APS
WO/2021/110989	VACCINE CONJUGATES	ULTIMOVACS AB
WO/2021/110990	ANTI-CLEC-1A ANTIBODIES AND ANTIGEN-BINDING FRAGMENT THEREOF	OSE IMMUNOTHERAPEUTICS
WO/2021/110991	CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY	UNIVERSITÄT ZüRICH
WO/2021/115977	LIQUID PHARMACEUTICAL COMPOSITION COMPRISING CYTISINE	ADAMED PHARMA S.A.
WO/2021/116000	INVERSE LATEX FOR A COSMETIC COMPOSITION COMPRISING A SPECIFIC CHELATING AGENT AND A POLYELECTROLYTE COMBINING A STRONG ACID FUNCTION AND A NEUTRAL FUNCTION	SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES - SEPPIC
WO/2021/116009	INVERSE LATEX FOR A COSMETIC COMPOSITION, COMPRISING A SPECIFIC CHELATING AGENT AND A POLYELECTROLYTE COMBINING A STRONG ACID FUNCTION AND A WEAK ACID FUNCTION	SOCIéTé D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES - SEPPIC
WO/2021/111005	NOVEL AGENTS AND USES THEREOF	FIORETOS, Thoas
WO/2021/111007	STABLE COMPOSITIONS OF FC MULTIMERS	CSL BEHRING LENGNAU AG
WO/2021/116114	AEROSOL HAIR DYEING DEVICE BASED ON A CROTONIC ACID COPOLYMER AND A FATTY AMINE	L'OREAL
WO/2021/116119	ANTIBODIES HAVING SPECIFICITY TO HER4 AND USES THEREOF	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/116182	POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING IL-13 AND TSLP	ABLYNX NV
WO/2021/116188	COMBINATION PRODUCT CONTRIBUTING TO THE WELL-BEING OF PREGNANT WOMEN, COMPRISING EPA, DHA, VITAMINS AND MINERALS	URGO RECHERCHE INNOVATION ET DEVELOPPEMENT
WO/2021/122239	INHIBITION OF TMEM16A BY BENZBROMARONE OR NICLOSAMIDE FOR TREATING POLYCYSTIC KIDNEY DISEASE AND/OR POLYCYSTIC LIVER DISEASE	UNIVERSITÄT REGENSBURG
WO/2021/116203	COMPOSITION OF EXTRACT OF DRIED STIGMAS OF CROCUS SATIVUS (SAFFRON) AND OF FLAVONOID(S) FOR THE TREATMENT OF SEVERE ALLERGIC ASTHMA	STRUNDEN, Christian
WO/2021/130022	VIRUS-MIMETIC NANOPARTICLES	UNIVERSITÄT REGENSBURG
WO/2021/116244	MODULATION OF DRUG RELEASE AND BIOAVAILABILITY OF COMPOSITIONS CONTAINING DOLUTEGRAVIR SODIUM AND OTHER ANTI HIV DRUGS	SANDOZ AG
WO/2021/144080	METHOD FOR INCORPORATING ACTIVE SUBSTANCES INTO THE SKIN	BEIERSDORF AG
WO/2021/116260	QUINAZOLINE DERIVATIVES AS LPA RECEPTOR 2 INHIBITORS	CHIESI FARMACEUTICI S.P.A.
WO/2021/122278	NON-STICK ANTIBIOTIC GELS	AO TECHNOLOGY AG
WO/2021/116275	DENTAL RESIN MODIFIED GLASS-IONOMER COMPOSITION AND KIT COMPRISING SAID COMPOSITION	DENTSPLY SIRONA INC.
WO/2021/116331	STIMULI - OR BIO- RESPONSIVE COPOLYMERS, THE POLYMERSOMES COMPRISING THE SAME AND THEIR USE IN DRUG DELIVERY	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/116367	CELLULOSE NANOCRYSTAL EFFECT PIGMENTS FOR COSMETIC APPLICATIONS	BASF COLORS & EFFECTS GMBH
WO/2021/116370	THICKENING SILICA AS FLUORIDE CARRIER FOR TAILORED DELIVERY AND SLOW RELEASE	GABA INTERNATIONAL HOLDING GMBH
WO/2021/116372	INHIBITORS OF KDM5A FOR USE IN TREATMENT OF IDIOPATHIC INFLAMMATORY MYOPATHIES	UNIVERSITEIT ANTWERPEN
WO/2021/116389	EPAC1 INHIBITORS FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS	INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
WO/2021/116420	USE OF TLR7 AND/OR TLR8 AGONISTS FOR THE TREATMENT OF LEPTOSPIROSIS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/122382	AQUEOUS COMPOSITION COMPRISING A CATIONIC POLYMER, AN ANIONIC POLYMER, AN ANIONIC SURFACTANT COMPRISING AT LEAST ONE CATIONIC COUNTERION, A FATTY PHASE AND A PIGMENT	L'OREAL
WO/2021/122383	AQUEOUS COMPOSITION COMPRISING A CATIONIC CELLULOSIC POLYMER, AN ANIONIC SURFACTANT COMPRISING AT LEAST ONE CATIONIC COUNTERION, A FATTY PHASE AND A PIGMENT	L'OREAL
WO/2021/116432	BIODEGRADABLE MICROCAPSULE SYSTEMS	PAPIERFABRIK AUGUST KOEHLER SE
WO/2021/116443	COMPOSITION COMPRISING PROPOLIS PARTICLES	POLLENERGIE
WO/2021/116475	AMPHOTERICIN B CONJUGATED STABILIZED GOLD NANOPARTICLES AND USES THEREOF	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/116476	AGONISTS OF RNA ADENOSINE N-6 METHYLATION FOR USE IN SUPPRESSING HIV-1 LATENT PROVIRUS ACTIVATION AND REPLICATION	CHEMESTMED LTD.
WO/2021/116477	METHOD OF SUPPRESSING CANCER BY RNA m6A METHYLTRANSFERASE METTL16 INHIBITORS	CHEMESTMED LTD.
WO/2021/228422	OXYBUTYNIN FOR INTRAVESICAL USE	FARCO-PHARMA GMBH
WO/2021/122412	AQUEOUS COMPOSITION FOR TREATING KERATIN FIBRES, COMPRISING A PLANT OIL, A HYDROCARBON-BASED OIL, A GLYCEROLATED NONIONIC SURFACTANT, A POLYSACCHARIDE AND A SOLVENT	L'OREAL
WO/2021/130038	USE OF LOSARTAN FOR THE TREATMENT OF FIBROTIC DISEASES, IN PARTICULAR EPIDERMOLYSIS BULLOSA	ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG
WO/2021/116487	COMPOUNDS FOR USE IN THE TREATMENT OF NIEMANN-PICK C DISEASE	SOM INNOVATION BIOTECH, S.A.
WO/2021/122434	COMBINATION OF AN AHR-INHIBITOR AND AN PD1-INHIBITOR ANTIBODY AND ITS USE IN THE TREATMENT OF CANCER	BAYER AKTIENGESELLSCHAFT
WO/2021/122481	COMPOSITION COMPRISING A NATURAL DYE AND A FATTY AMINE	L'OREAL
WO/2021/122482	COSMETIC OR DERMATOLOGICAL COMPOSITION ACTING IN PARTICULAR ON THE EFFECTS OF BLUE LIGHT ON SKIN AND ITS APPENDAGES, AND ASSOCIATED USES	SEDERMA
WO/2021/116498	ESKETAMINE FORMULATIONS AND METHODS FOR PREPARATION AND STORAGE	JANSSEN PHARMACEUTICA NV
WO/2021/197655	SYRINGE AND KIT FOR INTRAVESICAL USE	FARCO-PHARMA GMBH
WO/2021/122507	INACTIVATED PISCINE ORTHOREOVIRUS VACCINE	INTERVET INTERNATIONAL B.V.
WO/2021/122515	PARASITE CONTROL IN RUMINANTS	INTERVET INTERNATIONAL B.V.
WO/2021/122545	USE OF THE GDF-5 MUTANT FOR THE TREATMENT OF PAIN AND CARTILAGE DESTRUCTION	MERCK PATENT GMBH
WO/2021/122608	LOW-MOLECULAR GELLING AGENT AS FRAGRANT SUBSTANCE DISPENSING SYSTEM	HENKEL AG & CO. KGAA
WO/2021/122638	DEVICE FOR SPRAYING A TWO-PHASE COMPOSITION COMPRISING AN AQUEOUS PHASE COMPRISING ONE OR MORE POLYOLS AND AN OILY PHASE COMPRISING NON-SILICONE OILS	L'OREAL
WO/2021/122639	TWO-PHASE COMPOSITION COMPRISING AN AQUEOUS PHASE COMPRISING ONE OR MORE POLYOLS AT A CONTENT RANGING FROM 5% TO 30% BY WEIGHT AND AN OILY PHASE COMPRISING NON-SILICONE OILS	L'OREAL
WO/2021/122647	HIGH VISCOSITY ELASTIC GELS AND USES THEREFOR	WARWICK INTERNATIONAL GROUP LTD.
WO/2021/122717	NEW HENNA-BASED EXTRACT FOR USE IN DYEING KERATIN FIBERS, ITS PREPARATION METHOD AND COMPOSITIONS CONTAINING IT	L'OREAL
WO/2021/122733	BISPECIFIC ANTI-CCL2 ANTIBODIES	F. HOFFMANN-LA ROCHE AG
WO/2021/122741	PREBIOTIC AND PROBIOTIC TREATMENT TO REDUCE ORAL DYSBIOSIS AND PROMOTE EUBIOSIS	FUNDACIóN PARA EL FOMENTO DE LA INVESTIGACIóN SANITARIA Y BIOMéDICA DE LA COMUNITAT VALENCIANA
WO/2021/122758	COMPOSITIONS COMPRISING CYANIDIN-3-GALACTOSIDE FOR USE AS VASORELAXANT	EVONIK OPERATIONS GMBH
WO/2021/122809	COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND/OR TREATMENT OF DYSBIOSIS AND ANTIBACTERIAL ANTIDOTES FOR MICROBIOME-PROTECTION	EUROPEAN MOLECULAR BIOLOGY LABORATORY
WO/2021/122813	ANGIOGENESIS PROMOTING AGENTS FOR PREVENTION OF METASTATIC CANCER	UNIVERSITÄT BASEL
WO/2021/122838	NON-ELICITED DEDIFFERENTIATED <i>LAVANDULA ANGUSTIFOLIA</i> PLANT CELLS, EXTRACTS THEREOF AND COSMETIC USES THEREOF	L'OREAL
WO/2021/122840	COSMETIC COMPOSITION COMPRISING A CATIONIC ASSOCIATIVE POLYMER, A CARBOXYLIC ANIONIC SURFACTANT, OPTIONALLY A NONIONIC SURFACTANT AND AN AMPHOTERIC OR ZWITTERIONIC SURFACTANT	L'OREAL
WO/2021/130088	COSMETIC COMPOSITION COMPRISING A POLYMER COMPRISING AT LEAST ONE CATIONIC (METH)ACRYLAMIDE UNIT, A PARTICULAR SILICONE AND AT LEAST ONE SURFACTANT	L'OREAL
WO/2021/249664	ANTI-BLYS ANTIBODY FOR TREATING PROTEINURIC KIDNEY DISEASE	GLAXOSMITHKLINE INTELLECTUAL PROPERTY MANAGEMENT LIMITED
WO/2021/122873	PROCESS FOR TREATING KERATIN FIBERS USING A COMPOSITION COMPRISING A CARNITINE SALT OR CARNITINE-BASED SALT COMPRISING A HETEROCYCLIC ORGANIC ANION	L'OREAL
WO/2021/122874	PROCESS FOR TREATING KERATIN FIBERS USING A COMPOSITION COMPRISING A CARNITINE SALT OR CARNITINE-BASED SALT COMPRISING AN AROMATIC ORGANIC ANION	L'OREAL
WO/2021/122875	ANTIBODIES BINDING TO HLA-A2/MAGE-A4	F. HOFFMANN-LA ROCHE AG
WO/2021/122876	PROCESS FOR TREATING KERATIN FIBERS USING A COMPOSITION COMPRISING A CARNITINE SALT OR CARNITINE-BASED SALT COMPRISING AN AROMATIC ORGANIC ANION	L'OREAL
WO/2021/122896	CRYPTOSPORIDIOSIS VACCINE	INTERVET INTERNATIONAL B.V.
WO/2021/122923	STABILIZATION OF SELENITE IN A NUTRITIONAL SOLUTION BY DISSOLVED OXYGEN	BAXTER INTERNATIONAL INC.
WO/2021/122925	PARENTERAL NUTRITION SOLUTION COMPRISING A SELENIUM SOURCE	BAXTER INTERNATIONAL INC.
WO/2021/122928	ORAL RESPIRATORY VACCINE	INTERVET INTERNATIONAL B.V.
WO/2021/122935	METHOD FOR THE COSMETIC TREATMENT OF KERATIN FIBRES COMPRISING A STAGE OF APPLICATION OF A RARE EARTH METAL COMPOSITION AND A STAGE OF APPLICATION OF A COMPOSITION COMPRISING SURFACTANTS	L'OREAL
WO/2021/122946	METHOD FOR THE COSMETIC TREATMENT OF KERATIN MATERIALS EMPLOYING A RARE EARTH METAL COMPOSITION AND AN ALKALINE COMPOSITION	L'OREAL
WO/2021/122957	DENTAL ROOT CANAL FILLING COMPOSITION	DENTSPLY DETREY GMBH
WO/2021/122996	A PHARMACEUTICAL ORAL DOSAGE FORM OF Q203	QURIENT CO., LTD.
WO/2021/123003	PROCESS FOR THE COSMETIC TREATMENT OF KERATIN FIBRES USING A DETERGENT COMPOSITION AND A RARE EARTH METAL COMPOSITION	L'OREAL
WO/2021/123011	ASSOCIATION OF FAECALIBACTERIUM PRAUSNITZII STRAIN CNCM I-4573 WITH PENTASA<sp>®</sp> FOR THE TREATMENT AND PREVENTION OF GASTROINTESTINAL INFLAMMATION	EXELIOM BIOSCIENCES
WO/2021/123013	SMART DRUG DELIVERY SYSTEM AND PHARMACEUTICAL KIT FOR DUAL NUCLEAR MEDICAL CYTOTOXIC THERANOSTICS	JOHANNES GUTENBERG-UNIVERSITÄT MAINZ
WO/2021/123033	NOVEL G-CSF MIMICS AND THEIR APPLICATIONS	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/123047	MACROCYCLIC PEPTIDES	HERANTIS PHARMA OYJ
WO/2021/164925	COLLAGEN HYDROLYSATE AS ACTIVE SUBSTANCE AGAINST PERIODONTITIS OR GINGIVITIS	GELITA AG
WO/2021/123061	PROCESS FOR PREPARING A COMPOSITION FOR DYEING THE HAIR STARTING FROM A COMPOSITION IN POWDER FORM AND AN AQUEOUS COMPOSITION	L'OREAL
WO/2021/123084	EGFR INHIBITORS	F. HOFFMANN-LA ROCHE AG
WO/2021/123087	EGFR INHIBITORS	F. HOFFMANN-LA ROCHE AG
WO/2021/123088	A PHARMACEUTICAL COMPOSITION OF A PYRAZOLE COMPOUND DISPERSED IN A POLYMER MATRIX	INTERVET INTERNATIONAL B.V.
WO/2021/123089	ANTIBODIES TO CANINE INTERLEUKIN-4 RECEPTOR <i>ALPHA</i>	INTERVET INTERNATIONAL B.V.
WO/2021/123104	MULTIVALENT HVT VECTOR VACCINE	INTERVET INTERNATIONAL B.V.
WO/2021/123108	A PYRAZOLE PHARMACEUTICAL COMPOSITION	INTERVET INTERNATIONAL B.V.
WO/2021/123110	SEMI-SOLID NATURAL PERFUME	EXPRESSIONS PARFUMEES
WO/2021/123117	METHOD FOR PRODUCING OIL-IN-WATER EMULSIONS	FRESENIUS KABI AUSTRIA GMBH
WO/2021/123119	TREATMENT OF ACUTE HEART FAILURE	LUND, Lars H.
WO/2021/123121	LIPID-BASED COMPOSITIONS COMPRISING LIPOPHILIC SALTS AND ACIDIC PH MODIFIERS	CAPSUGEL BELGIUM NV
WO/2021/123131	COMPOSITION FOR THE TREATMENT OF HYPERTENSION AND/OR ASSOCIATED MORBIDITIES THERETO	BASF SE
WO/2021/123142	COMPOUNDS FOR TREATMENT OF EYE DISEASES ASSOCIATED WITH EXCESSIVE VASCULARISATION	ACTIVE BIOTECH AB
WO/2021/123144	PRO-PERFUME COMPOSITIONS	FIRMENICH SA
WO/2021/123164	OILY SOLID COSMETIC	L V M H RECHERCHE
WO/2021/123165	DOSAGE FORM COMPRISING AMORPHOUS SOLID SOLUTION OF EMPAGLIFLOZIN WITH POLYMER	KRKA, D.D., NOVO MESTO
WO/2021/123170	COSMETIC COMPOSITION COMPRISING AT LEAST ONE POLAR OIL, AN ALIPHATIC MONOALCOHOL, A MIXTURE OF POLYOLS AND AT LEAST ONE HYDROPHILIC ACTIVE AGENT	L'OREAL
WO/2021/123174	SIGMA-1 RECEPTOR LIGANDS AND THERAPEUTIC USES THEREOF	UNIVERSITE DE STRASBOURG
WO/2021/123192	EDOXABAN TABLETS	BIOHORM, S.L.
WO/2021/123198	LEUKEMIA TREATMENT	DEUTSCHES KREBSFORSCHUNGSZENTRUM
WO/2021/123202	FORMULATIONS OF ANTI-PD1 ANTIBODIES	FORMYCON AG
WO/2021/123228	PHARMACEUTICAL COMPOSITION COMPRISING GLP-1 ANALOGUE	KRKA, D.D., NOVO MESTO
WO/2021/130126	LIQUID COMPOSITION COMPRISING IBUPROFEN AND PHENYLEPHRINE	NUTRA ESSENTIAL OTC, S.L.
WO/2021/123229	SYNTHESIS OF LACTONE DERIVATIVES AND THEIR USE IN THE MODIFICATION OF PROTEINS	GENIE BIOTECH UK LTD.
WO/2021/123232	NUCLEIC ACID VACCINATION USING NEO-EPITOPE ENCODING CONSTRUCTS	EVAXION BIOTECH APS
WO/2021/123233	RETINOL-BASED COMPOSITION	L'OREAL
WO/2021/123243	METHODS AND VACCINE COMPOSITIONS TO TREAT CANCERS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/123245	NAD-PRECURSORS AND DIETARY RESTRICTION FOR TREATING AGE-RELATED MEDICAL CONDITIONS	LEIBNIZ-INSTITUT FüR ALTERNSFORSCHUNG - FRITZ-LIPMANN-INSTITUT E.V. (FLI)
WO/2021/123280	DIETARY SUPPLEMENT FOR LIPEDEMA PATIENTS	PANTEA GMBH
WO/2021/123289	SOLUBLE REAR LAYER FOR OTF	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/123291	OGA INHIBITOR COMPOUNDS	JANSSEN PHARMACEUTICA NV
WO/2021/123297	OGA INHIBITOR COMPOUNDS	JANSSEN PHARMACEUTICA NV
WO/2021/123300	TREATMENT OF HEPATIC AND CARDIOVASCULAR DISORDERS	LIFESEARCH
WO/2021/123302	COMPOSITION COMPRISING A ROSEWOOD EXTRACT	L'OREAL
WO/2021/123306	COMPOSITION COMPRISING A CATIONIC CELLULOSE-BASED POLYMER, A SULFONIC ANIONIC POLYMER AND A FIXING POLYMER	L'OREAL
WO/2021/123309	COMPOSITION COMPRISING A DISPERSION OF POLYMER PARTICLES IN A NON-AQUEOUS MEDIUM, A CATIONIC POLYMER AND AN ANIONIC POLYMER	L'OREAL
WO/2021/123311	COMPOSITION COMPRISING A SOLUBILIZED SOLID FATTY ALCOHOL AND A MONOALCOHOL	L'OREAL
WO/2021/123323	LON PROTEASE, ALPHA-HEMOLYSIN, CK1-ALPHA-1; C-MYB INHIBITOR OR A CEBP-DELTA INHIBITOR AS THERAPEUTICS	LINNANE PHARMA AB
WO/2021/123325	COMPOSITION COMPRISING A NATURAL DYE, A DISPERSANT, AN OIL AND A FATTY-PHASE THICKENER	L'OREAL
WO/2021/123329	HAIR DYEING COMPOSITION COMPRISING A DIRECT DYE, A SCLEROGLUCAN GUM AND A NON-IONIC ASSOCIATIVE POLYMER	L'OREAL
WO/2021/123332	LIPID NANOPARTICLES FOR DELIVERY OF NUCLEIC ACIDS	CUREVAC AG
WO/2021/123337	RETINOL-BASED COMPOSITION	L'OREAL
WO/2021/123341	COMPOSITION COMPRISING DIOSMIN	KRKA, D.D., NOVO MESTO
WO/2021/123345	PROCESS FOR COLOURING KERATIN MATERIALS USING A PARTICULAR OILY DISPERSION AND AT LEAST TWO AMINE COMPOUNDS THAT ARE DIFFERENT FROM EACH OTHER	L'OREAL
WO/2021/123347	PROCESS FOR THE COSMETIC TREATMENT OF KERATIN FIBRES USING A RARE-EARTH METAL AND A PARTICULAR POLYMER	L'OREAL
WO/2021/123352	RETINOL-BASED SERUM	L'OREAL
WO/2021/123355	PROBIOTICS FOR REGULATING BLOOD GLUCOSE	GENBIOMA APLICACIONES, S.L.
WO/2021/123377	COMPOSITION FOR THE TREATMENT OF INFLAMMATION AND/OR ASSOCIATED MORBIDITIES THERETO	BASF SE
WO/2021/123378	COMPOSITIONS COMPRISING BACTERIAL STRAINS	4D PHARMA RESEARCH LIMITED
WO/2021/123399	MICROFLUIDIC PRODUCTION OF BIOFUNCTIONALIZED GIANT UNILAMELLAR VESICLES FOR TARGETED CARGO DELIVERY	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/123419	COMPOSITION FOR THE TREATMENT OF AMYLOID-BETA ASSOCIATED DISEASES	BASF SE
WO/2021/130168	A PHARMACEUTICAL FORMULATION	WARSZAWSKIE ZAKLADY FARMACEUTYCZNE POLFA SA
WO/2021/123430	POLYMERIC NANOPARTICLES AS VACCINE ADJUVANTS	THE PROVOST, FELLOWS, SCHOLARS AND OTHER MEMBERS OF BOARD OF TRINITY COLLEGE DUBLIN
WO/2021/123432	IGG:TGFBETARII FUSION PROTEIN COMPOSITION	ARES TRADING S.A.
WO/2021/130170	PROCESS FOR THE PREPARATION OF DISPERSIONS COMPRISING INHALABLE IMMUNOSUPPRESSIVE ACTIVE INGREDIENTS	ZAMBON S.P.A.
WO/2021/130180	TOPICAL COMPOSITIONS COMPRISING PEA PROTEINS AND POLYPHENOLS	DEVINTEC SAGL
WO/2021/130181	NOVEL FAECAL COMPOSITION	LAURIDSEN, Hengameh, Chloe
WO/2021/130182	CAPSULE COMPRISING A FAECAL COMPOSITION	LAURIDSEN, Hengameh, Chloe
WO/2021/130192	COMPOSITION COMPRISING ASCORBIC ACID	L'OREAL
WO/2021/130195	METHOD OF TREATING VIRUS INFECTION USING A TLR7 AGONIST	F. HOFFMANN-LA ROCHE AG
WO/2021/130210	PROCESS FOR DESIGNING A RECOMBINANT POXVIRUS FOR A THERAPEUTIC VACCINE	TRANSGENE
WO/2021/130215	GOLDEN LIPID NANOPARTICLES FOR GENE THERAPY	UNIVERSIDAD DEL PAíS VASCO/EUSKAL HERRIKO UNIBERTSITATEA
WO/2021/130219	USES OF LIPOTEICHOIC ACID FROM BIFIDOBACTERIA	BIOPOLIS, S.L.
WO/2021/130223	TREATMENT INVOLVING IMMUNE EFFECTOR CELLS GENETICALLY MODIFIED TO EXPRESS ANTIGEN RECEPTORS	BIONTECH CELL & GENE THERAPIES GMBH
WO/2021/130225	IN VITRO AND IN VIVO GENE DELIVERY TO IMMUNE EFFECTOR CELLS USING NANOPARTICLES FUNCTIONALIZED WITH DESIGNED ANKYRIN REPEAT PROTEINS (DARPINS)	BIONTECH CELL & GENE THERAPIES GMBH
WO/2021/130226	COMPOSITION FOR THE PREPARATION OF PERINDOPRIL ARGININE GRANULES, A METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION COMPRISING THE GRANULES	KRKA, D.D., NOVO MESTO
WO/2021/130232	BILE ACID DERIVATIVES IN THE MEDICAL INTERVENTION OF ANXIETIES AND/OR STRESS SYMPTOMS	MEDIZINISCHE UNIVERSITÄT WIEN
WO/2021/130237	uPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL THERAPY	RIGSHOSPITALET
WO/2021/130255	DIHYDRO-CYCLOPENTA-ISOQUINOLINE DERIVATIVES	UCB BIOPHARMA SRL
WO/2021/130257	DIHYDRO-CYCLOPENTA-ISOQUINOLINE SULFONAMIDES DERIVATIVES	UCB BIOPHARMA SRL
WO/2021/130259	DIHYDROCYCLOPENTA-ISOQUINOLINE-SULFONAMIDE DERIVATIVES COMPOUNDS	UCB BIOPHARMA SRL
WO/2021/130260	TETRAHYDROBENZO-QUINOLINE SULFONAMIDE DERIVATIVES USEFUL AS IGE MODULATORS	UCB BIOPHARMA SRL
WO/2021/130262	TETRAHYDROBENZO-QUINOLINE SULFONAMIDES DERIVATIVE COMPOUNDS	UCB BIOPHARMA SRL
WO/2021/130264	TRANSPARENT COMPOSITION FOR USE IN SKINCARE AND/OR HAIRCARE	S.P.C.M. SA
WO/2021/130269	COMBINATION OF AN ALPHA-PLL WITH A BETA-LACTAM FOR TREATING ANTIBIOTIC BACTERIAL RESISTANCE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/130270	PHARMACEUTICAL COMBINATION OF ANTIVIRAL AGENTS TARGETING HBV AND/OR AN IMMUNE MODULATOR FOR TREATMENT OF HBV	F. HOFFMANN-LA ROCHE AG
WO/2021/170283	BIO-FERMENTED SURFACTANTS FOR REDUCING ABRASION OF DENTAL ENAMEL	HENKEL AG & CO. KGAA
WO/2021/130291	TUMOR-SPECIFIC CLAUDIN 18.2 ANTIBODIES	SOTIO A.S.
WO/2021/130305	COMPOSITION FOR TREATING OR PREVENTING AN ALLERGY OR ALLERGIC REACTION	APOSCIENCE AG
WO/2021/130329	RADIOLABELED PEPTIDES FOR NON-INVASIVE DIAGNOSIS AND TREATMENT OF CXCR4 EXPRESSING TUMORS	ISTITUTO NAZIONALE TUMORI IRCCS - FONDAZIONE G. PASCALE
WO/2021/130335	EMULSIFIED LIP GEL	L'OREAL
WO/2021/130349	COSMETIC COMPOSITIONS COMPRISING MELANOIDINS	KAFFE BUENO APS
WO/2021/130377	POLYMERIC NANOPARTICLES FOR ENHANCED CANCER TREATMENT	THE QUEEN'S UNIVERSITY OF BELFAST
WO/2021/130381	COMBINATION OF A HDAC INHIBITOR AND VX MOLECULES, AND ITS USE FOR THE TREATMENT OF CYSTIC FIBROSIS	CENTRE D'ETUDE DES CELLULES SOUCHES (CECS)
WO/2021/130382	COMBINATION OF A PROTEASOME INHIBITOR AND A HDAC INHIBITOR AND ITS USE FOR THE TREATMENT OF GENETIC DISEASES LINKED TO A PROTEIN CONFORMATIONAL DISORDER	CENTRE D'ETUDE DES CELLULES SOUCHES (CECS)
WO/2021/148229	COMPOSITION FOR WEIGHT MANAGEMENT OF A SUBJECT	MRS-BIOTECH
WO/2021/136763	ISOQUINOLINE DERIVATIVES FOR USE IN TREATING GLUT1 DEFICIENCY SYNDROME	GLIAPHARM SA
WO/2021/136784	A COMPOSITION FOR THE TREATMENT OF MALE INFERTILITY	LABORATORIO REIG JOFRé, S.A.
WO/2021/136786	PREPARATION COMPRISING ELEMENTAL SILVER FOR TREATMENT AND PREVENTION OF PERIODONTITIS	GUGGENBICHLER, Joseph Peter
WO/2021/136788	PROCESS FOR TREATING KERATIN FIBRES, COMPRISING THE APPLICATION OF A COMPOSITION COMPRISING A PARTICULAR COMPOUND COMPRISING AT LEAST TWO TETRAZOLES GROUPS	L'OREAL
WO/2021/136808	CONJUGATES UNDERGOING INTRAMOLECULAR REARRANGEMENTS	ASCENDIS PHARMA A/S
WO/2021/136812	BACTERIAL DELIVERY VEHICLES FOR IN VIVO DELIVERY OF A DNA PAYLOAD	ELIGO BIOSCIENCE
WO/2021/136827	COMPOUND FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISORDERS	ABAXYS THERAPEUTICS
WO/2021/136835	COMPOSITIONS AND METHODS FOR THE PREVENTION OF S. <i>AUREUS </i>INFECTION	ANTAGONIS
WO/2021/136841	PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF POST-SURGICAL PAIN	PEPTINOV
WO/2021/151619	USE OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE IN THE INHALATORY TREATMENT OF INFLAMMATORY PULMONARY DISEASES	METRIOPHARM AG
WO/2021/151620	USE OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE IN THE TREATMENT OF RARE CHRONIC INFLAMMATORY PULMONARY DISEASES	METRIOPHARM AG
WO/2021/170290	INHIBITORS OF HUMAN DEUBIQUITINASES FOR THE TREATMENT OF CORONAVIRAL INFECTIONS	IMMUNOLOGIK GMBH
WO/2021/190783	5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE FOR TREATMENT OF ACUTE LUNG INJURY	METRIOPHARM AG
WO/2021/219244	6'-METHOXYCINCHONAN-9-OLS FOR THE TREATMENT OF CORONAVIRAL INFECTIONS	IMMUNOLOGIK GMBH
WO/2021/233571	TREATMENT AGENT FOR ANTIVIRAL THERAPY, APPLICATOR, AND METHOD FOR PRODUCING A TREATMENT AGENT	NINODERM UG (HAFTUNGSBESCHRÄNKT)
WO/2021/244771	METHOD FOR SOLUBILIZING NATURAL, ENDOGENOUS AND SYNTHETIC CANNABINOIDS	ATHENION AG
WO/2021/249667	COMPOUND FOR THE TREATMENT OF CORONAVIRAL INFECTIONS	METRIOPHARM AG
WO/2021/148241	COSMETIC FORMULATION FOR TOPICAL ADMINISTRATION COMPRISING NOVEL PEPTIDES THAT IMPROVE APPEARANCE AND REGENERATION OF SKIN	ASC REGENITY LTD
WO/2021/160346	NUCLEIC ACID VACCINE AGAINST THE SARS-COV-2 CORONAVIRUS	INSTITUT PASTEUR
WO/2021/204423	USE OF 15-MEMBERED AZALIDES AS ACTIVE AGENTS IN THE TREATMENT OF VIRAL INFECTIONS	UNIVERSITY OF ZAGREB SCHOOL OF MEDICINE
WO/2021/209173	NOVEL THERAPEUTIC USE OF PLEUROMUTILINS	NABRIVA THERAPEUTICS GMBH
WO/2021/209174	THERAPEUTIC USE OF PLEUROMUTILINS	NABRIVA THERAPEUTICS GMBH
WO/2021/223914	PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC ADMINISTRATION COMPRISING BRIMONIDINE	PHARMATHEN S.A.
WO/2021/228434	PRESERVATIVE FREE PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC ADMINISTRATION CONTAINING CYCLOSPORINE	PHARMATHEN S.A.
WO/2021/254662	CROSSLINKED STARCH DERIVATIVE-BASED MATRIX	ROQUETTE FRERES
WO/2021/175497	METHOD FOR COLORING KERATIN MATERIAL, COMPRISING THE USE OF TWO STRUCTURALLY DIFFERENT SILANES AND TWO STRUCTURALLY DIFFERENT POLYMERS	HENKEL AG & CO. KGAA
WO/2021/197673	AGENTS FOR IMPROVED OXIDATIVE LIGHTENING OF KERATIN FIBRES	HENKEL AG & CO. KGAA
WO/2021/180369	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, ALGINIC ACID (SALT), A DYEING COMPOUND AND A POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/180370	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A GLYCEROL ESTER, A COLORING COMPOUND AND A POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/180372	PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED USING THE PIGMENT SUSPENSION	HENKEL AG & CO. KGAA
WO/2021/140101	PREPARATION AND USE OF CANNABIS NANO-FORMULATION	CANNAXAN GMBH
WO/2021/140103	COGNITIVE DISORDER PREVENTION AND THERAPY	ANIMA
WO/2021/140111	HAIR CONDITIONER ALLOWING THE USE OF SOAP AS SHAMPOO	LYNELINE SàRL
WO/2021/140113	CICLESONIDE FOR AMELIORATING QUALITY OF LIFE (QOL) IN EQUINES	BOEHRINGER INGELHEIM VETMEDICA GMBH
WO/2021/175499	PERSONAL CARE COMPOSITION AND METHODS	UNILEVER IP HOLDINGS B.V.
WO/2021/140123	VACCINES TARGETING NEISSERIA GONORRHOEAE	EVAXION BIOTECH APS
WO/2021/140131	USE OF TAXODIONE AS AN ANTI-GLYCATION AGENT	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/148249	NEW COMPOSITION AS SHAVING PREPARATION	BEIERSDORF AG
WO/2021/140141	COSMETIC TREATMENT METHOD	L'OREAL
WO/2021/140174	GLUCAGON AND GLP-1 CO-AGONISTS FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE AND DIABETIC KIDNEY DISEASE IN TYPE 2 DIABETES	MEDIMMUNE LIMITED
WO/2021/140183	ORAL SOLID CANNABINOID OIL COMPOSITION FOR TREATING GASTROINTESTINAL DISORDERS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/140194	COMPOUNDS FOR PROMOTING FOLLICLE MATURATION	AARHUS UNIVERSITET
WO/2021/136848	COMPOSITION FOR USE IN THE TREATMENT OF COGNITIVE DISORDERS	BIOSEARCH, S.A.
WO/2021/140228	COSMETIC COMPOSITION	CREASEARCH BV
WO/2021/140229	COSMETIC COMPOSITION	CREASEARCH BV
WO/2021/144211	EDIBLE TOOTHPASTE COMPOSITION TO BE SUCKED OR CHEWED, METHOD FOR PREPARING SAID TOOTHPASTE COMPOSITION	DANA, Jean Dominique
WO/2021/144231	HAIR CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/084139	NANO-DRY MELTING	BAYER AKTIENGESELLSCHAFT
WO/2021/144245	NATIVE AND POROUS STARCH AS WHITE PIGMENT IN TOOTHPASTE	ROQUETTE FRERES
WO/2021/144249	HYPOPARATHYROIDISM TREATMENT	ASCENDIS PHARMA BONE DISEASES A/S
WO/2021/144254	SALMONELLA-BASED DNA VACCINES IN COMBINATION WITH AN ANTIBIOTIC	VAXIMM AG
WO/2021/144267	HAIR TREATMENT COMPOSITIONS AND METHODS	UNILEVER IP HOLDINGS B.V.
WO/2021/144272	HAIR TREATMENT COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/144274	USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF JOINT PAIN INDUCED BY PHYSICAL ACTIVITY, AND CORRESPONDING COMPOSITIONS	NUVAMID SA
WO/2021/144302	BIOMARKERS FOR DETERMINING SUSCEPTIBILITY TO OXOPIPERAZINE DERIVATIVES AND METHODS OF USING SAME	INTHERA BIOSCIENCE AG
WO/2021/180378	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, HYALURONIC ACID (SALT), A DYEING COMPOUND AND A POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/180379	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, TWO DYEING COMPOUNDS AND A POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/144313	VIA CYCLOADDITION BILATERALLY FUNCTIONALIZED ANTIBODIES	SYNAFFIX B.V.
WO/2021/144314	VIA CYCLOADDITION BILATERALLY FUNCTIONALIZED ANTIBODIES	SYNAFFIX B.V.
WO/2021/144315	CONJUGATES OF ANTIBODIES AN IMMUNE CELL ENGAGERS	SYNAFFIX B.V.
WO/2021/144326	TOPICAL COMPOSITION COMPRISING HYDROXAMIC ACID AND ATRACTYLENOLIDE	UNILEVER IP HOLDINGS B.V.
WO/2021/144330	USE OF FXR AGONISTS FOR TREATING AN INFECTION BY HEPATITIS D VIRUS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/144333	PROBIOTIC COMPOSITION FOR USE AS AN ANTIOXIDANT	BIOPOLIS, S.L.
WO/2021/144338	METHOD OF TREATMENT OF CANCER OR TUMOUR	ADAPTIMMUNE LIMITED
WO/2021/160366	POLYACRYLATE-FREE COSMETIC PREPARATION	BEIERSDORF AG
WO/2021/144360	SMALL MOLECULE CSF-1R INHIBITORS IN THERAPEUTIC AND COSMETIC USES	F. HOFFMANN-LA ROCHE AG
WO/2021/144364	PARTICLES OF A MIXTURE OF IRON(III)-OXYHYDROXIDE, SUCROSE AND ONE OR MORE STARCHES, PREFERABLY OF SUCROFERRIC OXYHYDROXIDE	VIFOR (INTERNATIONAL) AG
WO/2021/144365	PRODUCT AND MANUFACTURING PROCESS FOR A GUM	MCNEIL AB
WO/2021/144367	LOZENGE	MCNEIL AB
WO/2021/144369	FIMH MUTANT, COMPOSITIONS THEREWITH AND USE THEREOF	JANSSEN PHARMACEUTICALS, INC.
WO/2021/144370	PRODUCT AND METHOD OF MANUFACTURING A GUM	MCNEIL AB
WO/2021/144381	COMPOSITIONS FOR ALLEVIATING THE SYMPTOMS OF LOW ANTERIOR RESECTION SYNDROME BY TOPICAL ADMINISTRATION TO THE NEORECTUM	REPOCEUTICALS A/S
WO/2021/164959	METHOD FOR PROVIDING PERSONALIZED CELLS WITH CHIMERIC ANTIGEN RECEPTORS (CAR) AGAINST TUMOR MICROENVIRONMENT CELLS	MILTENYI BIOTEC B.V. & CO. KG
WO/2021/144403	DOSAGE FORM WITH SUSTAINED RELEASE MELATONIN PELLETS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/148314	ACCELERATED ELIMINATION OF (S)-3-{4-[5-(2-CYCLOPENTYL-6-METHOXY-PYRIDIN-4-YL)-[1,2,4]OXADIAZOL-3-YL]-2-ETHYL-6-METHYL-PHENOXY}-PROPANE-1,2-DIOL	IDORSIA PHARMACEUTICALS LTD
WO/2021/144415	IMMUNOGLOBULIN SINGLE DOMAIN ANTIBODIES FOR DELIVERY OF MUCOSAL VACCINES	UNIVERSITEIT GENT
WO/2021/144446	PLANT EXTRACT COMPOSITION FOR THE TREATMENT OF LIVER STEATOSIS	MEDA PHARMA S.P.A.
WO/2021/144447	PLANT EXTRACT COMPOSITION FOR THE TREATMENT OF CARDIOVASCULAR AND METABOLIC DISEASES	MEDA PHARMA S.P.A.
WO/2021/144450	A COMPOSITION COMPRISING A FLUOROPHORE LABELLED UPAR-TARGETING PEPTIDE CONJUGATE	FLUOGUIDE A/S
WO/2021/144457	FORMULATIONS OF CD38 ANTIBODIES AND USES THEREOF	GENMAB A/S
WO/2021/144460	CONTROLLED RELEASE FORMULATIONS	UNIVERSIDAD DE ZARAGOZA
WO/2021/151694	SUNSCREEN WITH PIGMENT FILTER SEPARATION	BEIERSDORF AG
WO/2021/156043	TESTOSTERONE CONTAINING PHARMACEUTICAL COMPOSITION	DIURNAL LIMITED
WO/2021/148347	BILAYER TABLET COMPRISING TELMISARTAN AND AMLODIPINE	ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.
WO/2021/219255	NATURAL MATERIAL PAD	ORGANOID TECHNOLOGIES GMBH
WO/2021/148362	DIRECTLY COMPRESSIBLE POLYMER COMBINATIONS FOR MATRIX TABLETS WITH EXTENDED DRUG RELEASE	MERCK PATENT GMBH
WO/2021/148366	PLANT-BASED COMPOSITION IN A FORM SUITABLE FOR TOPICAL ADMINISTRATION AND ASSOCIATED PRODUCTION METHOD	MENELIK
WO/2021/148396	EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF CANCER	ASTRAZENECA AB
WO/2021/148405	INHIBITORS OF INTRACELLULAR BACTERIAL GROWTH AND PERSISTENCE AS ANTIBIOTICS	CONSEJO SUPERIOR DE INVESTIGACIONES (CSIC)
WO/2021/148427	HYDRATABLE CONCENTRATED SURFACTANT COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/148428	ISOTROPIC CONCENTRATE AND WASH COMPOSITIONS	UNILEVER IP HOLDINGS B.V.
WO/2021/148436	SUBSTANCE COMBINATION WITH ISOQUINOLINE ALKALOIDS AND A COCCIDIOSTAT OR COCCIDIOSIS INOCULANT	PHYTOBIOTICS FUTTERZUSATZSTOFFE GMBH
WO/2021/148439	METHODS FOR STIMULATING CEREBROVASCULAR FUNCTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/151756	BASE EDITOR LACKING HNH AND USE THEREOF	ETH ZURICH
WO/2021/164974	SHAVING AID CONTAINING HYDROXYALKYL CELLULOSES	BEIERSDORF AG
WO/2021/148496	USE OF TETRAPEPTIDES AND FUNCTIONALISED MICROCAPSULES AS SKIN PENETRATION CARRIERS	INFINITEC ACTIVOS, S.L.
WO/2021/148500	COMPOUNDS AND CONJUGATES THEREOF	MEDIMMUNE LIMITED
WO/2021/148501	COMPOUNDS AND CONJUGATES THEREOF	MEDIMMUNE LIMITED
WO/2021/148511	LIPID NANOPARTICLES	ETHERNA IMMUNOTHERAPIES NV
WO/2021/148572	COMPOSITION COMPRISING HYALURONIC ACID AND A POLYOL AND/OR CARBOXYMETHYL CELLULOSE	LABORATOIRES GENEVRIER SAS
WO/2021/148619	TOPICAL COMPOSITIONS COMPRISING A MACROLIDE IMMUNOSUPPRESSANT	BAUSCH HEALTH IRELAND LIMITED
WO/2021/148633	COMPLEX OF 7-DEACETYFORSKOLINE AND PVP	SCIPHARM S.à R.L.
WO/2021/148634	TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING THE INGREDIENT ROTIGOTINE AND AT LEAST ONE NON-AMINE-RESISTANT SILICONE ADHESIVE	LUYE PHARMA SWITZERLAND AG
WO/2021/148646	MICRIBIOTA-DERIVED PROTEINS INDUCING IL-10 RELEASE FROM HUMAN CELLS AND USES THEREOF	ENTEROME S.A.
WO/2021/148667	AESTHETIC DENTAL FILLING MATERIAL HAVING HIGH CURING DEPTH	IVOCLAR VIVADENT AG
WO/2021/151828	THE USE OF A POLYLYSINE FOR INCREASING THE GLOSS OF HAIR	BASF SE
WO/2021/151857	PRESSURISED METERED DOSE INHALERS COMPRISING A BUFFERED PHARMACEUTICAL FORMULATION	CHIESI FARMACEUTICI S.P.A.
WO/2021/151865	MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY	EVOTEC INTERNATIONAL GMBH
WO/2021/151872	ALLERGEN PROTECTION AGAINST URUSHIOLS	BEIERSDORF AG
WO/2021/151877	TOPICALLY APPLICABLE PREPARATION COMPRISING PEPTIDES FOR PROTECTING SKIN FROM ALLERGENS	BEIERSDORF AG
WO/2021/156104	METHOD FOR OBTAINING AN AQUEOUS EXTRACT OF LAVENDER, COMPOSITIONS COMPRISING SUCH AN EXTRACT AND THEIR COSMETIC USES	ISP INVESTMENTS LLC.
WO/2021/151879	PROTECTING SKIN FROM ALLERGENS	BEIERSDORF AG
WO/2021/151889	ANTI-αVβ8 INTEGRIN ANTIBODIES FOR USE IN TREATING KIDNEY DISEASE	MEDIMMUNE LIMITED
WO/2021/151905	TETRAHYDROCYCLOPENTA[B]INDOLE COMPOUNDS FOR THE TREATMENT OF RENAL DISEASE	TRANSITION THERAPEUTICS (IRELAND 2) LIMITED
WO/2021/151918	COSMETIC PRODUCT CAKE WITH ECOLOGICAL SUPPORT AND MANUFACTURING PROCESS THEREOF	INTERCOS S.P.A.
WO/2021/165001	HUMECTANT-FREE TOOTHPASTE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/151937	ECOLOGICAL SUPPORT FOR COSMETIC PRODUCTS AND RELATED FORMATION PROCESS.	INTERCOS S.P.A.
WO/2021/151946	COMPOSITIONS COMPRISING BACTERIAL STRAINS	4D PHARMA RESEARCH LIMITED
WO/2021/151956	COMPOSITION FOR TREATING INTESTINAL OR PULMONARY DISEASES	INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT
WO/2021/151963	PHARMACEUTICAL COMPOSITION FOR CONTROLLING PARASITES ON NON-HUMAN ORGANISMS	BAYER ANIMAL HEALTH GMBH
WO/2021/151964	USE OF AZOLE COMPOUNDS TO STIMULATE THE IMMUNE SYSTEM AND AS INHIBITORS FOR S-PLA2GIB	DIACCURATE
WO/2021/151974	INTERFERING WITH MRNA SPLICING TO ENHANCE RESPONSE TO CHECKPOINT IMMUNOTHERAPIES.	STICHTING HET NEDERLANDS KANKER INSTITUUT - ANTONI VAN LEEUWENHOEK ZIEKENHUIS
WO/2021/151984	TREATMENT OF CANCER	INNATE PHARMA
WO/2021/152009	GRANULAR PHARMACEUTICAL PRODUCT FOR ORAL ADMINISTRATION FROM A PRE-FILLED STRAW AND METHOD OF MANUFACTURING SUCH PHARMACEUTICAL PRODUCT	ALTERNO LABS D.O.O.
WO/2021/156140	POLYMORPH OF RUCAPARIB MESYLATE	SANDOZ AG
WO/2021/152060	CONTROLLED RELEASE SELEXIPAG COMPOSITION	ACTELION PHARMACEUTICALS LTD
WO/2021/152065	APREPITANT FOR USE IN THE TOPICAL TREATMENT OF FACIAL NEURALGIA	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
WO/2021/156145	ADONIRUBIN AND DHA FOR HEART HEALTH	DSM IP ASSETS B.V.
WO/2021/152115	BOTTOM-UP ASSEMBLY OF SYNTHETIC EXTRACELLULAR VESICLES	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/152119	HUMAN ANTI-INFLAMMATORY PEPTIDES FOR THE INHALATORY TREATMENT OF INFLAMMATORY PULMONARY DISEASES	ADVITA LIFESCIENCE GMBH
WO/2021/152129	AMORPHOUS SOLID DISPERSION OF 8-CHLORO-N-(4-(TRIFLUOROMETHOXY)PHENYL)QUINOLIN-2-AMINE	ABIVAX
WO/2021/152136	PASTE COMPRISING MAGNETIC ALKOXYSILANE-COATED METAL CONTAINING NANOPARTICLES	MAGFORCE AG
WO/2021/190810	IMPROVING THE FASTNESS TO WASHING OF PIGMENT-CONTAINING DYES BY USING AN OXIDATIVE PRETREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/156172	PHARMACEUTICAL COMPOSITION CONTAINING REGORAFENIB AND A STABILIZING AGENT	BAYER AKTIENGESELLSCHAFT
WO/2021/152172	HYPERBRANCHED POLYESTER POLYOL DERIVATIVE AS DRUG SOLUBILIZER	FREIE UNIVERSITÄT BERLIN
WO/2021/152175	PULMONARY DELIVERY OF ANTIBODIES	SANOFI
WO/2021/156213	LIPID NANOPARTICLES FOR DELAYED DELIVERY OF FRAGRANCE WITH ENHANCED WATER SOLUBILITY, THEIR PREPARATION AND USE	CLARIANT INTERNATIONAL LTD
WO/2021/152184	COMPOSITIONS COMPRISING AT LEAST AN AMYLIN RECEPTOR AGONIST AND A GLP-1 RECEPTOR AGONIST	ADOCIA
WO/2021/156223	NANOFORMULATIONS OF METHYL {4,6-DIAMINO-2-[5-FLUORO-1-(2-FLUOROBENZYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-YL]PYRIMIDIN-5-YL}CARBAMATE	ADVERIO PHARMA GMBH
WO/2021/156227	METHODS OF TREATING AND ASSESSING PULMONARY ARTERIAL HYPERTENSION WITH SELEXIPAG	ACTELION PHARMACEUTICALS LTD
WO/2021/156242	FORMULATIONS PROVIDING LONG-LASTING FRAGRANCE PERFORMANCE	FIRMENICH SA
WO/2021/156258	TREATMENT INVOLVING ANTIGEN VACCINATION AND BINDING AGENTS BINDING TO PD-L1 AND CD137	BIONTECH SE
WO/2021/156267	CORONAVIRUS VACCINE	CUREVAC AG
WO/2021/156275	COMPOSITIONS FOR THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION	NICOX S.A.
WO/2021/156277	IMMUNE CELL EXPRESSING ADAPTER CHIMERIC ANTIGEN RECEPTOR FOR SENSING SOLUBLE ANTIGENS	MILTENYI BIOTEC B.V. & CO. KG
WO/2021/156289	COMBINATION CONTAINING A DUOCARMYCIN DERIVATIVE-COMPRISING ANTIBODY-DRUG CONJUGATE AND THIOSULFATE	BYONDIS B.V.
WO/2021/156291	CONTROLLED RELEASE SYSTEM OF PHYTOCANNABINOIDS FORMULATIONS SOLUBLE IN AQUEOUS MEDIA, METHODS AND USES THEREOF	I+MED S. COOP.
WO/2021/156310	TAFA4 POLYPEPTIDE OR POLYNUCLEOTIDE FOR TREATING INFLAMMATORY DISEASE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/156326	ANTIBODIES FOR USE IN THERAPY	GENMAB A/S
WO/2021/156330	ORAL CARE COMPOSITION FOR ANIMALS	DR. KURT WOLFF GMBH & CO. KG
WO/2021/156340	PDAC TREATMENT REGIMEN	SWEDISH ORPHAN BIOVITRUM AB (PUBL)
WO/2021/156345	INJECTABLE COMPOSITION FOR SKIN AND SOFT TISSUE AUGMENTATION	MERZ PHARMA GMBH & CO. KGAA
WO/2021/156360	METHODS FOR DISCONTINUING A TREATMENT WITH A TYROSINE KINASE INHIBITOR (TKI)	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/156369	USE OF LOW DOSES OF HYDROXYCHLOROQUINE FOR THE TREATMENT OF LIPIN-1 DEFICIENCY	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/156381	ACTIVE INGREDIENT OF AN ERYTHROCYTES-CONTAINING COMPOSITION	GHASHGHAEINIA, Mehrdad
WO/2021/156385	LIPID COMPOSITION COMPRISING OMEGA-3 FATTY ACIDS	WELLNESS HOLDING B.V.
WO/2021/160519	TREATMENT OF PRIMARY BILIARY CHOLANGITIS WITH ELAFIBRANOR	GENFIT
WO/2021/156404	TREATMENT OF HPV-RELATED DISEASES	ISA PHARMACEUTICALS
WO/2021/156435	MUCOADHESIVE SOLID OR SEMISOLID OCULAR DELIVERY SYSTEMS BASED ON PREACTIVATED THIOMERS	BIOADHESIVE OPHTHALMICS
WO/2021/156437	FENFLURAMINE FOR USE IN TREATING PATIENTS WITH LENNOX-GASTAUT SYNDROME	ZOGENIX INTERNATIONAL LIMITED
WO/2021/156439	TRIAZOLE COMPOUNDS AS ADENOSINE RECEPTOR ANTAGONISTS	ASTRAZENECA AB
WO/2021/170374	COMPOSITION FOR USE IN PREVENTION OR TREATMENT OF OESOPHAGEAL DISEASES LINKED TO EPITHELIAL BARRIER DEFECTS	THELIAL B.V.
WO/2021/156451	C-X-C MOTIF CHEMOKINE RECEPTOR 4 ANTAGONIST	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/156455	LITCHI PRODUCTS AS DERMATOLOGICAL AND COSMETIC AGENTS	DR. AUGUST WOLFF GMBH & CO. KG ARZNEIMITTEL
WO/2021/156490	CORONA VIRUS BINDERS	VIB VZW
WO/2021/170380	IMPROVED PREPARATION	BEIERSDORF AG
WO/2021/160543	METHOD FOR TREATING VASO OCCLUSIVE CRISES ASSOCIATED WITH SICKLE CELL DISEASE	NICOX S.A.
WO/2021/156504	TREATMENT OF PANX1 ASSOCIATES DISEASES	NURITAS LIMITED
WO/2021/160608	PHARMACEUTICAL COMPOSITION COMPRISING LINAGLIPTIN AND METFORMIN	ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.
WO/2021/160650	A PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF A CANCER	ABILITY PHARMACEUTICALS S.L.
WO/2021/160659	GAS-FILLED MICROVESICLES FOR THERAPEUTIC USE	BRACCO SUISSE SA
WO/2021/170409	USE OF A COMBINATION OF A SACCHARIDE AND GLYCEROL FOR PREBIOTIC BENEFITS	UNILEVER IP HOLDINGS B.V.
WO/2021/160700	COMPOSITION COMPRISING RAMIPRIL AND INDAPAMIDE	ADAMED PHARMA S.A.
WO/2021/160708	COMBINATION OF REGORAFENIB AND MSLN-TTC FOR TREATING CANCER	BAYER AKTIENGESELLSCHAFT
WO/2021/160724	PROCESS FOR SITE-SPECIFIC MODIFICATION OF AN ANTIBODY	ORANO MED
WO/2021/204441	METHOD FOR DYEING KERATIN MATERIAL, COMPRISING THE USE OF A ORGANOSILICON COMPOUND, A POLYSACCHARIDE, A COLORING COMPOUND AND A POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/160763	FGFR TYROSINE KINASE INHIBITORS AND ANTI-PD1 AGENTS FOR THE TREATMENT OF UROTHELIAL CARCINOMA	JANSSEN PHARMACEUTICA NV
WO/2021/160764	FGFR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER	JANSSEN PHARMACEUTICA NV
WO/2021/160766	LIPID COMPOSITION AND USE THEREOF FOR DELIVERY OF A THERAPEUTICALLY ACTIVE AGENT TO ENDOTHELIUM	PANTHERNA THERAPEUTICS GMBH
WO/2021/160768	COMPOUNDS USEFUL AS ANTI-VIRAL AGENTS	NATURE CRETE PHARMACEUTICALS PC
WO/2021/160769	A BACTERIAL COMPOSITION FOR THE TREATMENT OF CANCER	UNIVERSITÄT ZüRICH
WO/2021/160850	MEASLES-VECTORED COVID-19 IMMUNOGENIC COMPOSITIONS AND VACCINES	INSTITUT PASTEUR
WO/2021/160873	NANOPARTICLES ENCAPSULATING SMALL MOLECULES	ETH ZURICH
WO/2021/165177	USE OF SGLT-2 INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF CARDIAC DISEASES IN FELINES	BOEHRINGER INGELHEIM VETMEDICA GMBH
WO/2021/160881	INTRANASAL MRNA VACCINES	ETHERNA IMMUNOTHERAPIES NV
WO/2021/165204	TOPICALLY ADMINISTRABLE LYSATE OF DEDIFFERENTIATED CELLS OF THE PLANT HELICHRYSUM STOECHAS FOR MOISTURIZING SKIN	SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES - SEPPIC
WO/2021/165205	TOPICALLY ADMINISTRABLE LYSATE (LY) OF DEDIFFERENTIATED CELLS OF THE PLANT HELICHRYSUM STOECHAS FOR ELIMINATING OR REDUCING INFLAMMATION OF THE SKIN	SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES - SEPPIC
WO/2021/165206	TREATMENT OF DRY AMD WITH INTEGRIN ANTAGONISTS	OXURION NV
WO/2021/165207	TRANSPARENT COLORED COSMETIC INGREDIENT FOR COSMETIC PRODUCTS, POSSIBLY CAPABLE OF AUTOMATICALLY CHANGING COLOR WHEN IRRADIATED BY ULTRAVIOLET LIGHT.	INTERCOS S.P.A.
WO/2021/165226	SUBCUTANEOUS ADMINISTRATION OF FACTOR VIII	BIOTEST AG
WO/2021/165227	AMPHIPHILIC POLYMERS AND THEIR USE FOR IMPROVED PRODUCTION OF NANOPARTICLES FOR THE TARGETED DELIVERY OF ANTIGENS	TOPAS THERAPEUTICS GMBH
WO/2021/165240	TAFOXIPARIN FOR THE TREATMENT OF PREECLAMPSIA	DILAFOR AB
WO/2021/175577	TRANSPARENT DENTIFRICE COMPRISING ZINC	UNILEVER IP HOLDINGS B.V.
WO/2021/175583	LIPID NANOPARTICLES COMPRISING A FRAGRANCE	CLARIANT INTERNATIONAL LTD
WO/2021/165273	PRO-MACROBODIES FOR THE ENHANCEMENT OF STRUCTURE RESEARCH	LEADXPRO AG
WO/2021/144476	PHARMACEUTICAL FORMULATIONS	NOVO NORDISK A/S
WO/2021/144477	GLP-1 COMPOSITIONS AND USES THEREOF	NOVO NORDISK A/S
WO/2021/165285	MONO- AND MULTI-TRIAZOLOMINIGASTRINS FOR TARGETING OF CCK2R-POSITIVE NEOPLASMS	PAUL SCHERRER INSTITUT
WO/2021/165306	OPTIMIZATION OF PEPTIDE-MELANIN BINDING	ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS
WO/2021/165312	VACCINE ADJUVANT COMPRISING AN INVERSE MICROLATEX	SOCIéTé D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES - SEPPIC
WO/2021/165316	PHARMACEUTICAL COMPOSITION COMPRISING DAPAGLIFLOZIN	ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A.
WO/2021/165348	PRESSURISED METERED DOSE INHALERS COMPRISING A BUFFERED PHARMACEUTICAL FORMULATION	CHIESI FARMACEUTICI S.P.A.
WO/2021/165369	TREATMENT OF CORNEAL VASCULARISATION	VESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/175605	OXYGEN/CARBON DIOXIDE COMPOSITIONS FOR MEDICAL USES	AVIATION WORKS LIMITED
WO/2021/175606	AN EFFECTIVE ANTI-ACNE PERSONAL CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/165402	CAPSULE COMPRISING A VITAMIN E ESTER FOR PREVENTING THE ONSET OF VAGINAL DYSBIOSIS AND RESULTING VAGINAL PATHOLOGIES	HULKA S.R.L.
WO/2021/165405	A PHARMACEUTICAL COMBINATION OF AN ARTEMISININ COMPOUND, 5-AMINOLEVULINIC ACID OR METHYL-5-AMINOLEVULINIC ACID AND A CHEMOTHERAPEUTIC AGENT	JLP HEALTH GMBH
WO/2021/165420	METHOD FOR TREATING CHRONIC GRAFT VERSUS HOST DISEASE	MESOBLAST INTERNATIONAL SàRL
WO/2021/170489	AGENTS FOR USE IN THE TREATMENT OF TISSUE DAMAGE	UCL BUSINESS PLC
WO/2021/165424	AGENTS FOR USE IN THE TREATMENT OF TISSUE DAMAGE 2	UCL BUSINESS PLC
WO/2021/165426	ANTIMICROBIAL COMPOSITIONS	FIRMENICH SA
WO/2021/165429	CXCL8 (INTERLEUKIN-8) ACTIVITY INHIBITOR AND CORTICOSTEROID COMBINATION AND PHARMACEUTICAL COMPOSITION AND USE THEREOF	DOMPE' FARMACEUTICI SPA
WO/2021/165452	MOLECULES TARGETING MUTANT RAS PROTEIN	AELIN THERAPEUTICS
WO/2021/165453	MOLECULES TARGETING PROTEINS	AELIN THERAPEUTICS
WO/2021/165456	MOLECULES TARGETING RAS PROTEIN	AELIN THERAPEUTICS
WO/2021/165463	METHOD OF TREATING BACTERIAL INFECTIONS AND PHARMACEUTICAL COMPOSITION FOR TREATING BACTERIAL INFECTIONS	INSTITUT NATIONAL DE RECHERCHE POUR L’AGRICULTURE, L’ALIMENTATION ET L’ENVIRONNEMENT
WO/2021/165472	MASITINIB FOR THE TREATMENT OF A MULTIPLE SCLEROSIS PATIENT SUBPOPULATION	AB SCIENCE
WO/2021/165477	USE OF MICA IN PRESSED POWDER	IMERTECH SAS
WO/2021/165484	DEPLETION OF EXT1 EXPRESSION AND/OR ACTIVITY IMPROVES CELLULAR PRODUCTION OF BIOLOGICAL ENTITIES	UNIVERSITé DE LIèGE
WO/2021/165499	INHIBITORS AND USES THEREOF	ENTHERA S.R.L.
WO/2021/165510	CXCL8 INHIBITOR AND PHARMACEUTICAL COMPOSITION THEREOF FOR USE IN THE TREATMENT OF CANCER-RELATED FATIGUE	DOMPE' FARMACEUTICI SPA
WO/2021/170516	FORMULATION BASED ON NATURAL INGREDIENTS FOR USE IN TREATING PROCTOLOGICAL DISORDERS	NATHURA S.P.A.
WO/2021/165537	A METHOD FOR SEPARATION OR DEPLETION OF EMPTY AAV CAPSIDS FROM FULL AAV CAPSIDS	BIA SEPARATIONS D.O.O.
WO/2021/165538	IMPROVED ANTI-SENESCENCE COMPOUNDS AND USES THEREOF	CLEARA BIOTECH B.V.
WO/2021/165543	PROPIONIBACTERIUM ACNES PROPHYLACTIC AND THERAPEUTIC IMMUNE TREATMENT	ORIGIMM BIOTECHNOLOGY GMBH
WO/2021/170548	PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF DYSMENORRHEA AND/OR PREMENSTRUAL SYNDROME (PMS)	CORNELLI, Umberto
WO/2021/170566	RESHAPING COMPOSITION FOR KERATIN FIBERS	KAO GERMANY GMBH
WO/2021/170568	RESHAPING COMPOSITION FOR KERATIN FIBERS	KAO GERMANY GMBH
WO/2021/175660	PREPARATION FOR MAGNETIZING KIDNEY STONES AND KIDNEY STONE FRAGMENTS AND KIT FOR REMOVING KIDNEY STONES AND KIDNEY STONE FRAGMENTS	TECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/165549	TREATMENT OF MEDICAL INDICATION	VALLAURIX TRADING SARL MC
WO/2021/170614	AEROSOL COMPRISING 5-METHOXY-N.N-DIMETHYLTRYPTAMINE	GH RESEARCH LIMITED
WO/2021/170618	COMPOSITIONS COMPRISING <i>LUFFA CYLINDRICA</i> ROOT EXTRACT	CLARIANT INTERNATIONAL LTD
WO/2021/170627	DIFLUOROCYCLOHEXYL DERIVATIVES AS IL-17 MODULATORS	UCB BIOPHARMA SRL
WO/2021/175672	COSMETIC COMPOSITION FOR FORMING A FILM HAVING ELEVATED ELASTICITY AND EXTENSIBILITY	COVESTRO DEUTSCHLAND AG
WO/2021/170684	KRAS EPITOPES AND ANTIBODIES	OBLIQUE THERAPEUTICS AB
WO/2021/170741	TREATMENT OF HBV	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/170763	ANTI-ADM-ANTIBODIES BINDING TO THE FREE N-TERMINUS FOR ACCELERATED TRANSITION OF ADM-GLY TO BIO-ADM IN PATIENTS WITH ADM-GLY/ BIO-ADM RATIO ABOVE A THRESHOLD AND COMBINATION WITH VITAMIN C	SPHINGOTEC GMBH
WO/2021/170772	COMBINATION TREATMENT WITH A P53 REACTIVATOR AND AN INHIBITOR OF CD47 MEDIATED SIGNALING	APREA THERAPEUTICS AB
WO/2021/170784	GENE THERAPY FOR MAPLE SYRUP URINE DISEASE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/170793	COMBINATION COMPRISING ALPELISIB AND 6-(2,4-DICHLOROPHENYL)-5-[4-[(3S)-1-(3-FLUOROPROPYL)PYRROLIDIN-3-YL]OXYPHENYL]-8,9-DIHYDRO-7H-BENZO[7]ANNULENE-2-CARBOXYLIC ACID	SANOFI
WO/2021/170806	USES AND COMPOSITIONS BASED ON POLYPHENOLS FOR IMPROVING THE ORAL BIOAVAILABILITY OF HYDROXYTYROSOL	BIOSEARCH, S.A.
WO/2021/170807	DAPTOMYCIN FORMULATION	XELLIA PHARMACEUTICALS APS
WO/2021/175716	COMPOSITE RNA PARTICLES	BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/170811	METHOD OF TREATING EYE DISEASE USING TRPV4 ANTAGONISTS	GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
WO/2021/170816	USE OF PEPTIDYLGLYCINE ALPHA-AMIDATING MONOOXYGENASE (PAM) FOR THERAPEUTIC PURPOSE	PAM THERAGNOSTICS GMBH
WO/2021/170817	COMPOSITION FOR DISPERSING A LIPOSOLUBLE COMPOUND IN AN AQUEOUS PHASE	SENSIENT COSMETIC TECHNOLOGIES
WO/2021/170821	METHOD FOR VIRUS PRODUCTION	TECHNISCHE HOCHSCHULE MITTELHESSEN
WO/2021/170828	HIGH POLYOL WASH COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/170831	ENZYME REPLACEMENT THERAPY FOR TREATING POMPE DISEASE	ELEVA GMBH
WO/2021/170834	COMPOSITION FOR THE PREVENTION AND TREATMENT OF DYSBIOSIS	MUCOSA INNOVATIONS, S.L.
WO/2021/170841	PHARMACEUTICAL COMPOSITIONS OF A THERAPEUTIC POLYENE MACROLIDE AND METHODS OF THEIR USE	BIOSERGEN AS
WO/2021/170848	INTERVENTION STRATEGY FOR PREVENTION OR TREATMENT OF DIABETES MELLITUS, AUTOIMMUNE DISEASE, INFLAMMATORY DISEASE OR CARDIOVASCULAR DISEASE	ACADEMISCH MEDISCH CENTRUM
WO/2021/175740	FOLATE PREPARATIONS FOR THE TREATMENT OF OCULAR DISEASES	APROFOL AG
WO/2021/175755	FORMULATION OF LISINOPRIL AND AMLODIPINE	ALKALOID AD SKOPJE
WO/2021/175763	TOPICAL COMPOSITION COMPRISING CANNABIDIOL	EMMAC LIFE SCIENCES LTD.
WO/2021/170869	CORONAVIRUS VACCINES	KATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/175773	DOSAGE FORM PROVIDING PROLONGED RELEASE OF TAPENTADOL PHOSPHORIC ACID SALT	GRüNENTHAL GMBH
WO/2021/175775	COSMETIC COMPOSITION WITH OPTIMIZED STARCH AND COSMETIC APPLICATIONS THEREOF	INTERCOS S.P.A.
WO/2021/170874	A METHOD OF PRODUCING A CRYSTALLINE FORM OF SODIUM 2-[(4S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4H-QUINAZOLIN-4-YL]ACETATE TRIHYDRATE	AIC246 GMBH & CO. KG
WO/2021/170875	PHARMACEUTICAL COMPOSITIONS COMPRISING 2-[(4<i>S</i>)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4<i>H</i>-QUINAZOLIN-4-YL]ACETATE AND SODIUM IONS	AIC246 GMBH & CO. KG
WO/2021/170878	SODIUM 2-[(4S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4H-QUINAZOLIN-4-YL]ACETATE AND PHARMACEUTICAL COMPOSITIONS THEREOF	AIC246 GMBH & CO. KG
WO/2021/170879	SODIUM 2-[(4S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4H-QUINAZOLIN-4-YL]ACETATE MONOHYDRATE, ITS PREPARATION AND USE	AIC246 GMBH & CO. KG
WO/2021/170882	POTASSIUM SALT OF 2-[(4<i>S</i>)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4<i>H</i>-QUINAZOLIN-4-YL]ACETIC ACID	AIC246 GMBH & CO. KG
WO/2021/175816	COMPOUNDS FOR USE IN A METHOD OF TREATING, PREVENTING AND/OR REDUCING THE SYMPTOMS OF PAIN	THE BECKLEY FOUNDATION
WO/2021/175823	PLD FOR USE IN COMBINATION IN THE TREATMENT OF CORONAVIRUS	PHARMA MAR, S.A.
WO/2021/175824	METHOD FOR ADMINISTRATION OF AN ANTI CANCER AGENT	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/175826	COMPOUNDS FOR USE IN THE TREATMENT OF CORONAVIRUS INFECTION	PHARMA MAR, S.A.
WO/2021/175829	COMPOUNDS FOR USE IN AUTOIMMUNE CONDITIONS	PHARMA MAR, S.A.
WO/2021/175831	COMPOUNDS FOR USE IN VIRAL INFECTIONS	PHARMA MAR, S.A.
WO/2021/175857	COMPOUNDS FOR USE IN INFLAMMATORY CONDITIONS	PHARMA MAR, S.A.
WO/2021/175877	COMPOSITION FOR USE IN A TREATMENT OF CERVICAL CELL ABNORMALITIES COMPRISING SELENITE COMPOUND AND ACID	SELO MEDICAL GMBH
WO/2021/175914	CONDITIONING REGIMEN FOR TRANSPLANT	HANSA BIOPHARMA AB
WO/2021/175924	TASQUINIMOD OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR USE IN COMBINATION THERAPY	ACTIVE BIOTECH AB
WO/2021/175926	COMPOSITION FOR POLYAMINE BIOSYNTHESIS	BM HEALTH GMBH
WO/2021/175960	FULLY SYNTHETIC, LONG-CHAIN NUCLEIC ACID FOR VACCINE PRODUCTION TO PROTECT AGAINST CORONAVIRUSES	ROCKETVAX AG
WO/2021/175971	HETEROCYCLIC DERIVATIVES AS TRMP8 ANTAGONISTS	GIVAUDAN SA
WO/2021/175998	COPROCOCCUS BACTERIA FOR USE IN THE TREATMENT OF METABOLIC SYNDROME AND INFLAMMATORY BOWEL DISEASES	INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L'ALIMENTATION ET L'ENVIRONNEMENT
WO/2021/176000	PROCESS FOR PRODUCING A HYDROLYSATE OF SCUTELLARIA ROOT, WHICH IS ENRICHED AND STANDARDIZED WITH FLAVONOIDS OF INTEREST, THE HYDROLYSATE OBTAINED BY SUCH A PROCESS, AND COSMETIC AND DERMOCOSMETIC APPLICATIONS OF SUCH A HYDROLYSATE	EXSYMOL
WO/2021/176001	METHOD FOR TREATING INFLAMMATORY LUNG DISEASES USING MESENCHYMAL LINEAGE PRECURSOR OR STEM CELLS	MESOBLAST INTERNATIONAL SàRL
WO/2021/176010	ANTIVIRAL TREATMENT	ECOSYNTH NV
WO/2021/176017	TREATMENT OF VIRAL INFECTION	PNEUMAGEN LTD
WO/2021/176026	COSMETIC COMPOSITION	GIVAUDAN SA
WO/2021/176035	BLOOD PREPARATION USEFUL FOR WOUND HEALING AND TISSUE REGENERATION	NOVYSTEM S.P.A.
WO/2021/176038	SYNERGISTIC AND TARGETING COMPOSITIONS FOR TREATMENT OF ARTERIAL AND VENOUS THROMBOSIS	ASTRAZENECA AB
WO/2021/176044	LOW DOSE HUMAN INTERLEUKIN-2 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS	CENTRE HOSPITALIER UNIVERSITAIRE DE NIMES
WO/2021/176045	IMIDAZOTRIAZINES ACTING ON CANCER VIA INHIBITION OF CDK12	BAYER AKTIENGESELLSCHAFT
WO/2021/254667	COBICISTAT FOR PREVENTION AND/OR TREATMENT OF CORONAVIRUS INFECTIONS	UNIVERSITÄT HEIDELBERG
WO/2021/176070	METHODS OF SLOWING BRAIN VOLUME LOSS	ACTELION PHARMACEUTICALS LTD
WO/2021/176074	COMPOSITION COMPRISING AN AVENANTHRAMIDE WITH IMPROVED SKIN PENETRATION	SYMRISE AG
WO/2021/176082	VIRAL MULTIMERIC PEPTIDE CONSTRUCTS FOR TARGETING PDZ DOMAINS	UNIVERSITY OF COPENHAGEN
WO/2021/176083	PHARMACEUTICAL COMPOSITIONS COMPRISING DASATINIB ANHYDROUS AND USES THEREOF	ZENTIVA K.S.
WO/2021/176085	STEROIDAL NITRONE F2 FOR USE IN THE PREVENTION AND/OR TREATMENT OF PERMANENT CEREBRAL ISCHAEMIA	ISQUAEMIA BIOTECH, S.L.
WO/2021/176088	COMPOUNDS FOR THE TREATMENT OF COVID-19	DOMPE' FARMACEUTICI SPA
WO/2021/176093	NICOTINAMIDE MONONUCLEOTIDE AND BIS-NICOTINAMIDE DINUCLEOTIDE DERIVATIVES FOR THE TREATMENT OF ARRHYTHMIA	NUVAMID SA
WO/2021/176094	LIPID CONJUGATED PEPTIDE INHIBITORS OF PICK1	UNIVERSITY OF COPENHAGEN
WO/2021/180602	SARS-COV-2 (SARS2, COVID-19) ANTIBODIES	HARBOUR ANTIBODIES BV
WO/2021/180603	SOFT CHEWABLE FORMED BODY FOR THE ADMINISTRATION TO ANIMALS	BAYER ANIMAL HEALTH GMBH
WO/2021/176096	PHARMACEUTICAL COMPOSITION COMPRISING SGLT2 INHIBITOR	KRKA, D.D., NOVO MESTO
WO/2021/180604	SARS-COV-2 (SARS2, COVID-19) ANTIBODIES	HARBOUR ANTIBODIES BV
WO/2021/176098	MODULATORS OF ARALAR FOR TREATING NEUROLOGICAL DISORDERS	UNIVERSITé DE LAUSANNE
WO/2021/180612	MIXTURE COMPOSITION COMPRISING GLYCOLIPIDS AND TRIETHYL CITRATE	EVONIK OPERATIONS GMBH
WO/2021/176100	IONTOPHORETIC COMPOSITION FOR ADMINISTERING S-KETAMINE	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/180643	HSD11B1 INHIBITORS FOR USE IN IMMUNOTHERAPY AND USES THEREOF	UNIVERSITE DE GENEVE
WO/2021/180727	THERAPEUTIC AGENT TARGETING HER2	HOBER BIOTECH AB
WO/2021/180731	COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE RIBOSIDE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES AND CONDITIONS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180732	COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE RIBOSIDE FOR PREVENTION AND TREATMENT OF NEUROLOGICAL DISEASES AND CONDITIONS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180739	COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE RIBOSIDE FOR PREVENTION AND TREATMENT OF VIRAL AND BACTERIAL INFECTIONS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180740	COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE RIBOSIDE FOR PREVENTION AND TREATMENT OF LUNG DISEASES AND CONDITIONS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180741	COMPOSITIONS AND METHODS CONTAINING REDUCED NICOTINAMIDE RIBOSIDE FOR PREVENTION AND TREATMENT OF PANCREATIC DISEASES AND CONDITIONS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/180742	METHYL-CYCLODEXTRIN FOR USE IN TREATING ENVELOPED VIRUS INFECTIONS SUCH AS COV-2	GARNIER, Patrice
WO/2021/180774	MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY	EVOTEC INTERNATIONAL GMBH
WO/2021/180780	TREATMENT AND/OR DIAGNOSIS OF A CANCER TYPE CHARACTERIZED BY EXPRESSING ZINC TRANSPORTER ZIP4	UNIVERSITAT POMPEU FABRA
WO/2021/180787	PROTEOLYSIS TARGETING CHIMERA (PROTAC) FOR DEGRADATION OF AURORA A-KINASE	JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG
WO/2021/180821	COMPOSITIONS OF IL-6/IL-6R ANTIBODIES AND METHODS OF USE THEREOF	TIZIANA LIFE SCIENCES PLC
WO/2021/180832	HYBRID CAR AND HYBRID TCR CELLS TO TREAT INFECTIOUS DISEASES	UNIVERSITEIT GENT
WO/2021/180839	ANTI-AGING CARE COMPOSITION COMPRISING PERFUMES	BASF SE
WO/2021/180848	SUNFLOWER PHOSPHOLIPID COMPOSITION CONTAINING PHOSPHATIDYLCHOLINE	LIPOID GMBH
WO/2021/180850	METHOD FOR TREATING INFLAMMATORY BOWEL DISEASE I	MESOBLAST INTERNATIONAL SàRL
WO/2021/180851	METHOD FOR TREATING INFLAMMATORY BOWEL DISEASE II	MESOBLAST INTERNATIONAL SàRL
WO/2021/180857	COMBINATIONS OF BETA-LACTAM COMPOUNDS, PROBENECID, AND VALPROIC ACID AND USES THEREOF	ITERUM THERAPEUTICS INTERNATIONAL LIMITED
WO/2021/180862	PHARMACEUTICAL COMPOSITIONS COMPRISING ELAGOLIX SODIUM	SYNTHON B.V.
WO/2021/180867	A NANOPARTICLE FOR USE IN THE TREATMENT OF AN OCULAR DISEASE	UNIVERSITÄT REGENSBURG
WO/2021/180884	FETUIN A FOR TREATMENT OF RENAL DISORDERS	UNIVERSITAET BERN
WO/2021/180885	TREATMENT OF STEM CELL DEFICIENCY	OSPEDALE SAN RAFFAELE S.R.L.
WO/2021/185675	PERSONAL CARE COMPOSITION, METHOD FOR USING SUCH COMPOSITIONS AND ITS IMPROVEMENT OF DEPOSITION EFFECT	BASF SE
WO/2021/180890	CD22 TARGETING-MOIETY FOR THE TREATMENT OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)	FUNDACIó INSTITUT DE RECERCA CONTRA LA LEUCèMIA JOSEP CARRERAS
WO/2021/180896	TOPICAL PREPARATIONS	EPITHEAL LIMITED
WO/2021/197802	TOPICAL COMPOSITION BASED ON POROUS PARTICLES AND A CROSSPOLYMER COMPRISING ADIPIC ACID AND NEOPENTYLGLYCOL	UNILEVER IP HOLDINGS B.V.
WO/2021/185680	A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS SEROTYPE 9, SEQUENCE TYPE 16	INTERVET INTERNATIONAL B.V.
WO/2021/180908	THERAPEUTIC SYSTEM FOR THE TOPIC, TRANSDERMAL AND TRANSCUTANEOUS APPLICATION OF CARBON MONOXIDE	JULIUS-MAXIMILIANS-UNIVERSITAET WUERZBURG
WO/2021/180913	NEW USE AND METHOD OF TREATMENT	REDWOOD PHARMA AB
WO/2021/180915	USE OF A NICOTINAMIDE MONONUCLEOTIDE OR SOME OF ITS DERIVATIVES FOR PREVENTING AND/OR TREATING DORSAL PAIN, AND CORRESPONDING COMPOSITIONS	NUVAMID SA
WO/2021/180916	USE OF A NICOTINAMIDE MONONUCLEOTIDE OR SOME OF ITS DERIVATIVES FOR THE PREVENTION AND/OR TREATMENT OF MUSCLE, LIGAMENT OR TENDON PAIN INDUCED BY PHYSICAL ACTIVITY, AND CORRESPONDING COMPOSITIONS	NUVAMID SA
WO/2021/180919	METHOD FOR THE TREATMENT OF A RESPIRATORY DISEASE, DISORDER, OR CONDITION RESULTING FROM A VIRAL INFECTION	SOFTHALE NV
WO/2021/180943	COMPOSITIONS IMPROVING POXVIRUS STABILITY	BAVARIAN NORDIC A/S
WO/2021/180963	A PROTEASE INHIBITOR REGIMEN FOR TREATING SUBJECTS INFECTED WITH HIV	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/180969	CYCLIC PEPTIDES AND THEIR CONJUGATES FOR ADDRESSING ALPHA-V-BETA-6 INTEGRIN IN VIVO	TECHNISCHE UNIVERSITÄT MüNCHEN
WO/2021/180972	DETOXIFIED LIPOPOLYSACCHARIDES (LPS), NATURALLY NON-TOXIC LPS, AND USES THEREOF	HEPHAISTOS-PHARMA
WO/2021/180973	BIFIDOBACTERIUM LONGUM	PRECISIONBIOTICS GROUP LIMITED
WO/2021/185719	RGD-CONTAINING PEPTIDE AND USE THEREOF FOR CANCER TREATMENT	AC BIOSCIENCE SA
WO/2021/185723	THERAPEUTIC TREATMENT OF CHROMATINOPATHIES	UNIVERSITA' DEGLI STUDI DI TRENTO
WO/2021/185728	BIOCOMPOSITES COMPRISING PROBIOTICS, COLLAGEN AND BACTERIAL EXTRACELLULAR POLYSACCHARIDE AND USES THEREOF	BIOSEARCH, S.A.
WO/2021/185736	CONSUMER PRODUCT COMPRISING A PLURALITY OF MICROCAPSULES DEFINED BY THE MEAN TOTAL SURFACE AREA	GIVAUDAN SA
WO/2021/185746	COMPOUNDS FOR USE IN TREATMENT OF RESPIRATORY DISEASE	AARHUS UNIVERSITET
WO/2021/180981	STABILIZATION OF PHARMACEUTICAL COMPOSITIONS COMPRISING POLYSORBATE	LEK PHARMACEUTICALS D.D.
WO/2021/185773	GOLD-CONTAINING AGENTS FOR THE TREATMENT OF LUNG INFECTIONS	PRODUKEM MOLEKULARES DESIGN GMBH
WO/2021/185775	ANTIGEN-SPECIFIC T CELL RECEPTORS AND T CELL EPITOPES	BIONTECH CELL & GENE THERAPIES GMBH
WO/2021/190979	WHITENING ORAL CARE COMPOSITIONS	RHODIA OPERATIONS
WO/2021/185783	COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/185791	TREATMENT OF EPILEPSY	KATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/185798	POLYPEPTIDE FOR THE THERAPY OF GLOMERULAR KIDNEY DISEASE AND ANALYSIS OF THE COURSE AND PROGNOSIS OF DEPENDENT SYNDROMES	PHARIS BIOTEC GMBH
WO/2021/185802	COMPOSITION FOR ENHANCING UROLITHIN PRODUCTION IN A HUMAN SUBJECT	MIGALIS APS
WO/2021/185804	SCORED TABLET	GRüNENTHAL GMBH
WO/2021/185807	A TARGETING MODULE COMPRISING PD-L1 AND/OR PD-L2 FOR USE IN A METHOD FOR STIMULATING A CHIMERIC ANTIGEN RECEPTOR MEDIATED IMMUNE RESPONSE IN A MAMMAL	GEMOAB GMBH
WO/2021/190993	COMPOSITIONS CONTAINING RHAMNOLIPIDE, ALKYL POLYGLYCOSIDE AND ACYL LACTYLATE	EVONIK OPERATIONS GMBH
WO/2021/185821	LIQUID FORMULATIONS OF GLUCAGON ANALOGUES	ZEALAND PHARMA A/S
WO/2021/185832	NEW THERAPEUTIC TREATMENT	SWEDISH ORPHAN BIOVITRUM AG
WO/2021/185838	NEW THERAPEUTIC USE OF ANAKINRA FOR COVID-19	SWEDISH ORPHAN BIOVITRUM AB (PUBL)
WO/2021/185842	USE OF SUBSTANCE AND PHARMACEUTICAL COMPOSITION THEREOF, AND MEDICAL TREATMENTS OR USES THEREOF	PVAC MEDICAL TECHNOLOGIES LTD
WO/2021/185844	USE OF SUBSTANCE AND PHARMACEUTICAL COMPOSITION THEREOF, AND MEDICAL TREATMENTS OR USES THEREOF	PVAC MEDICAL TECHNOLOGIES LTD
WO/2021/185851	VACCINE COMPOSITIONS FOR HIV PREVENTION AND TREATMENT	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/185874	USE OF LACTOFERRIN	MEAD JOHNSON NUTRITION COMPANY
WO/2021/185876	USE OF LACTOFERRIN	MEAD JOHNSON NUTRITION COMPANY
WO/2021/185887	REPEATED TOPICAL APPLICATION OF CAPSAICIN PATCH FOR TREATING INITIAL NON-RESPONDERS	GRüNENTHAL GMBH
WO/2021/185890	GINSENOSIDE COMPOSITIONS	GIVAUDAN SA
WO/2021/185897	GINSENOSIDE COMPOSITIONS	GIVAUDAN SA
WO/2021/185912	METHOD FOR THE TREATMENT NLRP3-ASSOCIATED DISEASES	SOFTHALE NV
WO/2021/185920	PROCESS FOR BLEACHING KERATIN FIBERS USING AN OXIDIZING COMPOSITION AND UV-VISIBLE RADIATION	L'OREAL
WO/2021/185921	LIQUID FORMULATION OF GM-CSF FOR INHALATION	DRUGRECURE APS
WO/2021/185948	A STABILIZED PROTEIN OF INTEREST	MICREOS HUMAN HEALTH B.V.
WO/2021/185953	COSMETIC COMPOSITION AND TREATMENT FOR TREATING SKIN SAGGING	SEDERMA
WO/2021/185959	ESTROGEN-RELATED RECEPTOR ALPHA AGONISTS FOR THE TREATMENT AND THE PROGNOSIS OF BONE METASTASES	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/185969	VARIANTS OF HLYA AND USES THEREOF	NUMAFERM GMBH
WO/2021/186000	IMPROVED LIQUID COMPOSITION FOR CLEANING, SANITIZING AND/OR DISINFECTING	CORTICALIS AS
WO/2021/186001	DOSE TREATMENTS OF TAUOPATHIES	AC IMMUNE SA
WO/2021/186024	NEW ANTI-VEGFC ANTIBODIES AND USES THEREOF	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
WO/2021/204517	COMPOSITION FOR USE IN PREVENTING ATHEROSCLEROSIS DEVELOPPMENT	ALGOSOURCE
WO/2021/186035	CYCLOTIDES IN COMBINATION WITH KAPPA OPIOID RECEPTOR LIGANDS FOR MS THERAPY	MEDIZINISCHE UNIVERSITÄT WIEN
WO/2021/186041	JOSAMYCIN FOR USE IN PREVENTION AND TREATMENT OF FIBROSIS	UNIVERSITÄT ROSTOCK
WO/2021/186042	PLASMID COMPRISING ALOPECIA ANTIGEN	NOVO NORDISK A/S
WO/2021/186053	COMPOUNDS FOR TREATING OR PREVENTING A CORONAVIRIDAE INFECTION & METHODS AND USES FOR ASSESSING THE OCCURRENCE OF A CORONAVIRIDAE INFECTION	ABIVAX
WO/2021/186054	SORTILIN ANTAGONISTS FOR USE IN THE TREATMENT OF DIABETIC RETINOPATHY	INSUSENSE APS
WO/2021/186060	RADIOLABELED GASTRIN ANALOGUE FOR USE IN A METHOD OF TREATING AND/OR IMAGING CCKB RECEPTOR POSITIVE DISEASES, IN PARTICULAR PULMONARY AND EXTRAPULMONARY SMALL-CELL CARCINOMA	DEBIOPHARM INTERNATIONAL S.A.
WO/2021/186061	IDEBENONE FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN PATIENTS DIAGNOSED WITH A CORONAVIRUS INFECTION	BEMIDO SA
WO/2021/204520	COMPOSITION COMPRISING RESVERATROL	GALENUS G.H. AG
WO/2021/186074	COMPOSITIONS FOR THE TREATMENT OF AUTISM SPECTRUM DISORDER	STALICLA SA
WO/2021/191094	ERBB-TARGETED THERAPIES FOR NEUROPATHIC PAIN	UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH
WO/2021/191108	TREATMENT OR PREVENTION OF ACUTE ORGAN DAMAGE INDUCED BY VIRAL INFECTION WITH A NK1 INHIBITOR AND/OR A GABAPENTINOID	PLUS VITECH, S.L.
WO/2021/191131	PROTEIN DISULFIDE ISOMERASE INHIBITORS FOR USE IN THE TREATMENT OF ALPHA 1-ANTITRYPSIN DEFICIENCY	UNIVERSITE DE BORDEAUX
WO/2021/191136	DMEH ENHANCER	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/186078	METHOD FOR PRODUCING POLYMERSOMES	HEIDELBERG UNIVERSITY
WO/2021/186079	COLLOIDAL CARRIER SYSTEMS FOR TRANSFER OF AGENTS TO A DESIRED SITE OF ACTION	HEIDELBERG UNIVERSITY
WO/2021/186080	HEAT-TREATED PLATELET-DERIVED GROWTH FACTOR EXTRACT FOR USE IN A METHOD OF PREVENTING OR TREATING A TISSUE DEFECT	PANGERŠIČ, Rok
WO/2021/213749	COLOR-STABLE SUNSCREEN	BEIERSDORF AG
WO/2021/197906	CLEANSING COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/197908	METHOD OF TREATING THE SCALP	UNILEVER IP HOLDINGS B.V.
WO/2021/191169	1,2,4-TRIOXANE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME FOR USE IN THE TREATMENT OF COVID-19	ARTEMIFLOW GMBH
WO/2021/213752	TRANSPARENT COSMETIC GEL	BEIERSDORF AG
WO/2021/213753	ENVIRONMENTALLY FRIENDLY COSMETIC SUNSCREEN	BEIERSDORF AG
WO/2021/213760	ENVIRONMENTALLY FRIENDLY SUNSCREEN	BEIERSDORF AG
WO/2021/191185	COMPOSITIONS COMPRISING NATURALLY DERIVED PRESERVATIVES	UNILEVER IP HOLDINGS B.V.
WO/2021/191197	COMBINATION THERAPY COMPRISING AN AXL INHIBITOR	BERGENBIO ASA
WO/2021/191226	MOUTHWASH, IN PARTICULAR FOR TREATING THE HUMAN ORAL AND PHARYNGEAL CAVITY	SANIXTREME GMBH & CO. KG
WO/2021/191236	NUCLEOTIDE ANALOGUES FOR THE TREATMENT OF CORONAVIRUSES	R.G.C.C. HOLDINGS AG
WO/2021/191240	COMBINATION THERAPY	ANTABIO SAS
WO/2021/191243	PIGMENT COMPRISING RAPHANUS SATIVUS EXTRACT AND MONTMORILLONITE	GIVAUDAN SA
WO/2021/191251	COMPOSITIONS COMPRISING ONE OR MORE HMO'S WITH A CORE OF LacNAc-Lac	FRIESLANDCAMPINA NEDERLAND B.V.
WO/2021/191253	METHODS FOR PRODUCING HEME PEROXIDASES	TECHNISCHE UNIVERSITÄT WIEN
WO/2021/191265	RNA PARTICLES COMPRISING POLYSARCOSINE	BIONTECH RNA PHARMACEUTICALS GMBH
WO/2021/191266	AEROSOLIZATION OF HDL FOR THE TREATMENT OF LUNG INFECTIONS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/191268	A MODIFIED RELEASE MULTIPLE UNIT ORAL DOSAGE FORM OF DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE AND A PROCESS FOR ITS PREPARATION	INIBSA GINECOLOGíA, S.A.
WO/2021/191273	COMPOSITIONS FOR USE IN TREATING MEIBOMIAN GLAND DYSFUNCTION	HOVIONE SCIENTIA LIMITED
WO/2021/191274	NEW STRATEGY TO TREAT AND PREVENT DISEASES CAUSED BY ENTEROBACTERIAE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/191278	DIMALEATE FORM OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYANOPHENYL)UREA	LEK PHARMACEUTICALS D.D.
WO/2021/239292	TREATMENT OF CANCER	IMMUTEP S.A.S.
WO/2021/191297	VIRUCIDAL HAND CREAM FORMULATION	UNIVERSITÄT BASEL
WO/2021/191305	CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF COVID-19	DOMPE' FARMACEUTICI SPA
WO/2021/191312	METHODS OF TREATING COVID-19 WITH RIFAXIMIN	BAUSCH HEALTH IRELAND LIMITED
WO/2021/191318	SOLID DISPERSIONS OF RIFAXIMIN FOR THE TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY	BAUSCH HEALTH IRELAND LIMITED
WO/2021/191320	OPHTHALMIC FORMULATION COMPRISING N-[5-(AMINOSULFONYL)-4-METHYL-1,3- THIAZOL-2-YL]-N-METHYL-2-[4-(2-PYRIDINYL)PHENYL]ACETAMIDE HEMIHYDRATE	AICURIS GMBH & CO. KG
WO/2021/191336	A COMBINATION OF FLAVONOIDS AND SPHINGOSINE 1 PHOSPHATE LYASE INHIBITORS FOR THE TREATMENT OF LUNG INFLAMMATION	AC BIOSCIENCE SA
WO/2021/191342	VIRUSTATIC AGENT	REINMüLLER, Johannes
WO/2021/191353	METHODS FOR PROVIDING A VACCINE	WüRFEL, Wolfgang
WO/2021/198041	A PHARMACEUTICAL COMPOSITION COMPRISING HYDROXYCHLOROQUINE, CHLOROQUINE, OR METABOLITE THEREOF	BLACKHAWK PARTNERS LIMITED
WO/2021/198051	BIO-BASED POLYURETHANE DISPERSIONS FOR DECORATIVE COSMETIC APPLICATIONS	COVESTRO DEUTSCHLAND AG
WO/2021/191412	CATHEPSIN SUBSTRATES & CATHEPSIN INHIBITORS AND USES THEREOF	ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
WO/2021/191413	DISINFECTANT COMPOSITIONS	ARCH UK BIOCIDES LTD
WO/2021/191416	DRY POWDER FORMULATION FOR PULMONARY DELIVERY AND METHODS OF USE	ASTRAZENECA AB
WO/2021/191417	COMPOUNDS FOR USE IN THE TREATMENT OF SYNUCLEINOPATHIES	SOM INNOVATION BIOTECH, S.A.
WO/2021/191422	NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES FOR THE TREATMENT OF BACTERIAL INFECTIONS	NUVAMID SA
WO/2021/191431	A CONSUMABLE PRODUCT COMPRISING MALTED CEREALS FOR PROMOTING RECOVERY AT PHYSICAL ACTIVITY	LANTMÄNNEN FUNCTIONAL FOODS AB
WO/2021/191432	TARGETING QUORUM-SENSING PEPTIDES FOR DIAGNOSIS, TREATMENT AND/OR PREVENTION OF COLORECTAL CANCER METASTASIS	UNIVERSITEIT GENT
WO/2021/191435	USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF ADRENOLEUKODYSTROPHY OR ADRENOMYELONEUROPATHY	POXEL
WO/2021/191436	METHODS FOR TREATMENT OF VIRUS	APEIRON BIOLOGICS AG
WO/2021/198099	USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF DIABETIC NEPHROPATHY	POXEL
WO/2021/204568	A TOPICAL COMPOSITION FOR TREATMENT OF PRURITUS	UNIVERSITÄT BASEL
WO/2021/191455	NEW THERAPEUTIC TARGETS WITH AN ANTI-INFLAMMATORY AND ANTI-INTERFERON EFFECT	UNIVERSITE DE PARIS
WO/2021/191456	COMPOSITIONS FOR THE TREATMENT OF A RESPIRATORY CONDITION	VECTURA LIMITED
WO/2021/198115	TREATMENT	UNION THERAPEUTICS A/S
WO/2021/198116	FORMULATION	UNION THERAPEUTICS A/S
WO/2021/191460	NEW THERAPEUTIC TARGETS WITH AN ANTI-INFLAMMATORY AND ANTI-INTERFERON EFFECT	UNIVERSITE DE PARIS
WO/2021/191461	AN INSULIN SENSITIZER FOR USE IN THE PREVENTION AND/OR TREATMENT OF THE DAMAGES CAUSED BY RETINAL DETACHMENT	SORBONNE UNIVERSITE
WO/2021/191462	COMPOSITION COMPRISING ANTIMICROBIAL AGENT AND ITS USES	SHARED VISION TECHNOLOGY LTD.
WO/2021/204572	BEADS COMPRISING A BUFFER SYSTEM	CHEMISCHE FABRIK BUDENHEIM KG
WO/2021/198135	METHOD OF TREATING VIRAL INFECTIONS	IMMUPHARMA FRANCE SA
WO/2021/198139	VIRUCIDAL COMPOSITIONS AND USE THEREOF	ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
WO/2021/228465	METHOD FOR TREATING HUMAN HAIR WITH AGENTS CONTAINING MIXTURES OF ORGANIC C1-C6 ALKOXY SILOXANES	HENKEL AG & CO. KGAA
WO/2021/191464	USE OF CONJUGATES COMPRISING TUMOUR-SELECTIVE LIGANDS AND GROUPS CAPABLE OF RELEASING CARBON MONOXIDE (CO), FOR EXERTING IMMUNOMODULATORY EFFECTS IN CANCER TREATMENT	INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES
WO/2021/198176	POLYPEPTIDE FOR THE PROPHYLAXIS AND TREATMENT OF VIRAL INFECTIONS	PHARIS BIOTEC GMBH
WO/2021/198177	BIOMATERIAL COMPRISING A POROUS RESORBABLE MATRIX AND ASSOCIATED MANUFACTURING METHOD	UNIVERSITE GRENOBLE ALPES
WO/2021/198191	QUINAZOLINONE DERIVATIVES AND USES THEREOF FOR TREATING A CANCER	ENYO PHARMA
WO/2021/191469	COMPOSITION FOR THE TREATMENT OF GASTRO-INTESTINAL DYSFUNCTION AND/OR ASSOCIATED MORBIDITIES THERETO	BASF SE
WO/2021/191470	COMPOSITION COMPRISING GLYCERIDES FOR THE TREATMENT OF GASTRO-INTESTINAL DYSFUNCTION AND/OR ASSOCIATED MORBIDITIES THERETO	BASF SE
WO/2021/198195	AGONIST COMBINATION	ZEALAND PHARMA A/S
WO/2021/198196	GLP-1/GLP-2 DUAL AGONISTS	ZEALAND PHARMA A/S
WO/2021/198198	OIL-IN-WATER EMULSION COMPRISING A SOLID LIPID MATERIAL	FIRMENICH SA
WO/2021/191474	ACTIVITY-DEPENDENT GENE THERAPY FOR NEUROLOGICAL DISORDERS	UCL BUSINESS LTD.
WO/2021/198212	OPHTHALMIC FORMULATION AND ITS USE	OY FINNSUSP AB
WO/2021/198216	NEW METHOD TO TREAT THE HEPATOTOXICITY INDUCED BY AMANITINS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/198220	TREATMENT AND PREVENTION OF SECONDARY INFLAMMATION IN PATIENTS SUFFERING FROM A VIRAL INFECTION	ALLERO THERAPEUTICS B.V.
WO/2021/198223	TREATMENT OF SYMPTOMATIC VIRAL DISEASES	SYNACT PHARMA APS
WO/2021/198229	SELECTIVE GIP RECEPTOR AGONISTS COMPRISING A CHELATING MOIETY FOR IMAGING AND THERAPY PURPOSES	ANTAROS MEDICAL AB
WO/2021/198253	USE OF BIOMARKERS IN THE TREATMENT OF FIBROTIC CONDITIONS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/198254	BIOCHANIN A DERIVATIVES FOR TREATMENT OF BEST1 -RELATED RETINOPATHIES	UNIVERSITÄT REGENSBURG
WO/2021/198255	AN NK-1 RECEPTOR ANTAGONIST FOR TREATING A DISEASE SELECTING FROM SEPSIS, SEPTIC SHOCK,, ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) OR MULTIPLE ORGAN DYSFUNCTION SYNDROME (MODS)	NERRE THERAPEUTICS LIMITED
WO/2021/198256	COMPOSITION HAVING IMPROVED VOLUNTARY ACCEPTANCE	BAYER ANIMAL HEALTH GMBH
WO/2021/198258	TREATMENT INVOLVING NON-IMMUNOGENIC RNA FOR ANTIGEN VACCINATION	BIONTECH SE
WO/2021/198284	USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF CARDIOVASCULAR DISEASES	POXEL
WO/2021/198285	HOMOGENEOUS LIQUID COMPOSITION COMPRISING 1,2-OCTANEDIOL AND USE THEREOF	MINASOLVE SAS
WO/2021/198288	METHODS AND COMPOSITIONS	ALLIGATOR BIOSCIENCE AB
WO/2021/198312	VIRAL INFECTIONS- TREATMENT WITH CONVALESCENT PLASMA/SERUM	REGEN LAB SA
WO/2021/198316	COMPOUNDS, COMPOSITIONS AND DEVICES FOR USE IN THE PREVENTION OR TREATMENT OF CORONA-VIRUS INFECTIONS	VOSSENSTEYN
WO/2021/198327	LIQUID PHARMACEUTICAL FORMULATIONS POLYETHYLENE GLYCOL-BASED PRODRUGS OF ADRENOMEDULLIN AND USE	BAYER AKTIENGESELLSCHAFT
WO/2021/198328	PHARMACEUTICAL FORMULATIONS POLYETHYLENE GLYCOL-BASED PRODRUGS OF ADRENOMEDULLIN AND USE	BAYER AKTIENGESELLSCHAFT
WO/2021/198332	CONDENSATION PRODUCT FOR USE IN A METHOD FOR THE TREATMENT OF COVID-19	BASF SE
WO/2021/198333	BISPECIFIC ANTIGEN BINDING MOLECULES TARGETING OX40 AND FAP	F. HOFFMANN-LA ROCHE AG
WO/2021/198336	USE OF HAEMOGLOBIN FROM ANNELIDS FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROME	HEMARINA
WO/2021/198346	EZRIN PEPTIDE 1 FOR USE IN A METHOD OF TREATING COVID-19	DR. NESSELHUT BESITZGESELLSCHAFT MBH
WO/2021/198353	A FLEXIBLE FOIL FOR THE DELIVERY OF THERAPEUTIC CARGOS	DANMARKS TEKNISKE UNIVERSITET
WO/2021/198369	AGENTS FOR USE IN THE THERAPEUTIC OR PROPHYLACTIC TREATMENT OF RETINAL PIGMENT EPITHELIUM ASSOCIATED DISEASES	PANDA-JONAS, Songhomitra
WO/2021/198376	NOVEL SALMONELLA-BASED CORONAVIRUS VACCINE	VAXIMM AG
WO/2021/204634	TOPICAL PHARMACEUTICAL COMPOSITION IN THE FORM OF AN AQUEOUS GEL COMPRISING AT LEAST AMITRIPTYLINE	ALGOTHERAPEUTIX
WO/2021/198395	SURFACTANT PROTEIN D FOR USE IN TREATING CORONAVIRUS INFECTIONS	TRIMUNOCOR LIMITED
WO/2021/198399	COMPOSITIONS AND METHODS CONTAINING N-ACETYLCYSTEIN AND NICOTINAMIDE RIBOSIDE FOR PREVENTION AND TREATMENT OF NEUROLOGICAL DISEASES AND CONDITIONS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/204649	GM-CSF ANTAGONISTS FOR USE IN THE TREATMENT OF SEVERE PULMONARY COVID-19, CYTOKINE RELEASE SYNDROME AND/OR ACUTE RESPIRATORY DISTRESS SYNDROME	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/204655	MODIFIED VECTORS FOR PRODUCTION OF RETROVIRUS	GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
WO/2021/198410	AMYLOSE/CAROTENOIDS COMPLEXATION PROCESS	ECLYPSE INK BIOTECHNOLOGY
WO/2021/198413	STABILIZED VACCINE COMPOSITIONS	JANSSEN VACCINES & PREVENTION B.V.
WO/2021/198415	METHODS OF TREATMENT USING NICLOSAMIDE	SOFTHALE NV
WO/2021/198439	REDUCED CALORIC INTAKE AND IMMUNOTHERAPY FOR THE TREATMENT OF CANCER	IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE
WO/2021/198440	COMPOSITIONS FOR CORONAVIRUS INFECTION TREATMENT AND/OR PREVENTION	FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
WO/2021/198442	ISOQUINOLINE DERIVATIVES FOR USE IN THERAPY	VESTLANDETS INNOVASJONSSELSKAP AS
WO/2021/198449	TUMOR ANTIGENS FOR LIVER CANCER IMMUNOTHERAPY	ISTITUTO NAZIONALE TUMORI IRCCS - FONDAZIONE G. PASCALE
WO/2021/198454	METHOD FOR TREATING HYPERINFLAMMATION USING MESENCHYMAL LINEAGE PRECURSOR OR STEM CELLS	MESOBLAST INTERNATIONAL SàRL
WO/2021/198464	WOUND CARE COMPOSITIONS AND METHODS OF PREPARATION THEREOF	T.J.SMITH AND NEPHEW,LIMITED
WO/2021/204705	CARBOXYLATE LIGAND MODIFIED FERRIC IRON HYDROXIDE COMPOSITIONS FOR USE IN THE TREATMENT OR PREVENTION OF IRON DEFICIENCY ASSOCIATED WITH LIVER DISEASES	NEMYSIS LTD.
WO/2021/204713	AXL INHIBITORS FOR ANTIVIRAL THERAPY	BERGENBIO ASA
WO/2021/198500	NOVEL IMMUNOMODULATOR	VIROKINE THERAPEUTICS LTD
WO/2021/209274	HYDRATABLE COSMETIC COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/204717	AMINOQUINOLINES FOR TREATING CORONAVIRUS INFECTIONS	OXANDIA LTD
WO/2021/198504	ACTIVE SUBSTANCES FOR MEDICAL USE	INFLAMED PHARMA GMBH
WO/2021/198506	USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)	POXEL
WO/2021/198511	METHODS AND COMPOSITIONS FOR TREATMENT OF SARS-COV-2 INFECTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/198516	COMPOSITION	INOCELLS B.V.
WO/2021/198517	COMPOSITION	INOCELLS B.V.
WO/2021/198524	REGIMEN FOR REPEATED TOPICAL APPLICATION OF CAPSAICIN PATCH	GRüNENTHAL GMBH
WO/2021/204751	PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF LIVER DISEASES	POXEL
WO/2021/204755	PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF LIVER DISEASES	POXEL
WO/2021/204756	METHODS FOR THE TREATMENT OF HEADACHE DISORDERS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/204757	TREATMENT OF ARDS AND OTHER PARAMETERS RELATED TO COVID-19	STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM
WO/2021/204762	CRYSTALLINE FORMS OF A TYK2 INHIBITOR	SAREUM LIMITED
WO/2021/204781	ARTC1 LIGANDS FOR CANCER TREATMENT	UNIVERSITÄT ZüRICH
WO/2021/204800	DIFLUOROCYCLOHEXYL DERIVATIVES AS IL-17 MODULATORS	UCB BIOPHARMA SRL
WO/2021/204801	DIFLUOROCYCLOHEXYL DERIVATIVES AS IL-17 MODULATORS	UCB BIOPHARMA SRL
WO/2021/204802	LABELLED SUBSTANCE AND METHODS OF DETECTION OF INFLAMMATION AND INFECTION USING SAID SUBSTANCE	PVAC MEDICAL TECHNOLOGIES LTD
WO/2021/204812	25-HYDROXYVITAMIN D2 AND/OR D3 FOR USE IN OBESITY	CARBOGEN AMCIS B.V.
WO/2021/204814	NACHR, SUCH AS NICOTINE, FOR USE IN THE PREVENTION AND THE TREATMENT OF COVID-19 DISEASE	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
WO/2021/198534	PLASMA KALLIKREIN INHIBITORS FOR USE IN THE TREATMENT OF CORONAVIRAL DISEASE	OXURION NV
WO/2021/204825	INACTIVATED SARS-CoV-2 VIRUS VACCINE	VALNEVA AUSTRIA GMBH
WO/2021/198535	USE OF AN ARSENIC COMPOUND FOR TREATING A SHORT OR LONG CYTOKINE STORM IN VARIOUS AUTOIMMUNE/INFLAMMATORY DISEASES IN HUMANS OR ANIMALS	MEDSENIC
WO/2021/204843	TOPICAL USE OF ERLOTINIB FOR TREATING KERATODERMAS IN CHILDREN	LABORATOIRES C.T.R.S.
WO/2021/204861	COMPOSITIONS FOR USE IN THE INHIBITION OF CORONAVIRUS REPLICATION	NORDIC PHARMA LAB APS
WO/2021/204873	IMMUNOGENIC COMPOSITION COMPRISING AN ANTIGENIC MOIETY AND A LIPOSOMAL FORMULATION, METHOD OF PRODUCING THE COMPOSITION, THE COMPOSITION FOR USE AS A MEDICAMENT, IN PARTICULAR FOR USE AS A VACCINE	INNOMEDICA HOLDING AG
WO/2021/239307	NOVEL TRANSDUCTION ENHANCERS AND USES THEREOF	UNIVERSITÄT ZüRICH
WO/2021/204883	PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY BOWEL DISEASES	CVASTHERA
WO/2021/204889	METHOD FOR PRODUCING A POROUS ACTIVE INGREDIENT CARRIER BY MEANS OF HOT-MELT EXTRUSION	RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH
WO/2021/204923	PIPERAZINE DERIVATIVES AS ANTIVIRAL AGENTS FOR USE IN THE TREATMENT OF A CORONAVIRUS INFECTION	VIRONOVA MEDICAL AB
WO/2021/204924	COMPOUNDS FOR USE IN THE TREATMENT OF HYPERCYTOKINEMIA	VIRONOVA MEDICAL AB
WO/2021/204935	MEMBRANES FOR MEDICAL DEVICES	DEFYMED
WO/2021/204955	COMPOUNDS FOR TREATING PNEUMONIA, SEPSIS, AND CORONAVIRUS INFECTION	HEIDELBERG IMMUNOTHERAPEUTICS GMBH
WO/2021/204969	PEPTIDES AND COMBINATIONS OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST AN INFECTION BY SARS-COV-2 (COVID-19)	EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET
WO/2021/204985	USE OF VIDOFLUDIMUS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/204991	IMMUNOSTIMULATORY COMPOSITIONS	BAYER ANIMAL HEALTH GMBH
WO/2021/204994	OFATUMUMAB FOR TREATING MS WHILE MAINTAINING SERUM IGG	NOVARTIS AG
WO/2021/204998	NATURAL ANTIBODIES IN PROPHYLAXIS AND THERAPY	HEIDELBERG IMMUNOTHERAPEUTICS GMBH
WO/2021/205010	NUCLEIC ACIDS ENCODING HUMAN FUS PROTEIN AND USE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)	INSERM - INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE
WO/2021/205017	IMPROVEMENTS IN VACCINE FORMULATIONS FOR MEDICAL USE	VALNEVA AUSTRIA GMBH
WO/2021/205025	COMBINATORY TREATMENT FOR LYMPHOMA	UNIVERSITE DE PARIS
WO/2021/205026	PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ENVELOPED DNA OR RNA VIRUS INDUCED INFECTIONS AND DISORDERS	LOGICK ENERGETICS B.V.
WO/2021/205027	INDIVIDUALIZED THERAPEUTIC ANTICANCER VACCINE	VACCIBODY AS
WO/2021/205029	USE OF MASITINIB FOR THE TREATMENT OF CORONAVIRUS DISEASE 2019 (COVID-19)	AB SCIENCE
WO/2021/213822	COMPOSITIONS COMPRISING CYS-PEPTIDES	EVONIK OPERATIONS GMBH
WO/2021/209402	IMMUNOCONJUGATES	F. HOFFMANN-LA ROCHE AG
WO/2021/209405	MULTI-PHASE COSMETIC COMPOSITION COMPRISING AT LEAST TWO IMMISCIBLE OILY PHASES	CHANEL PARFUMS BEAUTE
WO/2021/219360	COMPRESSED TABLET COMPRISING L-THEANINE	DSM IP ASSETS B.V.
WO/2021/209419	BI- AND MONOCYCLIC NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/209425	ALKYNYL NUCLEOSIDE ANALOGS FOR TREATMENT OF HEPATITIS E	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/209427	SPIROCYCLIC NUCLEOSIDE ANALOGUES FOR THE TREATMENT OF HEPATITIS E	JANSSEN SCIENCES IRELAND UNLIMITED COMPANY
WO/2021/209437	NATURAL COMPOSITION FOR HAIR GROWTH STIMULATION AND HAIR LOSS PREVENTION AND TREATMENT WITHOUT PRESERVATIVES	FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E. V.
WO/2021/209441	USE OF A POLAR EXTRACT OF <i>SKELETONEMA</i> IN PHOTODYNAMIC THERAPY	IFREMER
WO/2021/209442	NATURAL COMPOSITION FOR HAIR GROWTH STIMULATION AND HAIR LOSS PREVENTION AND TREATMENT	FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E. V.
WO/2021/209450	RESINIFERATOXIN COMPOSITIONS	MESTEX AG
WO/2021/209452	DOSAGE UNITS AND REGIMEN, USES, METHODS OR FORMULATIONS OF COMPOSITIONS COMPRISING A RECOMBINANT PROTEIN COMPRISING INTERLEUKIN-12 AND AN ANTIBODY BINDING THE EXTRA-DOMAIN B OF FIBRONECTIN	PHILOGEN S.P.A.
WO/2021/209455	COMPOSITION FOR IMPROVING COGNITIVE FUNCTION	ACTIV'INSIDE
WO/2021/209458	COMBINATION TREATMENT OF CANCER	ARES TRADING S.A.
WO/2021/209459	METHODS OF USING SOLID DISPERSIONS OF RIFAXIMIN FOR THE TREATMENT OF SICKLE CELL DISEASE	BAUSCH HEALTH IRELAND LIMITED
WO/2021/223966	ADENOMYOSIS ASSOCIATED INFERTILITY AND HDAC INHIBITORS	NADEZHDA REPRODUCTIVE SCIENCE OOD
WO/2021/209465	PEPTIDE FOR THE TREATMENT OF NET-ASSOCIATED DISEASES	UNIVERSITEIT MAASTRICHT
WO/2021/209471	ULIPRISTAL ACETATE OTF	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/209472	ORAL THIN FILM WITH SMOOTH FUSED FILM	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/209493	MEANS AND METHODS OF PREVENTING AND TREATING INFECTIONS	SOLYPLUS GMBH
WO/2021/219376	PERSONAL CARE COMPOSITIONS WITH ENHANCED SOLUBILITY ACTIVES	UNILEVER IP HOLDINGS B.V.
WO/2021/219378	STABILIZED COSMETIC COMPOSITIONS WITH N, N'-DI-ACETYL CYSTINE	UNILEVER IP HOLDINGS B.V.
WO/2021/209510	INHIBITORS OF TRPC6 FOR TREATING RESPIRATORY CONDITIONS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/209520	MOLECULES FOR USE IN THE TREATMENT OF VIRAL INFECTIONS	ISTITUTO EUROPEO DI ONCOLOGIA S.R.L.
WO/2021/209521	VECTORS FOR THE TREATMENT OF ACID CERAMIDASE DEFICIENCY	GENETHON
WO/2021/209539	PYRROLO[1,2-D][1,2,4]TRIAZINE-2-YL-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY	JANSSEN PHARMACEUTICA NV
WO/2021/209541	TAXIFOLIN FORMULATION COMPRISING THIAMINE	EVANIUM HEALTHCARE GMBH
WO/2021/209545	COMPOSITION COMPRISING TRABECTEDIN AND AN AMINO ACID	EVER VALINJECT GMBH
WO/2021/209548	COMPOSITIONS AND METHODS FOR TREATING HAIR FOLLICLE-LINKED CONDITIONS	HENLEZ APS
WO/2021/209552	PYRAZOLO[1,5-D][1,2,4]TRIAZINE-5(4H)-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY	JANSSEN PHARMACEUTICA NV
WO/2021/209562	LIPOSOMAL COMPOSITION FOR PREVENTING OR EARLY TREATMENT OF PATHOGENIC INFECTION	STATENS SERUM INSTITUT
WO/2021/209563	COMPOUNDS FOR USE IN THE TREATMENT OF VIRAL INFECTIONS BY RESPIRATORY SYNDROME-RELATED CORONAVIRUS	SOM INNOVATION BIOTECH, S.A.
WO/2021/213891	USE OF A MULTIFUNCTIONAL LIGAND FOR TREATING DRY EYES, MEIBOMIAN GLAND DYSFUNCTIONS AND LACRIMAL GLAND DYSFUNCTIONS	H4 ORPHAN PHARMA
WO/2021/209566	O/W EMULSION CONTAINING ETHANOL	DR. KURT WOLFF GMBH & CO. KG
WO/2021/213898	A CHIMERIC ENDOLYSIN POLYPEPTIDE.	MICREOS HUMAN HEALTH B.V.
WO/2021/209589	PHOSPHOLIPIDS AND PHOSPHOLIPID METABOLITES FOR TREATING VIRAL AND BACTERIAL PNEUMONIA AND SEPSIS	ANDREAS HETTICH GMBH & CO. KG
WO/2021/209590	IMPROVED PROBIOTIC STRAINS AND USES THEREOF	AMUCIN OY LTD
WO/2021/233614	COMPOSITIONS AND METHODS FOR PROVIDING SCALP CARE BENEFITS	UNILEVER IP HOLDINGS B.V.
WO/2021/209591	CONTRACEPTIVE COMPOSITIONS WITH REDUCED ADVERSE EFFECTS	ESTETRA SRL
WO/2021/209593	ACTIVE PRINCIPLE COMPRISING A PEEL EXTRACT OF IMMATURE PUNICA GRANATUM FRUIT AND USES FOR PREVENTING AND/OR COMBATTING ACNE	SOCIETE INDUSTRIELLE LIMOUSINE D'APPLICATION BIOLOGIQUE
WO/2021/209594	BROMODOMAIN INHIBITORS FOR THE PREVENTION AND/OR TREATMENT OF CORONAVIRUS INFECTIONS AND DISEASES CAUSED THEREBY	EBERHARD KARLS UNIVERSITAET TUEBINGEN MEDIZINISCHE FAKULTAET
WO/2021/209596	THERAPEUTIC USE OF PLEUROMUTILINS	NABRIVA THERAPEUTICS GMBH
WO/2021/209607	SCD83 FOR WOUND HEALING, HAIR GROWTH, AND SKIN AND HAIR CARE	FRIEDRICH-ALEXANDER-UNIVERSITÄT ERLANGEN-NüRNBERG
WO/2021/209608	MEDICAL METHODS AND MEDICAL USES	JOSEPH, Bertrand Marie René
WO/2021/213923	MEDICAL USE OF DARIDOREXANT	IDORSIA PHARMACEUTICALS LTD
WO/2021/213924	CORONAVIRUS VACCINE	BIONTECH SE
WO/2021/213931	NOVEL NON-PROTEINIC FURIN INHIBITOR	EPHYLA
WO/2021/209620	CYSTEINE PROTEASE INHIBITORS FOR USE IN THE PREVENTION AND/OR TREATMENT OF CORONAVIRUS	ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG
WO/2021/209623	COMPOSITION COMPRISING AT LEAST ONE PROTOBERBERINE ALKALOID AND METHOD FOR MANUFACTURING SAME	ELEONOR SPRL
WO/2021/209625	HIGH POTENCY NATURAL KILLER CELLS	ONK THERAPEUTICS LIMITED
WO/2021/228492	PERSONAL CARE COMPOSITION WITH VISUALLY DISTINCT AQUEOUS AND OIL PHASE	UNILEVER IP HOLDINGS B.V.
WO/2021/209627	MODULATION OF T CELL CYTOTOXICITY AND RELATED THERAPY	CANCER RESEARCH TECHNOLOGY LIMITED
WO/2021/209631	FMT PERFORMANCE PREDICTION TEST TO GUIDE AND OPTIMIZE THERAPEUTIC MANAGEMENT OF GVHD PATIENTS	MAAT PHARMA
WO/2021/209633	METHODS AND FORMULATIONS FOR ADMINISTRATION OF THIOCARBAMATE DERIVATIVES A2A INHIBITORS	ITEOS BELGIUM SA
WO/2021/213946	PROPHYLAXIS AND TREATMENT OF CORONAVIRUS INFECTION	ENGLMEIER, Ludwig
WO/2021/213948	A VACCINE TO PROTECT AGAINST MYCOPLASMA HYOPNEUMONIAE	INTERVET INTERNATIONAL B.V.
WO/2021/213949	A COMBINATION OF VACCINES TO PROPHYLACTICALLY TREAT A PIG	INTERVET INTERNATIONAL B.V.
WO/2021/209644	USING C1 ESTERASE INHIBITOR TO TREAT VIRAL INFECTION-RELATED ACUTE RESPIRATORY DISTRESS	PHARMING INTELLECTUAL PROPERTY B.V.
WO/2021/209645	COMPOSITION FOR TREATING KERATIN TISSUE	PVAC MEDICAL TECHNOLOGIES LTD
WO/2021/213992	METHOD OF GENERATING A DRIED DRUG FORMULATION	HOFFMANN-LA ROCHE INC.
WO/2021/228502	PERSONAL CARE COMPOSITION WITH VISUALLY DISTINCT AQUEOUS AND OIL PHASE	UNILEVER IP HOLDINGS B.V.
WO/2021/228503	PERSONAL CARE COMPOSITION WITH VISUALLY DISTINCT AQUEOUS AND OIL PHASE	UNILEVER IP HOLDINGS B.V.
WO/2021/214018	TREATMENT REGIMEN WITH MINOXIDIL AND CAFFEINE	DR. KURT WOLFF GMBH & CO. KG
WO/2021/214023	COMBINATION OF FINERENONE AND A SGLT2 INHIBITOR FOR THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR AND/OR RENAL DISEASES	BAYER AKTIENGESELLSCHAFT
WO/2021/219428	METHOD FOR DELIPIDATING PLANT EXTRACTS	MAX ZELLER SOEHNE AG
WO/2021/214033	VIDOFLUDIMUS FOR USE IN THE TREATMENT OR PREVENTION OF VIRAL DISEASES	IMMUNIC AG
WO/2021/214043	IMMUNIZATION SCHEME FOR VARIANT SURFACE GLYCOPROTEIN CARRIERS	DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS
WO/2021/214045	HPMC CAPSULE WITH REDUCED POWDER RETENTION	CAPSUGEL FRANCE SAS
WO/2021/214053	PROCESS FOR DENSIFYING KERATIN FIBERS, BASED ON SILICONE, AN ALKOXYSILANE AND A COLORING AGENT	L'OREAL
WO/2021/214055	COMPOSITION COMPRISING AT LEAST ONE ALKOXYSILANE OF FORMULA (I), AT LEAST ONE NON AMINO SILICONE OF FORMULA (II) AND AT LEAST ONE COLORING AGENT	L'OREAL
WO/2021/214056	PROCESS FOR THE TREATMENT OF KERATIN FIBERS EMPLOYING A COMPOSITION COMPRISING AT LEAST ONE ALKOXYSILANE OF FORMULA (I), AT LEAST ONE NON AMINO SILICONE OF FORMULA (II) HAVING A WEIGHT-AVERAGE MOLECULAR WEIGHT OF LESS THAN OR EQUAL TO 1500 G/MOL AND AT LEAST ONE COLORING AGENT	L'OREAL
WO/2021/214081	SARS-COV-2 VACCINES	NEC ONCOIMMUNITY AS
WO/2021/233630	ORAL CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/228519	PERSONAL CARE COMPOSITION WITH VISUALLY DISTINCT AQUEOUS AND OIL PHASE	UNILEVER IP HOLDINGS B.V.
WO/2021/214119	THERAPEUTIC COMBINATION FOR THE TREATMENT OF BREAST CANCER	IFOM - FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE
WO/2021/214126	DRUG ANTIBODY CONJUGATES	PHARMA MAR, S.A.
WO/2021/214129	ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE TREATMENT OF CANCER	UNIVERSITé CATHOLIQUE DE LOUVAIN
WO/2021/219458	GRANULES COMPRISING SURFACE-REACTED CALCIUM CARBONATE AS EXCIPIENT	OMYA INTERNATIONAL AG
WO/2021/214139	COMPOSITION FOR USE IN THE TREATMENT OF GROUP-B STREPTOCOCCUS (GBS) INFECTIONS	GIELLEPI S.P.A.
WO/2021/214158	CO-CRYSTAL OF GABAPENTIN, KETOPROFEN AND LYSINE, PHARMACEUTICAL COMPOSITIONS AND THEIR MEDICAL USE	DOMPE' FARMACEUTICI SPA
WO/2021/214163	SYNERGISTIC ADMIXTURES OF GABAPENTIN AND KETOPROFEN, PHARMACEUTICAL COMPOSITIONS AND THEIR MEDICAL USE	DOMPE' FARMACEUTICI SPA
WO/2021/214170	ORALLY ADMINISTERED HYDROGEL COMPOSITION, KIT AND USE	KIFIK
WO/2021/214175	ALPHA-2 ADRENERGIC RECEPTOR AGONISTS FOR THE PREVENTION AND/OR THE TREATMENT OF SPLEEN DISORDERS	UNIVERSITé CATHOLIQUE DE LOUVAIN
WO/2021/214179	SYNTHETIC <i>STREPTOCOCCUS PNEUMONIAE</i> SACCHARIDE CONJUGATES TO CONSERVED MEMBRANE PROTEIN	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/214200	ROCK INHIBITORS FOR USE IN TREATING OR PREVENTING PULMONARY EDEMA	ATRIVA THERAPEUTICS GMBH
WO/2021/214205	PERFUME SYSTEM FOR PERFUMED CONSUMER PRODUCT	FIRMENICH SA
WO/2021/214209	PRODUCT AND PROCESS FOR THE DECONTAMINATION OF NANOPARTICLES FROM THE SKIN	LEIBNIZ-INSTITUT FüR POLYMERFORSCHUNG DRESDEN E.V.
WO/2021/214220	GLUCAGON ANALOGUES AS LONG-ACTING GLP-1/GLUCAGON RECEPTOR AGONISTS IN THE TREATMENT OF FATTY LIVER DISEASE AND STEATOHEPATITIS	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/214221	ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY CONJUGATES AND FOLFIRI	SANOFI
WO/2021/214222	ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY CONJUGATES, TRIFLURIDINE AND TIPIRACIL	SANOFI
WO/2021/214223	ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY CONJUGATES AND FOLFOX	SANOFI
WO/2021/214227	ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY CONJUGATES AND CETUXIMAB	SANOFI
WO/2021/214233	TREATMENT OF HYPOTHALAMIC OBESITY	SANIONA A/S
WO/2021/214234	SYNERGISTIC PRESERVATIVE/PERSONAL CARE COMPOSITION CONTAINING AN ALKYLENE GLYCOL ESTER	ARCH UK BIOCIDES LTD
WO/2021/214245	NOVEL PHARMACOLOGICAL CHAPERONE COMPOUNDS OF HUMAN ACID ALPHA-GLUCOSIDASE AND THE THERAPEUTIC USE THEREOF	UNIVERSITé GRENOBLE ALPES
WO/2021/214253	DOSAGE REGIMEN FOR THE TREATMENT OF CANCER	ASTRAZENECA AB
WO/2021/214254	PHARMACEUTICAL FORMULATIONS	ASTRAZENECA AB
WO/2021/219495	METHODS FOR TREATING OR PREVENTING A VIRAL INFECTION OR INHIBITING VIRAL REPLICATION	DALCOR PHARMA UK LTD., LEATHERHEAD, ZUG BRANCH
WO/2021/214270	COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS	ASTRAZENECA AB
WO/2021/214279	REPLICATION-COMPETENT CONTROLLED HERPESVIRUSES EXPRESSING A SARS COV-2 ANTIGEN	HSF PHARMACEUTICALS
WO/2021/214282	METHODS FOR PREVENTING INDUCTION OF IMMUNE RESPONSES TO THE TRANSDUCED CELLS EXPRESSING A TRANSGENE PRODUCT AFTER OCULAR GENE THERAPY	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/214292	COMPOSITION COMPRISING FIBRE AND MULBERRY	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/214293	COMPOSITION COMPRISING A DNA-DEGRADING ENZYME FOR USE IN A METHOD FOR THE TREATMENT OF IMMUNOSUPPRESSION AFTER ACUTE TISSUE INJURY	KLINIKUM DER UNIVERSITÄT MüNCHEN (KUM)
WO/2021/214296	TREATMENT OF CORONA VIRUS INFECTIONS	JOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN
WO/2021/239346	METHODS OF TREATMENT OF VIRAL DISEASES	SOFTHALE NV
WO/2021/214297	IMMUNIZATION AGAINST SARS-COV-RELATED DISEASES	ISA PHARMACEUTICALS B.V.
WO/2021/214300	COMPOSITION COMPRISING A FIBROUS MATERIAL	WEIDMANN HOLDING AG
WO/2021/214303	PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS	UNIVERSITÄTSKLINIKUM JENA
WO/2021/214320	PLASMINOGEN FOR USE IN TREATING AND PREVENTING LUNG DYSFUNCTION	PREVIPHARMA CONSULTING GMBH
WO/2021/214321	NOVEL COMBINATION FOR THE TREATMENT OF AIDS	21C BIO
WO/2021/214326	USE OF MULBERRY EXTRACT FOR CONTROLLING POSTPRANDIAL GLUCOSE RESPONSE	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/214328	PH-DEPENDENT RELEASE NANOPARTICLES FOR INCORPORATION OF ACTIVE SUBSTANCES, PREPARATION METHOD AND THERAPEUTIC USES OF SAME	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/116503	THERAPEUTIC COMPOSITIONS COMPRISING DEUTERATED OR PARTIALLY DEUTERATED N,N-DIMETHYLTRYPTAMINE COMPOUNDS	SMALL PHARMA LTD
WO/2021/214337	SYSTEMIC FORMULATION OF A PYRIDINONE DERIVATE FOR COELIAC DISEASE	DR. FALK PHARMA GMBH
WO/2021/214338	SYSTEMIC FORMULATION OF A PYRIDINONE DERIVATE FOR TG2-RELATED DISEASES	DR. FALK PHARMA GMBH
WO/2021/214339	VACCINE AGAINST HUMAN-PATHOGENIC CORONAVIRUSES	ACM BIOLABS PTE LTD
WO/2021/214341	SRC KINASE ACTIVATORS AND/OR ENG FUNCTION INHIBITORS AS ENHANCERS OF SKIN HOMEOSTASIS/REGENERATION AND HAIR GROWTH	DERMA INNOVATE S.L.
WO/2021/219543	SEMAGLUTIDE FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS	NOVO NORDISK A/S
WO/2021/219545	COMPOSITION FOR TREATING AND/OR PREVENTING VESTIBULODYNIA	PEPTONIC MEDICAL AB
WO/2021/219547	ANHYDROUS COSMETIC COMPOSITION COMPRISING POLYOLS, MONOALCOHOLS, FATTY AMINES AND AT LEAST 0.1% OF CARBOXYLIC ACIDS	L'OREAL
WO/2021/219576	MULTIPARTICULATE DOSAGE FORM CONTAINING EVA COPOLYMER AND ADDITIONAL EXCIPIENT	GRüNENTHAL GMBH
WO/2021/219577	DOSAGE FORM COMPRISING HOT-MELT EXTRUDED PELLETS CONTAINING EVA COPOLYMER AND GLIDING AGENT	GRüNENTHAL GMBH
WO/2021/219581	SYSTEM AND METHOD FOR PROVIDING FERTILITY ENHANCING DIETARY RECOMMENDATIONS IN INDIVIDUALS WITH PROSTATE CONDITIONS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/239360	PEG-FREE SOAP GEL PREPARATION	BEIERSDORF AG
WO/2021/224058	COMPOSITION COMPRISING ALBUMIN FOR USE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) BY PLASMA EXCHANGE	GRIFOLS WORLDWIDE OPERATIONS LIMITED
WO/2021/219619	METHODS TO GENERATE VACCINE COMPOSITIONS THAT PRIME HUMAN LEUKOCYTE ANTIGEN CLASS I RESTRICTED CD8 T-CELL RESPONSES AGAINST VIRAL NON-VIRION-INTEGRAL DERIVED EPITOPES	GENOVIE AB
WO/2021/219622	HAND SANITISER COMPOSITION	DSM IP ASSETS B.V.
WO/2021/219624	A NICOTINE ORAL DELIVERY PRODUCT	JT INTERNATIONAL SA
WO/2021/219634	METHOD FOR PRODUCING MILK LIKE PRODUCTS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/219635	METHOD FOR PRODUCING MILK LIKE PRODUCTS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/219639	PHARMACEUTICAL COMPOSITION AND METHOD FOR INDUCING AN IMMUNE RESPONSE	R.G.C.C. HOLDINGS AG
WO/2021/224068	PEPTIDES CONTAINING A PCNA INTERACTING MOTIF FOR USE IN THE TREATMENT OF SOLID CANCER	THERAPIM PTY LTD
WO/2021/219671	TREATMENT OF PULMONARY COMPLICATIONS OF CORONAVIRUS INFECTIONS	NOORIK BIOPHARMACEUTICALS AG
WO/2021/219691	DAPAGLIFLOZIN AND AMBRISENTAN FOR THE PREVENTION AND TREATMENT OF COVID-19	ASTRAZENECA AB
WO/2021/219710	SOLID COMPOSITIONS COMPRISING A GLP-1 AGONIST AND HISTIDINE	NOVO NORDISK A/S
WO/2021/219719	METHODS FOR RADIOLABELLING PSMA BINDING LIGANDS AND THEIR KITS	ADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/219720	METHODS FOR RADIOLABELING PSMA BINDING LIGANDS AND THEIR KITS	ADVANCED ACCELERATOR APPLICATIONS (ITALY) SRL
WO/2021/219722	AEROSOL DEVICE CONTAINING A COMPOSITION COMPRISING AT LEAST ONE SILICONE ACRYLIC COPOLYMER AND AT LEAST ONE PROPELLANT	L'OREAL
WO/2021/219750	ANTI-CANCER VACCINES AND RELATED THERAPY	THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
WO/2021/219762	USE OF A SYNTHETIC AAV CAPSID FOR GENE THERAPY OF MUSCLE AND CENTRAL NERVOUS SYSTEM DISORDERS	GENETHON
WO/2021/219763	IONIC LIQUID AS AN ANTIPERSPIRANT	NOVIGO GMBH & CO. KG
WO/2021/228570	USE OF SULCONAZOLE COMPOUNDS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/219808	SOLID AND LIQUISOLID FORMULATIONS OF CORALLOPYRONIN A	RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN
WO/2021/224114	ANTIBACTERIAL COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/228574	SUNSCREEN HAVING LOW TACKINESS AND HIGH UV PROTECTION	BEIERSDORF AG
WO/2021/219817	LIQUISOLID PHARMACEUTICAL FORMULATION AND PROCESS FOR MANUFACTURING	RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN
WO/2021/224118	PERSONAL CARE COMPOSITIONS COMPRISING A METAL PIROCTONE COMPLEX	UNILEVER IP HOLDINGS B.V.
WO/2021/219846	STIMULATION OF THE GROWTH OF GUT BIFIDOBACTERIA	ADARE PHARMACEUTICALS SAS
WO/2021/239384	MINERAL-OIL-FREE W/O EMULSION WITH A VARIABLE CONSISTENCY	BEIERSDORF AG
WO/2021/239385	SUNSCREEN WITH A COMBINATION OF CARNAUBA WAX AND HYDROGENATED RAPESEED OIL	BEIERSDORF AG
WO/2021/224133	AN ANTIPERSPIRANT COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/219857	HELP APHERESIS FOR THE TREATMENT OF SERIOUSLY ILL COVID-19 PATIENTS	SEIDEL, Dietrich
WO/2021/224138	METHODS OF REDUCING MORTALITY RISK IN SUBJECTS SUFFERING FROM AN UNDERLYING DISEASE OR CONDITION BY ADMINISTRATION OF METHYLNALTREXONE	BAUSCH HEALTH IRELAND LIMITED
WO/2021/219879	TREATMENTS OF INFLAMMATORY BOWEL DISEASE	AQILION AB
WO/2021/219881	5-CHLORO-4-HYDROXY-1-METHYL-2-OXO-N-PHENYL-QUINOLINE-3-CARBOXAMIDE POTASSIUM SALT FOR TREATING INFLAMMATORY BOWEL DISEASES	AQILION AB
WO/2021/224144	METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF COVID-19	WISTA LABORATORIES LTD.
WO/2021/224145	METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF COVID-19	WISTA LABORATORIES LTD.
WO/2021/224146	METHYLTHIONINIUM COMPOUNDS FOR USE IN THE TREATMENT OF HYPOXEMIA	WISTA LABORATORIES LTD.
WO/2021/224153	COMBINATION OF MICRONUTRIENTS TO STIMULATE THE ENDOGENOUS PRODUCTION OF HYDROGEN SULFIDE (H<sb>2</sb>S)	PARTHENOGEN SAGL
WO/2021/224167	AN ANTIPERSPIRANT COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/254685	SUBSTANCE FOR DYEING KERATIN FIBERS, CONTAINING SPECIFIC NONIONIC EMULSIFIERS, PIGMENTS AND AMINOSILICONES	HENKEL AG & CO. KGAA
WO/2021/224169	HYDROGEL IRRADIATION	ASCENDIS PHARMA A/S
WO/2021/259538	PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED USING THE PIGMENT SUSPENSION	HENKEL AG & CO. KGAA
WO/2021/259539	METHOD FOR DYEING KERATINOUS MATERIAL BY MEANS OF A POLYETHYLENE GLYCOL ETHER OF A PROPYLENE GLYCOL FATTY ACID ESTER	HENKEL AG & CO. KGAA
WO/2021/219896	TREATMENT AND/OR PREVENTION OF A DISEASE OR A SYNDROME RELATED TO A VIRUS INFECTION	ATLAS BIOTECHNOLOGY S.A.
WO/2021/224198	Mifepristone oral form for its use in cervix ripening and labour induction	DISPHAR INTERNATIONAL BV
WO/2021/224203	THE USE OF HYPERBRANCHED COPOLYMERS FOR BALANCING MICROBIAL GROWTH	DSM IP ASSETS B.V.
WO/2021/233672	METHOD FOR OBTAINING AN EXTRACT OF SANDALWOOD, COMPOSITIONS COMPRISING SAME AND COSMETIC USES THEREOF	ISP INVESTMENTS LLC.
WO/2021/224234	ANTIVIRAL USE OF CILENGITIDE	HELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/224235	USE OF DOPAMINE D3 PARTIAL AGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS	BIOPROJET PHARMA
WO/2021/224259	METHOD FOR COSMETIC TREATMENT BY COMBINED ILLUMINATION AND APPLICATION OF A COMPOSITION COMPRISING NIACINAMIDE, AND ASSOCIATED DEVICE	LIGHTINDERM
WO/2021/224260	EXOSOME-ANCHORING FUSION PROTEINS AND VACCINES	BIOVELOCITA S.R.L
WO/2021/224261	SOLUBLE TORS AND FUSIONS TO ANTI-CD3 RECOGNISING KRAS G12D FOR THE TREATMENT OF CANCER	IMMUNOCORE LIMITED
WO/2021/224264	ANTIPATHOGEN VESICLE	EK BIOSCIENCES GMBH
WO/2021/224270	METHOD TO TREAT VIRAL INFECTION INDUCED BY A CORONAVIRUS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/224301	PEPTIDES FOR PREVENTING OR TREATING VIRAL INFECTIONS	SORBONNE UNIVERSITE
WO/2021/224313	NOVEL AMORPHOUS ACTIVE PHARMACEUTICAL INGREDIENTS	DISRUPTIVE MATERIALS PHARMA AB
WO/2021/233681	DRUG DELIVERY SYSTEM BASED ON CALCIUM PHOSPHATE NANOPARTICLES FUNCTIONALIZED WITH BIOACTIVE COMPOUNDS FROM EUPHORBIA EXTRACT AND THE USES THEREOF	CELLBITEC, S.L.
WO/2021/224334	COMBINATION CONTAINING TWO NICOTINE-CONTAINING DRUGS FOR THE TREATMENT OF COVID-19	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/224338	TREATMENT OF HYPERURICEMIA	FREDERIKSBERG HOSPITAL
WO/2021/224354	PHARMACEUTICAL COMBINATION COMPRISING A BRAIN AMINOPEPTIDASE A INHIBITOR, A DIURETIC AND A BLOCKER OF THE SYSTEMIC RENIN-ANGIOTENSIN SYSTEM	QUANTUM GENOMICS
WO/2021/224356	NEW COMPOSITIONS AND METHODS OF TREATING COVID-19 DISEASE	4LIVING BIOTECH
WO/2021/144478	COMBINATION TREATMENT FOR FUMARATE-RELATED DISEASES	IMCYSE SA
WO/2021/224381	COMBINATION THERAPY FOR TREATING CANCER	ASTRAZENECA AB
WO/2021/224382	COMPOUNDS FOR THE TREATMENT OF COVID-19	DOMPE' FARMACEUTICI SPA
WO/2021/254687	PIGMENT SUSPENSION AND COSMETIC PRODUCT PREPARED USING THE PIGMENT SUSPENSION	HENKEL AG & CO. KGAA
WO/2021/224397	IMMUNOGENIC PEPTIDES WITH EXTENDED OXIDOREDUCTASE MOTIFS	IMCYSE SA
WO/2021/254688	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, AN ALKYL(POLY)GLYCOSIDE, A DYEING COMPOUND AND A POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/259543	METHOD FOR DYEING KERATINOUS MATERIAL, COMPRISING THE USE OF AN ORGANOSILICON COMPOUND, A DERIVATIVE OF ALKYLATED SILANOL, A COLORING COMPOUND AND A POST-TREATMENT AGENT	HENKEL AG & CO. KGAA
WO/2021/259544	PIGMENT SUSPENSION AND COSMETIC AGENT PREPARED USING THE PIGMENT SUSPENSION	HENKEL AG & CO. KGAA
WO/2021/224403	IMMUNOGENIC PEPTIDES WITH NEW OXIDOREDUCTASE MOTIFS	IMCYSE SA
WO/2021/224416	METHODS TO GENETICALLY MODIFY CELLS FOR DELIVERY OF THERAPEUTIC PROTEINS	CELLECTIS S.A.
WO/2021/224419	PHOTOOXIDATIVE INACTIVATION OF PATHOGENS INCLUDING SARS-CoV-2	SCHIKORA, Detlef
WO/2021/224429	EXOSOME-ANCHORING CORONAVIRUS FUSION PROTEINS AND VACCINES	BIOVELOCITA S.R.L
WO/2021/224432	IL-18 BINDING PROTEIN (IL-18BP) IN RESPIRATORY DISEASES	AB2 BIO SA
WO/2021/224439	CLICK OMVs	DE STAAT DER NEDERLANDEN, VERT. DOOR DE MINISTER VAN VWS, MINISTERIE VAN VOLKSGEZONDHEID, WELZIJN EN SPORT
WO/2021/224444	PROCESS FOR PRODUCING AN ORAL THIN FILM COMPRISING MICROPARTICLES	LTS LOHMANN THERAPIE-SYSTEME AG
WO/2021/224449	STEM CELLS FOR TREATMENT OF RESPIRATORY DISORDERS	XINTELA AB
WO/2021/224455	COMPOSITION TO BE USED FOR STRENGTHENING THE IMMUNE SYSTEM IN HUMAN AND ANIMAL TO ACQUIRE PAN-IMMUNITY	LEGACY HEALTHCARE (SWITZERLAND) SA
WO/2021/228714	ANTIVIRAL COMPOSITION COMPRISING EEYARESTATIN I	UNIVERSIDAD DE CASTILLA LA MANCHA
WO/2021/224463	COSMETIC COMPOSITION COMPRISING CELLODEXTRINS	PFEIFER & LANGEN GMBH & CO. KG
WO/2021/224467	TREATMENT OF PROSTATE CANCER WITH A COMBINATION OF ABIRATERONE ACETATE AND NIRAPARIB	JANSSEN PHARMACEUTICA NV
WO/2021/224469	TREATMENTS OF PROSTATE CANCER WITH COMBINATIONS OF ABIRATERONE ACETATE AND NIRAPARIB	JANSSEN PHARMACEUTICA NV
WO/2021/224471	PHARMACEUTICAL FORMULATIONS OF ABIRATERONE ACETATE AND NIRAPARIB	JANSSEN PHARMACEUTICA NV
WO/2021/224494	NEW TREATMENTS OF VIRAL INFECTIONS	KANCERA AB
WO/2021/224499	BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20	GENMAB A/S
WO/2021/228731	FELINE SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 VACCINE	INTERVET INTERNATIONAL B.V.
WO/2021/224503	PARAPOXVIRUS FOR CONDITIONING FOR AND TREATMENT OF CORONAVIRUS INFECTIONS	AICURIS GMBH & CO. KG
WO/2021/228746	A NOVEL ANTIBODY BINDING SPECIFICALLY TO HUMAN CEACAM1/3/5 AND USE THEREOF	LEUKOCOM GMBH
WO/2021/228750	COMPATIBLE SOLUTES FOR PREVENTING OR TREATING SARS-COV-2 INFECTIONS	BITOP AG
WO/2021/228758	ATR INHIBITORS FOR THE TREATMENT OF CANCER	ASTRAZENECA AB
WO/2021/228760	FORMULATIONS OF ANTI-IL-33 ANTIBODIES	MEDIMMUNE LIMITED
WO/2021/228762	USE OF TMPRSS2 INHIBITORS FOR THE TREATMENT OF LUNG VIRAL INFECTIONS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/228768	PREVENTION OF INFECTIOUS DISEASES BY MODULATING THE IMMUNE SYSTEM	VAKZINE PROJEKT MANAGEMENT GMBH
WO/2021/224505	MODULATION OF MIXED LINEAGE KINASE DOMAIN-LIKE PROTEIN SIGNALING	EBERHARD KARLS UNIVERSITÄT TüBINGEN
WO/2021/228783	METHODS FOR TREATING MULTIPLE MYELOMA	JANSSEN PHARMACEUTICA NV
WO/2021/228788	COMPOSITION COMPRISING METHYLFOLATE	ALFASIGMA S.P.A.
WO/2021/228800	SLOW RELEASE PLASMINOGEN ACTIVATOR FORMULATION FOR USE IN THE TREATMENT OF THROMBOTIC OR HAEMORRHAGIC DISEASE	OP2LYSIS
WO/2021/228805	METHODS AND COMPOSITIONS USING SERPIN PRODUCING BACTERIA	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/228816	ADMINISTRATION OF HOMOLOGOUS ADENOVIRAL VECTORS	JANSSEN VACCINES & PREVENTION B.V.
WO/2021/228817	EMID2 PROTEIN AS ANTI-CANCER TREATMENT	INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY - ICGEB
WO/2021/228824	COSMETIC COMPOSITION BASED ON BIOSOURCED ISODODECANE AND PREPARATION METHOD THEREOF	GLOBAL BIOENERGIES
WO/2021/228832	RED CELL EXTRACELLULAR VESICLES (RCEVS) CONTAINING CARGOES AND METHODS OF USE AND PRODUCTION THEREOF	ERYTECH PHARMA
WO/2021/228846	COMPOUND FOR PREVENTING OR TREATING A VIRAL INFECTION	INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
WO/2021/228849	USE OF DI- AND TRICARBOXYLIC FATTY ACIDS IN THE PREVENTION OF BIOFILM FORMATION	KATHOLIEKE UNIVERSITEIT LEUVEN
WO/2021/228852	SOLID SOLUTION MADE FROM GUM ARABIC AND AT LEAST ONE LIPOSOLUBLE ACTIVE SUBSTANCE	METABOLIC TUNING AG
WO/2021/233735	PHARMACEUTICAL PREPARATION FOR USE IN THE TREATMENT OF SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS)	CYTOPHARMA GMBH
WO/2021/228853	VACCINE AGAINST SARS-COV VIRUS	OSE IMMUNOTHERAPEUTICS
WO/2021/228863	USES AND FORMULATIONS OF CANNABINOIDS	ADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/228865	USES AND FORMULATIONS OF CANNABINOIDS	ADD ADVANCED DRUG DELIVERY TECHNOLOGIES LTD.
WO/2021/228866	AN ANTITHROMBIC MOLECULE HAVING APAC ACTIVITY FOR THE PREVENTION AND/OR TREAETMENT OF THROMBOCYTOPENIA	APLAGON OY
WO/2021/228867	METHODS FOR IMAGE-GUIDED RADIOTHERAPY	UNIVERSITE CLAUDE BERNARD LYON 1
WO/2021/228875	TREATMENT OF RESPIRATORY VIRAL INFECTIONS	KYON BIOTECH AG
WO/2021/239463	CROSSLINKABLE PREPOLYMERS FOR CHEMICALLY STABLE POLYMER GELS	LUMENDO AG
WO/2021/228917	PREVENTION OF VISIBLE PARTICLE FORMATION IN PARENTERAL PROTEIN SOLUTIONS	F. HOFFMANN-LA ROCHE AG
WO/2021/228921	INHALABLE LACTOSE CONTAINING COMPOSITION	MEGGLE GMBH & CO. KG
WO/2021/228937	UROGENITAL CLEANSING COMPOSITION	PEPTONIC MEDICAL AB
WO/2021/228942	PROTEASE FORMULATION FOR TREATMENT OF MICROBIAL INFECTIONS	ZYMIQ TECHNOLOGY AB
WO/2021/254697	METAMIZOLE DERIVATIVES FOR THE PREVENTION AND TREATMENT OF PULMONARY HYPERTENSION	CHARITé - UNIVERSITÄTSMEDIZIN BERLIN
WO/2021/228956	NEW METHOD TO TREAT CUTANEOUS T-CELL LYMPHOMAS AND TFH DERIVED LYMPHOMAS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/228983	A PHARMACEUTICAL COMPOSITION COMPRISING AN ARSENIC COMPOUND, AN INDUCTOR OF TYPE-1 IFN AND A PROTEIN KINASE INHIBITOR FOR TREATING CANCER	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/239471	CANCER TREATMENT STRATEGIES USING ARENAVIRUS VECTORS	HOOKIPA BIOTECH GMBH
WO/2021/229002	TREATMENT OF COMPLICATIONS CAUSED BY INFECTIONS OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS	JOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN
WO/2021/229013	PEPTIDIC SCAFFOLDS, PROCESSES FOR MANUFACTURING THE SAME, AND USES THEREOF AS SOLUBLE SUPPORTS	SYNHELIX
WO/2021/229014	COMPOSITION OF NANOPARTICLES AS CARRIER FOR HPV-DERIVED IMMUNOGENIC FRAGMENTS	LIFE SCIENCE INKUBATOR BETRIEBS GMBH & CO. KG
WO/2021/229015	COMPOSITION OF NANOPARTICLES	LIFE SCIENCE INKUBATOR BETRIEBS GMBH & CO. KG
WO/2021/229020	NANOPARTICLES AS CARRIER-SYSTEM FOR ADJUVANTS/ANTIGENS	LIFE SCIENCE INKUBATOR BETRIEBS GMBH & CO. KG
WO/2021/229035	UBIQUITIN-LIGASE INHIBITORS FOR THE TREATMENT OF CANCER	FUNDACIóN PROFESOR NOVOA SANTOS
WO/2021/244831	THERAPEUTIC SOLID DOSAGE FORMS	SMALL PHARMA LTD
WO/2021/239478	SUNSCREEN WITH A COMBINATION OF WAXES, CETYL PALMITATE AND HYDROGENATED RAPESEED OIL	BEIERSDORF AG
WO/2021/229065	NEW IMMUNOGENIC COMPOSITIONS AND USE THEREOF FOR PREPARING HEPATITIS C AND HEPATITIS B VACCINES	UNIVERSITE DE TOURS
WO/2021/229086	COMPOSITION FOR THE TREATMENT AND/OR PREVENTION OF MARINE MOLLUSC VIRAL INFECTION	IFREMER
WO/2021/233796	MCT FORMULATIONS FOR IMPROVING COGNITIVE FUNCTIONS	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/259554	BIODEGRADABLE ADHESIVE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/229100	BRADYKININ B2 RECEPTOR ANTAGONIST FOR TREATMENT OF SARS-COV2-INFECTION	HELMHOLTZ ZENTRUM MüNCHEN DEUTSCHES FORSCHUNGSZENTRUM FüR GESUNDHEIT UND UMWELT (GMBH)
WO/2021/229101	STEM CELLS FOR TREATING SKIN LESIONS	RIGSHOSPITALET
WO/2021/229102	MEANS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL AGGREGATION	VIB VZW
WO/2021/233834	SARS-COV-2 ANTIBODIES AND METHODS OF SELECTING AND USING THE SAME	ASTRAZENECA UK LIMITED
WO/2021/229104	ANTI-CD38 SINGLE-DOMAIN ANTIBODIES IN DISEASE MONITORING AND TREATMENT	UNIVERSITé DE LIèGE
WO/2021/233851	NEW MALONITRILE DERIVATIVES	F. HOFFMANN-LA ROCHE AG
WO/2021/233853	THE USE OF CHELATORS FOR THE PREVENTION OF VISIBLE PARTICLE FORMATION IN PARENTERAL PROTEIN SOLUTIONS	F. HOFFMANN-LA ROCHE AG
WO/2021/233874	ELAFIBRANOR FOR THE TREATMENT OF PRIMARY SCLEROSING CHOLANGITIS	GENFIT
WO/2021/233885	MIMOTOPE PEPTIDES OF THE SPIKE PROTEIN FROM THE SARS-COV-2 VIRUS	SYNTHETIC VACCINES LTD
WO/2021/233899	USE OF PSYCHOTROPIC DRUGS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/233901	PROBIOTIC BACTERIA FOR TREATING ALZHEIMER'S DISEASE	RRW B.V.
WO/2021/233902	PLANT COMPOUNDS FOR TREATING ALZHEIMER'S DISEASE	RRW B.V.
WO/2021/259557	COSMETIC PREPARATION COMPRISING ANTIPERSPIRANT INORGANIC SALTS, CARBOXYLIC ACIDS AND 1,3-PROPANEDIOL	BEIERSDORF AG
WO/2021/233923	IMPROVEMENT OF INSOLUBLE FIBRE FERMENTABILITY AND SHORT CHAIN FATTY ACID PRODUCTION BY BIFIDOBACTERIUM LONGUM	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/233924	METHODS FOR ENHANCING ADOPTIVE CELL TRANSFER IMMUNOTHERAPIES	HANSA BIOPHARMA AB
WO/2021/233927	ANTIBODY THAT BINDS SPECIFICALLY TO THE SARS COV 2 SPIKE PROTEIN, AND METHODS FOR ITS MANUFACTURE	IGNOVA GMBH
WO/2021/233944	PARA-AMINO-BENZYL LINKERS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN CONJUGATES	LES LABORATOIRES SERVIER
WO/2021/233948	METHOD TO TREAT A PATHOGEN LUNG INFECTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/233950	COMPOUNDS FOR USE IN THE REACTIVATION OF HIV IN LATENT HIV-INFECTED CELLS	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/233956	EZETIMIBE FOR TREATING ENVELOPED VIRUS INFECTIONS	MELETIOS THERAPEUTICS
WO/2021/233960	USE OF HUMAN MILK OLIGOSACCHARIDES IN NUTRITIONAL COMPOSITIONS FOR ENHANCING BONE DEVELOPMENT AND/OR BONE STRENGTH	SOCIéTé DES PRODUITS NESTLé S.A.
WO/2021/233962	METHODS FOR THE DIAGNOSIS AND TREATMENT OF CYTOKINE RELEASE SYNDROME	INSTITUT CURIE
WO/2021/233966	METHODS FOR THE TREATMENT OF CORONAVIRUS INFECTIONS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/233967	INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USES THEREOF	INTERVET INTERNATIONAL B.V.
WO/2021/233971	BBETA-15-42 FOR THE TREATMENT OF VIRAL ENDOTHELITIS	JOHANN WOLFGANG GOETHE-UNIVERSITÄT FRANKFURT AM MAIN
WO/2021/233973	COMPOSITIONS FOR REDUCING SALTY TASTE AND USES THEREOF	FIRMENICH SA
WO/2021/233988	COMPOSITION COMBINING JONZAC THERMAL SPRING WATER AND A CENTELLA ASIATICA EXTRACT AND THE REPAIRING/HEALING EFFECT THEREOF	LABORATOIRES LéA
WO/2021/233989	VIRAL VACCINE VECTOR FOR IMMUNIZATION AGAINST A BETACORONAVIRUS	HENNRICH, Alexandru Adrian
WO/2021/234005	A PERSONAL CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/234006	COMPOSITIONS AND METHODS FOR TREATING CANCER EXPRESSING CD90 AND CD326	MILTENYI BIOTEC B.V. & CO. KG
WO/2021/244852	THERAPEUTIC ANTIBODIES WITH NEUTRALIZING ACTIVITY AGAINST SARS-COV-2 GLYCOPROTEIN S	CORAT THERAPEUTICS GMBH
WO/2021/234007	PROPOFOL FOR DIAGNOSIS OF PRIMARY HEADACHE	TESA LABTEC GMBH
WO/2021/234008	ORAL FILM FOR SAFE ADMINISTRATION OF API	TESA LABTEC GMBH
WO/2021/234009	ANTI-AGING COSMETIC COMPOSITIONS COMPRISING NMN	NUVAMID SA
WO/2021/239544	OPHTHALMIC COMPOSITION BASED ON HYALURONIC ACID TO PROTECT FROM DAMAGES CAUSED BY ENVIRONMENTAL POLLUTION	COLOMBO, Stefano
WO/2021/234014	ANTI-ACNE COMPOSITIONS	L'OREAL
WO/2021/244854	USE OF SAA, RSAA, OR INHIBITORS OF SAA IN THE TREATMENT OF DYSREGULATED INFLAMMATION	LIKA ANTISEPSIS GBR
WO/2021/239546	USE OF A MINERAL BLEND AS COSMETIC AGENT FOR WET COSMETIC COMPOSITIONS	OMYA INTERNATIONAL AG
WO/2021/234031	A PARTICLE ENCAPSULATING HYDROPHILIC OR AMPHIPHILIC BIOLOGICAL COMPOUNDS	SPHERA ENCAPSULATION S.R.L.
WO/2021/259560	CO-GROUND ACTIVE(S) COMPRISING PRODUCT COMPRISING SURFACE-REACTED CALCIUM CARBONATE	OMYA INTERNATIONAL AG
WO/2021/234055	COMPOSITIONS AND METHODS FOR PROVIDING SKIN CARE BENEFITS	UNILEVER IP HOLDINGS B.V.
WO/2021/234057	PEPTIDE FOR USE IN THE PREVENTION AND/OR TREATMENT OF A DISEASE CAUSED BY A VIRUS AFFECTING THE RESPIRATORY TRACT	FUNDACIóN PARA EL FOMENTO DE LA INVESTIGACIóN SANITARIA Y BIOMéDICA DE LA COMUNITAT VALENCIANA (FISABIO)
WO/2021/234074	COMPOSITION COMPRISING DIFFERENT SPECIFIC COLLAGENS AND USES ON THE SKIN	MONDERNA HEALTH & WELLNESS
WO/2021/234084	MAXI-K POTASSIUM CHANNEL OPENERS FOR THE TREATMENT OF FRAGILE X ASSOCIATED DISORDERS	KAERUS BIOSCIENCE LIMITED
WO/2021/234094	CEFTRIAXONE COMPOSITIONS WITH MAGNESIUM COMPONENT	XELLIA PHARMACEUTICALS APS
WO/2021/234097	MEK-INHIBITORS FOR THE TREATMENT OR PREVENTION OF CORONAVIRUS INFECTIONS AND/OR COVID-19 CYTOKINE STORM	ATRIVA THERAPEUTICS GMBH
WO/2021/254721	AGENT FOR DYEING KERATINOUS FIBRES, CONTAINING PIGMENTS AND C<sb>2</sb>-C<sb>30</sb> ALKYL METHICONES	HENKEL AG & CO. KGAA
WO/2021/239578	EMULSIONS FOR CONTROLLED DRUG RELEASE	AVIGNON UNIVERSITE
WO/2021/234111	COMPOSITION COMPRISING SAFRANAL AND PROBIOTICS	ACTIV' INSIDE
WO/2021/234127	NUCLEOSIDE ANALOGUE TO INHIBIT THE MAIN PROTEASE OF SARS-CoV-2 VIRUS	INSTITUT DE RECHERCHE EN SEMIOCHIMIE ET ETHOLOGIE APPLIQUEE
WO/2021/234128	NUCLEOSIDE ANALOGUES TO INHIBIT THE MAIN PROTEASE OF A CORONAVIRUS	INSTITUT DE RECHERCHE EN SEMIOCHIMIE ET ETHOLOGIE APPLIQUEE
WO/2021/254723	A PERSONAL CARE COMPOSITION BASED ON TITANIUM OXIDE AND A CROSSPOLYMER OF ADIPIC ACID AND NEOPENTYL GLYCOL	UNILEVER IP HOLDINGS B.V.
WO/2021/234134	BARK-FREE, STABLE DOUBLE EMULSION	CAPSUM
WO/2021/234135	BARK-FREE, STABLE DISPERSION	CAPSUM
WO/2021/239622	BRANCHED AMINO-ACID-BASED POLYMERS FOR HAIR STRENGTHENING	BASF SE
WO/2021/234159	MORINGA PEREGRINA SEED EXTRACT RICH IN 2,5-DIFORMYLFURAN, PROCESS FOR OBTAINING SAME AND USE THEREOF IN COSMETIC COMPOSITIONS	AGENCE FRANCAISE POUR LE DEVELOPPEMENT D'AL ULA
WO/2021/234165	PROTEIN HYDROLYSATE OF <i>MORINGA PEREGRINA</i> SEED CAKE FOR ITS APPLICATION AS A MEDICAMENT, PROCESS FOR OBTAINING SAME AND PHARMACEUTICAL AND DERMATOLOGICAL COMPOSITIONS	AGENCE FRANCAISE POUR LE DEVELOPPEMENT D'AL ULA
WO/2021/234166	EXTRACT OF MORINGA PEREGRINA SEED CAKE, METHOD FOR OBTAINING SAME AND USE THEREOF IN COSMETIC OR NUTRICOSMETIC COMPOSITIONS	AGENCE FRANCAISE POUR LE DEVELOPPEMENT D'AL ULA
WO/2021/249751	COSMETIC PRODUCT WITH HIGH DEGREE OF EMPTYING OF THE PREPARATION FROM THE PACKAGING	BEIERSDORF AG
WO/2021/254729	AVERMECTINS FOR USE IN TREATING CORONAVIRIDAE INFECTION	HUVEPHARMA EOOD
WO/2021/239643	BENZYLAMINE DERIVATIVES AS DDRS INHIBITORS	CHIESI FARMACEUTICI S.P.A.
WO/2021/239662	PI3K GAMMA INHIBITOR PEPTIDE FOR TREATMENT OF FIBROPROLIFERATIVE VASCULAR DISEASES	KITHER BIOTECH S.R.L.
WO/2021/234178	TNFα IMMUNOCONJUGATE THERAPY FOR THE TREATMENT OF BRAIN TUMORS	PHILOGEN S.P.A
WO/2021/239666	THERAPEUTIC METHODS	DIACCURATE
WO/2021/239667	NEW THERAPY FOR THE TREATMENT OF TUMORS	UNIVERSITà DEGLI STUDI DI TRENTO
WO/2021/239687	TCDTA-DERIVED FE(III) COMPLEXES FOR USE IN MAGNET RESONANCE IMAGING WITH LIVER AND KIDNEY EXCRETION	CHARITé - UNIVERSITÄTSMEDIZIN BERLIN
WO/2021/249760	A COSMETIC COMPOSITION COMPRISING 6-METHYL-PICOLINAMIDE	UNILEVER IP HOLDINGS B.V.
WO/2021/239709	METHOD FOR PRODUCING A LIPOSOME DISPERSION	LEON-NANODRUGS GMBH
WO/2021/239720	COSMETIC COMPOSITION COMPRISING AT LEAST 30% BY WEIGHT OF BRANCHED ALKANE AND A COMBINATION OF PARTICULAR SILICONES	L'OREAL
WO/2021/239730	NANOPARTICLES, IONIZING RADIATION AND INNOVATIVE THERAPEUTIC COMBINATIONS THEREOF	NANOBIOTIX
WO/2021/234181	USE OF FAP INHIBITOR IN A METHOD OF DIAGNOSIS	UNIVERSITÄT HEIDELBERG
WO/2021/259580	HIGHLY VISCOUS COSMETIC NANOEMULSION	BEIERSDORF AG
WO/2021/239742	ENCAPSULATED COMPOSITION COMPRISING CORE-SHELL MICROCAPSULES AND PROCESS FOR ITS PREPARATION	GIVAUDAN SA
WO/2021/239786	EGFR TKIS FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER	ASTRAZENECA AB
WO/2021/244910	HYPERIMMUNE IGG AND/OR IGM COMPOSITIONS AND METHOD FOR PREPARING THEREOF AND METHOD FOR OBTAINING HYPERIMMUNE HUMAN PLASMA FROM A DONOR	GRIFOLS WORLDWIDE OPERATIONS LIMITED
WO/2021/239790	METHOD FOR THE TREATMENT OF VIRUS INFECTION WITH IVIG AND CONVALESCENT PLASMA	GRIFOLS WORLDWIDE OPERATIONS LIMITED
WO/2021/239796	METHOD FOR THE TREATMENT OF A VIRAL INFECTION WITH HUMAN ALPHA-1 ANTITRYPSIN	GRIFOLS WORLDWIDE OPERATIONS LIMITED
WO/2021/239798	SOLID SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (S-SNEDDS)	EVONIK OPERATIONS GMBH
WO/2021/239809	TREATMENT OF COVID-19 PATIENTS	ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS
WO/2021/239812	POLYPEPTIDE USEFUL IN ADOPTIVE CELL THERAPY	QUELL THERAPEUTICS LIMITED
WO/2021/239815	FIBROBLAST GROWTH FACTOR 21 (FGF21) GENE THERAPY FOR CENTRAL NERVOUS SYSTEM DISORDERS	UNIVERSITAT AUTòNOMA DE BARCELONA
WO/2021/239817	THERAPEUTIC COMBINATIONS COMPRISING AGONISTS OF FERROPTOSIS FOR TREATING PROLIFERATIVE DISORDERS	CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG-SPEYER-HAUS
WO/2021/254750	USE OF INDOLE COMPOUNDS FOR TREATING SIGNS OF SKIN AGING	UNILEVER IP HOLDINGS B.V.
WO/2021/254751	USE OF INDOLE COMPOUNDS FOR TREATING SIGNS OF SKIN AGING	UNILEVER IP HOLDINGS B.V.
WO/2021/254752	USE OF DIINDOLYLMETHANE COMPOUNDS FOR TREATING SIGNS OF SKIN AGING	UNILEVER IP HOLDINGS B.V.
WO/2021/254753	USE OF INDOLE COMPOUNDS FOR TREATING SIGNS OF SKIN AGING	UNILEVER IP HOLDINGS B.V.
WO/2021/254754	USE OF INDOLE COMPOUNDS FOR TREATING SIGNS OF SKIN AGING	UNILEVER IP HOLDINGS B.V.
WO/2021/239838	SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) POLYPEPTIDES AND USES THEREOF FOR VACCINE PURPOSES	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/239844	SGLT-2 INHIBITORS OR IL-1R ANTAGONISTS FOR REDUCTION OF HYPOGLYCAEMIA IN PREDIABETES	UNIVERSITÄTSSPITAL BASEL
WO/2021/239850	USE OF NMN TO REDUCE IMMUNODEPRESSION AND IMMUNOSENESCENCE	NUVAMID SA
WO/2021/239878	TREATMENT OF INFECTIONS	ACT THERAPEUTICS LTD
WO/2021/239880	NUCLEIC ACID BASED COMBINATION VACCINES	CUREVAC AG
WO/2021/239890	BIFIDOBACTERIA FOR PREVENTING, REDUCING OR TREATING SKIN AGING	DUPONT NUTRITION BIOSCIENCES APS
WO/2021/239892	MONO- AND BIS-NITROSYLATED PROPANEDIOLS FOR THERAPEUTIC USE	ATTGENO AB
WO/2021/239893	AMORPHOUS SOLID DISPERSION OF ACALABRUTINIB	BEND RESEARCH, INC.
WO/2021/239905	COMPOUNDS FOR THE PREVENTION, TREATMENT AND DIAGNOSIS OF THROMBI	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/239906	MONO- AND BIS-NITROSYLATED ALKYL POLYOLS FOR THERAPEUTIC USE	ATTGENO AB
WO/2021/239915	FOXO INHIBITORS FOR USE IN THE TREATMENT OF DISEASES CAUSED BY ABNORMAL PROCESSING OF TDP-43 AND/OR FUS PROTEINS	ADMINISTRACIóN GENERAL DE LA COMUNIDAD AUTóNOMA DE EUSKADI
WO/2021/239917	COMBINATION SOLID ORAL DOSAGE FORMS OF GONADOTROPIN-RELEASING HORMONE ANTAGONISTS	MYOVANT SCIENCES GMBH
WO/2021/244964	COMPOSITIONS AND METHODS FOR TREATING INFECTIONS AND NETOPATHY	BLACK CAT BIO LIMITED
WO/2021/239935	NEUTRALIZING ANTIBODIES AGAINST SARS-RELATED CORONAVIRUS	UNIVERSITÄT ZU KÖLN
WO/2021/239938	COSMETIC COMPOSITION WITH ENHANCED COLOR STABILITY FOR RETINOIC ACID PRECURSOR	UNILEVER IP HOLDINGS B.V.
WO/2021/239943	AZELASTINE AS ANTIVIRAL TREATMENT	CEBINA GMBH
WO/2021/239961	A COMPOSITION COMPRISING HP-HMG FOR USE IN TREATING INFERTILITY	FERRING B.V.
WO/2021/239965	CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR P95HER2 AND USES THEREOF	FUNDACIó PRIVADA INSTITUT D'INVESTIGACIó ONCOLòGICA DE VALL HEBRON
WO/2021/239968	CD40 BINDING PROTEIN	STRIKE PHARMA AB
WO/2021/239976	TRIARYLPYRIDINE COMPOUNDS AND USE THEREOF FOR TREATING CANCER	INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
WO/2021/244983	COOLING PERSONAL CARE COMPOSITION COMPRISING A POLYOL AND A POLYOXYEHTYLENE-POLYOXYPROPYLENE BLOCK COPOLYMER	UNILEVER IP HOLDINGS B.V.
WO/2021/239980	A PEPTIDE COCKTAIL	HUBRO THERAPEUTICS AS
WO/2021/239987	MULTISPECIFIC ANTIBODY	NUMAB THERAPEUTICS AG
WO/2021/239992	ANTIFUNGAL PRODRUGS	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
WO/2021/239996	IMMUNOMODULATORY COMPLEX AND USES THEREOF FOR THERAPY	COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
WO/2021/240004	PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION	ADOCIA
WO/2021/240006	PHARMACEUTICAL COMPOSITION IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION INCLUDING AT LEAST A RAPID-ACTING INSULIN ANALOG AND A GLUCAGON SUPPRESSOR WITH PRANDIAL ACTION	ADOCIA
WO/2021/244996	SYNTHETIC OLIGOSACCHARIDE VACCINES AGAINST STREPTOCOCCUS PNEUMONIAE WITH MICROPARTICLE ADJUVANT FORMULATIONS	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/245001	MICROEMULSION FOR THE TREATMENT OF DRY EYE SYNDROME	AZAD PHARMA AG
WO/2021/240013	VACCINE FORMULATIONS	IMNATE SARL
WO/2021/245018	A HIGH SPF SKIN CLEANSING COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/245032	NUTRACEUTIC COMPOSITION CONTAINING LIMONENE AND A DRY EXTRACT OF COCOA FIBRE FOR THE TREATMENT OF OBESITY	TARGETING GUT DISEASE SRL
WO/2021/254773	A TOPICAL ANTIMICROBIAL COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/245081	COMPOSITION COMPRISING AT LEAST THREE TYPES OF POLYSACCHARIDES, AT LEAST ONE PASTY COMPOUND OF PLANT ORIGIN AND WATER	L'OREAL
WO/2021/245082	A HIGH UV PROTECTION CLEANSING COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/245095	METHOD TO IMPROVE IMMUNOTHERAPIES	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/245107	MODULATORS OF PURINERGIC RECEPTORS AND RELATED IMMUNE CHECKPOINT FOR TREATING ACUTE RESPIRATORY DISTRESS SYNDROM	INSTITUT GUSTAVE ROUSSY
WO/2021/245111	RECOMBINANT RHABDOVIRUS ENCODING FOR A CD80 EXTRACELLULAR DOMAIN FC-FUSION PROTEIN	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/245140	DIAGNOSIS, PREVENTION AND TREATMENT OF CORONAVIRUS INFECTION	EMERGEX VACCINES HOLDING LIMITED
WO/2021/245159	NATURALLY DERIVED SURFACTANT SYSTEM AND COMPOSITION COMPRISING THE SAME	UNILEVER IP HOLDINGS B.V.
WO/2021/245160	NATURALLY DERIVED SURFACTANT SYSTEM WITH POLYGLYCEROL ESTERS AND COMPOSITIONS COMPRISING THE SAME	UNILEVER IP HOLDINGS B.V.
WO/2021/245172	STABILIZATION OF 1,2,4-TRIOXANE COMPOUNDS BY CHLOROGENIC ACIDS	ARTEMIFLOW GMBH
WO/2021/245179	LIQUID OPHTHALMIC COMPOSITION COMPRISING A SPIRULINA PLATENSIS FULL EXTRACT	WELIFEPHARMA SAGL
WO/2021/245184	HUMAN ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-CoV-2)	NEURIMMUNE AG
WO/2021/245199	GLP1R AGONIST NMDAR ANTAGONIST CONJUGATES	KØBENHAVNS UNIVERSITET
WO/2021/254790	AN ANTIMICROBIAL COMPOSITION FOR TACKLING MALODOUR	UNILEVER IP HOLDINGS B.V.
WO/2021/245204	STABLE FORMULATION OF EFINACONAZOLE	THE MATERIA COMPANY LIMITED
WO/2021/245206	TOPICAL SOLUTION OF EFINACONAZOLE WITH HIGH SUBUNGUAL PENETRATION	THE MATERIA COMPANY LIMITED
WO/2021/245207	USE OF E. COLI STRAINS EXPRESSING HIGH LEVEL OF ALPHA-GAL TO MODULATE IMMUNITY AND PROVIDE PROTECTION AGAINST INFECTIOUS DISEASES IN ANIMALS	INSTITUT NATIONAL DE RECHERCHE POUR L' AGRICULTURE, L' ALIMENTATION ET L' ENVIRONNEMENT
WO/2021/245223	HIGH DOSE AND LOW VOLUME BOTULINUM TOXIN TREATMENT OF FACIAL WRINKLES	MERZ PHARMA GMBH & CO. KGAA
WO/2021/245224	METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING OCULAR DISEASES	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/245233	IMPROVING ANTIBODY TOLERABILTY ASSOCIATED WITH INTRAVENOUS ADMINISTRATION	BIOINVENT INTERNATIONAL AB
WO/2021/249886	AQUEOUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS COMPRISING A FATTY ACID MONOESTER, A FATTY ACID SALT, A PULLULAN AND A POLYOL	L'OREAL
WO/2021/245237	MODEL FOR PREDICTION OF TOLERABILITY ISSUES IN CONNECTION WITH INTRAVENOUS ADMINISTRATION OF THERAPEUTIC ANTIBODIES	BIOINVENT INTERNATIONAL AB
WO/2021/245238	IMPROVING ANTIBODY TOLERABILITY ASSOCIATED WITH INTRAVENOUS ADMINISTRATION	BIOINVENT INTERNATIONAL AB
WO/2021/245249	TREATMENT OF CD30-POSITIVE CANCER	TESSA THERAPEUTICS LTD.
WO/2021/245254	USE OF MULTIFUNCTIONAL LIGANDS FOR TREATING THE RESPIRATORY DISTRESS AND CYTOKINE STORM SYNDROMES ASSOCIATED WITH CORONAVIRUS VIRAL INFECTIONS	H4 ORPHAN PHARMA
WO/2021/245260	THERAPEUTIC NANOCARRIER SYSTEM AND METHODS OF USE	GREGORIOU, Yiota
WO/2021/245263	PSMA TARGETING UREA-BASED LIGANDS FOR PROSTATE CANCER RADIOTHERAPY AND IMAGING	RIGSHOSPITALET
WO/2021/245280	USE OF A PHOSPHODIESTERASE 10 INHIBITOR FOR THE TREATMENT OF TOURETTE SYNDROME	NOEMA PHARMA AG
WO/2021/245281	METHODS OF TREATMENT OF TUBEROUS SCLEROSIS COMPLEX	NOEMA PHARMA AG
WO/2021/249921	NANOPARTICLES AS BIORESORBABLE AND RADIOPAQUE ACTIVE-INGREDIENT CARRIERS FOR THE THERAPY OF CANCERS OF THE PANCREAS	FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
WO/2021/254803	THICKENED ALKALYZATION COMPONENT FOR OXIDATIVE HAIR LIGHTENING PRODUCT	HENKEL AG & CO. KGAA
WO/2021/254804	AGENT FOR DYEING KERATINOUS MATERIAL, IN PARTICULAR HUMAN HAIR, CONTAINING AMINOSILICONES, PIGMENTS AND ALKYLPOLYGLYCOSIDES	HENKEL AG & CO. KGAA
WO/2021/249951	METHODS AND COMPOSITIONS FOR TREATMENT OF BRAIN VIRAL INFECTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/245291	TREM-1 INHIBITOR FOR USE IN THE TREATMENT OF A SUBJECT SUFFERING FROM A CORONAVIRUS INFECTION	INOTREM
WO/2021/249960	COMPOSITIONS COMPRISING NARCISSUS SPP. PLANT EXTRACT AND USE THEREOF	CLARIANT INTERNATIONAL LTD
WO/2021/249969	COMBINATION PRODUCT FOR THE TREATMENT OF CANCER DISEASES	MERCK PATENT GMBH
WO/2021/249974	FUCOIDAN-FUNCTIONALIZED POLYSACCHARIDE PARTICLES WITH T-PA FOR TARGETED THROMBOLYTIC THERAPY	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/249982	ANTIVIRAL COMPOUND	SIBYLLA BIOTECH S.R.L.
WO/2021/249990	ANTI-HBV ANTIBODIES AND METHODS OF USE	HOFFMANN-LA ROCHE INC.
WO/2021/249996	COMPOSITIONS COMPRISING 2X-121 AND METHODS FOR TREATING CORONAVIRUS INFECTION	ONCOLOGY VENTURE APS
WO/2021/250001	RETINOL-BASED COMPOSITION	L'OREAL
WO/2021/250008	RETINOL-BASED COMPOSITION	L'OREAL
WO/2021/250010	ATP-HYDROLYZING ENZYME USEFUL FOR TREATING DYSBIOSIS	MV BIOTHERAPEUTICS SA
WO/2021/254835	A TOPICAL ANTIMICROBIAL COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/250019	COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF URINARY TRACT INFECTIONS AND FOR USE IN COSMETICS	G. POHL-BOSKAMP GMBH & CO. KG
WO/2021/250025	SMALL-MOLECULE INHIBITORS OF THE FRS2-FGFR INTERACTION AND THEIR USE IN MEDICINE, IN THE PREVENTION AND TREATMENT OF CANCER	UNIVERSITÄT ZüRICH
WO/2021/250029	SMALL-MOLECULE INHIBITORS OF THE FRS2-FGFR INTERACTION	UNIVERSITÄT ZüRICH
WO/2021/250038	COMPOUND AND METHOD FOR THE TREATMENT OF CORONAVIRUSES	APTEEUS
WO/2021/250043	ASSAY FOR THE DETECTION OF THE CYS-LIKE PROTEASE (MPRO) OF SARS-COV-2	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
WO/2021/250061	PROTEIN OR PEPTIDE, ESPECIALLY FOR PROPHYLAXIS AND/OR TREATMENT OF AN INFECTION AND/OR INFECTIOUS DISEASE AND/OR A SEQUELA THEREOF	PROF. DR. MED. CHRISTOPH KARLE PRAXIS FüR DIAGNOSTIK HOHENLOHE
WO/2021/250081	NRF2 ACTIVATOR FOR USE IN TREATING DILATED CARDIOMYOPATHIES	GENETHON
WO/2021/250082	TREATMENT OF DILATED CARDIOMYOPATHIES	GENETHON
WO/2021/254851	PROCYANIDINS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION TRIGGERED BY COVID-19	HORPHAG RESEARCH IP (PYC) LTD.
WO/2021/250110	PROCESS FOR THE PREPARATION OF AN EXTRACT OF EPILOBIUM SPP. WITH HIGH OENOTHEIN B CONTENT	ISTITUTO FARMOCHIMICO FITOTERAPICO EPO S.R.L. ED IN FORMA ABBREVIATA: EPO S.R.L.
WO/2021/250130	PREVENTION, REDUCTION, OR AMELIORATION OF OLD PERSON SMELL	FIRMENICH SA
WO/2021/250178	NOVEL LACTOCOCCUS LACTIS STRAIN FOR THE PRODUCTION OF BIOACTIVE COMPOUNDS HAVING ANTIMICROBIAL EFFECT	INNOVACIóN EN GESTIóN Y CONSERVACIóN DE UNGULADOS S.L. (INGULADOS)
WO/2021/250193	METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/250194	SMALL MOLECULE MODULATORS OF IL-17	LEO PHARMA A/S
WO/2021/250196	NEW USE OF RABEXIMOD	CYXONE AB
WO/2021/250198	METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FGFR3-RELATED COGNITIVE DEFICIT	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/250199	RABEXIMOD IN THE TREATMENT OF RHEUMATOID ARTHRITIS	CYXONE AB
WO/2021/250200	CANCER THERAPY	PROKARIUM LIMITED
WO/2021/250204	ORAL FORMULATION COMPRISING A CRYSTALLINE FORM OF RABEXIMOD	CYXONE AB
WO/2021/259663	COSMETIC COMPOSITION FOR IMPROVING APPEARANCE OF SKIN	UNILEVER IP HOLDINGS B.V.
WO/2021/250205	IMPROVED ADHESIVE DRUG CARRIER	UMC UTRECHT HOLDING B.V.
WO/2021/250207	BROMELAIN PROTEASE, BROMELAIN, JACALIN-LIKE LECTIN, EXTRACT FROM THE STEM AND/OR THE FRUIT OF A PINEAPPLE PLANT, COMBINATION PREPARATION, BROMELAIN PROTEASE INHIBITOR, PROTEIN/PROTEASE MIX, AND GLYCATED BROMELAIN PROTEIN FORMED BY EXOGENOUS NON-ENZYMATIC GLYCATION, FOR USE IN THE TREATMENT OR PROPHYLAXIS OF VIRUS INFECTIONS CAUSED BY CORONAVIRUSES IN A HUMAN OR ANIMAL	URSAPHARM ARZNEIMITTEL GMBH
WO/2021/250212	PEPTIDES FOR TREATMENT OF SEPSIS AND CANCER	NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY (NTNU)
WO/2021/250219	A RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) VACCINE AGAINST CORONAVIRUS DISEASE	BAVARIAN NORDIC A/S
WO/2021/259668	USE OF A BORON CLUSTER AS TRANSMEMBRANE CARRIER	JACOBS UNIVERSITY BREMEN GGMBH
WO/2021/250231	THIENOPYRIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CORONAVIRUS INFECTION	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/259669	NANOPARTICULATE COMPOSITION	ALGIAX PHARMACEUTICALS GMBH
WO/2021/250236	COMPOSITION COMPRISING NANOPARTICLES, METHOD FOR THE PREPARATION OF A COMPOSITION COMPRISING NANOPARTICLES AND USES OF THE COMPOSITION FOR DENTAL TREATMENT	UNIVERSITAT INTERNACIONAL DE CATALUNYA, FUNDACIó PRIVADA
WO/2021/250239	A HYDROALCOHOLIC GEL AND A METHOD OF MANUFACTURING SAID GEL	VIRAMAL LIMITED
WO/2021/250240	DIAZA-18-CROWN-6 DERIVATIVE USEFUL FOR CHELATING RADIUM, CONJUGATE AND RADIUM CHELATE COMPRISING THE SAME, AND USES THEREOF	ORANO
WO/2021/259673	HYDROXYCHLOROQUINE LIQUID COMPOSITIONS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/254909	THICKENED ALKALYZATION COMPONENT FOR OXIDATIVE HAIR DYEING PRODUCT	HENKEL AG & CO. KGAA
WO/2021/250260	MODULATORS OF TIGHT JUNCTION PERMEABILITY	THE UNIVERSITY OF BATH
WO/2021/250263	LIPID NANOPARTICLES	ETHERNA IMMUNOTHERAPIES NV
WO/2021/254919	SELECTIVE TMPRSS2 INHIBITORS AND MEDICAL USE THEREOF	MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E.V.
WO/2021/254928	METHYLENE BLUE AND RIBOFLAVIN FOR PROPHYLACTIC AND THERAPEUTIC ANTI-VIRAL THERAPY	CERNY, Erich, H.
WO/2021/254937	FECAL MATTER FOR TREATMENT OF CACHEXIA	ACADEMISCH MEDISCH CENTRUM
WO/2021/250275	ANTIBODY FORMULATION DILUENT	ICHNOS SCIENCES SA
WO/2021/254978	COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS	MERCK PATENT GMBH
WO/2021/254982	COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS	MERCK PATENT GMBH
WO/2021/254998	BIODEGRADABLE UV ABSORBERS	BASF SE
WO/2021/255003	IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS	GIVAUDAN SA
WO/2021/255025	IMPROVEMENTS IN ULTRASOUND-MEDIATED THERAPY	BRACCO SUISSE SA
WO/2021/255046	HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/255047	HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/255048	HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/255049	HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/255050	HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/255051	HAIR CONDITIONING COMPOSITION FOR IMPROVED DEPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/255129	NOVEL USE OF A MODULATOR OF GLUCOSYLCERAMIDE DEGRADATION FOR VIRAL INFECTIONS	SPEDDING RESEARCH SOLUTIONS, SAS
WO/2021/259742	MODIFIED EXOTOXIN A PROTEINS	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/259743	KLEBSIELLA PNEUMONIAE O-ANTIGEN VACCINE	GLAXOSMITHKLINE BIOLOGICALS SA
WO/2021/255156	NOVEL DIPEPTIDE COMPOUNDS, METHOD FOR THE PRODUCTION THEREOF AND A NOVEL THERAPEUTIC USE OF DIPEPTIDE COMPOUNDS	UNIVERSITE PARIS-SACLAY
WO/2021/259748	COMPOSITIONS COMPRISING ZINC AND ANTIMICROBIAL AGENT	UNILEVER IP HOLDINGS B.V.
WO/2021/255159	FORMULATION COMPRISING DAPRODUSTAT	GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
WO/2021/255160	METHOD FOR PRODUCING PERSONALIZED COSMETICS	BASF SE
WO/2021/255172	MARC1 INHIBITORS FOR TREATMENT OF LIPID METABOLISM DISORDERS	CLEMENT, Bernd
WO/2021/255177	METHOD FOR PRODUCING A PERSONALIZED COSMETIC PREPARATION	BASF SE
WO/2021/255179	PLASMA-TREATED HYDROGEL COMPOSITIONS AND USES THEREOF	UNIVERSITAT POLITèCNICA DE CATALUNYA
WO/2021/255182	TREATMENT AND PREVENTION OF DISEASE CAUSED BY TYPE IV COLLAGEN DYSFUNCTION	SINGAPORE HEALTH SERVICES PTE. LTD.
WO/2021/255194	COMPOSITION COMPRISING A SHORT-CHAIN FATTY ACID SALT AND AT LEAST ONE LONG-CHAIN FATTY ACID	L'OREAL
WO/2021/255200	GELLED COMPOSITION COMPRISING A SHORT-CHAIN FATTY ACID SALT	L'OREAL
WO/2021/255204	NEW STRATEGY FOR TREATING PANCREATIC CANCER	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/255217	AMATOXIN AND AMATOXIN CONJUGATES FOR USE IN INHIBITION OF RNA VIRUS REPLICATION	HEIDELBERG PHARMA RESEARCH GMBH
WO/2021/255218	A PHARMACEUTICAL COMBINATION COMPRISING AN ANTI-VIRAL PROTONOPHORE AND A SERINE PROTEASE INHIBITOR	CHARITé - UNIVERSITÄTSMEDIZIN BERLIN
WO/2021/255219	SWINE INFLUENZA A VIRUS VACCINE COMPRISING A NUCLEIC ACID CONSTRUCT HAVING A SPECIFIC ORDER OF GENES	INTERVET INTERNATIONAL B.V.
WO/2021/255222	SWINE INFLUENZA A VIRUS VACCINE COMPRISING TWO DISTINCT RNA REPLICON PARTICLES	INTERVET INTERNATIONAL B.V.
WO/2021/259772	PREPARATIONS CONTAINING BERRY EXTRACTS FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF VIRAL INFECTIONS CAUSED BY CORONAVIRIDAE	EVONIK OPERATIONS GMBH
WO/2021/255226	ANTIVIRAL USE OF CALIXARENES	CEBINA GMBH
WO/2021/259783	POLYMER-CARGO-COMPLEXES COMPRISING CROSS-LINKED COPOLYMERS AND CARGO MOLECULES	HELMHOLTZ-ZENTRUM FüR INFEKTIONSFORSCHUNG GMBH
WO/2021/255239	OXOPIPERAZINE DERIVATIVES FOR THE TREATMENT OF CANCER	INTHERA BIOSCIENCE AG
WO/2021/255245	GENE THERAPY EXPRESSION SYSTEM ALLOWING AN ADEQUATE EXPRESSION IN THE MUSCLES AND IN THE HEART OF SGCG	GENETHON
WO/2021/255246	ACALABRUTINIB MALEATE DOSAGE FORMS	ACERTA PHARMA B.V.
WO/2021/255251	PULMONARY FORMULATION COMPRISING CANNABINOIDS	CANNOVEX BV
WO/2021/255252	FORMULATION COMPRISING CANNABINOIDS	CANNOVEX BV
WO/2021/255255	COMPOSITION COMPRISING A POLYOL, A POLYGLYCEROL ESTER, A HYALURONIC ACID SALT AND A SPECIFIC HYDROPHILIC POLYMER	L'OREAL
WO/2021/255260	COMPOSITION COMPRISING A POLYOL AND AT LEAST ONE POLYGLYCERYL ESTER	L'OREAL
WO/2021/255264	BIODEGRADABLE COMPOSITIONS AND IMPLANTS	RE-VANA THERAPEUTICS LTD
WO/2021/255270	SELF-AMPLIFYING SARS-COV-2 RNA VACCINE	ZIPHIUS VACCINES
WO/2021/259809	PROCESS FOR DYEING KERATIN FIBERS USING A DIRECT DYE AND A SACCHARINATE SALT AND COMPOSITION COMPRISING THEM	L'OREAL
WO/2021/259810	COMPOSITION FOR SIMULTANEOUS BLEACHING AND DYEING OF KERATIN FIBERS, COMPRISING A PARTICULAR HETEROCYCLIC SALT, AND PROCESS USING THIS COMPOSITION	L'OREAL
WO/2021/255282	CONJUGATED AND LABELLED APELIN, PREPARATION AND USES THEREOF	UNIVERSITE D'AIX MARSEILLE
WO/2021/255295	SWELLABLE GELATIN COMPOSITIONS	UNIVERSITEIT GENT
WO/2021/259866	DIMETHYL SULFONE FOR TREATMENT OF CHRONICALLY HEAT STRESSED POULTRY	EVONIK OPERATIONS GMBH
WO/2021/259869	OXINE-CONTAINING CELL RADIOLABELLING AGENTS	KING'S COLLEGE LONDON
WO/2021/259925	CONJUGATE OF SAPONIN AND SINGLE-DOMAIN ANTIBODY, PHARMACEUTICAL COMPOSITION COMPRISING SAID CONJUGATE, THERAPEUTIC USE THEREOF	SAPREME TECHNOLOGIES B.V.
WO/2021/259927	ANTI-CD2 ANTIBODIES	ZELARION MALTA LIMITED
WO/2021/259928	COMBINATION COMPRISING AN ADC OR AN AOC COMPRISING A VHH, AND A SAPONIN OR A LIGAND-SAPONIN CONJUGATE	SAPREME TECHNOLOGIES B.V.
WO/2021/259943	HAIR CARE COMPOSITION	UNILEVER IP HOLDINGS B.V.
WO/2021/259944	CONJUGATE OF A SINGLE DOMAIN ANTIBODY, A SAPONIN AND AN EFFECTOR MOLECULE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, THERAPEUTIC USE OF SAID PHARMACEUTICAL COMPOSITION	SAPREME TECHNOLOGIES B.V.
WO/2021/259962	COMPOSITIONS AND KITS OF PARTS COMPRISING N,N-DIMETHYLTRYPTAMINE AND HARMINE AND THEIR USE IN THERAPY	UNIVERSITY OF ZüRICH
WO/2021/259963	IMMUNIZATION AGAINST WNT4 FOR TREATMENT AND PROPHYLAXIS OF BREAST CANCER	PANDORA ENDOCRINE INNOVATION B.V.
WO/2021/259972	ANTICANCER COMBINATION THERAPY COMPRISING A SOS1 INHIBITOR AND A KRAS G12C INHIBITOR	BOEHRINGER INGELHEIM INTERNATIONAL GMBH
WO/2021/259973	COMPOSITION COMPRISING A PARTICULAR SILICONE EMULSION, A PARTICULAR (METH)ACRYLAMIDE POLYMER, SURFACTANTS AND A CATIONIC POLYSACCHARIDE	L'OREAL
WO/2021/259974	COMPOSITION COMPRISING A POLYMER COMPRISING AT LEAST ONE CATIONIC (METH)ACRYLAMIDE UNIT, A PARTICULAR SILICONE AND A CHEMICAL OXIDIZING AGENT AND/OR AN OXIDATION DYE	L'OREAL
WO/2021/260048	COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE COPOLYMER COMPRISING AT LEAST TWO DIFFERENT POLYMER UNITS BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN IN A FATTY MEDIUM	L'OREAL
WO/2021/260054	SAPONIN DERIVATIVES FOR USE IN MEDICINE	SAPREME TECHNOLOGIES B.V.
WO/2021/260061	SAPONIN DERIVATIVES FOR USE IN MEDICINE	SAPREME TECHNOLOGIES B.V.
WO/2021/260062	PROCESS FOR TREATING KERATIN FIBRES, COMPRISING THE APPLICATION OF A MAKEUP-REMOVING COMPOSITION, THE KERATIN FIBRES HAVING BEEN DYED BEFOREHAND	L'OREAL
WO/2021/260065	MVA-BASED VACCINE AGAINST COVID-19 EXPRESSING SARS-COV-2 ANTIGENS	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS (CSIC)
WO/2021/260068	VASOPRESSIN-2 RECEPTOR ANTAGONIST PEPTIDES AND USES THEREOF	COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES
WO/2021/260078	COSMETIC COMPOSITION COMPRISING A POLYHYDROXYALKANOATE COPOLYMER BEARING A(N) (UN)SATURATED HYDROCARBON-BASED CHAIN AND A SURFACTANT	L'OREAL
WO/2021/260079	COSMETIC COMPOSITION COMPRISING A GRAFTED POLYHYDROXYALKANOATE COPOLYMER IN A FATTY MEDIUM	L'OREAL
WO/2021/260093	SOFT GELATIN CAPSULES	ITF RESEARCH PHARMA, S.L.U
WO/2021/260109	A COMBINATION OF A CBP/p300 BROMODOMAIN INHIBITOR AND AN EGFR INHIBITOR FOR USE IN TREATING EGFR-MUTANT NSCLC	TOLREMO THERAPEUTICS AG
WO/2021/260110	HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF FIBROTIC DISEASE	TOLREMO THERAPEUTICS AG
WO/2021/260111	COMBINATION OF A CBP/P300 BROMODOMAIN INHIBITOR AND A KRAS INHIBITOR FOR THE TREATMENT OF CANCER	TOLREMO THERAPEUTICS AG
WO/2021/260120	ARIMOCLOMOL FOR TREATING GAUCHER DISEASE	ORPHAZYME A/S
WO/2021/260129	HUMANIZED ANTIGEN BINDING UNITS FOR TARGETING OSTEOSARCOMA CELLS	OSLO UNIVERSITETSSYKEHUS HF
WO/2021/260131	VIRUS-LIKE PARTICLES OF CMV MODIFIED BY FUSION	SAIBA AG
WO/2021/260139	METHODS OF TREATMENT AND DIAGNOSTIC OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH INTENSE STRESS	INSERM (INSTITUT NATIONAL DE LA SANTé ET DE LA RECHERCHE MéDICALE)
WO/2021/260141	COMPOSITION	INEOS SERVICES BELGIUM SA
WO/2021/260145	METHOD FOR INCORPORATING ORGANIC COMPOUNDS IN SOLUTION WITHIN A HYDROGEL	LABORATOIRES VIVACY
WO/2021/260152	INHIBITORS OF ACID SPHINGOMYELINASE FOR PREVENTING AND TREATING THE COVID-19 DISEASE	ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS
WO/2021/260164	THROMBIN C-TERMINAL PEPTIDES TO TREAT CORONAVIRAL INFECTIONS	IN2CURE AB
WO/2021/260168	USE OF COMPOUNDS AS SELF-TANNING SUBSTANCES AND TANNING COMPOSITIONS THEREOF	CHEMCOM S.A.
WO/2021/260176	SYNTHETIC EPITOPES OF BETACORONAVIRUSES	VIROMETIX AG
WO/2021/260186	ENGINEERED T CELLS CONDITIONALLY EXPRESSING A RECOMBINANT RECEPTOR, RELATED POLYNUCLEOTIDES AND METHODS	JUNO THERAPEUTICS GMBH
WO/2021/260193	PREVENTION OF AXONAL DAMAGE USING ANTIBODY BINDING TO AMYLOID BETA 1-42	MEDIMMUNE LIMITED
WO/2021/260197	ENHANCED OLIGONUCLEOTIDES FOR MODULATING FUBP1 EXPRESSION	F. HOFFMANN-LA ROCHE AG
WO/2021/260198	AGARICUS BLAZEI FERMENTED GRAINS AGAINST LAWSONIA INTRACELLULARIS INFECTION	NUTRECO IP ASSETS B.V.
WO/2021/260202	METHODS AND PREBIOTIC COMPOUNDS FOR IMPROVING ORAL HYGIENE AND RELATED ORAL CARE COMPOSITIONS	S&C CONSULTANCY
WO/2021/260208	SULFATED PEPTIDES FOR CHEMOKINE RECEPTOR ANTIBODY GENERATION	BAYER AKTIENGESELLSCHAFT
WO/2021/260209	CCR8 ANTIBODIES AND USES THEREOF	BAYER AKTIENGESELLSCHAFT
WO/2021/260210	ANTI CCR8 ANTIBODY THERAPY: BIOMARKERS & COMBINATION THERAPIES	BAYER AKTIENGESELLSCHAFT
WO/2021/260211	TARGETED RELEASE RIFAXIMIN COMPOSITIONS	BAUSCH HEALTH IRELAND LIMITED
WO/2021/105524	PHARMACEUTICAL COMPOSITION OF IBUPROFEN SALT WITH LYSINE IN THE FORM OF AN ORAL SOLUTION	MMC INTERNATIONAL HEALTH HOLDING, S.L.
WO/2021/219903	CANNABINOIDS FOR USE IN SUPRESSING CANCER STEM CELLS	EMERALD HEALTH BIOTECHNOLOGY ESPAÑA S.L.
WO/2021/250289	PROBIOTIC FOR THE TREATMENT OF INFERTILITY AND RECURRENT PREGNANCY LOSS	BIOSEARCH, S.A.
WO/2021/019116	PHARMACEUTICAL COMPOSITION FOR USE IN THE PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF L-DOPA-INDUCED DYSKINESIA	UNIVERSIDADE DE SANTIAGO DE COMPOSTELA
WO/2021/023903	HYPOLEPTINEMIC COMPOSITION AND USE THEREOF	UNIVERSITAT ROVIRA I VIRGILI
WO/2021/023908	FOOD PRODUCT DERIVED FROM THE OLIVE PLANT, PRODUCTION METHOD AND ASSOCIATED USES	ROQUE INICIATIVAS SL
WO/2021/044073	RECOMBINANT NANNOCHLOROPSIS GADITANA PROTEIN	UNIVERSIDAD DE CáDIZ
WO/2021/058847	COMBINED USE OF BIOTIN AND THIAMINE IN THE TREATMENT OF HUNTINGTON'S DISEASE	CONSEJO SUPERIOR DE INVESTIGACIONES CIENTíFICAS (CSIC)
WO/2021/099662	THERANOSTIC SYSTEM FOR DIRECTED DIFFUSION OF THERAPEUTIC AND IMAGING AGENTS TO CANCER CELLS	UNIVERSITAT POLITèCNICA DE VALèNCIA
WO/2021/099665	PLACENTAL DECIDUA PARIETALIS STEM CELLS FOR USE IN CHRONIC STRESS URINARY INCONTINENCE	FUNDACIóN PARA LA INVESTIGACIóN BIOMéDICA DEL HOSPITAL 12 DE OCTUBRE
WO/2021/136862	LIQUID GALENIC COMPOSITION FOR ORAL USE COMPRISING MELATONIN AND A ZINC SALT AND CORRESPONDING METHOD AND USE	LABORATORIOS VIÑAS S.A.
WO/2021/152192	LOW AND VERY LOW MOLECULAR WEIGHT HEPARINS FOR THE TREATMENT OF DEEP VEIN THROMBOSIS	LABORATORIOS FARMACéUTICOS ROVI, S.A.
WO/2021/165558	BREAKABLE GALENIC CAPSULE	FINGERCLIK, S.L.
WO/2021/198545	USE OF BREASTMILK EXOSOMES AS RADIOISOTOPE VEHICLE FOR THE DIAGNOSIS AND TREATMENT OF NEOPLASMS	INSTITUTO DE SALUD CARLOS III (ISCIII)
WO/2021/205049	COMPOUNDS FOR THE PROPHYLAXIS AND/OR TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME	SERVICIO ANDALUZ DE SALUD